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Coronary artery disease (CAD), or narrowing of the coronary arteries due to atherosclero-
sis, remains one of the leading causes of morbidity and mortality worldwide. However, a 
substantial number of patients that present with an acute coronary event due to rupture 
or erosion of an atherosclerotic plaque do not experience any prior symptoms. This 
observation emphasizes the need to improve early detection of atherosclerosis. Tradition-
ally, imaging of the coronary arteries has focused on the assessment of luminal dimen-
sions and the presence of severe stenosis by means of invasive coronary angiography. 
However, invasive coronary angiography can only assess the degree of stenosis and is less 
suited to evaluate the presence of atherosclerosis, including the presence of (potentially 
high-risk) plaques. As a result, there is an emerging need for imaging modalities that 
can identify atherosclerotic plaques with high-risk features indicating increased vulner-
ability. In this regard, particularly non-invasive techniques may be valuable as they may 
identify high-risk patients at a relatively early stage and may provide the opportunity for 
novel treatment strategies. Additionally, non-invasive imaging techniques may be used to 
monitor progression and/or regression of coronary atherosclerosis and thus possibly to 
evaluate the effectiveness of anti-atherosclerotic therapies at a larger scale. Accordingly, 
the present chapter will focus on invasive and non-invasive imaging modalities for the 
evaluation of atherosclerosis and detection of vulnerable lesions in the coronary arteries.
CHARACTERISTICS OF THE POTENTIALLY “VULNERABLE PLAQUE”
Due to the lack of prospective data and natural history studies, most details concerning 
the potentially vulnerable plaque have been derived from retrospective post-mortem 
studies.1-3 It has been established that the majority of acute coronary events (>70%) are 
caused by plaque rupture followed by thrombus formation.3 The most common substrate 
for superimposed thrombus formation is presumed to be the thin capped fi broatheroma; 
a plaque with a large necrotic core and thin fi brous cap (<65 mm thick) infi ltrated by 
macrophages and lymphocytes (Figure 1).4 The thin fi brous cap contains a decreased 
smooth muscle content which in certain circumstances can rupture and cause the throm-
bogenic parts of the plaque to be exposed into the lumen. This subsequently leads to the 
activation of the clotting cascade and the formation of a thrombus which can compromise 
the lumen resulting in an acute coronary syndrome (ACS). In the remaining ~30% of acute 
coronary events, thrombosis may be due to other causes than plaque rupture, including 
plaque erosion, intraplaque hemorrhage and calcifi ed nodules.3 The various atheroscle-
rotic lesions and their association with thrombus are described in Table 1. 
Additional characteristics of plaques prone to rupture include large plaque volume, 
positive remodeling, presence of microcalcifi cations and proximal location of the lesion. 
It has still not been fully elucidated which trigger actually causes the plaque to rupture, 
















by studies assessing macrophage infi ltration, in particular the fi brous cap is locally heavily 
infl amed (Figure 1).5 Infl ammation is often a result from endothelial dysfunction. Initially, 
endothelial dysfunction results from a disturbance in blood fl ow (fl ow reversal or oscillat-
ing shear stress) at bifurcations or tortuousness of vessels.6 However, not only blood fl ow 
disturbances but also cardiovascular risk factors such as hypercholesterolemia, smoking 
and diabetes have been suggested to induce endothelial dysfunction.7 8 Due to endo-
thelial cell activation, increased expression of adhesion molecules (e.g. selectins, VCAMs 
(vascular cell adhesion molecules) and ICAMs (intercellular adhesion molecules) promote 
the infi ltration and homing of monocytes. Consequently, the monocytes migrate into the 
plaque and convert into macrophages, contributing to the process of atherogenesis.7
At present, there is no widely accepted diagnostic technique for the identifi cation of 
vulnerable plaques. However, several invasive and non-invasive imaging modalities are 
currently under development that may allow to some extent detection of plaques prone 
to rupture.
Figure 1. Histological specimen 
of infl amed thin capped 
fi broatheroma with trichrome 
stain, rendering lipid colorless, 
collagen blue and erythrocytes 
red. (A) Atherosclerotic 
coronary artery containing 
a large lipid core and thin 
fi brous cap, with post-mortem 
injected contrast in lumen. 
(B) Detail of the fi brous cap 
demonstrating that the cap is 
heavily infl amed. The fi brous cap 
consists of many macrophages 
and within the necrotic core 
extra-vasated erythrocytes can 
be seen indicating a possible 
plaque rupture. Reprinted with 








INVASIVE IMAGING OF ATHEROSCLEROTIC PLAQUES
Invasive coronary angiography
Invasive coronary angiography is currently the gold standard for the diagnosis of CAD 
and provides an accurate and detailed overview of the anatomy of the coronary artery 
tree, including precise quantifi cation of the degree of stenosis. Accordingly, the technique 
is extensively used to guide further treatment strategies, such as coronary angioplasty or 
bypass surgery. 
However, evaluation of percentage diameter stenosis has limited value in predicting 
future cardiac events. Indeed, as demonstrated during the follow-up of patients admit-
ted for acute myocardial infarction, almost two-thirds of plaques prone to rupture were 
located in non-fl ow limiting atherosclerotic lesions and only a minority was located in 
severely obstructed lesions.9 10 Although the likelihood of occlusion for an individual 
Table 1. Morphological description of atherosclerotic lesions. Table modifi ed from Virmani et al.3 
SMC, smooth muscle cell; TCFA, thin capped fi broatheroma. 
Lesion name Lesion description Thrombus
Non-atherosclerotic intimal lesions
Intimal thickening Normal accumulation of SMCs in the intima 
without lipid or macrophage foam cells.
Absent
Intimal xanthoma Subendothelial accumulation of foam cells in 
intima without necrotic core or fi brous cap.
Absent
Progressive atherosclerotic lesions
Pathologic intimal thickening SMCs in proteoglycan-rich matrix with areas 
of extracellular lipid accumulation without 
necrosis
Absent
With erosion Luminal thrombosis, plaque same as above Thrombus most often mural 
and infrequently occlusive
Fibrous cap atheroma Well-formed necrotic core with overlying 
fi brous cap
Absent
With erosion Luminal thrombosis; plaque same as above, 
no communication of thrombus with necrotic 
core
Thrombus most often 
mural and infrequently 
occlusive
TCFA Thin fi brous cap infi ltrated with macrophages 
and lymphocytes, rare SMCs, and an 
underlying necrotic core
Absent, with intraplaque 
hemorrhage/fi brin
With rupture Fibroatheroma with cap disruption; luminal 
thrombus communicates with underlying 
necrotic core
Thrombus usually occlusive
Calcifi ed nodule Eruptive nodular calcifi cation with underlying 
fi brocalcifi c plaque
Thrombus usually non-
occlusive
Fibrocalcifi c plaque Collagen-rich usually with signifi cant 
stenosis; large areas of calcifi cation with few 

















lesion is directly related to the severity of stenosis, non-obstructive lesions are far more 
common and thus may frequently cause coronary occlusion due to their greater number 
(Figure 2). Accordingly, evaluation of the percentage diameter stenosis by means of inva-
sive coronary angiography does not allow differentiation between stable and unstable 
plaques.
Notably, novel promising angiographic acquisition approaches have been developed 
recently. One of these acquisition methods is rotational 3-dimensional coronary angio-
graphy, a new imaging technique in which the gantry is mechanically rotated around the 
patient providing a multitude of x-ray projections during a single contrast injection.11 
Using this technique, motion information of the coronary arteries can be extracted includ-
ing vessel displacement and pulsation.12 Furthermore, reconstruction of 3-dimensional 
images from 2-dimensional projections using specially developed dedicated software 
may further enhance angiographic assessment of coronary arteries (Figure 3). However, 
whether this novel technique will allow more accurate evaluation of atherosclerotic 
plaques remains to be determined more precisely.13 Overall, it seems evident that invasive 
coronary angiography is an excellent modality for detecting obstructive coronary artery 
disease, however, detailed imaging of atherosclerosis such as determining the presence of 
vulnerable plaque characteristics, remodeling and infl ammation, is still not feasible using 
this technique. Therefore other, more insightful modalities are needed for this purpose.
Figure 2. Bar graphs representing stenosis severity and related risk of myocardial infarction (MI) 
as assessed by repeated angiographic examination. As can be observed from the fi gure, lesions 
that are non-signifi cant (< 50% stenosis) on prior angiography are frequently the underlying cause 
of MI. Moreover, non-signifi cant lesions outnumber the more severely obstructive lesions and 
therefore account for the majority of MI. The bar graphs are constructed from data published by 









With respect to imaging of atherosclerosis, substantial progress has been achieved with 
the development of intravascular ultrasound (IVUS). IVUS is a minimally invasive imaging 
modality which uses miniaturized crystals incorporated at the catheter tip to provide real-
time, high-resolution, cross-sectional images of the arterial wall and lumen. Axial resolu-
tion is approximately 150 μm and the lateral resolution 300 μm. As a result, the technique 
provides high-resolution images of the atherosclerotic process in the arterial wall. 
Importantly, the technique has been extensively validated against histological autopsy 
specimens of human coronary arteries.14-17 Both lumen and vessel dimensions, such as 
plaque and vessel area, plaque distribution, lesion length and remodeling index, can be 
accurately determined in vivo. In addition, semi-quantitative tissue characterization can 
be achieved based on plaque echogenicity. In conventional grayscale ultrasound images, 
calcium highly refl ects ultrasound which appears as a bright and homogenous signal, 
resulting in acoustic shadowing.15 18 In addition, the severity of calcifi cations can be quan-
tifi ed by measuring the angle or arc of calcium. Hypo-echoic or low refl ectance in IVUS 
images are usually due to lipid-laden lesions (also referred to as “soft” or “sonolucent” 
plaques). An example is provided in Figure 4. Grayscale IVUS features of potentially vul-
nerable plaques have been evaluated prospectively by Yamagishi et al.19 The investigators 
Figure 3. (A) Illustration of 
three-dimensional coronary 
modeling based on two 
angiograms acquired in two 
different projection geometries.
(B) Modifi ed American Heart 
Association (AHA) classifi cation 
of coronary segments. Reprinted 

















evaluated 114 coronary plaques without luminal obstruction and assessed which plaques 
during a follow-up period of 21-months were related to an acute coronary event. Interest-
ingly, it was reported that large, eccentric, positive remodeled plaques with an echolucent 
zone were at increased risk of instability (Figure 5). In addition, several retrospective stud-
ies confi rmed that IVUS was able to identify plaques at higher risk of rupture (large echo-
lucent area, thin fi brous cap).20-22 Moreover, studies examining the differences between 
ruptured plaques and non-ruptured plaques in the same coronary artery demonstrated 
that the IVUS-derived lumen eccentricity index of ruptured plaques was greater.23
In addition, IVUS has been increasingly used as the gold standard in trials evaluating 
progression or regression of plaque in the coronary arteries. Indeed, unlike angiography, 
accurate quantifi cation of plaque volume and area is provided by IVUS. Interestingly, Von 
Birgelen and co-workers performed IVUS examination of the left main coronary artery in 
56 patients during initial angiography and repeated imaging after 18 months.24 Adverse 
cardiovascular events occurred in 18 patients during follow-up; in patients with events, 
annual plaque progression was signifi cantly greater than in the remaining asymptomatic 
patients. Hence, it seems feasible that IVUS-measured progression of coronary plaque 
may serve as a marker for future cardiovascular events.
Nevertheless, the main limitation of grayscale IVUS remains its inability to accurately 
differentiate plaque composition. In particular, areas with low echo refl ectance such 
as fi brous tissue, fi bro-fatty tissue and thrombus remain hard to distinguish.14 18 More 
 
 Figure 4. Coronary angiogram (A) of the left anterior descending coronary artery and 
corresponding intravascular ultrasound (IVUS) images (B and C) of a 55 year old patient presenting 
with an acute coronary syndrome. In panel B an IVUS frame is provided showing a large plaque 
area with an echolucent zone (arrowhead) and luminal obstruction, possibly suggesting the 









recently, integrated backscatter IVUS (IB-IVUS) systems have been developed to overcome 
this problem. Using this technique, a 2-dimensional color-coded map is constructed 
which refl ects the tissue characteristics of the coronary arterial wall. In a prospective study 
by Sano et al., tissue characteristics of vulnerable plaques in patients prior to presen-
tation with ACS were evaluated using IB-IVUS.25 The authors demonstrated that tissue 
characteristics of vulnerable plaques before causing an ACS were different from those of 
plaques related to stable angina. However, a low positive predictive value of only 42% was 
reported for the identifi cation of lipid area, indicating that further improvement is needed 
before application of this technique is feasible.
Virtual histology intravascular ultrasound 
Virtual histology intravascular ultrasound (VH IVUS) can potentially differentiate plaque 
composition more accurately than conventional grayscale IVUS. The technique is based 
on radiofrequency analysis of intravascular ultrasound backscatter signals. A combination 
of spectral parameters were used to develop statistical classifi cation schemes for analysis 
of in vivo IVUS data in real-time. Using these parameters, color-coded maps of plaque 
composition for each cross-sectional image are provided which are superimposed on 
the grayscale IVUS images. As illustrated in Figure 6, these tissue maps can differentiate 
Figure 5. Coronary plaque in the right coronary artery (RCA) of a patient presenting with an acute 
coronary syndrome as evaluated by coronary angiography (left) and intravascular ultrasound (right). 
(A) A mild concentric lesion at the distal part of the RCA. (B) In the proximal portion a signifi cant 
eccentric lesion with an echolucent area (arrow) and high plaque burden of 67%. (C) More 

















fi brous (dark green), fi bro-fatty (light green), dense calcium (white) and necrotic core (red) 
areas. Since its introduction, the technique has been validated with histology in several 
studies.26 27 Nair and colleagues have shown accuracies of 90.4% for fi brous, 92.8% for 
fi bro-fatty, 90.9% for calcifi ed and 89.5% for necrotic core regions demonstrating the 
potential of this imaging tool for analyzing plaque composition.26 
The ability of VH IVUS to evaluate the presence of vulnerable plaques was fi rst demon-
strated by Rodriguez-Granillo et al.28 The investigators observed that vulnerable plaques 
as determined on VH IVUS were more prevalent in patients presenting with ACS than stable 
angina pectoris. Similar results were recently reported by Pundziute and co-workers who 
demonstrated that in culprit lesions of patients with ACS, the thin capped fi broatheroma 
was more prevalent than in plaques of patients presenting with stable symptoms (Figure 
7).29 Interestingly, the presence of positive remodeling identifi ed by VH IVUS was found to 
be similarly linked to the presence of vulnerable plaques. A retrospective study using VH 
IVUS demonstrated that positive remodeled plaque contained signifi cantly more necrotic 
core and features of high-risk plaque, whereas negative remodeled plaques showed a 
more stable phenotype.30 
Of note, in addition to remodeling, Valgimigli et al. demonstrated that plaque composi-
tion on VH IVUS was infl uenced by the location of the plaque in the coronary artery tree.31 
As shown by VH IVUS, proximal segments of coronary arteries had a larger necrotic core 
area when compared to distal coronary segments whereas the other plaque components 
(fi brous, fi bro-fatty and dense calcium) were distributed evenly along the coronary artery 
tree. Accordingly, distance from the ostium was demonstrated to be inversely associ-
 
Figure 6. Plaque characterization by virtual histology intravascular ultrasound (VH IVUS). (A) 
Traditional grayscale intravascular ultrasound (IVUS) frame showing coronary plaque. (B) Example 
of VH IVUS color-coded map superimposed on grayscale IVUS frame. The colors correspond to 
different tissue types such as fi brous (dark green), fi bro-fatty (light green), dense calcium (white) 
and necrotic core (red). Panel B shows a plaque with predominantly necrotic core, small dense 








ated to plaque vulnerability, possibly explaining the higher incidence of culprit lesions in 
proximal parts of the coronary artery tree.
Interestingly, in addition to evaluating progression or regression in plaque burden, VH 
IVUS may also have the ability to monitor changes in plaque composition (and possibly 
even plaque vulnerability) after treatment with anti-atherosclerotic therapy. Serruys et 
al. assessed the effect of the direct lipoprotein-associated phospholipase A2 (Lp-PLA2) 
inhibitor darapladib on plaque composition by VH IVUS.32 The investigators showed that 
necrotic core size increased in patients receiving placebo. In contrast, Lp-PLA2 inhibition 
prevented further progression of necrotic core, suggesting stabilization of atherosclerosis. 
Although VH IVUS is a promising imaging modality for plaque characterization, some 
limitations remain. Importantly, detection of the thin fi brous cap (<65 μm) is not yet fea-
sible as VH IVUS has limited radial resolution of only 100 μm. However, with the introduc-
tion of 40 MHz catheters imaging of the thin fi brous cap may eventually become possible.
Optical coherence tomography 
Optical coherence tomography (OCT) is an unique high-resolution imaging technique 
which uses low coherence, near infrared light for intravascular imaging of the coronary 
artery wall. It has excellent spatial resolution of 10-20 μm which is ten times higher than 
the resolution of IVUS. Furthermore, using histological controls, it has been demonstrated 
that OCT is superior than IVUS in detecting important features of vulnerable plaque com-
ponents including thickness of fi brous cap, thrombus and density of macrophages.33-35 
One of the fi rst investigations to demonstrate the feasibility of plaque characteriza-
tion with OCT in vivo was performed by Jang et al.36 Furthermore, using this technique 
the authors reported a higher frequency of thin capped fi broatheroma in patients with 
ACS as compared to patients with stable angina pectoris. In addition, Kubo et al. com-
pared assessment of culprit plaque morphology on OCT to grayscale IVUS and coronary 
angioscopy.37 The authors concluded that OCT was superior in identifying the thin capped 
fi broatheroma and thrombus, and that OCT was the only modality that could distinguish 
the thickness of fi brous cap (Figure 8).
Another interesting feature of OCT is that it enables quantifi cation of macrophages 
within fi brous caps. Tearney and colleagues showed in vitro, by comparing OCT images 
Figure 7. The prevalence of thin capped 
fi broatheroma (TCFA) in patients presenting with 
stable symptoms versus patients presenting with 
an acute coronary syndrome (ACS) evaluated by 
virtual histology intravascular ultrasound. TCFA 
were more frequently observed in plaques of 
patients with ACS (32%) as compared to patients 
with stable symptoms (3%). The bar graph is 
















to histological specimens, that a high positive correlation exists between OCT measure-
ments and fi brous cap macrophage density (r=0.84).38 In vivo, Raffel and colleagues 
demonstrated a signifi cant relationship between systemic infl ammation (white cell blood 
count) and macrophage density in fi brous caps identifi ed by OCT.39 
At present, it is important to realize that there are some important limitations in the 
use of OCT. Blood leads to signifi cant attenuation of the emitted infrared light, therefore 
regular saline fl ushes or balloon occlusion of the artery is necessary for adequate imaging. 
Consequently, data acquisition is time-consuming and is therefore limited to focal lesion 
exploration. Furthermore, the penetration depth of near infrared light is only 1-2 mm. As 
a result, OCT is not able to visualize the complete plaque and vessel wall and quantita-
tive measurements of plaque and/or lipid volume are currently not possible. However, a 
second-generation OCT technology, namely optical frequency domain imaging (OFDI), 
has recently been developed, which enables imaging of the coronary arteries with a short, 
non-occlusive saline fl ush and rapid spiral pullback.40
OTHER INTRA-CORONARY TECHNIQUES
Intravascular Ultrasound Palpography
Intravascular palpography is a technique based on intravascular ultrasound. This imag-
ing modality allows assessment of local mechanical tissue properties by assessing tissue 
deformation or strain. At a given pressure limit, fatty tissue components will show more 
deformation than fi brous components. Accordingly, palpography uses these differences 
in tissue deformation to differentiate between various plaque components. Indeed, dif-
ferences of strain between fi brous, fi bro-fatty and fatty components of the plaque of 
coronary and femoral arteries have been reported in vitro.41 In addition, a distinctive 
 
Figure 8. Intraluminal thrombi in corresponding images of optical coherence tomography (A), 
coronary angioscopy (B), and intravascular ultrasound (C). (A) Thrombus with optical coherence 
tomography signal attenuation (T). (B) Large white thrombus (WT) and small red thrombus 
(RT) adhering to a rough surface of yellow plaque. (C) Thrombus (arrows) identifi ed as a mass 
protruding into the vessel lumen from the surface of the vessel wall. Reprinted with permission 








strain pattern was found with a high sensitivity and specifi city (89%) for the detection 
of thin capped fi broatheroma in postmortem coronary arteries. Schaar et al. performed 
the fi rst clinical study using palpography in patients to assess the incidence of vulner-
able plaque.42 In 55 patients presenting with stable symptoms, unstable symptoms and 
acute myocardial infarction, palpography was performed and the number of deformable 
plaques was assessed. The investigators reported that patients with stable angina pectoris 
had signifi cantly fewer deformable plaques (high strain spots) per vessel as compared to 
patients presenting with unstable angina pectoris or acute myocardial infarction (Figure 
9). Thus, although additional validation is required, intravascular ultrasound palpography 
appears to have potential for the identifi cation of vulnerable plaque characteristics. 
Intracoronary angioscopy
Intracoronary angioscopy is an imaging technique which uses optic fi bers to allow direct 
visualization of the plaque surface, presence of thrombus and color of the luminal surface. 
A normal artery appears as glistening white, whereas a plaque can be categorized based 
on its angioscopic color such as yellow or white. Additionally, thrombus can be identi-
fi ed as white (platelet rich) or red (platelets and erythrocytes) (Figure 8B). Uchida and 
co-workers performed intracoronary angioscopy in 157 patients presenting with stable 
angina.43 In a 12-month follow-up period, ACS occurred more frequently in patients with 
glistening yellow plaques (69%) than in those with white plaques (3%).
Of interest, intracoronary angioscopy can also be applied as a tool for monitoring 
changes in plaque morphology following pharmaceutical therapy. Using this technique, 
Takano and colleagues were able to demonstrate an effect of preventive treatment with 
atorvastatin.44 Interestingly, lipid-lowering therapy with atorvastatin changed plaque color 
and morphology as determined by angioscopy, thereby suggesting plaque stabilization. 
A major limitation of angioscopy remains that, similar to OCT, the technique requires a 
blood-free fi eld while investigation is restricted to a limited part of the vessel. 
Figure 9. Bar graph representing the relation between 
the number of high strain spots as assessed by 
palpography and clinical presentation in 55 patients. 
High strain spots correspond to the more vulnerable 
plaques. More high strain spots were demonstrated by 
palpography in patients presenting with unstable angina 
pectoris and acute myocardial infarction as compared 
to patients presenting with stable angina pectoris. Bar 
















NON-INVASIVE IMAGING OF ATHEROSCLEROTIC PLAQUES
Calcium score
It has been well established that the presence of coronary artery calcifi cations (CAC) 
confi rms the presence of atherosclerosis. In fact, an association between visible CAC on 
invasive coronary angiography and the risk of cardiovascular events has been demon-
strated in the early 1980s.45 The introduction of electron beam computed tomography 
(EBCT) allowed non-invasive evaluation of CAC and resulted in the development of the 
widely established quantifi cation method by Agatston.46 More recently, assessment of 
CAC is performed by means of multislice computed tomography (MSCT) (Figure 10). 
The relation between the presence and extent of CAC and presence of coronary artery 
stenosis has been assessed in several studies.47-49 As expected, a high sensitivity of CAC 
for the presence of obstructive CAD has been reported. However, extensive calcifi cations 
can be present in the absence of luminal narrowing. As a result, specifi city for obstructive 
CAD is low. Accordingly, the technique may be more suited to provide an estimate of total 
plaque burden rather than stenosis severity. 
Importantly, the information on calcifi ed plaque burden has been shown to translate 
in prognostic information. Indeed, the value of CAC scoring for risk stratifi cation has 
been extensively studied. A large clinical trial by Greenland and colleagues showed the 
distinct incremental value of CAC scoring over the Framingham risk score in asymptom-
atic patients.50 In addition, Detrano et al. demonstrated that CAC performed equally well 
among the four major racial and ethnical groups.51 In a even larger cohort of 25,253 
asymptomatic individuals, Budoff and colleagues confi rmed that CAC was an independent 
Figure 10. Example of coronary calcium on non-contrast enhanced multislice computed 
tomography (MSCT) axial images. Calcifi cations appear as bright white dense structures on MSCT. 
Panel A shows a 57 year old patient without evidence of coronary calcifi cations in the left anterior 
descending coronary artery (LAD). Panel B shows a 53 year old patient with calcifi cations in the 








predictor of mortality and that risk scores increased proportionally with higher CAC 
scores (Figure 11).52 Particularly in patients initially classifi ed as being at intermediate risk, 
knowledge of the extent of CAC may be valuable to refi ne risk stratifi cation and determine 
further management. 
In addition to risk stratifi cation, it has been suggested that CAC scoring may allow non-
invasive monitoring of changes in atherosclerotic plaque burden. Several investigations 
have demonstrated a halt in progression or even regression of coronary calcifi cations as 
a result of reductions in serum low-density lipoprotein (LDL) cholesterol concentrations.53 
However, other investigations failed to show such effect despite effective reductions in 
systemic infl ammation or LDL cholesterol concentrations. Possibly, changes in calcifi ed 
plaque burden may not adequately refl ect changes in total atherosclerotic plaque burden. 
Moreover, it has been suggested that plaque stabilization may even be associated with a 
relative increase of coronary calcifi cations rather than decrease. Indeed, it remains impor-
tant to realize that the presence or absence of calcium itself is not a direct marker for 
vulnerability. Since no information is obtained on the presence of non-calcifi ed plaques, 
CAC scoring does not allow for reliable distinction between potentially unstable versus 
stable plaques.54 
Figure 11. Cumulative survival by coronary artery calcifi cation score adjusted for risk factors such 
as age, hypercholesterolemia, diabetes, smoking, hypertension, and a family history of premature 
coronary artery disease. Increasing calcium scores were associated with worse survival and each 
increment of calcium score was associated with signifi cant increased risk of all-cause mortality. 
















Multislice computed tomography angiography
MSCT is a rapidly evolving imaging tool that allows non-invasive visualization of coronary 
atherosclerosis. Since the introduction of 4-slice scanners, the technique has developed 
rapidly and 64-slice and even 320-slice systems are currently available. Accordingly, the 
temporal and spatial resolution have improved resulting in superior image quality and 
diagnostic accuracy for the detection of CAD. Although the resolution of MSCT remains 
inferior as compared to invasive coronary angiography, high diagnostic accuracies have 
been demonstrated for the detection of signifi cant CAD.55 Additionally, the technique 
may be of use in the work-up of patients presenting to the emergency department with 
suspected ACS. Promising results were reported by Hoffmann and co-workers who dem-
onstrated that the absence of signifi cant coronary artery stenosis (73 of 103 patients) and 
non-signifi cant coronary atherosclerotic plaque (41 of 103 patients) on MSCT accurately 
ruled out ACS.56 Accordingly, a high negative predictive value was observed indicating 
that MSCT angiography may be a valuable gatekeeper for invasive coronary angiography. 
Furthermore, MSCT is not only able to identify coronary artery stenosis but also has 
the potential to provide information on lesion morphology and plaque composition. As 
illustrated in Figure 12, the technique can distinguish non-calcifi ed, mixed and calcifi ed 
plaques. Due to the substantially higher density values, identifi cation of calcifi ed plaque 
is relatively simple on MSCT. However, identifi cation of non-calcifi ed plaque is more 
Figure 12. Example of plaque imaging 
performed on 320-slice multislice computed 
tomography coronary angiography. (A) 
Curved multiplanar reconstruction of the 
left anterior descending artery (LAD) with 
non-calcifi ed plaque (arrow). (A) Curved 
multiplanar reconstruction of the LAD 
demonstrating mixed plaque (arrow). (C) 
Curved multiplanar reconstruction of the 









demanding because of the more subtle difference in attenuation and relatively larger 
infl uence of body-mass index, cardiac output and amount of contrast injected. Interest-
ingly, comparison of density measurements of non-calcifi ed plaques on MSCT to invasive 
IVUS showed that the attenuation within hyper-echoic (fi brous) plaques was higher than 
within hypo-echoic (lipid-rich) plaques (mean attenuation values of 121 ± 34 HU versus 
58 ± 43 HU).57 However, for individual lesions a substantial overlap between hyper-echoic 
and hypo-echoic attenuation values was observed, indicating that, at this stage, further 
characterization of non-calcifi ed plaque is not yet feasible.
Plaque composition as evaluated by MSCT has been linked to clinical presentation. 
Motoyama and colleagues compared plaque morphology on MSCT in 38 patients with 
ACS versus 33 patients with stable angina pectoris and demonstrated that plaques associ-
ated with ACS showed lower density values, positive remodeling and spotty calcifi ca-
tion.58 Moreover, Pundziute and colleagues compared plaque characteristics on 64-slice 
MSCT and VH IVUS in patients with ACS and stable angina pectoris and demonstrated 
that non-calcifi ed (32%) and mixed plaques (59%) were more frequently present in ACS.29 
In line with these fi ndings, using 64-slice MSCT, Henneman et al. demonstrated in 40 
patients suspected of ACS that CAC was absent in a large proportion of patients (33%). 
However, as illustrated in Figure 13, in these patients non-calcifi ed plaques were highly 
prevalent (39%).59 As a result, atherosclerosis and even obstructive CAD were frequently 
observed, even in the absence of detectable calcium. Thus, the investigators suggested 
that in patients presenting with ACS, absence of CAC does not reliably exclude CAD. 
Preliminary studies have suggested that information on atherosclerosis derived from 
MSCT angiography may also provide prognostic information.60 61 Interestingly, van Werk-
hoven et al. demonstrated that the presence of substantial non-calcifi ed plaque burden 
was an independent predictor of events (all-cause mortality, non-fatal myocardial infarc-
tion, and unstable angina requiring revascularization).62 However, further investigations 
are required in larger patient populations to confi rm these observations.
Figure 13. Prevalence of different plaque types in patients presenting with suspected acute 
coronary syndrome (ACS). A high prevalence of non-calcifi ed and mixed plaques was observed in 
















In addition, MSCT may potentially be applied to monitor progression and/or regres-
sion of coronary plaque burden. Preliminary results from an experimental animal model 
reported that MSCT could accurately document serial changes in aortic plaque burden 
which correlated well with measurements derived from magnetic resonance imaging 
(MRI).63 In humans, Burgstahler and co-workers studied the effect of lipid-lowering 
therapy on coronary plaque burden with MSCT after one year.64 Although no differences 
were found in total plaque burden and CAC, signifi cantly lower non-calcifi ed plaque 
burden was demonstrated after lipid-lowering therapy. 
While MSCT angiography may have potential for non-invasive evaluation of plaque 
composition and subsequent identifi cation of patients at higher risk of events, several 
important limitations remain. Firstly, the technique is associated with radiation exposure, 
although signifi cant dose reductions have been achieved with recent advances in scanner 
hardware and acquisition protocols.65-67 In addition, the resolution remains inferior as 
compared to invasive atherosclerosis imaging techniques and no validated algorithms 
are currently available for quantifi cation of observations. Further improvement in plaque 
characterization however, is expected by the development of dual-energy MSCT or dedi-
cated contrast agents. 
Magnetic resonance imaging
MRI is a versatile imaging technique with a high potential to visualize vessel anatomy. 
The technique is able to differentiate atherosclerotic tissue without exposure to radia-
tion using features such as chemical composition, water content, molecular motion-, or 
diffusion. Due to recent improvements in MR techniques such as high-resolution and 
multi-contrast MR (time-of-fl ight (TOF) imaging T1- and T2- weighted and proton density 
(PD) weighted imaging), plaque characterization has become possible as demonstrated 
in experimental models, histological specimens, human carotid arteries and the aortic 
wall in vivo (Table 2).68-71 Fayad and colleagues assessed aortic wall plaque composition 
with MR images matched to transesophageal echocardiograms, demonstrating a strong 
correlation for plaque composition, thickness and extent.68 In several studies the potential 
of MRI to characterize different plaque characteristics, including the fi brous cap, lipid core 
and even the presence of hemorrhage in human carotid atherosclerotic plaques (Figure 
Table 2. Multicontrast weightings and corresponding plaque characterization on magnetic 
resonance imaging (MRI). Intensities are relative to that of the sternomastoid muscle. Table 
modifi ed from Yuan et al.94 TOF, time of fl ight; PD, proton density.
Component TOF T1-weighted T2-weighted PD-weighted 
Hemorrhage High High - moderate Variable Variable 
Lipid-rich necrotic core Moderate High Variable High 
Calcifi cation Low Low Low Low 








14), has been demonstrated.72 73 In addition, a good correlation has been identifi ed 
between fi brous cap integrity on MRI and histopathological specimens.69
Plaque imaging with MRI of the coronary arteries remains challenging as deep loca-
tion, motion and respiratory artifacts and small caliber vessels remain obstacles for 
accurate coronary visualization and plaque differentiation. Nevertheless, several novel 
approaches for coronary plaque imaging are currently under development and may 
potentially allow accurate evaluation of atherosclerotic plaque in the coronary arteries.74 
In particular ‘black-blood’ techniques (an imaging approach in which the blood appears 
black and the arterial wall can be seen) are promising for accurately portraying plaque 
presence, size and morphology with sub-millimeter resolution and high reproducibility.75 
Kim et al. recently applied a novel 3D free breathing black-blood fast gradient technique 
with real-time motion correction developed by Botnar et al. to evaluate patients with 
non-signifi cant CAD and compared these patients to a control group without CAD.76 77 
The investigators demonstrated that MRI could identify signifi cantly increased vessel wall 
thickness with preserved lumen size in patients with non-signifi cant CAD. 
High-resolution MRI in combination with molecular contrast agents targeted to 
specifi c cells or molecules offers an interesting alternative approach for more detailed 
plaque characterization.78-80 In particular contrast agents dedicated to the identifi cation 
of vulnerable plaque components are of considerable interest. Paramagnetic contrast 
agents such as gadolium (T1 shortening contrast with a high affi nity for lipid-rich lesions) 
are able to assess the more subtle differences in plaque composition.79 Furthermore, T2 
shortening contrast agents such as ultra small superparamagnetic particles of iron oxide 
(USPIOs) have been studied both in vitro and in vivo. Interestingly, these particles were 
found to accumulate in plaques with high macrophage content and cause signal decrease 
in MR images.81 Additionally, promising results have been achieved with fi brin targeted 
contrast agents, which have the potential to allow non-invasive molecular imaging of 
thrombus. Spuentrup and colleagues demonstrated in an experimental animal model that 
 
Figure 14. Example of MR image (T2-
weighted) of the carotid arteries. A stenotic 
lesion of the right internal carotid artery can 
be observed just distal of the bifurcation 
(arrow). The arrowhead indicates a high 
signal artifact of the close-placed superfi cial 
phase-array coil. Finally, in the enlargement, 
a hypo-intense signal within the plaque 
corresponding to lipid accumulation can be 
observed. Reprinted with permission from 
















using these agents, acute pulmonary, cardiac and coronary thrombosis could be accu-
rately visualized by MR imaging.82 Furthermore, continued advances in radiofrequency 
hardware have resulted in an increase in the operating fi eld strength from 1.5T (tesla) to 
3T and even 7T. At 3T an approximately two-fold increase in signal-to-noise-ratio can be 
obtained, resulting in a four-fold reduction in scanning time and signifi cant increase in 
temporal resolution. 
Moreover, recent studies support MRI as an effective tool to evaluate plaque regression 
following lipid-lowering therapy. Corti et al. demonstrated in 18 hypercholesterolemic 
patients that MRI could document a marked reduction in atherosclerotic lesion size 
induced by statin therapy in humans.83 Accordingly MRI may become a particular attrac-
tive modality to non-invasively monitor the effect of anti-atherosclerotic interventions in 
vivo.
Nevertheless, detailed characterization of plaque including the identifi cation of 
high-risk features remains diffi cult at present. Although much is expected from current 
developments, evidently more data are needed before plaque characterization with MRI 
may be clinically used for identifi cation and management of patients at risk. 
Molecular imaging with nuclear techniques
Using dedicated tracers, nuclear imaging techniques such as single photon emission 
tomography (SPECT) and positron emission tomography (PET) can target distinct media-
tors and regulators involved in the cascade of atherosclerosis. As a result of increasing 
knowledge regarding the pathophysiology of atherosclerosis, several radionuclide-
labeled tracers that serve as markers of infl ammation, angiogenesis, apoptosis and lipid 
metabolism have been developed for plaque imaging (Table 3). 
Matrix metalloproteinases (MMP) are released by activated macrophages and are 
therefore used to identify proteolytic activity in atherosclerotic lesions. MMPs modulate 
the degrading of the extracellular matrix and the thin fi brous cap of an atherosclerotic 
lesion, contributing to the vulnerability of the plaque. In several animal models the fea-
sibility of in vivo imaging of MMP activity using radionuclide-labeled MMP inhibitors has 
been shown.84-86
Additionally, it has been proposed that apoptosis is one of the features of an athero-
sclerotic unstable lesion and that apoptosis consequently leads to growth of the necrotic 
core and infl uences plaque stability. Annexin A5 has a high affi nity for phospatidylserine 
(exposed on the plasma membrane of apoptotic cells) and therefore radionuclide-labeled 
Annexin A5 can be used as a marker of apoptotic cells in atherosclerotic lesions. In experi-
mental models, a direct correlation was demonstrated between Annexin A5 uptake, mac-
rophage burden and histologically demonstrated apoptosis.87 In a small patient cohort 
with a history of transient ischemic attack, Annexin A5 imaging of carotid atherosclerosis 
was performed by Kietselaer et al.88 Imaging was performed before carotid surgery and 
correlated to histopathology fi ndings. The investigators reported that Annexin A5 uptake 
in carotid lesions correlated highly with plaque instability. However, only preliminary data 








Finally, PET imaging with F18-fl uorodeoxyglucose (FDG) is currently considered to be 
one of the most promising imaging modalities for the identifi cation of vulnerable lesions. 
FDG is a radionuclide tracer that competes with glucose for uptake into metabolically 
active cells, especially macrophages, and enables quantifi cation via PET. Within carotid 
artery atherosclerotic plaques, Rudd et al. demonstrated with FDG PET that FDG was taken 
up by resident macrophages in atherosclerotic plaque but not by surrounding cellular 
plaque components.89 The authors suggested that FDG may be capable of imaging and 
possibly even quantifi cation of plaque infl ammation. In addition, FDG PET could poten-
tially be used to serially monitor changes in atherosclerotic plaque macrophage content. 
In an experimental rabbit model, Worthley and co-workers demonstrated that assessment 
of progression and/or regression of macrophage content in atherosclerotic plaques was 
feasible using this non-invasive technique.90 In addition, Tahara et al. showed in 43 patients 
that FDG PET, co-registered with computed tomography data, was able to visualize sig-
nifi cantly reduced plaque infl ammation following 3 month treatment with simvastatin.91 
Table 3 . Targets for molecular imaging of plaque vulnerability. Table modifi ed from Narula et 
al.95 FDG - fl uorodeoxyglucose; HLA - human leukocyte antigen; ICAM - intercellular adhesion 
molecule 1; MCP-1 - monocyte chemotactic protein 1; MMP - matrix metalloproteinase; PS - 
phosphatidylserine; SRA - scavenger receptor A; VCAM - vascular cell adhesion molecule; VEGF - 
vascular endothelial growth factor.
Process targeted Targets Target agents
Monocyte migration
Reversible prelude with intima Selectins Microbubbles with antibodies
Receptors for chemotactic peptides MCP-1 Radiolabeled MCP-1
Activation-dependent receptors ICAM or VCAM Antibodies; radiolabeled or on microbubbles
Subintimal activation of monocytes
Lipid scavenging receptors SRA I,II Oxidized LDL
FcγRIII Radiolabeled non-specifi c IgG or Fc 
fragments
Other phagocyte receptors PS receptor PS-rich microbubbles
Others Superparamagnetic iron (USPIOs); 
nanoparticulate CT contrast
Immune activation HLA expression Radiolabeled antibody
Heightened metabolic activity FDG Positron-labeled FDG
Macrophage apoptosis
Cell membrane PS expression Radiolabeled Annexin A5
Cell apoptosis pathways Caspase substrate Radiolabeled DEVD
Collateral products from macrophages
Cytokines MMPs MMP inhibitor or substrate; radiolabeled or 
fl uorochromes



















However, thus far FDG imaging of the coronary arteries has been challenging because 
of cardiac motion, FDG uptake in the myocardium and limited resolution of PET. Possibly, 
co-registration of the functional images with high-resolution anatomical data obtained 
with MSCT in combination with dedicated protocols to suppress myocardial uptake could 
possibly overcome this limitation (Figure 15).92 93 
SUMMARY AND CONCLUSION
Plaque rupture followed by coronary occlusion due to thrombosis is responsible for 
a large number of acute coronary events. Identifi cation of lesions before they rupture 
would allow initiation of aggressive systemic or even local therapy and could potentially 
improve outcome. Due to absence of natural history data, the precursor of vulnerable 
lesions remains largely unknown and most details have been derived from retrospective 
post-mortem studies. On the basis of these investigations, it has been suggested that 
the most common substrate for superimposed thrombus formation is the thin capped 
fi broatheroma; a plaque with a large necrotic core and an infl amed thin fi brous cap (<65 
mm thick) infi ltrated by macrophages and lymphocytes. 
Figure 15. Example of the co-registration of functional imaging with F-18 fl uorodeoxyglucose 
(FDG) positron emission tomography (PET) and anatomical imaging with multislice computed 
tomography (MSCT). (A) On MSCT axial images a non-calcifi ed plaque in left main coronary artery 
(arrow) was identifi ed. (B) Corresponding image after fusion with F-18 FDG PET, localizing the 
infl ammatory PET signal with a maximal standard uptake value of 2.1 to the non-calcifi ed plaque 








As discussed in the current chapter, extensive effort is invested in the development of 
imaging tools to characterize coronary atherosclerosis with the ultimate goal of detecting 
vulnerable lesions. To this end, several techniques are currently under investigation, with 
each technique having specifi c advantages as well as limitations. Importantly, the clini-
cal relevance in terms of predicting outcome and changing management remains to be 
established for all currently available techniques. 
At present, invasive techniques, such as OCT and VH IVUS, provide the most detailed 
information and are currently employed in prospective natural history studies. Applica-
tion of these techniques will remain largely restricted to symptomatic high-risk patients 
due to their invasive nature and a non-invasive technique would allow application on a 
wider scale. At present, non-invasive approaches cannot provide detailed characteriza-
tion of the individual vulnerable coronary plaque. However, direct in vivo comparisons 
with invasive modalities may substantially improve our understanding and interpreta-
tion of non-invasive observations. Consequently, this information may be translated 
into enhanced strategies for risk stratifi cation. In addition, the measurements of plaque 
vulnerability obtained with either invasive or non-invasive imaging techniques may be 
used as surrogate endpoint for prospective anti-atherosclerotic therapy trials.32 Possibly, 
the combination of imaging techniques targeting both morphological and functional 
characteristics may be of particular value. 
Evidently, large prospective studies are needed to further defi ne the potential role 
of each imaging technique in the identifi cation of vulnerable plaques. Moreover, much 
uncertainty remains on how these vulnerable lesions should be treated. In addition to 
increased intensity of systemic therapy, such as aspirin and statin therapy, also local or 
regional therapeutic approaches (such as plaque sealing) have been suggested. However, 
no robust data are currently available to support their effectiveness. Potentially, imaging 
techniques may be proven of great value in the development of such individually targeted 
treatment strategies.
OUTLINE OF THE THESIS
The aim of this thesis was to evaluate the role of imaging in the assessment and charac-
terization of atherosclerosis and vulnerable plaque in the coronary arteries. Non-invasive 
computed tomography coronary angiography (CTA) is a relatively new technique for 
the evaluation of coronary atherosclerosis. Therefore, the performance of CTA in char-
acterizing coronary atherosclerosis was assessed and was compared to invasive imaging 
techniques, in addition to determining the impact on clinical management.
In Part 1, the current advances of coronary CTA in characterizing atherosclerosis and 
vulnerable plaque were explored. Chapter 2 explores the ability of the novel 320-row 
CTA to characterize different plaque components as compared to plaque imaging with 
















plaque composition were evaluated in relation to the degree of stenosis as assessed both 
non-invasively by CTA and invasively by VH IVUS. In Chapter 4, the spatial relationship 
between the site of greatest stenosis and site of greatest vulnerability was evaluated with 
VH IVUS on a per-vessel basis. The aim of Chapter 5 was to systematically investigate the 
diagnostic performance of CTA for two endpoints, namely detecting signifi cant stenosis 
(using invasive coronary angiography as the reference standard) versus detecting the 
presence of atherosclerosis (using IVUS as the reference of standard). Assessment of the 
length of coronary lesions was compared between CTA and quantitative coronary angiog-
raphy in patients who underwent subsequent percutaneous coronary intervention (PCI) 
in Chapter 6. The purpose of the next chapters was to systematically compare high-risk 
plaque features on CTA, such as the pattern of calcifi cations (Chapter 7) and presence 
of positive remodeling (Chapter 8) and relate these characteristics on CTA to vulnerable 
plaque characteristics on VH IVUS. 
In Part 2, the relation between characterization of atherosclerosis on CTA and the 
effect on clinical management was evaluated. Chapter 9 focuses on the evolving role of 
coronary CTA (including coronary calcium scoring) on the diagnosis of patients with acute 
chest pain. In addition, an overview of a wide range of other CT applications is provided, 
including triple rule-out, evaluation of plaque composition, myocardial function, and 
perfusion. As CTA is inherently associated with patient radiation exposure, Chapter 10 
addresses effective strategies for radiation dose reduction. The diagnostic accuracy of 
320-row CTA in the non-invasive evaluation of signifi cant stenosis and atherosclerosis 
in patients referred for CTA as well as in patients presenting with acute chest pain is 
evaluated in Chapter 11 and Chapter 12, respectively. Chapter 13 evaluates the relation 
between the value of the calcium score and plaque characteristics (on CTA and VH IVUS) 
in patients with suspected acute coronary syndrome. The aim of Chapter 14 was to evalu-
ate the role of non-invasive CTA as a gatekeeper before invasive coronary angiography. 
Lastly, Chapter 15 evaluates the value of CTA variables of atherosclerosis to predict the 
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Background: Recently, 320-row multidetector computed tomography angiography (CTA) 
has been introduced. However, the relation between plaque observations on 320-row CTA 
versus virtual histology intravascular ultrasound (VH IVUS) remains relatively unknown. 
Therefore, the objective of this study was to compare plaque observations on 320-row 
CTA to VH IVUS. 
Methods: In total, 65 patients underwent 320-row CTA followed by VH IVUS. On CTA, 
three plaque types were identifi ed: non-calcifi ed, mixed and calcifi ed. Attenuation values 
(Hounsfi eld Units (HU)) were measured in 3 regions of interest. On VH IVUS, plaque 
composition (% fi brotic, fi bro-fatty, necrotic core, dense calcium) and presence of thin 
cap fi broatheroma (TCFA, more high risk) were evaluated. 
Results: Overall, of the 272 plaques identifi ed on CTA, 110 plaques (40%) were non-
calcifi ed, 142 plaques were mixed (52%) and 20 plaques (8%) were calcifi ed. Non-calcifi ed 
plaques demonstrated the lowest attenuation values (70 ± 37 HU), followed by mixed 
plaques (258 ± 219 HU) and calcifi ed plaques (836 ± 226 HU). Plaque classifi cation on 
CTA showed good agreement to VH IVUS. As compared with calcifi ed plaques, non-
calcifi ed plaques contained more fi bro-fatty tissue (54 ± 23% versus 47 ± 21%, p=0.001). 
Moreover, mixed and calcifi ed plaques contained more dense calcium (9 ± 6% and 10 ± 
7%, respectively) than non-calcifi ed plaques (6 ± 6%, p<0.001). More necrotic core was 
present in mixed plaque (16 ± 8%) than in non-calcifi ed (12  ± 7%) and calcifi ed plaques 
(14 ± 7%)(p<0.001). Interestingly, mixed plaques most often corresponded to the pres-
ence of TCFA on VH IVUS (22%). 
Conclusion: Plaque observations on 320-row CTA show good agreement to relative 
plaque composition on VH IVUS. Moreover, mixed plaques on 320-row CTA parallel the 









Coronary multidetector computed tomography angiography (CTA) has generated great inter-
est in recent years. The technique has been shown to have a high diagnostic performance in 
the non-invasive assessment of patients with known or suspected coronary artery disease 
(CAD).1-3 An important advantage of coronary CTA is that not only luminal narrowing can 
be visualized but also atherosclerotic plaque composition in the arterial wall. Indeed, three 
different plaques types can be distinguished by CTA: non-calcifi ed, mixed and calcifi ed plaque. 
Interestingly, certain plaque characteristics on CTA have been associated with acute coronary 
syndromes. For instance, the presence of non-calcifi ed and mixed coronary plaques has been 
related to acute coronary syndromes (ACS), whereas calcifi ed plaques were related to stable 
CAD.4 Nonetheless, plaque characterization with CTA has been notoriously demanding, partic-
ularly with earlier generation CTA systems because of limited spatial and temporal resolution.
Recently, a novel CTA system has been introduced equipped with 320-detector rows 
which can provide 16-cm anatomical coverage in one gantry rotation.5 Accordingly, the 
320-row system allows a volumetric scanning approach, covering the entire heart in a 
single heart beat. Additionally, volume scanning eliminates the problem of stair-step arti-
facts caused by inter-heartbeat variations as well as a reduction in cardiac motion artifacts 
often observed during step-and-shoot acquisition techniques and helical imaging. More 
importantly, volume scanning offers a distinct decrease in radiation dose and contrast 
administration in comparison with traditional helical scanning, as only one gantry rotation 
is needed to image the entire heart (350 ms).6 7 Moreover, contrast is more homogenously 
distributed through the coronary arteries, thereby potentially improving the ability and reli-
ability to characterize plaque composition.8 Accordingly, these developments have resulted 
in overall improved image quality and diagnostic accuracy for the detection of CAD.6 7 
However, no previous literature concerning the ability of plaque characterization in 
vivo with the new 320-detector row CTA technique has been published. Therefore, the aim 
of the present study was to evaluate the accuracy of coronary plaque characterization by 
the novel non-invasive 320-row CTA as compared to fi ndings of invasive virtual histology 
intravascular ultrasound (VH IVUS).
METHODS
Patients and study protocol
The study group consisted of 65 symptomatic patients who presented at the outpatient clinic 
for the evaluation of chest pain and underwent non-invasive 320-row CTA followed by invasive 
coronary angiography and VH IVUS of 1 to 3 vessels. No interventions or changes in the clini-
cal condition of the patients occurred between the examinations. Contra-indications for CTA 
were 1) (supra) ventricular arrhythmias, 2) renal insuffi ciency (glomerular fi ltration rate <30 
ml/min), 3) known allergy to iodine contrast material, 4) severe claustrophobia, 5) pregnancy. 































CTA was performed using a 320-row CTA scanner (Aquilion ONE, Toshiba Medical Systems, 
Otawara, Japan) with 320 detector rows (each 0.50 mm wide) and a rotation time of 350 
ms resulting in a spatial resolution of 0.5 mm and temporal resolution of 175 ms for half 
reconstruction. Beta-blocking medication (metoprolol 50 or 100 mg, single dose, 1 hour 
prior to CTA examination) were administered if the heart rate was ≥65 beats/min, unless 
contra-indicated. In addition, nitroglycerin (0.4 or 0.8 mg sublingual) was administered 
5 minutes prior to CTA examination. For the 320-row contrast enhanced scan the entire 
heart was imaged in a single heartbeat, with a maximum of 16 cm cranio-caudal cover-
age, using prospective ECG triggering. The phase window was adjusted according to the 
heart rate: if the heart rate was ≥60 beats/min the phase window was opened at 65-85% 
of R-R interval, if the heart rate was stable and <60 beats/min the phase window was 
opened at 70-80% of R-R interval. Tube voltage and current were adapted to body mass 
index (BMI) and thoracic anatomy. Tube voltage was 100 kV (BMI <23 kg/m2), 120 kV (BMI, 
23-35 kg/m2), or 135 kV (BMI >35 kg/m2) and maximal tube current was 400-580 mA 
(depending on body weight and thoracic anatomy). Contrast material was administered in 
a triple-phase protocol: fi rst a bolus of 60 to 80 ml, followed by 40 ml of a 50:50 mixture 
of contrast and saline, followed by saline fl ush with a fl ow rate of 5-6 ml/sec (Iomeron 400 
®, Bracco, Milan, Italy). Automatic bolus arrival detection was applied in the left ventricle 
with a threshold of +180 Hounsfi eld Units. All images were acquired during an inspiratory 
breath-hold of approximately 4-8 seconds. Firstly, a data set was reconstructed at 75% 
of R-R interval, with a slice thickness of 0.50 mm and a reconstruction interval of 0.25 
mm. In case of motion artifacts, multiple phases were reconstructed to obtain maximal 
diagnostic image quality. Subsequently, raw data sets were transferred to a remote work-
station (Vitrea FX 1.0, Vital Images, Minnetonka, MN, USA). Radiation dose was quantifi ed 
with a dose-length product conversion factor of 0.014 mSv/(mGy x cm).9 As previously 
described, if scanning was performed prospectively full dose at 70-80% of R-R interval, 
estimated mean radiation dose was 3.9 ±1.3 mSv (range 2.7-6.2 mSv).10 When scanning 
prospectively full dose at 65-85% of R-R interval, estimated mean radiation dose was 6.0 
±3.0 mSv (range 3.1-11.8 mSv).
Coronary plaque assessment
For data evaluation, 320-row CTA angiographic examinations were evaluated by 2 experi-
enced readers including an interventional cardiologist blinded to conventional coronary 
angiography and VH IVUS fi ndings. Agreement between observers was achieved in con-
sensus. Firstly, general information on the coronary anatomy was obtained by evaluating 
three-dimensional volume rendered reconstructions. Secondly, the coronary arteries were 
evaluated using axial images, curved multiplanar reconstructions and maximum intensity 
projections. Furthermore, the coronary arteries were divided into segments according to 








for the presence of any atherosclerotic plaque (defi ned as structures >1 mm2 within and/
or adjacent to the coronary artery lumen, which could be clearly distinguished from the 
vessel lumen).12 Per segment one coronary plaque was selected at the site of the most 
severe luminal narrowing. Subsequently, axial slices were visually examined for the pres-
ence of signifi cant luminal narrowing by determining the presence of ≥50% reduction 
of luminal diameter. To describe plaque composition, plaques were further classifi ed 
as: 1) non-calcifi ed plaque (plaques with lower CTA attenuation values as compared to 
contrast-enhanced lumen without any calcifi cation), 2) mixed plaque (non-calcifi ed and 
calcifi ed elements in single plaque) 3) calcifi ed plaque (plaques with high CTA attenuation 
values as compared to contrast-enhanced lumen). Of note, very small calcifi cations can 
still be missed by CTA.13 As previously described, a good intra-observer agreement was 
observed for the classifi cation of plaque type on CTA.14 15 Furthermore, within the plaque, 
the CTA attenuation values measurements in Hounsfi eld Units (HU) were made using 3 
circular regions of interest (area of 1.5 mm2) that were placed in the center of the plaque. 
Consequently, the mean attenuation values (HU) were determined per plaque. 
VH IVUS
Image acquisition
A dedicated IVUS-console (Volcano Corporation, Rancho Cordova, CA, USA) was used for 
the examination. Intracoronary nitrates were administrated prior to insertion of the IVUS 
catheter. VH IVUS was performed with a 20 MHz, 2.9 F phased-array IVUS catheter, (Eagle 
Eye, Volcano Corporation, Rancho Cordova, CA, USA) which was introduced distally in the 
coronary artery. A cine run was made before and after contrast injection to record the 
starting position of the IVUS catheter. Subsequently, motorized automated IVUS pullback 
was performed using a speed of 0.5 mm/s until the catheter reached the guiding catheter. 
Radiofrequency signals were collected at the R wave and images were stored on CD-ROM 
or DVD for off-line analysis. Of note, the typical resolution of a 20 MHz IVUS catheter is 80 
microns axially and 200 to 250 microns laterally.16 
Coronary plaque assessment
Offl ine analysis of the VH IVUS images was performed using dedicated software (pcVH 2.1 
and VIAS 3.0, Volcano Corporation, Rancho Cordova, CA, USA). The lumen and the media-
adventitia interface were defi ned by automatic contour detection and on all individual 
frames manual editing was performed. The four plaque components were differentiated 
into different color-codes (fi brotic tissue labeled in dark green, fi bro-fatty in light green, 
necrotic core in red and dense calcium in white), as validated previously.17 For each target 
plaque, plaque length was measured (mm).16 Furthermore, plaques were visually qualita-
tively classifi ed on 3 consecutive frames at the minimal lumen area site. Classifi cation was 





























(i) Pathological intimal thickening; defi ned as a mixture of fi brous and fi bro-fatty tissues, 
a plaque burden ≥40% and <10% necrotic core and dense calcium. 
(ii) Fibroatheroma; defi ned as having a plaque burden ≥40% and a confl uent necrotic 
core occupying 10% of the plaque area or greater in 3 successive frames with evidence 
of an overlying fi brous cap.
(iii) TCFA; defi ned as a lesion with a plaque burden ≥40%, the presence of confl uent 
necrotic core of >10%, and no evidence of an overlying fi brous cap in 3 successive 
frames. 
(iv) Fibrocalcifi c plaque; defi ned as a lesion with a plaque burden ≥40%, being mainly 
composed of fi brotic tissue, having dense calcium >10% and a confl uent necrotic core 
of <10% (higher amount accepted if necrotic core was located exclusively behind the 
accumulation of calcium).18 19 
Statistical analysis
For each plaque type on CTA, the number and mean CTA attenuation values were 
assessed. On VH IVUS, relative plaque composition and plaque type was also assessed 
for each lesion. After initial plaque assessment, plaques on CTA were matched to plaques 
on VH IVUS using landmarks such as coronary ostia, side-branches and calcium deposits 
to allow accurate comparison between CTA and VH IVUS. Distances from the landmarks 
to the lesion were measured on curved multiplanar reconstructions on CTA and matched 
with the longitudinal images of VH IVUS. Plaque type classifi cation on 320-row CTA was 
compared to both plaque composition and plaque type on VH IVUS. Finally, mean CTA 
attenuation values were compared between the various plaque types as assessed on VH 
IVUS. Continuous values were expressed as means (±standard deviation) and differences 
in plaque composition, type and Hounsfi eld units were assessed using a nested analysis 
of variance (ANOVA). Categorical values are expressed as number (percentages) and com-
pared between groups with 2-tailed Chi-square test. A p-value of <0.05 was considered 




The CTA and VH IVUS examinations were performed without complications in 65 patients. 
However, 3 patients were excluded due to non-diagnostic CTA image quality as a result 
of motion artifacts (n=2) and occurrence of an ectopic heart beat (n=1). Baseline patient 
characteristics of the remaining 62 patients are presented in Table 1. Mean heart rate 
was 57 ±7 beats/min. In total, 272 plaques were identifi ed in which comparison between 
320-row CTA and VH IVUS was possible. Fifty plaques (18%) corresponded to signifi cant 








Baseline 320-row CTA and VH IVUS results
Overall, of the 272 plaques identifi ed on CTA, 110 plaques (40%) were non-calcifi ed, 142 
plaques were mixed (52%) and 20 plaques (8%) were calcifi ed. Mean CTA attenuation 
value of the plaques was 224 ±222 HU. Non-calcifi ed plaques demonstrated the lowest 
attenuation values (70 ±37 HU), followed by mixed plaques (258 ±219 HU) and calcifi ed 
plaques (836 ±226 HU) (Figure 1).
VH IVUS examinations were acquired during invasive coronary angiography in 153 
of the 186 available vessels (right coronary artery=51, left anterior descending coronary 
artery=56, left circumfl ex coronary artery=46). On VH IVUS, mean lesion length was 27.5 
±17.5 mm. Furthermore, the most prevalent plaque component was fi brotic tissue (52 
Table 1. Patient characteristics of study population
n (%)
Gender (M/F) 46 / 16
Age (years) 58 ±10




Positive family history 31 (50%)
Current smoking 21 (34%)
Obese (BMI ≥30 kg/m2) 9 (15%)
Previous CAD
Previous myocardial infarction 15 (24%)
Previous PCI 16 (26)%
Heart rate (beats/min) during CTA 57 ±7
CAD; coronary artery disease, BMI; body mass index, PCI; percutaneous coronary intervention, CTA; 


























Figure 1. Comparison of attenuation 
values as measured in Hounsfi eld Units 
(HU) on 320-row multidetector computed 
tomography angiography (CTA) between 
the different plaque types on CTA. A 
signifi cant difference in CTA attenuation 
values is demonstrated between non-






























±18%), followed by fi bro-fatty tissue (28 ±14%), necrotic core (14 ±8%) and dense cal-
cium (8 ±6%). The more vulnerable plaque type (TCFA) was present in 44 plaques (16%).
Comparison between 320-row CTA and VH IVUS
A good agreement was found when comparing plaque type classifi cation on 320-row 
CTA to plaque composition on VH IVUS as demonstrated in Table 2. As compared with 
calcifi ed plaques, non-calcifi ed plaques contained signifi cantly more fi bro-fatty tissue on 
VH IVUS (54 ±23% versus 47 ±21% in calcifi ed plaques, p=0.001). Moreover, mixed and 
calcifi ed plaques on CTA contained signifi cantly more dense calcium (9 ±6% and 10 ±7%, 
respectively) on VH IVUS than non-calcifi ed plaques (6 ±6%, p<0.001). In addition, signifi -
cantly more necrotic core was present in mixed plaque (16 ±8%) than in non-calcifi ed (12 
±7%) and calcifi ed plaques (14 ±7%)(p<0.001). Example of plaque evaluation on 320-row 
CTA as compared to VH IVUS is shown in Figure 2.
The results comparing plaque types on CTA against qualitively assessed plaque types 
on VH IVUS are reported in Table 3. As expected, pathological intimal thickening on VH 
IVUS was most often observed in non-calcifi ed plaques (20 (21%)) as compared to mixed 
plaques (14 (9%), p=0.03) and calcifi ed plaques (0 (0%)) on CTA. Interestingly, the more 
high risk plaques on VH IVUS (TCFA) were most often observed in mixed plaques on CTA 
(22%, Figure 3). Moreover, fi brocalcifi c plaques on VH IVUS were most often observed in 
the calcifi ed plaques (9 (47%) versus 5 (5%) in non-calcifi ed, p<0.001) on CTA.
Furthermore, mean CTA attenuation values were compared between the different 
plaque types as assessed on VH IVUS (Figure 4). As shown, the more advanced plaque 
types on VH IVUS corresponded to higher CTA attenuation values. Pathological intimal 
thickening had the lowest mean attenuation value of 141 ±124 HU, followed by the 
fi broatheroma (mean attenuation value of 209 ±205 HU), TCFA (mean attenuation value 
of 251 ±222) and in the fi brocalcifi c plaques (mean attenuation value of 387 ±293 HU) 
the highest attenuation values were found. Interestingly, CTA attenuation value measure-
Table 2. Comparison between plaque composition on virtual histology intravascular ultrasound (VH 










Lesion length (mm) 29 ±20 27 ±16 24 ±15 0.64
Fibrotic (%) 54 ±23 51 ±16 47 ±21 0.001
Fibro-fatty (%) 18 ±15 18 ±13 20 ±13 0.62
Necrotic Core (%) 12 ±7 16 ±8 14 ±7 <0.001
Dense Calcium (%) 6 ±6 9 ±6 10 ±7 <0.001















Figure 2. Example of comparison between plaque composition on 320-row multidetector 
computed tomography angiography (CTA) and virtual histology intravascular ultrasound (VH IVUS). 
In panel (A), a curved multiplanar reconstruction of the left anterior descending coronary artery is 
shown demonstrating no plaque at cross-section B and a mixed plaque at cross-section C and D. 
In panel (B, C and D) corresponding grayscale and VH IVUS images are shown. In panel (B), only 
minor intimal thickening is demonstrated. In panel (C), a plaque with a large plaque burden (≥40%), 
large necrotic core (≥10%) and no evidence of a fi brous cap is shown, suggesting the presence of 
a thin cap fi broatheroma. In panel (D) another cross-section is demonstrated showing extensive 
calcifi cations on both CTA and VH IVUS images. 
Table 3. Comparison between plaque type on virtual histology intravascular ultrasound (VH IVUS) 
and 320-row multidetector computed tomography angiography (CTA)







Presence PIT 20 (21%) 14 (9%) 0 (0%) 0.03
Presence FA 58 (62%) 73 (52%) 8 (42%) 0.58
Presence TCFA 11 (10%) 31 (22%) 2 (10%) 0.03
Presence FC 5 (5%) 23 (16%) 9 (47%) <0.001
VH IVUS, virtual histology intravascular ultrasound; CTA, multidetector computed tomography; PIT, 






























ments of mixed plaques (258 ±219 HU) on CTA paralleled average attenuation values of 
TCFA (251 ±222 HU) on VH IVUS.
DISCUSSION
The present study evaluated the ability of plaque characterization on 320-row CTA as 
compared to invasive VH IVUS. In summary, the fi ndings of the present study demon-
strated that plaque characterization on 320-row CTA showed a good correlation with 
VH IVUS plaque characteristics. First, non-calcifi ed plaques on 320-row CTA contained 
signifi cantly more fi brotic tissue on VH IVUS than calcifi ed plaques and mixed plaques 
on CTA. In addition, dense calcium on VH IVUS was most often observed in calcifi ed 
plaques on CTA. Importantly, the highest amount of necrotic core (the more vulnerable 
plaque component) on VH IVUS was demonstrated in mixed plaque on 320-row CTA. 
Of particular interest was the fi nding that TCFA were most prevalent in mixed plaques, 
suggesting a possible higher degree of vulnerability in mixed plaques on CTA. 
Second, the more advanced plaque types on VH IVUS corresponded to higher CTA 
attenuation values. Interestingly, CTA attenuation values of the more vulnerable plaque 
type (TCFA) on VH IVUS paralleled CTA attenuation values of the mixed plaques on 320-

















Figure 3. Comparison of presence (%) of thin 
cap fi broatheroma (TCFA) between the different 
plaque types on 320-row multidetector computed 
tomography angiography (CTA). Signifi cantly more 
TCFA were present in mixed plaques (22%) as 
compared to non-calcifi ed (10%) and calcifi ed plaque 
(10%). 


























Figure 4. Comparison of attenuation values as 
measured in Hounsfi eld Units (HU) on 320-row 
multidetector computed tomography (CTA) between 
the different plaque types on virtual histology 
intravascular ultrasound (VH IVUS). A signifi cant 
increase in CTA attenuation values is demonstrated 
for the more advanced plaque on VH IVUS. PIT, 
pathological intimal thickening; FA, fi broatheroma; 








standard deviations. Thus, distinction between the more subtle plaque features using CTA 
attenuation values does not seem feasible at this time.
Although 320-row CTA has only recently been introduced, preliminary data are avail-
able concerning the diagnostic performance of 320-row CTA.20 De Graaf et al recently 
evaluated the diagnostic accuracy of 320-row CTA for detection of signifi cant stenosis 
(defi ned as ≥50% luminal narrowing) in 64 patients using quantitative coronary angiog-
raphy as the reference of standard.6 The authors demonstrated an excellent diagnostic 
accuracy of 320-row for detection of signifi cant stenosis, reporting sensitivity, specifi city, 
and positive and negative predictive values on a patient basis of 100%, 88%, 92%, and 
100%, respectively. Dewey et al also assessed the diagnostic accuracy 320-row CTA as 
compared to conventional coronary angiography in 30 patients.7 The authors concluded 
that 320-row CTA has a high diagnostic accuracy for detection of signifi cant stenosis while 
signifi cantly reducing radiation dose. 
The main advantage of the 320-row CTA, as compared to 64-row CTA, is the 16 cm 
anatomical coverage that can cover an entire organ, such as the heart, in a single gantry 
rotation. Indeed, 320-row CTA can accurately acquire images of the heart in a single 
beat (350 ms) as compared to the typical 6-10 seconds needed for 64-row systems.21 
Accordingly, this approach does not only lead to a marked reduction in radiation dose, 
it also eliminates helical acquisition artifacts. Additionally, due to the volume scanning 
approach, contrast is more homogenously distributed through the coronary arteries, 
thereby potentially improving the ability and reliability to characterize plaque composi-
tion with 320-row CTA. Nevertheless, the temporal (175 ms) and spatial resolution (0.5 
mm) of the 320-row CTA systems remain similar to the latest generation 64-row CTA 
systems.21
Regarding plaque observations with CTA, several previous studies have correlated 
plaque composition on CTA to plaque characteristics on invasive IVUS. Initially, Pohle et 
al compared plaque composition on 16-row CTA to grayscale intravascular ultrasound 
in 32 patients.22 The investigators identifi ed 252 sites with non-calcifi ed plaques on CTA 
and correlated the CTA attenuation values with invasive IVUS plaque characteristics. Inter-
estingly, differences between subtle plaque features such as the more “vulnerable“ lipid 
rich plaque (mean attenuation value of 58 ±43HU) and the more “stable” fi brous plaque 
(mean attenuation value of 121 ±34 HU) were demonstrated, although the overlap of 
attenuation values between individual characteristics were still substantial. Consequently, 
over the years newer generation CTA systems have been introduced with improved spatial 
and temporal resolution. Amongst others, Sun et al evaluated plaque characterization on 
64-row CTA.23 The investigators studied 26 patients with 40 lesions that underwent both 
64-row CTA and IVUS and observed that although CTA was able to distinguish between 
fi brous and calcifi ed plaques to a signifi cant degree, there was no difference between 
lipid rich (mean attenuation value of 79 ±34 HU) and fi brous plaque components (mean 
attenuation value of 90 ±27 HU). When compared to histology, Chopard et al also dem-
onstrated that differentiation between fi brous and lipid rich plaques with grayscale IVUS 





























Only limited data are available regarding plaque composition assessment with VH 
IVUS in relation to CTA. In our institution, a previous comparison was made between CTA 
and VH IVUS, regarding the difference in plaque composition and vulnerability between 
lesions with signifi cant (≥50% luminal narrowing) and non-signifi cant stenosis on invasive 
coronary angiography in 78 patients. Interestingly, no evident relation existed between 
the degree of stenosis and plaque composition or vulnerability, as evaluated by CTA and 
VH IVUS.25 In addition, Pundziute et al compared plaque composition between 64-row 
CTA and VH IVUS in 50 patients with 168 lesions.26 Parallel to the current fi ndings, the 
investigators also observed a good correlation between CTA and VH IVUS and demon-
strated that TCFA was most often present in mixed plaque on CTA. However, the authors 
observed the largest amount of necrotic core in plaques deemed to be fully calcifi ed 
on CTA, whereas in the current study necrotic core was largest in mixed plaques. This 
discrepancy can be possibly explained by differences in resolution between 64-row and 
320-row CTA. Indeed, due to improved image quality, 320-row CTA could be superior 
in differentiating non-calcifi ed elements within presence of calcifi ed elements than 
64-row CTA and thus allow more refi ned plaque characterization. Of note, dual-source 
CTA systems have recently been introduced that can operate two X-ray tubes at differ-
ent kV settings. Accordingly, this may lead to more comprehensive characterization of 
atherosclerotic plaque, in particular the more calcifi ed plaques.27
Several histopathological studies have observed that high-risk plaque features include 
the presence of a large necrotic core and thin fi brous cap (TCFA).19 28 29 Indeed, the rupture 
of TCFA is thought to be the primary cause of ACS. There is an emerging need for imaging 
modalities that can identify atherosclerotic plaques with high-risk features, thus improving 
identifi cation of patients that are at increased risk for events. In vivo, Rodriquez-Granillo 
et al demonstrated that VH IVUS was able to observe a higher degree of necrotic core 
and presence of TCFA in ACS patients as compared to patients with stable CAD.30 In addi-
tion, VH IVUS could identify signifi cantly more necrotic core in culprit lesions of patients 
presenting with ACS. However, VH IVUS is an invasive technique, restricted to patients 
referred for invasive coronary angiography and interventional procedures. Thus, a non-
invasive modality that can identify patients at high risk would be preferred. Therefore, 
a number of previous studies have evaluated which plaque characteristics on CTA were 
related to increased plaque vulnerability. For instance, Pundziute et al compared plaque 
features on CTA between patients presenting with ACS and stable CAD and showed that 
mixed plaques were more prevalent in patients with ACS.31 In addition, Motoyama et al 
compared plaque features of 38 patients with ACS to 33 patients with stable complaints.32 
Interestingly, features of mixed plaques such as spotty calcifi cation and low attenuation 
non-calcifi ed plaque elements were more often observed in patients with ACS. Impor-
tantly, when assessing the predictive value of plaque characteristics on CTA, the same 
authors demonstrated that these features (spotty calcifi cations, positive remodeling 
and low attenuation non-calcifi ed plaque) were also prospectively related to the occur-
rence of ACS.33 The aforementioned fi ndings are in line with previous observations by 








calcifi cations are more often present in plaques related to ACS.34 35 Of note, concerning 
the prognostic value of plaque composition on CTA, Pundziute et al demonstrated that 
mixed plaques were associated with more adverse events during follow-up.36 Accordingly, 
these observations as well as our current fi ndings further support the notion that lesions 
classifi ed as mixed on CTA may have a higher likelihood of vulnerability. 
However, with the latest generation 320-row CTA scanners, exact characterization of the 
lipid core and thin fi brous cap is not feasible at the moment. Nonetheless, although direct 
identifi cation of TCFA may not be possible, non-invasive techniques may still be valuable, 
as they may identify patients with a higher likelihood of having vulnerable plaques at a 
relatively early stage and may provide an opportunity for intensifi ed treatment strategies. 
Limitations
The following limitations of the present study should be considered. First, the present study 
only evaluated 62 patients in a single center. Ideally, a larger patient population should be 
studied, preferably in a multicenter setting. Secondly, CTA is related with ionizing radia-
tion exposure. Therefore, patients and image protocols should be carefully selected to 
prevent unnecessary exposure to radiation. Thirdly, severe calcifi cations on CTA can cause 
beam hardening and blooming artifacts and as a result can infl uence plaque classifi cation. 
Similarly on VH IVUS, due to acoustic shadowing, it is diffi cult to assess plaque composi-
tion behind severe calcifi cations. Therefore, possibly small non-calcifi ed elements within 
the more heavily calcifi ed parts of the plaque may have been missed. Fourthly, descriptive 
studies have reported the infl uence of luminal contrast-enhancement on plaque attenu-
ation values. However, in the present study we did not adjust for intra-coronary lumen 
contrast-enhancement as there is currently no validated algorithm available for this 
purpose. Lastly, no quantitative measurements were performed on plaque assessed with 
320-row CTA, such as plaque volume, length and remodeling index, however, currently 
new dedicated software techniques are being developed to facilitate these measurements 
in the future. 
Conclusion
Plaque observations on 320-row CTA show good agreement to relative plaque composi-
tion on VH IVUS. Moreover, mixed plaques on 320-row CTA parallel the more high risk 
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Background: Imaging of coronary plaques has traditionally focused on evaluating 
degree of stenosis, as the risk for adverse cardiac events increases with stenosis sever-
ity. However, the relation between plaque composition and severity of stenosis remains 
largely unknown. Therefore, the objective of this study was to assess plaque composition 
(non-invasively by multislice computed tomography (MSCT) angiography and invasively 
by virtual histology intravascular ultrasound (VH IVUS)) in relation to degree of stenosis.
Methods: 78 patients underwent MSCT (identifying 3 plaque types; non-calcifi ed, calci-
fi ed, mixed) followed by invasive coronary angiography and VH IVUS. VH IVUS evaluated 
plaque burden, minimal lumen area and plaque composition (fi brotic, fi bro-fatty, necrotic 
core, dense calcium) and plaques were classifi ed as fi brocalcifi c, fi broatheroma, thin 
capped fi broatheroma (TCFA), pathological intimal thickening. For each plaque, percent 
stenosis was evaluated by quantitative coronary angiography. Signifi cant stenosis was 
defi ned > 50% stenosis. 
Results: Overall, 43 plaques (19%) corresponded to signifi cant stenosis. Of the 227 
plaques analyzed, 70 were non-calcifi ed plaques (31%), 96 mixed (42%) and 61 calci-
fi ed (27%) on MSCT. Plaque types on MSCT were equally distributed among signifi cant 
and non-signifi cant stenoses. VH IVUS identifi ed that plaques with signifi cant stenosis 
had higher plaque burden (67 ± 11% vs. 53 ± 12%, p<0.05) and smaller minimal lumen 
area (4.6 (3.8 - 6.8) mm² vs. 7.3 (5.4 - 10.5) mm², p<0.05). Interestingly, no differences 
were observed in % fi brotic, fi bro-fatty, dense calcium and necrotic core. Non-signifi cant 
stenoses were more frequently classifi ed as pathological intimal thickening (46 (25%) vs. 
3 (7%), p<0.05), although TCFA (more vulnerable plaque) was distributed equally (p=0.18).
Conclusion: No evident relation exists between the degree of stenosis and plaque com-









Imaging of atherosclerosis has traditionally focused on evaluating the degree of stenosis, 
as the risk for adverse cardiac events increases with stenosis severity.1 However, plaque 
composition rather than degree of stenosis may play a pivotal role in the development of 
acute atherothrombotic events and sudden cardiac death. Indeed, rupture of a vulnerable 
plaque (plaque with a large necrotic core, macrophage infi ltration and thin fi brous cap) 
has been considered to be the primary cause of acute coronary syndromes (ACS).2 In 
addition, it has been shown that almost two-thirds of vulnerable plaques are located in 
non-obstructive atherosclerotic lesions.3 4 Moreover, non-obstructive lesions outnumber 
the more severely obstructive lesions and therefore account for the majority of ruptured 
plaques.5 6 Possibly, direct visualisation of atherosclerosis rather than merely identifying 
obstructive disease may improve risk stratifi cation for future events.
Multislice computed tomography (MSCT) has been demonstrated to be a promising 
tool for non-invasive assessment of atherosclerotic plaque burden and composition.7 An 
important advantage of MSCT is that the technique not only visualizes luminal narrowing 
but can also identify atherosclerotic plaque in the arterial vessel wall.7 8 Accordingly, in 
contrast to invasive coronary angiography, lesions that show outward (positive) remodel-
ing without luminal narrowing can also be easily identifi ed. In addition, information on 
plaque composition can be obtained and lesions can be differentiated into non-calcifi ed, 
mixed or calcifi ed. Interestingly, retrospective studies comparing plaque composition on 
MSCT between patients presenting with ACS and stable coronary artery disease (CAD) 
showed that non-calcifi ed and mixed plaques were associated with ACS.9 10 
With respect to invasive techniques, virtual histology intravascular ultrasound (VH 
IVUS) is a promising modality for the assessment of coronary plaque characteristics in 
vivo. VH IVUS has been validated against histopathology and shows good accuracy for 
the determination of different plaque components such as fi brotic, fi bro-fatty, necrotic 
core and dense calcium.11 The predictive accuracy of VH IVUS plaque composition assess-
ment, when compared to histopathology, was 90.4% for fi brous, 92.8% for fi bro-fatty, 
89.5% for necrotic core, and 90.9% for dense calcium regions. Using this technique, it 
was demonstrated that differences in plaque composition can be related to particular 
clinical settings. Indeed, in a study by Rodriguez-Granillo et al., VH IVUS derived thin 
capped fi broatheroma (vulnerable plaque) were found more often in patients with ACS 
than patients with stable CAD.12 Accordingly, VH IVUS may be useful for the evaluation of 
atherosclerotic plaque composition in vivo.
The purpose of this study was to evaluate if differences in plaque composition are 
related to the degree of stenosis. To this end, plaque composition was evaluated non-
































Patients and study protocol
The study group consisted of 78 symptomatic patients who presented at the outpatient 
clinic (Leiden, the Netherlands) for the evaluation of chest pain and underwent MSCT 
coronary angiography followed within a month by clinically referred invasive coronary 
angiography and VH IVUS of 1 to 3 vessels. Contra-indications for MSCT were 1) (supra) 
ventricular arrhythmias, 2) renal insuffi ciency (glomerular fi ltration rate < 30 ml/min), 3) 
known allergy to iodine contrast material, 4) severe claustrophobia, 5) pregnancy. Exclu-
sion criteria for IVUS were severe vessel tortuousness, severe stenosis or vessel occlusion. 
In each patient, the presence of CAD risk factors such as diabetes mellitus, systemic 
hypertension, hypercholesterolemia, positive family history, smoking and obesity, were 
recorded. The Framingham 10-year risk for hard CAD events was calculated as previ-
ously described in the National Cholesterol Education Program’s Adult Treatment Panel 
III report.13 Subsequently, the study population was then categorized as at low (< 10%), 
intermediate (10 - 20%) and high risk (> 20%).
MSCT
Data acquisition 
MSCT coronary angiography was performed using either a 64-detector row helical scan-
ner (Aquilion 64, Toshiba Multi-slice system, Toshiba Medical Systems, Otawara, Japan) or 
a 320-detector row volumetric scanner (Aquilion ONE, Toshiba Medical Systems, Otawara, 
Japan). Unless contra-indicated, if the heart rate ≥ 65 beats/min, beta-blockers (meto-
prolol 50 or 100 mg, single dose, 1 hour prior to examination) were administered. For the 
64-slice contrast enhanced scan, collimation was 64 x 0.5 mm, tube voltage 100 to 135 kV 
and tube current 250 to 350 mA, depending on body shape. Non-ionic contrast material 
(Iomeron 400, Bracco, Milan, Italy) was administered with an amount of 80 to 110 ml 
followed by a saline fl ush with a fl ow rate of 5 ml/sec. For the 320-slice contrast enhanced 
scan the heart was imaged in a single heartbeat, using prospective triggering with expo-
sure interval depending on the heart rate. Scan parameters were: 350 ms gantry rotation 
time, 100 to 135 kV tube voltage and a tube current of 400 to 580 mA, depending on body 
mass index. In total, 60 to 90 ml contrast material (Iomeron 400) was administered with a 
rate of 5 - 6 ml/sec followed by a saline fl ush. Subsequently, data sets were reconstructed 
and transferred to a remote workstation as previously described.14
Coronary plaque assessment 
MSCT angiograms were evaluated using dedicated software (Vitrea 2.0 or Vitrea FX 1.0, 
Vital images, Minnetonka, MN, USA). MSCT angiographic examinations were evaluated in 
consensus by 2 experienced readers including an interventional cardiologist blinded to 
conventional coronary angiography and IVUS fi ndings. According to the modifi ed Ameri-








Each segment was evaluated for the presence of any atherosclerotic plaque using axial 
and/or orthogonal images and curved multiplanar reconstructions. Structures > 1 mm2 
within and/or adjacent to the coronary artery lumen, which could be clearly distinguished 
from the vessel lumen, were defi ned as plaques.7 Per segment one coronary plaque 
was selected at the site of the most severe luminal narrowing. To verify the presence 
of calcifi cations, the calcium score was evaluated prior to determining plaque composi-
tion. Plaques were further classifi ed as: 1) non-calcifi ed plaque (plaques with lower CT 
(computed tomography) attenuation compared to contrast-enhanced lumen without 
any calcifi cation), 2) mixed plaque (non-calcifi ed and calcifi ed elements in single plaque) 
3) calcifi ed plaque (plaques with high CT attenuation compared to contrast-enhanced 
lumen). 
Conventional coronary angiography
Conventional coronary angiography was performed according to standard protocols. 
Vascular access was obtained through the femoral approach according to the Seldinger 
technique with the use of a 6F or 7F sheath. Quantitative coronary angiography (QCA) 
analysis was performed by observer unaware of MSCT and IVUS fi ndings with the use of 
QCA-CMS version 6.0 (Medis, Leiden, The Netherlands). For each plaque examined both 
with MSCT and VH IVUS, percent diameter stenosis as measured by quantitative coronary 
angiography was reported. Measurements were performed on at least two orthogonal 
projections. The highest percent diameter stenosis was used for further analysis. Signifi -
cant stenosis was defi ned as > 50% stenosis.
VH IVUS
Image acquisition
VH IVUS examinations were acquired during coronary angiography in 136 of the 225 
available vessels with the use of a dedicated IVUS-console (Volcano Corporation, Rancho 
Cordova, CA, USA). After administration of nitrates locally, VH IVUS was performed with 
a 20 MHz, 2.9 F phased-array IVUS catheter, (Eagle Eye, Volcano Corporation, Rancho 
Cordova, CA, USA) which was introduced distally in the coronary artery. A speed of 0.5 
mm/s was used for motorized automated pullback until the catheter reached the guiding 
catheter. Images were stored on CD-ROM or DVD for off-line analysis.
Image analysis
VH IVUS analysis was performed by two experienced observers blinded to baseline 
patient characteristics with the use of dedicated software (pcVH 2.1, Volcano Corporation, 
Rancho Cordova, CA, USA). The lumen and the media-adventitia interface were defi ned by 
automatic contour detection and on all individual frames manual editing was performed. 
All four plaque components were differentiated into different color-codes (fi brotic tissue 
being labeled in dark green, fi bro-fatty in light green, necrotic core in red and dense 































calculated and percentage plaque burden was calculated as plaque plus media cross sec-
tional area (CSA) divided by external elastic membrane CSA multiplied by 100.17 Plaque 
composition was calculated as percentage of the plaque burden. 
Qualitative evaluation of plaque type was visually assed at the minimal lumen area site 
as assessed on IVUS using the following classifi cation: (i) Pathological intimal thickening 
(PIT); defi ned as a mixture of fi brous and fi bro-fatty tissues, a plaque burden ≥ 40% and < 
10% necrotic core and dense calcium. (ii) Fibroatheroma (FA); defi ned as having a plaque 
burden ≥ 40% and a confl uent necrotic core occupying 10% of the plaque area or greater 
in 3 successive frames with evidence of an overlying fi brous cap. (iii) Thin capped fi broath-
eroma (TCFA); defi ned as a lesion with a plaque burden ≥ 40%, the presence of confl uent 
necrotic core of > 10%, and no evidence of an overlying fi brous cap. (iiii) Fibrocalcifi c 
plaque (FC); defi ned as a lesion with a plaque burden ≥ 40%, being mainly composed 
of fi brotic tissue, having dense calcium > 10% and a confl uent necrotic core of < 10% 
(higher amount accepted if necrotic core was located exclusively behind the accumula-
tion of calcium).18 19 To match plaques identifi ed on MSCT with plaques identifi ed on VH 
IVUS; landmarks such as coronary ostia, side-branches and calcium deposits were used. 
Distances from the landmarks to the lesion were measured on multiplanar reconstructions 
on MSCT and matched with the longitudinal images of VH IVUS. 
Statistical analysis
Continuous values are expressed as means (± standard deviation) if normally distributed 
and compared with the 2-tailed t-test for independent samples. If not normally distributed, 
values are expressed as medians (interquartile range) and compared with the 2-tailed 
Mann-Whitney test. Categorical values are expressed as number (percentages) and com-
pared between groups with 2-tailed Chi-square test. Binary logistic regression analysis 
was used to calculate the relation of signifi cant stenosis with the different plaque types as 
identifi ed on MSCT or VH IVUS. A p-value of < 0.05 was considered statistically signifi cant. 
Statistical analysis was performed using SPSS 14.0 software (SPSS Inc., Chicago. Illinois).
RESULTS
Patients and study protocol
In total, 78 patients were identifi ed that had undergone MSCT and invasive coronary 
angiography with VH IVUS. A patient example is provided in Figure 1. Three patients 
were excluded due to absence of any identifi able plaques on MSCT. In all patients MSCT 
angiograms and VH IVUS studies were of diagnostic image quality. Patient characteristics 
of the remaining 75 patients are summarized in Table 1. In 89 vessels (40%) VH IVUS could 
not be performed due to severe vessel stenosis, vessel tortuousness, vessel occlusion 
or time limitations in the catheterization laboratory. As a result, 136 vessels (60%) were 
available for analysis. In total, 227 plaques were identifi ed on MSCT in which correspond-










Figure 1. An example of combination of non-invasive imaging with 320-slice multislice computed 
tomography (MSCT) angiography and invasive imaging with coronary angiography and virtual 
histology intravascular ultrasound (VH IVUS). A 53 year old female was referred because of chest 
pain and intermediate risk profi le, exercise testing was inconclusive and the patient was referred for 
anatomical evaluation by MSCT. An intermediate lesion in de mid left anterior descending coronary 
artery (LAD) was identifi ed on MSCT. Consequently, the patient was further referred for coronary 
angiography combined with (VH) IVUS. (Panel A) Three-dimensional reconstruction depicting a 
lesion (arrow) with intermediate luminal narrowing in the mid LAD. (Panel B) Curved multiplanar 
reconstruction of the LAD and the corresponding lesion (arrow) showing a mixed plaque. 
(Panel C) The fi ndings were confi rmed on conventional coronary angiography and quantitative 
coronary angiography (QCA) analysis demonstrating luminal narrowing of 42% (arrow). (Panel D) 































was 29 ± 9%. Forty-three plaques (19%) corresponded to a signifi cant stenosis (average 
percentage stenosis 61 ± 9%) and 184 plaques (81%) corresponded to a non-signifi cant 
stenosis (average percentage stenosis 22 ± 2%).
Compositional characteristics in relation to angiographic degree of stenosis
Composition on MSCT 
Of the 227 plaques analyzed, 70 were non-calcifi ed plaques (31%), 96 were mixed (42%) 
and 61 were calcifi ed (27%) on MSCT. The different plaque types as identifi ed by MSCT 
were equally distributed among signifi cant and non-signifi cant stenoses (Figure 2). Plaque 
type on MSCT was not signifi cantly related to stenosis (non-calcifi ed plaque; OR (CI 95%) 
0.9 (0.4 - 1.8), p=0.68, mixed plaque; OR (CI 95%) 1.5 (0.8 - 1.9), p=0.26); calcifi ed plaque 
OR (CI 95%) 0.7 (0.3 - 1.7), p=0.41). 
Composition on VH IVUS 
In 136 vessels and 227 plaques, VH IVUS was successfully performed. The average plaque 
length analyzed was 22 ± 17 mm. Overall, the most prevalent plaque component was 
fi brotic tissue (52 ± 12%), followed by fi bro-fatty tissue (22 ± 16%), necrotic core (15 ± 
Table 1. Patient characteristics of study population.
n (%)
Gender (M / F) 43 / 32
Age (years) 59 ± 11
Risk factors for CAD (%)
Diabetes Mellitus 22 (29%)
Hypertension 45 (60%)
Hypercholesterolemia 57 (76%)
Positive family history 33 (44%)
Current smoking 38 (51%)
Obese (BMI ≥ 30 kg/m2) 14 (19%)
Previous CAD
Previous myocardial infarction 20 (27%)




Heart rate (bpm) during MSCT 62 ± 9
Prevalence of signifi cant CAD (defi ned as at least 1 stenosis with 
> 50% luminal narrowing on QCA)
29 (39%)









9%) and dense calcium (11 ± 10%). As expected and can be derived from Table 2, plaques 
with a signifi cant stenosis had a signifi cantly higher plaque burden (67 ± 11% versus 53 ± 
12%, p<0.05) and smaller minimum lumen area (4.6 (3.8 - 6.8) mm² versus 7.3 (5.4 - 10.5) 
mm², p<0.05) than compared to plaques without signifi cant stenosis. Interestingly, no 
differences were observed in the amount of fi brotic tissue (51 ± 10% versus 53 ± 13%, 
p=0.62), fi bro-fatty tissue (21 (9 - 33) % versus 18 (10 - 29) %, p=0.42), necrotic core (15 ± 
8% versus 15 ± 9%, p=0.95) and dense calcium (8 (3 - 15) % versus 9 (3 - 15) %, p=0.77). 
Qualitative visual evaluation of coronary plaques revealed that pathological intimal 
thickening was more frequently observed in lesions with non-signifi cant stenosis (3 (7%) 
versus 46 (25%), p<0.05), however, the more vulnerable plaques (thin capped fi broath-
eroma) were distributed equally (10 (23%) versus 27 (15%), p= 0.18) (Figure 3). Pathologi-
cal intimal thickening was signifi cantly related to non-signifi cant stenosis (OR (CI 95%) for 
signifi cant stenosis 0.2 (0.1 - 0.8), p=0.02), although there was no relation between the 
more vulnerable plaque types (thin capped fi broatheroma) and signifi cant stenosis (OR 
(CI 95%) 1.8 (0.8 - 4.0), p=0.18).
Figure 2. Bar graph demonstrating the relative distribution of different plaque types as determined by 
multislice computed tomography (MSCT) in lesions with signifi cant and non-signifi cant stenosis (p=ns).
Table 2. Differences in plaque composition between lesions with signifi cant and non-signifi cant 






Plaque burden (%) 67 ± 11 53 ± 12 <0.05
MLA mm² 4.6 (3.8 - 6.8) 7.3 (5.4 - 10.5) <0.05
% Fibrotic 51 ± 10 53 ± 13 0.62
% Fibro-fatty 21 (9 - 33) 18 (10 - 29) 0.42
% Necrotic core 15 ± 8 15 ± 9 0.95
































In the present study differences in plaque composition and vulnerability between lesions 
with signifi cant and non-signifi cant stenosis were assessed using non-invasive MSCT 
angiography and invasive VH IVUS. The main fi ndings of coronary plaque characterization 
using MSCT and VH IVUS can be summarized as follows.
No differences in plaque composition between signifi cant and non-signifi cant stenosis 
were demonstrated non-invasively by MSCT and invasively by VH IVUS. MSCT showed 
that the proportion of non-calcifi ed, mixed and calcifi ed plaques were similar between 
signifi cant and non-signifi cant lesions. VH IVUS confi rmed these fi ndings, revealing no 
differences in plaque composition (fi brotic, fi bro-fatty, necrotic core and dense calcium) 
between signifi cant and non-signifi cant stenosis. Importantly, no differences were observed 
in plaque vulnerability between signifi cant and non-signifi cant stenosis as demon strated 
by an even distribution of thin capped fi broatheroma and percent necrotic core.
Figure 3. Differences in percentage of visually assessed plaque types on virtual histology 
intravascular ultrasound (VH IVUS) between lesions with signifi cant and non-signifi cant stenosis. 
Signifi cantly more lesions classifi ed as pathological intimal thickening (PIT) were present in non-
signifi cant stenosis as compared to signifi cant stenosis (A). Percentage of fi broatheroma (FA), thin 
capped fi broatheroma (TCFA) and fi brocalcifi c (FC) plaques were not signifi cantly different between 








In the present study non-calcifi ed, mixed and calcifi ed plaques on MSCT were equally 
distributed between lesions with signifi cant and non-signifi cant stenosis. The observa-
tions on MSCT corresponded to the fi ndings on VH IVUS, indicating that plaque composi-
tion did not differ between lesions with signifi cant and non-signifi cant stenosis. These 
results are in line with previous studies exploring plaque composition with grayscale IVUS 
in relation to luminal narrowing on coronary angiography.20 
Nonetheless, qualitative evaluation of plaque type on VH IVUS revealed more early 
stage atherosclerosis in non-signifi cant stenosis, as refl ected by a higher prevalence of 
pathological intimal thickening. On the other hand, one would also expect to fi nd more 
advanced plaque composition in lesions with signifi cant stenosis, including a higher degree 
of calcium. Indeed, other non-invasive imaging techniques, such as calcium scoring on 
electron beam computed tomography, have demonstrated that calcium is more prevalent 
in patients with larger atherosclerotic plaque burden and that a moderate relation exists 
between the extent of coronary calcium and presence of obstructive CAD.21 However in 
the present study, no differences were found between the prevalence of calcifi ed plaques 
on MSCT in signifi cant and non-signifi cant stenosis. These fi ndings were confi rmed by 
an even distribution of dense calcium on VH IVUS. This could possibly be explained by 
the fact that there is a marked discrepancy between apparent angiographic luminal nar-
rowing and actual extent of atherosclerosis. Indeed, due to compensatory enlargement 
or positive remodeling, a substantial build up of plaque can occur before resulting in 
luminal narrowing and reduction of blood fl ow. Therefore, plaque composition gradually 
becomes more advanced while remaining non-signifi cant (in terms of luminal narrowing) 
for a considerable period of time. Of note, recently Sipahi and co-workers demonstrated 
that type of arterial remodeling (negative or positive) does not predict subsequent pro-
gression of atherosclerosis in patients undergoing statin therapy.22 Interestingly, similar 
observations to our results were reported by Mintz et al. using IVUS. The authors reported 
that coronary calcium correlated well with plaque burden but not with angiographical 
luminal narrowing.23 Accordingly, angiographic intermediate lesions were as likely to 
contain signifi cant amounts of calcium as severe lesions. 
Interestingly, also no difference in the proportion of non-calcifi ed and mixed lesions was 
observed on MSCT among lesions with signifi cant and non-signifi cant stenosis. Although 
data are scarce, it has been suggested that non-calcifi ed and mixed plaques on MSCT may 
be associated with increased plaque vulnerability.10 24 Indeed, studies comparing plaque 
patterns on MSCT between patients presenting with ACS and stable CAD have consistently 
shown that non-calcifi ed and mixed plaques are more prevalent in patients with ACS.9 10 
In addition, these lesions have been demonstrated to correspond with a larger amount 
of necrotic core and a higher prevalence of thin capped fi broatheroma on VH IVUS.10 
Accordingly, these observations suggest that the observation of non-calcifi ed or mixed 
plaque on MSCT may potentially be of clinical relevance, regardless of stenosis severity.
Importantly, the observation of similar plaque composition between signifi cant and 
non-signifi cant stenosis translated into no differences in plaque vulnerability on VH IVUS, 































core on VH IVUS. Similar observations have been reported by serial angiographic studies 
showing that vulnerability was poorly related to angiographic degree of luminal narrow-
ing.3 4 25 In line with these studies, investigations directly addressing plaque composition 
also reported a lack of agreement between plaque vulnerability and degree of stenosis. 
Using conventional grayscale IVUS, Yamagishi et al. prospectively examined coronary 
plaques with IVUS and found no differences in degree of luminal narrowing between 
plaques prior to ACS and plaques that remained stable.26 In addition, Saam et al. studied 
carotid arteries of 192 subjects with non-invasive magnetic resonance plaque character-
ization and demonstrated that vulnerable lesions were equally present in lesions with 
signifi cant and non-signifi cant stenosis.27 
Clinical implications
At present, MSCT is increasingly used in the evaluation of patients presenting with 
suspected CAD. Accordingly, the main objective in these patients is to determine the 
presence of signifi cant stenosis in the coronary arteries and high diagnostic accuracies 
have been reported for this purpose.28 In addition, data supporting its prognostic value 
are starting to emerge.29 30 In several studies the presence of signifi cant CAD on MSCT has 
been shown to result in a higher likelihood of coronary events. However, assessment of 
the presence, extent and type of atherosclerosis in addition to the degree of stenosis may 
potentially further refi ne risk stratifi cation. In a preliminary prognostic study by Pundziute 
et al, the presence of non-signifi cant stenosis was shown to be associated with worse 
outcome as compared to complete absence of any atherosclerosis.31 Our current observa-
tions further support this concept, showing no difference in plaque composition and 
vulnerability between signifi cant and non-signifi cant lesions. Moreover, the incremental 
prognostic value of MSCT variables describing extent as well as type of atherosclerosis 
was recently evaluated by van Werkhoven et al.30 Interestingly, the authors showed that 
the presence of substantial non-calcifi ed plaque burden (regardless of stenosis severity) 
on MSCT was an independent predictor of adverse cardiac events providing incremen-
tal prognostic value over the presence of a signifi cant stenosis.30 Accordingly, these as 
well as our current observations may be of help in understanding the potential value of 
assessing plaque burden and plaque type on MSCT and suggest that evaluation of MSCT 
angiograms should not be restricted to assessment of luminal narrowing alone. Possibly, 
incorporation of information on the presence, extent, and composition of atherosclerosis 
may allow refi ned and more individualized risk stratifi cation and thus improved identifi ca-
tion of patients requiring more aggressive therapy. However, available data are scarce and 
need to be confi rmed in larger patient cohorts.
Limitations
Imaging of severely stenotic or occluded lesions with IVUS is not possible. Therefore, the 









No evident relation between the degree of stenosis and plaque composition or vulner-
ability, as evaluated non-invasively by MSCT and invasively by VH IVUS, was observed. 
Evaluation of plaque composition may provide valuable information incremental to 
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Background: Previous angiographic studies have shown that almost two-thirds of vulner-
able plaques are located in non-obstructive lesions. Possibly, the site of greatest vulner-
ability is not always located at the site of most severe stenosis. Therefore, the purpose of 
this study was to evaluate the difference in location between the site of greatest vulner-
ability and the site of most severe narrowing as assessed by virtual histology intravascular 
ultrasound (VH IVUS). 
Methods: Overall, 77 patients (139 vessels) underwent VH IVUS. The site of greatest vul-
nerability was defi ned as the cross-section with the largest necrotic core area per vessel, 
the maximum necrotic core (Max NC) site. The site of most severe narrowing was defi ned 
as the minimum lumen area (MLA). Per vessel the distance from both the Max NC site and 
MLA site to the origo of the coronary artery was evaluated. In addition, the presence of a 
thin cap fi broatheroma (TCFA) was assessed. 
Results: The mean difference (mm) between the MLA site and Max NC site was 
10.8±20.6mm (P<0.001). Interestingly, the Max NC site was located at the MLA site in 7 
vessels (5%) and proximally to the MLA site in 92 vessels (66%). Importantly, a higher % 
of TCFA was demonstrated at the Max NC site as compared to the MLA site (24% versus 
9%, P<0.001).
Conclusion: The present fi ndings demonstrate that the site of greatest vulnerability is 
rarely at the site of most severe narrowing. Most often, the site of greatest vulnerability is 









Previous angiographic studies have shown that almost two-thirds of vulnerable plaques 
are located in non-obstructive atherosclerotic lesions.1 2 Nevertheless, at present, inter-
ventional strategies are mainly targeted towards management of acute coronary syn-
dromes at the site of most severe luminal narrowing. Whether this approach adequately 
covers the more vulnerable regions remains uncertain. Thus far, the spatial relationship 
between the location of most severe narrowing and vulnerable rupture sites has not been 
fully elucidated. 
Virtual histology intravascular ultrasound (VH IVUS) is a promising tool for the assess-
ment of plaque composition.3 Using spectral analysis of radiofrequency backscatter 
signals, this technique has the ability to evaluate 4 plaque components, namely fi brotic, 
fi bro-fatty, necrotic core and calcifi ed tissue. The accuracy of VH IVUS for the determina-
tion of plaque components has been validated against histopathology in human coronary 
arteries and was 90.4% for fi brous, 92.8% for fi bro-fatty, 89.5% for necrotic core and 
90.9% for dense calcium.3 4 Recently, a large prospective multi-centre study by Stone et al. 
showed a strong predictive value of the presence of thin cap fi broatheroma (TCFA) on VH 
IVUS.5 In a cohort of 697 patients, the presence of TCFA on VH IVUS was demonstrated to 
be an independent predictor of major adverse cardiovascular events. 
The aim of the present study was to improve understanding of the spatial relationship 
between the location of the site of greatest vulnerability and the location of most severe 
narrowing. Therefore, we compared the location of the maximum necrotic core area (site 
of greatest vulnerability) with the location of the minimum lumen area (site of most severe 
narrowing) with VH IVUS.
METHODS
Patients
The study population consisted of 77 patients with chest pain referred for invasive coro-
nary angiography (ICA). Patients were clinically referred for invasive coronary angiogra-
phy because of known or suspected coronary artery disease (CAD). Referral for invasive 
coronary angiography was based on clinical presentation and/or imaging results. VH 
IVUS was performed to further evaluate the extent and severity of disease. Both patients 
presenting with stable chest pain and acute coronary syndrome (ACS) were evaluated. 
Patients with ACS included unstable angina and non-ST-segment elevation myocardial 
infarction defi ned according to the guidelines of the European Society of Cardiology6 
and the American College of Cardiology (ACC)/American Heart Association.7 Patient data 
were prospectively collected in the departmental Cardiology Information System (EPD-
Vision®, Leiden University Medical Center, Leiden, the Netherlands) and retrospectively 
analyzed. Contra-indications for VH IVUS were severe vessel tortuosity, severe luminal 
























such as diabetes, hypertension, hypercholesterolemia, positive family history, smoking 
and obesity, was recorded. 
VH IVUS acquisition
VH IVUS was performed according to standard clinical protocol during ICA using a novel 
dedicated IVUS-console (s5tm Imaging system, Volcano Corporation, Rancho Cordova, CA, 
USA). After local intracoronary admission of 200 μg nitroglycerin, VH IVUS was performed 
with a 20 MHz, 2.9 F phased-array IVUS catheter (Eagle Eye, Volcano Corporation, Rancho 
Cordova, CA, USA). The IVUS catheter was positioned distally in the coronary artery and 
motorized automated IVUS pullback was performed using a speed of 0.5 mm/s until the 
catheter reached the guiding catheter. Images were obtained at the R-wave peak on the 
ECG. At an average heart rate of 60/min, the incremental distance between frames was 
approximately 0.5 mm. Cine runs were performed to record the starting position of the VH 
IVUS catheter. Images were stored on DVD for further offl ine analysis. 
VH IVUS analysis
Images were analyzed offl ine using specially developed dedicated software for images 
acquired on the s5tm IVUS Imaging system (QCU- CMS 4.59, Medis, Leiden, The Nether-
lands). Vessels without evidence of major atherosclerotic plaque (plaque burden <40%) or 
with previous stent placement were excluded from further analysis. All IVUS examinations 
were evaluated by two experienced observers. First, the IVUS run was visually assessed to 
confi rm that the pullback had been performed at a constant speed.
Second, contour detection of the external elastic membrane (EEM) and lumen was 
performed. The area enclosed by the contours of EEM and lumen was defi ned as plaque 
area. Percentage plaque burden was calculated as plaque cross-sectional area (CSA) plus 
media CSA divided by EEM CSA multiplied by 100 according to the American College of 
Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measure-
ment and Reporting of Intravascular Ultrasound Studies (IVUS).8 Subsequently, using 
radiofrequency backscatter analysis, four plaque components were differentiated into 
color codes as validated previously.3 Accordingly, fi brotic tissue was labeled in dark green, 
fi bro-fatty in light green, dense calcium in white and necrotic core in red.
The site of most severe narrowing was defi ned as the cross-section with the small-
est cross-sectional lumen area in the entire vessel, the minimum lumen area site (MLA). 
Multiple defi nitions are available to defi ne the site of greatest vulnerability on VH IVUS. As 
amount of necrotic core is quantifi able on VH IVUS, the site of greatest vulnerability was 
defi ned as the cross-section with the largest necrotic core area per vessel, the maximum 
necrotic core (Max NC) site. Subsequently, per vessel, the maximum necrotic core (Max 
NC) site and MLA site were identifi ed. First, in each vessel the distance from both the Max 
NC site and MLA site to the ostium of the coronary artery was measured with a dedicated 
software tool in the longitudinal IVUS view. Distances were calculated based on the pull-
back speed of motorized automated pullback at a rate of 0.5 mm/s. Difference between 








site to origo. Furthermore, classifi cation of plaque type and composition was performed 
at both the Max NC site and MLA site. Plaque components were reported as absolute 
values and percentages of plaque area. In addition, visual plaque type classifi cation was 
obtained according to the following categorization:9, 10
1. Pathological intimal thickening; defi ned as a mixture of fi brotic and fi bro-fatty tissues, 
a plaque burden ≥40% and <10% necrotic core and dense calcium.
2. Fibroatheroma; defi ned as having a plaque burden ≥40% and a confl uent necrotic 
core occupying 10% of the plaque area or greater in three successive frames with 
evidence of an overlying fi brous cap.
3. TCFA; defi ned as a lesion with a plaque burden ≥40%, the presence of confl uent 
necrotic core of >10%, and no evidence of a large fi brous cap.
4. Fibrocalcifi c plaque; defi ned as a lesion with a plaque burden ≥40%, with dense 
calcium >10% and a percentage necrotic core of <10% (higher amount accepted if 
necrotic core was located exclusively behind the accumulation of calcium). 
Statistical analysis
Statistical analyses were performed using SPSS (version 17.0, SPSS Inc., Chicago, IL, USA). 
First, the spatial relationship (in mm) between Max NC and MLA site was assessed. In a 
sub-analysis, the impact of clinical presentation (patients with stable CAD versus patients 
with ACS) and the difference in length between the Max NC and MLA site was evalu-
ated. Furthermore, differences in plaque composition and type between both the Max 
NC and MLA site were compared. When normally distributed, continuous variables were 
expressed as mean (± standard deviation) and compared with independent sample t-test 
for unpaired samples or the dependent t-test for paired samples. If not normally distrib-
uted, variables were presented as median and interquartile range. Unpaired samples were 
analyzed using non-parametric Mann-Whitney test and paired variables were analyzed 
with Wilcoxon signed rank tests. Categorical variables were expressed as numbers and 
percentages, and compared with the Chi-square test. A p-value of p<0.05 was considered 
signifi cant. 
RESULTS
Overall, 77 patients were evaluated. Patient characteristics are presented in Table 1. In 
total, 169 vessels were analyzed with VH IVUS, in 30 vessels (18%) previous PCI was per-
formed and these vessels were therefore excluded. Thus, 139 vessels were included for 
further analysis. 
The spatial relationship between the Max NC and MLA site is demonstrated in Figure 1. 
Interestingly, the Max NC site was located in the same location as the MLA site in only 
























Table 1. Patient characteristics of study population. 
n (%)
Age (years) 59 ± 10 
Gender (% male) 64 (70%) 
Risk factors for CAD 
Obesity (Body mass index ≥ 30 kg/m2) 21 (23%) 
Diabetes 27 (29%) 
Hypertension† 54 (59%) 
Hypercholesterolemia‡ 47 (51%) 
Family history of CAD 44 (48%) 
Smoking 32 (35%) 
Aspirin use 49 (53%) 
Statin use 60 (65%) 
Previous PCI 25 (27%) 
Previous myocardial infarction 17 (19%) 
Presentation with ACS 62 (67%) 
Data are absolute values, percentages or means ± standard deviation.
†Defi ned as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90
mm Hg or the use of antihypertensive medication.
‡Serum total cholesterol ≥230 mg/dL or serum triglycerides ≥200 mg/dL or treatment with lipid 
lowering drugs.
Abbreviations: CAD, coronary artery disease; ACS, acute coronary syndrome, PCI, percutaneous 
coronary intervention.
Figure 1. Spatial relationship of the maximum necrotic core site (Max NC) as compared to minimal 








MLA site in 92 vessels (66%) and located distally from the MLA site in 40 vessels (29%). 
Accordingly, the mean difference (mm) between the MLA site and Max NC site was 10.8 
± 20.6 mm (P<0.001). Regarding the more proximally located Max NC sites, the mean 
difference between Max NC and MLA site was 19.6 ± 19.7 mm (P<0.001). Concerning 
the more distally located Max NC sites, the mean difference between Max NC site and 
MLA was 7.4 ± 7.8 mm (P<0.001). The differences in distance between Max NC site and 
MLA site were assessed between patients with ACS (n=52) and patients with stable CAD 
(n=25). Interestingly, no difference in distance between Max NC and MLA was observed 
(10.7 ± 20.5 mm for stable CAD vs. 10.9 ± 20.8 mm for patients with ACS, P=0.699). Figure 
2 shows an example of a vessel with the site of greatest vulnerability located proximal to 
the MLA site.
The differences in absolute and relative plaque composition between the Max NC and 
MLA site are demonstrated in Table 2. As expected, the Max NC site contained signifi cantly 
more necrotic core as compared to the MLA site (31% (23 - 40%) versus 19% (10 - 19%), 
P<0.001). Moreover, the MLA site contained signifi cantly more fi brotic tissue than the 
Max NC site (57% (47 - 65%) versus 49% (41 - 57 %), P<0.001). Furthermore, the MLA site 
contained signifi cantly more fi bro-fatty tissue than the Max NC site (13% (6 - 24%) versus 
6% (3 - 12%), P<0.001). Lastly, plaque burden was signifi cantly larger at the MLA site than 
at Max NC site (63% (54 - 74%) versus 59% (43 - 68%), P<0.001).
Figure 2. Example of a coronary artery with the site of maximum necrotic core (Max NC) located 
proximal from the minimal lumen area (MLA) site. Panel A demonstrates a longitudinal view of 
the intravascular ultrasound (IVUS) images. As demonstrated, the Max NC site (C) is not located at 
the minimum lumen area (MLA) site (B), but 16.4 mm proximal of the MLA site. Panel B shows the 
grayscale cross-sectional slices and the corresponding virtual histology IVUS images of the MLA 
site. Panel C shows the grayscale cross-sectional slices and the corresponding virtual histology IVUS 
images for the Max NC site. Interestingly, although the MLA site has signifi cant luminal narrowing 
























The difference in plaque type between MLA and Max NC sites was assessed. Interest-
ingly, pathological intimal thickening was most often observed at the MLA site as com-
pared to the Max NC site (26% versus 1%, P<0.001). In addition, lesions at the Max NC site 
were more often classifi ed as a fi broatheroma than lesions at the MLA site (71% versus 
60%, P=0.04). Furthermore, the percentage of fi brocalcifi c plaque was similar at both the 
MLA site and Max NC site (5% versus 4%, P=0.78). Importantly, as demonstrated in Figure 
3, a signifi cantly higher percentage of TCFA was present at Max NC site as compared to 
the MLA site (24% versus 9%, P<0.001). Moreover, if TCFA was identifi ed at the Max NC 
site, only in 33% of cases the MLA site also demonstrated a TCFA. No signifi cant differ-
ences were observed between plaque type and composition between proximal and distal 
Max NC sites (Table 3). 
Table 2. Comparison of plaque composition between maximum necrotic core (Max NC) site and 
minimum lumen area site (MLA). 
VH IVUS
plaque composition
Max NC site MLA site P-value
Lumen area (mm2) 7.3 (5.1 - 10.9) 4.3 (3.1 - 6.9) <0.001 
Vessel area (mm2) 18.7 (14.9 – 23.8) 14.0(10.4 - 17.4) <0.001 
Plaque area (mm2) 11.2 (8.5 - 13.6) 8.9 (6.1 - 11.2) <0.001 
Plaque burden 59% (49 – 68%) 63% (54 – 74%) <0.001 
Fibrotic (mm2) 3.8 (2.6 - 4.9) 3.2 (2.1 - 4.6) 0.01
Fibro-fatty (mm2) 0.5 (0.2 - 1.0) 0.7 (0.2 - 1.5) <0.001 
Necrotic core (mm2) 2.3 (1.5 - 3.1) 1.2 (0.5 - 1.8) <0.001 
Dense calcium (mm2) 0.8 (0.3 - 1.3) 0.3 (0.1 - 0.8) <0.001 
Fibrotic 49% (41 – 57%) 57% (47 – 65%) <0.001 
Fibro-fatty 6% (3 – 12%) 13% (6 – 24%) <0.001 
Necrotic core 31% (24 – 40%) 19% (9 – 28%) <0.001 
Dense calcium 10% (5 – 16%) 6% (1 – 12%) <0.001 
Data are presented as medians and interquartile range
Figure 3. Difference in presence of 
thin cap fi broatheroma (TCFA) between 
minimum lumen area (MLA) site and 
maximum necrotic core (Max NC) site. 
As demonstrated, TCFA was signifi cantly 
more often observed at the Max NC site as 









The present study evaluated the spatial relationship between the site of most severe nar-
rowing and greatest vulnerability with the use of invasive VH IVUS. Interestingly, it was 
demonstrated that the site of greatest vulnerability (defi ned as maximum necrotic core 
area) was rarely located at the site of most severe narrowing (defi ned as the minimum 
lumen area). Most often (in 66% of vessels), the site of greatest vulnerability was located 
proximal from the site of most severe narrowing. Of particular interest was the fi nding 
that a higher percentage of TCFA (plaque phenotype with high-risk of rupture) was dem-
onstrated at the site of greatest vulnerability.
Histopathological studies have observed that high-risk plaque features include the 
presence of a large necrotic core, infl ammatory cells at the shoulders of the plaque and 
a thin fi brous cap.10 11 Indeed, the rupture of a thin cap fi broatheroma is thought to be 
the primary cause of an acute coronary syndrome.12 Moreover, several landmark angio-
graphic studies have reported that the presence of plaque rupture was poorly related to 
angiographic degree of luminal narrowing.1 13 14 As demonstrated during the follow up of 
patients admitted for acute myocardial infarction, almost two thirds of plaques prone to 
rupture were located in non fl ow-limiting atherosclerotic lesions, and only a minority were 
located in severely obstructed lesions.1 Interestingly, the fi ndings of the current study 
support this concept, demonstrating invasively with VH IVUS that the more vulnerable 
sites were not at the site of most severe narrowing, but were located more proximally. 
Therefore, it could be of importance to identify the presence of a high-risk lesion with 
either non-invasive or invasive modalities, even at sites without the presence of signifi cant 
luminal narrowing. 
Table 3. Comparison of plaque composition and type between the maximum necrotic core (Max 
NC) site located proximal and distal from the minimum lumen area (MLA). 
VH IVUS 
characteristics
Max NC site proximal
to MLA site




Fibrotic 49% (41 - 56%) 49% (39 - 58%) 0.96
Fibro-fatty 6% (3 – 12%) 5% (3 - 10%) 0.40
Necrotic core 31% (24 - 40%) 34% (24 - 39%) 0.74
Dense calcium 10% (6 – 14%) 10% (4 - 19%) 0.91
Plaque type
Pathological intimal thickening 0 (0%) 1 (1%) 0.51 
Fibroatheroma 32 (24%) 63 (48%) 0.18 
Thin cap fi broatheroma 7 (5%) 23 (17%) 0.35 
Fibrocalcifi c plaque 1 (1%) 5 (4%) 0.46 
























Previous reports exploring the relation between the location of the site of most severe 
narrowing and site of greatest vulnerability using VH IVUS have demonstrated compa-
rable fi ndings.15-17 Rodriguez et al. performed VH IVUS in 40 patients and assessed the 
difference in plaque characteristics between plaque rupture site and site of most severe 
narrowing.17 Similar to the current fi ndings, the authors demonstrated a signifi cantly 
higher percentage of necrotic core at the plaque rupture site (16.8%) as compared with 
the site of most severe narrowing (11.8%). Consequently, the authors concluded that 
the plaque rupture sites had a worse plaque phenotype than the site of most severe 
narrowing. In addition, Konig et al. performed an analysis with VH IVUS in 48 patients 
and demonstrated that the site of severest stenosis was not always located at the site 
with the highest percentage necrotic core.16 However, the aforementioned investigations 
performed an analysis on a per-lesion basis, whereas the present study investigated the 
entire vessel with VH IVUS. Indeed, a vessel-based analysis provides a more complete 
evaluation and relevant vulnerable plaque sites are less likely to be missed.
A possible explanation for the current fi ndings could be the relation between presence 
of positive remodeling and plaque vulnerability. Indeed, compensatory enlargement of 
the vessel wall, including eccentric plaque growth, is strongly associated with necrotic 
core area, macrophage infi ltration and the occurrence of acute cardiac events.18 19 Also 
during in vivo VH IVUS studies, a similar connection between positive remodeling and 
plaque composition has been reported.19 20 However, with traditional invasive coronary 
angiography, lesions with outward (positive) remodeling are frequently missed. Invasive 
coronary angiography is only able to show the contrast fi lled lumen and is unable to 
visualize atherosclerosis in the arterial wall (with the exception of large calcifi cations) and 
reference segments.21 As a consequence, coronary angiography alone will not detect the 
exact location of the site of greatest vulnerability in the majority of patients. Furthermore, 
due to the difference in location between the site of most severe narrowing and the site 
of greatest vulnerability, percutaneous coronary intervention (PCI) of the high risk lesion 
will be less accurate. Incomplete coverage of a high-risk lesion can lead to increased rates 
of in-stent restenosis, dissection and stent thrombosis.22 23 Therefore, identifi cation of the 
site of greatest vulnerability, in addition to the site of most severe narrowing, could possi-
bly be of importance for clinical management and outcome. In addition, PCI is most often 
performed in fl ow-limiting lesions in order to relieve chest pain symptoms. However, no 
consensus exists regarding the type of treatment for vulnerable regions and systemic 
anti-atherosclerotic measures (statins) are currently preferred. Nevertheless, studies are 
ongoing evaluating other alternatives (e.g. bio-absorbable stents) for effective treatment 
of vulnerable plaque regions.24
The following limitations of the present study should be considered. First, the present 
study only evaluated 77 patients in a single center. Ideally, a larger patient population 
should be studied, preferably in a multicenter setting. Secondly, due to acoustic shadow-
ing it is diffi cult to assess plaque composition behind severe calcifi cations on VH IVUS. 
Therefore, possibly small non-calcifi ed elements within the more heavily calcifi ed parts 








is not yet feasible as VH IVUS has limited radial resolution of only 100 μm. A technique 
such as optical coherence tomography (OCT) imaging would permit these measurements; 
however, OCT was not performed in the present study.
Conclusion
The present fi ndings demonstrate that the site of greatest vulnerability is rarely at the 
site of most severe narrowing. Moreover, the site of greatest vulnerability is frequently 
located proximal from the site of most severe narrowing. Potentially, due to insuffi cient 
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Background: The positive predictive value of multidetector computed tomography 
angiography (CTA) for detecting signifi cant stenosis remains limited. Possibly CTA may be 
more accurate in the evaluation of atherosclerosis rather than in the evaluation of stenosis 
severity. However, a comprehensive assessment of the diagnostic performance of CTA in 
comparison to both conventional coronary angiography (CCA) and intravascular ultra-
sound (IVUS) is lacking. Therefore, the aim of the study was to systematically investigate 
the diagnostic performance of CTA for 2 endpoints, namely detecting signifi cant stenosis 
(using CCA as the reference standard) versus detecting the presence of atherosclerosis 
(using IVUS as reference of standard).
Methods: A total of 100 patients underwent CTA followed by both CCA and IVUS. Only 
those segments in which IVUS imaging was performed were included for CTA and QCA 
analysis. On CTA, each segment was evaluated for signifi cant stenosis (defi ned as ≥50% 
luminal narrowing), on CCA signifi cant stenosis was defi ned as a stenosis ≥50%. Secondly, 
on CTA, each segment was evaluated for atherosclerotic plaque, atherosclerosis on IVUS 
was defi ned as a plaque burden of ≥40% on cross-sectional area. 
Results: CTA correctly ruled out signifi cant stenosis in 53 of 53 (100%) patients. However, 
9 patients (19%) were incorrectly diagnosed as having signifi cant lesions on CTA resulting 
in sensitivity, specifi city, positive and negative predictive values of 100%, 85%, 81% and 
100%. CTA correctly ruled out the presence of atherosclerosis in 7 patients (100%) and 
correctly identifi ed the presence of atherosclerosis in 93 patients (100%). No patients 
were incorrectly classifi ed, resulting in sensitivity, specifi city, positive and negative predic-
tive values of 100%.
Conclusion: The present study is the fi rst to confi rm using both CCA and IVUS that the 
diagnostic performance of CTA is superior in the evaluation of the presence or the absence 









With the introduction of multidetector computed tomography angiography (CTA) technol-
ogy, non-invasive imaging of coronary anatomy has become possible. The technique has 
developed rapidly and is increasingly used for the evaluation of coronary artery disease 
(CAD), although the precise role of CTA in the assessment of CAD has not been adequately 
defi ned yet. On the basis of the high specifi city and the high negative predictive value, 
CTA has an excellent ability of ruling out signifi cant CAD.1-3 
However, relatively low positive predictive values have been reported and frequently 
the presence of a signifi cant stenosis that is observed on CTA is not confi rmed on con-
ventional coronary angiography (CCA).4 This discrepancy between CTA and CCA has been 
attributed to the inferior spatial and temporal resolution of CTA when compared with 
CCA and at present it seems that the technique remains inferior to CCA. However, one 
could also question the use of CCA as a reference standard. In contrast to the lumino-
graphic approach of CCA, CTA is a cross-sectional or tomographic imaging technique. As 
a result, CTA allows direct visualization of the coronary vessel wall and thus the presence 
of coronary atherosclerosis. It is anticipated that precisely this information will become 
increasingly important in the evaluation and subsequent management of patients with 
CAD.5 Possibly the true strength of coronary CTA may therefore lie in the evaluation of 
atherosclerosis rather than evaluation of signifi cant stenosis. 
Thus far diagnostic accuracy studies have only evaluated the performance of CTA using 
invasive CCA as the standard of reference.1 3 4 Nonetheless, it is conceivable that CTA may 
perform better when compared with IVUS (using atherosclerosis as endpoint) than when 
compared with CCA (using signifi cant stenosis as endpoint). However, thus far no studies 
have addressed this issue by combing these endpoints in a large cohort of patients. Such 
a comprehensive evaluation would provide valuable information to further understand 
how CTA should be used in clinical practice. Therefore, the purpose of this study was 
to provide a systematic evaluation concerning both the diagnostic accuracy for the 
detection of signifi cant stenosis (using CCA as the reference standard) and the diagnostic 
accuracy for the detection of atherosclerosis (using IVUS as the reference standard) in a 
large cohort of patients. 
METHODS
Patients and study protocol
The study group consisted of 106 patients without known CAD who were clinically referred 
for coronary CTA because of chest pain or elevated risk profi le. On the basis of imaging 
results and clinical presentation patients were referred for CCA in combination with IVUS of 
1 - 3 vessels and enrolled in the present study. Contra-indications for CTA were 1) (supra) 
ventricular arrhythmias, 2) renal insuffi ciency (glomerular fi ltration rate <30 ml/min), 3) 






















criteria for IVUS were severe vessel tortuousness, severe stenosis or vessel occlusion. In 
each patient, the presence of CAD risk factors including diabetes, systemic hypertension, 
hypercholesterolemia, positive family history, smoking and obesity, were recorded. Patients 
were classifi ed as having a low, intermediate or high pre-test likelihood of CAD using the 
method described by Diamond and Forrester.6 The study protocol was approved by the 
institutional ethics committee, and informed consent was obtained in all patients.
Multidetector computed tomography angiography
Data acquisition 
Beta-blocking medication (metoprolol 50 or 100 mg, single oral dose, 1 hour prior to 
examination) was administered in case of a heart rate ≥65 beats/min and in the absence 
of contra-indications. CTA was performed using either a 64-detector row helical scanner 
(Aquilion 64, Toshiba Medical Systems, Toshiba Medical Systems, Otawara, Japan) or a 
320-detector row volumetric scanner (Aquilion ONE, Toshiba Medical Systems, Otawara, 
Japan). For the 64-row contrast-enhanced scan, collimation was 64 x 0.5 mm, tube voltage 
100 - 135 kV and tube current 250 - 350 mA, depending on body posture. Non-ionic 
contrast material (Iomeron 400, Bracco, Milan, Italy) was administered with an amount 
of 80 - 110 ml followed by a saline fl ush with a fl ow rate of 5 ml/s. Data acquisition 
was performed during an inspiratory breath hold of ~ 8 - 10 seconds. Datasets were 
reconstructed from the retrospectively gated raw data, the best phase was reconstructed 
with an interval of 0.3 mm. Using a single test slice reconstructed throughout the vari-
ous phases of the heart cycle, other suitable R-R intervals were examined for additional 
reconstructions. 
For the 320-row contrast-enhanced scan the heart was imaged in a single heartbeat, 
using prospective triggering with exposure interval depending on the heart rate. Scan 
parameters were: 350 ms gantry rotation time, 100 - 135 kV tube voltage, and a tube 
current of 400 - 580 mA, depending on body mass index (BMI). In total, 60 - 90 ml contrast 
material (Iomeron 400) was administered with a fl ow rate of 5 - 6 ml/s followed by a 
saline fl ush. Automatic peak enhancement detection in the left ventricle was used for 
timing of the bolus using a threshold of +180 Hounsfi eld Units. Data acquisition was 
performed during an inspiratory breath hold of ~ 4 - 6 seconds. Subsequently, data sets 
were reconstructed and transferred to a remote workstation as previously described.7
Data analysis 
CTA scans were evaluated using dedicated software (Vitrea 2.0 or Vitrea FX 1.0, Vital 
images, Minnetonka, MN, USA). CTA examinations were evaluated by two experienced 
readers (blinded to CCA and IVUS results). Disagreement between readers was resolved 
in consensus. Three-dimensional rendered reconstructions were used to obtain general 
information on the anatomy of the coronary arteries. Coronary arteries were subsequently 
divided into 17 segments according to a modifi ed American Heart Association classifi ca-








for the presence of luminal narrowing using axial and/or orthogonal images and curved 
multiplanar reconstructions. Atherosclerotic lesions were deemed signifi cant stenosis if 
resulting in ≥50% luminal narrowing. Lesions below this threshold were considered to 
be non-signifi cant. Second, to evaluate the presence of atherosclerosis, each segment 
was evaluated for the presence of any atherosclerotic plaque on axial and/or orthogonal 
images and curved multiplanar reconstructions. Structures >1 mm2 within and/or adja-
cent to the coronary artery lumen, which could be clearly distinguished from the vessel 
lumen, were defi ned as atherosclerotic plaque.9 
Conventional and quantitative coronary angiography (QCA)
CCA was performed according to standard protocols. QCA analysis was performed on 
a segmental basis by an observer unaware of CTA and IVUS fi ndings with the use of 
QCA-CMS version 6.0 (Medis, Leiden, The Netherlands). QCA was performed only in 
those segments with plaque. Plaque on invasive CCA was defi ned as any evidence of 
luminal narrowing of any degree, clinically signifi cant or not, or evidence of calcifi cation 
on angiogram before or after contrast injection.10 The tip of the catheter was used for cali-
bration and for each segment examined both with CTA and IVUS, the reference diameter 
and minimum luminal diameter were measured and percentage diameter stenosis was 
reported. Measurements were performed on at least two orthogonal projections and the 
highest percentage diameter stenosis was used for further analysis. Signifi cant stenosis 
was defi ned as ≥50% luminal narrowing. 
Intravascular ultrasound
Image acquisition 
IVUS examinations were acquired during CCA in 219 of the 300 available vessels with 
the use of a dedicated IVUS-console (Volcano Corporation, Rancho Cordova, CA, USA). 
IVUS was performed with a 20 MHz, 2.9 F phased-array IVUS catheter (Eagle Eye, Volcano 
Corporation, Rancho Cordova, CA, USA), which was introduced distally in the coronary 
artery under fl uoroscopic guidance, after administration of nitrates locally. A motorized 
automated pullback with a continuous speed of 0.5 mm/s was used until the catheter 
reached the guiding catheter. Cine runs before and after contrast injections were per-
formed to confi rm the position of the IVUS catheter. Images were stored on CD-ROM or 
DVD for offl ine analysis.
Image analysis 
IVUS analysis was performed by two blinded observers. Lumen and external elastic 
membrane (EEM) contours were manually traced to determine lumen area and EEM area 
(QCU-CMS, version 4.5, Leiden, the Netherlands). In each segment, the site with minimum 
lumen area (mm2) was identifi ed. Additionally, cross-sectional area measurements of EEM, 
lumen area and percentage plaque burden (plaque and media area / EEM area multiplied 






















IVUS guidelines of the American College of Cardiology.11 The presence of visually evident 
atherosclerosis on IVUS was defi ned as a plaque burden of ≥40% cross-sectional area on 
at least three consecutive frames.12 An example of an IVUS cross-sectional image with a 
plaque burden of ≥40% is demonstrated in Figure 1.
Statistical analysis 
Only those segments in which IVUS imaging was performed were included for CTA and 
QCA analysis. First, the diagnostic accuracy (sensitivity, specifi city, positive and negative 
predictive values including 95% confi dence intervals) of CTA for the detection of signifi -
cant stenosis (luminal narrowing ≥50% on CCA) was calculated on segmental, vessel and 
patient basis. CCA was the standard of reference for detection of signifi cant stenosis and a 
segment, vessel or patient was classifi ed as true positive if a signifi cant stenosis was identi-
fi ed correctly by CTA. Second, the diagnostic accuracy (sensitivity, specifi city, positive and 
negative predictive values including 95% confi dence intervals) of CTA for the detection of 
atherosclerosis (plaque burden ≥40% on cross-sectional area on IVUS) was calculated on 
segmental, vessel and patient basis. IVUS was the standard of reference for the detection 
of atherosclerosis and a segment, vessel, or patient was classifi ed as true positive if the 
presence of atherosclerosis was identifi ed correctly by CTA. In the analysis on a vessel 
basis, the left main was considered part of the left anterior descending artery (LAD) and 
the intermediate branch was considered part of the left circumfl ex artery (LCx). Initially, 
the diagnostic accuracy was determined excluding segments of non-diagnostic image 
quality. In a subsequent analysis, non-diagnostic segments were included in the analysis 
and were considered positive for stenosis and atherosclerosis. Differences between the 
diagnostic accuracy for the two different endpoints were considered signifi cant at the 
A B
Figure 1. Example of intravascular ultrasound IVUS) cross-sectional image without (A) and with 
border detection (B). Cross-sectional image of coronary atherosclerosis with vessel border (green) 
and lumen (red) border tracing demonstrated in panel B. The IVUS image corresponds to a plaque 








0.05 level if 95% confi dence intervals did not overlap. Continuous values were expressed 
as means (± standard deviation) if normally distributed and compared with the two-tailed 
t-test for independent samples. If not normally distributed, values were expressed as 
medians and interquartile range (IQR) and compared with the 2-tailed Mann-Whitney 
test. A p-value of <0.05 was considered statistically signifi cant. 
To account for possible clustering of coronary artery segments and vessels within 
patients, the generalized estimating equation (GEE) method was applied for stenosis and 
atherosclerosis evaluation. When compared to QCA, CTA was scored as signifi cant steno-
sis present (luminal narrowing ≥50% and non-diagnostic segments) or absent (luminal 
narrowing <50%). When compared to IVUS, CTA was scored as atherosclerosis present 
(including non-diagnostic segments) or absent. First, regular binary logistic regression 
analysis was performed to evaluate the predictive value of CTA for the presence of sig-
nifi cant stenosis on QCA and the predictive value of CTA for presence of atherosclerosis 
on IVUS. Second, to adjust for clustering of segments within patient, GEE analyses were 
performed with proc GENMOD with a binominal distribution for the outcome variable, 
the link function specifi ed as logit, and patients as separate subjects. In both analyses the 
parameters of estimation and the standard error were virtually identical, suggesting that 
Table 1. Patient characteristics of the study.
Gender (male/female) 64/36
Age (years) 57 ± 11




Positive family history 44 (44%)
Current smoking 47 (47%)
Obese (BMI ≥30 kg/m2) 21 (21%)
Symptoms (%)
Typical angina 27 (27%)
Atypical angina 27 (27%)





Prevalence segments with ≥50% luminal narrowing on QCA 58 (11%)
Prevalence segments with ≥40% plaque burden on IVUS 329 (65%)






















no clustering within patients was present. Statistical analysis was performed using SPSS 
14.0 software (SPSS Inc., Chicago. Illinois, USA).
RESULTS
Patient characteristics
In the study population of 106 patients, overall image quality on CTA was reduced in 6 
patients (6%). Reasons for reduced image quality were the presence of motion artifacts, 
increased noise due to a high BMI, elevated heart rate and breathing. Accordingly, these 
patients were not included in the analysis. Patient characteristics of the remaining 100 
patients are presented in Table 1. The average age of the patient group was 57 ± 11 years 
and 64 were male (64%). The majority of patients (57%) had an intermediate pre-test 
likelihood for CAD. The average interval between CTA and CCA including IVUS was 61 
± 73 days. In total, in 528 segments both CTA and invasive data (CCA and IVUS analysis) 
were available (right coronary artery = 72, left anterior descending coronary artery = 87, 
left circumfl ex coronary artery = 60). Image quality was insuffi cient in 18 segments (3%) 
because of small vessel size (n= 8), a high BMI resulting in increased noise (n=3) and 
motion artifacts (n=7) and these segments were excluded. For this study estimated mean 
radiation dose for the 320-row CTA was 3.2 ± 1.1 mSv if scanned full dose at 75% of R-R 
interval. In patients who were scanned full dose at 65-85% of R-R interval, estimated mean 
radiation dose was 7.1 ± 1.7 mSv. For the 64-row CTA the estimated mean radiation dose 
was 18.1 ± 5.9 mSv in patients scanned for the full R-R interval, retrospectively gated.
Diagnostic accuracy of CTA for the detection of signifi cant stenosis
The diagnostic accuracy of CTA (with 95% confi dence intervals) for the detection of 
signifi cant stenosis on a segment, vessel and patient basis excluding and including non-
diagnostic segments is presented in Table 2. When excluding non-diagnostic segments, 
the presence of stenosis was correctly ruled out by CTA in 435 of 452 segments, without 
signifi cant stenosis on CCA, whereas 57 of the 58 segments were correctly classifi ed as 
having a signifi cant stenosis. However, CTA overestimated a total of 17 lesions deemed 
non-signifi cant on CCA and underestimated 1 lesion which was signifi cant on CCA. On a 
segmental basis, this resulted in a sensitivity and specifi city of respectively 98% and 96%, 
and positive and negative predictive values of 77% and 99%, respectively. On a vessel 
basis, a total of 47 vessels out of the 219 vessels were identifi ed as signifi cant stenosis on 
CCA. CTA correctly identifi ed all the 47 vessels as signifi cant (100%). In the remaining 172 
vessels, CTA correctly identifi ed 158 vessels as non-signifi cant (92%). However, 14 vessels 
were overestimated as signifi cant CAD by CTA. On a vessel basis, this resulted in a sensi-
tivity and specifi city of respectively 100% and 92%, and positive and negative predictive 
values of 77% and 100%, respectively. On a patient basis, CTA correctly ruled out signifi -








correctly identifi ed 38 of 38 patients (100%) with one or more signifi cant lesions. However, 
nine patients (19%) were incorrectly classifi ed as having signifi cant lesions on CTA. 
Diagnostic accuracy of CTA for the detection of atherosclerosis 
The diagnostic accuracy of CTA (with 95% confi dence intervals) for the detection of athero-
sclerosis on a segment, vessel and patient basis, excluding and including non-diagnostic 
segments is presented in Table 3. In the 510 evaluated segments, median minimal lumen 
area was 6.7 mm2 (IQR 4.5 - 10.1 mm2), median EEM area was 14.0 mm2 (IQR 10.0 - 20.0 
mm2) and median percentage plaque burden was 42% (IQR 34 - 50%). When excluding 
non-diagnostic segments, 329 segments with atherosclerosis were detected by IVUS, of 
which 326 were correctly identifi ed by CTA (sensitivity 99%). CTA incorrectly classifi ed 
three segments as without atherosclerosis. In addition, of the 181 segments considered 
without atherosclerosis by IVUS, atherosclerosis was correctly excluded in 179 segments 
by CTA (specifi city 99%) and two segments were incorrectly classifi ed as positive for 
atherosclerosis. On a vessel basis, 172 vessels out of 173 vessels which were deemed 
positive for atherosclerosis by IVUS were correctly identifi ed by CTA (99%). Moreover, CTA 
correctly ruled out presence of atherosclerosis in the 45 out of 46 vessels deemed nega-
tive for atherosclerosis by IVUS. Thus, CTA overestimated only one vessel as positive and 
underestimated one vessel as negative for atherosclerosis. On a vessel basis, this resulted 
in a sensitivity and specifi city of respectively, 99% and 98% and a positive and negative 
predictive value of 99% and 98%, respectively. On a patient basis CTA correctly ruled out 
the presence of atherosclerosis in 7 patients (100%), and correctly identifi ed the presence 
Table 2. Diagnostic accuracy for the detection of signifi cant stenosis, excluding and including non-
diagnostic segments. 
Segmental Analysis Vessel Analysis Patient Analysis
Excluding non-diagnostic segments
Sensitivity 57/58 (98%, 95%-100%) 47/47 (100%) 38/38 (100%)
Specifi city 435/452 (96%, 94%-97%) 158/172 (92%, 88%-96%) 53/62 (85%, 78%-93%)
PPV 57/74 (77%, 69%-85%) 47/61 (77%, 67%-88%) 38/47 (81%, 71%-90%)
NPV 435/436 (99.7%, 99%-100%) 158/158 (100%) 53/53 (100%)
Diagnostic Accuracy 492/510 (96%, 95%-98%) 205/219 (94%, 90%-97%) 91/100 (92%, 86%-96%)
Including non-diagnostic segments
Sensitivity 60/61 (98%, 95%-100%) 47/47 (100%) 38/38 (100%)
Specifi city 435/467 (93%, 91%-95%) 149/172 (87%, 82%-92%) 53/62 (85%, 78%-93%)
PPV 60/92 (65%, 55%-75%) 47/70 (67%, 56%-78%) 38/47 (81%, 71%-90%)
NPV 435/436 (99.7%, 99%-100%) 149/149 (100%) 53/53 (100%)
Diagnostic Accuracy 495/528 (94%, 92%-96%) 196/219 (90%, 85%-94%) 91/100 (92%, 86%-96%)
Accuracy and 95% confi dence intervals of CTA to detect signifi cant stenosis using CCA as the 
standard of reference [segmental (n=510), vessel (n=219) and patient (n=100) analysis], excluding 
and including non-diagnostic segments.






















Table 3. Diagnostic accuracy for the detection of atherosclerosis, excluding and including non-
diagnostic segments.
Segmental Analysis Vessel Analysis Patient Analysis
Excluding non-diagnostic segments
Sensitivity 326/329 (99%, 98%-100%) 172/173 (99%, 98%-100%) 93/93 (100%)
Specifi city 179/181 (99%, 97%-100%) 45/46 (98%, 94%-100%) 7/7 (100%)
PPV 326/328 (99%, 99%-100%) 172/173 (99%, 98%-100%) 93/93 (100%)
NPV 179/182 (98%, 97%-100%) 45/46 (98%, 94%-100%) 7/7 (100%)
Diagnostic Accuracy 505/510 (99%, 98%-99.8%) 217/219 (99%, 98%-100%) 100/100 (100%)
Including non-diagnostic segments
Sensitivity 343/346 (99%, 98%-100%) 172/173 (99%, 98%-100%) 93/93 (100%)
Specifi city 179/182 (98%, 97%-100%) 45/46 (98%, 94%-100%) 7/7 (100%)
PPV 343/346 (99%, 98%-100%) 172/173 (99%, 98%-100%) 93/93 (100%)
NPV 179/182 (98% (97%-100%) 45/46 (98 %, 94%-100%) 7/7 (100%)
Diagnostic Accuracy 522/528 (99%, (98%-99.7%) 217/219 (98%, 99%-100%) 100/100 (100%)
Accuracy and 95% confi dence intervals of CTA for the detection of atherosclerosis, with IVUS as the 
standard of reference [segmental (n=510), vessel (n=219) and patient (n=100) analysis], excluding 
and including non-diagnostic segments.
PPV; positive predictive value, NPV; negative predictive value.
p<0.001
p=0.484
Figure 2A. Difference in percentage luminal 
narrowing between true and false positives 
for detection of signifi cant stenosis on 
multidetector computed tomography 
angiography (CTA). Box plot graph illustrating 
the difference in percentage luminal narrowing 
on conventional coronary angiography (CCA) 
between true positive (median = 61%) and false 
positive (median = 39%) lesions for signifi cant 
stenosis on CTA. 
Figure 2B. Difference in percentage plaque 
burden between true and false positives for 
signifi cant stenosis on multidetector computed 
tomography angiography (CTA).
Boxplot illustrating the difference in percentage 
plaque burden on intravascular ultrasound 
(IVUS) between lesions true positive (median 
= 56%) and false positive (median = 56%) for 








of atherosclerosis in 93 patients (100%) resulting in sensitivity, specifi city, positive and 
negative predictive values of 100%.
Quantitative analysis of CCA and IVUS characteristics of lesions with 
correct and incorrect diagnosis of signifi cant stenosis on CTA 
To explore the differences between lesions correctly identifi ed as a signifi cant stenosis by 
CTA (true positives) and lesions incorrectly identifi ed as signifi cant lesions by CTA (false 
positives), CCA, and IVUS characteristics were compared. As demonstrated in Figure 2A, 
percentage luminal narrowing on CCA was signifi cantly higher in true positives when 
compared with false positives (61% (IQR 57 - 70%) versus 39% (IQR 28 - 43%) p<0.001). 
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Figure 3. Case example of a 65 year old male with extensive coronary artery disease (CAD) 
as demonstrated by 320-row multidetector computed tomography angiography (CTA) and 
intravascular ultrasound (IVUS) while conventional coronary angiography (CCA) showed no 
signifi cant CAD. (A) 3D volume rendered reconstruction providing an overview of the left anterior 
descending coronary artery (LAD) showing signs of extensive atherosclerosis in the mid LAD 
(arrow). (B) An enlargement of the mid LAD demonstrating presence of extensive calcifi cations. (C) 
Multiplanar reconstruction of the LAD demonstrating the presence of diffuse atherosclerosis in the 
mid LAD (arrow) with luminal narrowing, enlargement showing cross-sectional view of the LAD 
with calcifi ed and non-calcifi ed elements. (D) CCA demonstrating no signs of signifi cant luminal 
narrowing in the LAD. (E) IVUS cross-sectional image of the mid LAD confi rming the presence of 






















However, minimal lumen area on IVUS was not signifi cantly different between true 
positives and false positives (3.9 mm2 (IQR 3.0 - 5.6 mm2) versus 4.1 mm2 (IQR 3.6 - 7.6 
mm2), p=0.136). More importantly, plaque burden on IVUS was not signifi cantly different 
between true and false positives (56% (IQR 50 - 62%) versus 56% (IQR 46 - 63%), p=0.484) 
implying that substantial atherosclerosis is present in lesions that are falsely classifi ed as 
positive for stenosis on CTA despite the absence of signifi cant luminal narrowing (Figure 
2B). A case example of a patient with stenosis on CTA in the absence of signifi cant stenosis 
on CCA is provided in Figure 3.
DISCUSSION
The present study is the fi rst to perform a comprehensive evaluation of the diagnostic 
performance of CTA. We systematically investigated the diagnostic accuracy of CTA for 
the detection of signifi cant stenosis (with CCA as the reference standard) as well as for 
the detection of atherosclerosis (using IVUS as the reference standard) in a large patient 
population. In the current study, regarding the accuracy of CTA to detect signifi cant steno-
sis, a negative predictive value of 100% and a diagnostic accuracy of 92% were observed 
on a patient level. Importantly, no patients with signifi cant stenosis were missed. Never-
theless, nine patients (9% of the total population) were incorrectly classifi ed as having a 
signifi cant stenosis resulting in a limited positive predictive value of 81%. However, when 
the defi nition of disease was changed from signifi cant stenosis (gold standard CCA) to the 
presence of atherosclerosis (gold standard IVUS), the performance of CTA improved and 
an excellent diagnostic accuracy was observed. Further exploration of lesions incorrectly 
classifi ed as having signifi cant stenosis on CTA confi rmed the presence of substantial 
plaque burden in these segments. The fi ndings of the present study demonstrate that 
CTA may be superior in the evaluation of the presence or the absence of visually evi-
dent atherosclerosis on IVUS when compared with the evaluation of signifi cant stenosis. 
Accordingly, CTA may therefore perform better in the assessment of atherosclerosis rather 
than the evaluation of stenosis severity. Conceivably, precisely this information on athero-
sclerosis, which cannot be derived from CCA, may become increasingly important in the 
defi nition and subsequent management of CAD.5
The present observations regarding the diagnostic accuracy for detection of signifi cant 
stenosis are in line with the previous literature using 64-row CTA.1 3 Recently in a multicen-
tre trial, the diagnostic performance of 64-row CTA was investigated in 230 symptomatic 
patients with suspected CAD, reporting a sensitivity and specifi city of 95% and 83% on 
a patient basis, respectively.1 However, while in this study the negative predictive value 
(on a patient basis) was high (99%), a relatively low positive predictive value of 64% was 
reported. Indeed, due to limitations in spatial resolution it has been established that CTA 
cannot precisely grade the severity of stenosis and frequently overestimates the degree of 
luminal narrowing. Similarly, in the present study, 17 segments were incorrectly identifi ed 








stenosis of only 77% on segmental basis and 81% on patient basis. Therefore, while CTA 
remains an excellent tool for ruling out the presence of signifi cant stenosis, a substantial 
proportion of lesions are overestimated, thereby resulting in incorrect diagnosis. 
Importantly, when changing the defi nition of CAD from the presence of signifi cant 
stenosis to the presence of atherosclerosis, the overestimated lesions were no longer 
false positive studies. Comparison with IVUS revealed that in all of these patients despite 
the absence of signifi cant luminal narrowing, substantial plaque burden was present. 
Accordingly, CTA had excellent diagnostic accuracy for the detection of atherosclerosis 
when compared with IVUS. Importantly, no patients with visually evident atherosclerosis 
(as determined on IVUS) were missed nor was the presence of atherosclerosis incorrectly 
diagnosed. On a segmental and vessel level, only slightly lower values were observed. 
Accurate assessment of atherosclerosis with CTA has previously been demonstrated in 
several investigations. When compared with histology, a good correlation for detecting 
and characterizing atherosclerotic plaque was reported.13 In vivo, Leber et al observed a 
sensitivity and specifi city for 16-row CTA of respectively 85% and 92% to detect coronary 
lesions as determined on IVUS.9 Evaluation of the characteristics of lesions missed on CTA 
revealed that particularly small plaques located in distal segments were not identifi ed. In 
contrast, larger and proximally located plaques, which may be considered more clinically 
relevant, were accurately detected. 
Clinical implications
At present, CCA is the gold standard for detecting severely stenotic lesions and remains 
the basis for referral for surgical and catheter-based revascularization. However, CCA has 
a tendency to underestimate total atherosclerotic plaque burden (partly due to positive 
remodeling) and more detailed characterization of atherosclerosis is not feasible at pres-
ent. Currently, the gold standard for assessing and quantifying coronary artery plaque 
burden is IVUS. Nevertheless, the use of this invasive technique is restricted to patients 
with a high likelihood of having signifi cant lesions requiring intervention. In contrast, 
non-invasive CTA will typically be used in lower likelihood patients and thus to evaluate 
the presence of CAD in more early stages. This technique has been proved very useful 
in the clinical setting and particularly due to the high negative predictive value it can 
accurately rule out the presence of signifi cant disease in the majority of patients with 
a low to intermediate pre-test risk profi le. While the technique accurately rules out the 
presence of signifi cant stenosis, the limited positive predictive value (potentially resulting 
in unnecessary invasive procedures) has been a cause of concern. However in this regard, 
two issues are important to acknowledge. First, as demonstrated in the current study, 
coronary segments false positive for signifi cant stenosis may not necessarily be false 
positive for atherosclerosis. Accordingly, these fi ndings may still be considered relevant 
for risk stratifi cation and initiation of anti-atherosclerotic measures. Second, regardless 
of the actual severity of the detected lesion, functional testing remains essential to 
determine the haemodynamical consequences of the lesion.14 The presence and extent 






















basis for further referral for CCA and possible revascularization. Considering these issues, 
it is conceivable that the emphasis of CTA, which traditionally has been on the evaluation 
of signifi cant stenosis, may shift towards the evaluation of atherosclerosis. 
As demonstrated in our systematic comparison of CTA with both CCA and IVUS, the 
diagnostic accuracy of CTA for detecting the presence of atherosclerosis was superior 
over the detection of signifi cant stenosis. In fact, the ability of CTA to accurately exclude 
the presence of atherosclerosis may be considered superior over other non-invasive tech-
niques. Importantly, supporting data are emerging that patients without any evidence 
of atherosclerotic plaques on CTA have excellent prognosis that is maintained over a 
relatively long period of time.15 16 In these patients, CTA may obviate the need for further 
testing and unnecessary aggressive therapy. In contrast, patients with atherosclerotic 
plaques on CTA have been shown to have worse outcome. These patients may thus be-
nefi t from intensifi ed treatment, while further evaluation with functional testing remains 
essential to determine the need for revascularization. On the basis of these and the current 
observations, it is conceivable therefore that shifting the use of CTA from mere stenosis 
assessment towards evaluation of atherosclerosis may have several advantages for clinical 
management and may allow improved risk stratifi cation.
Limitations
In the current study, only patients with suffi cient CTA image quality for the evaluation of 
both the presence of signifi cant stenosis and atherosclerosis were included. In addition, a 
verifi cation bias could be present, as in a limited number of cases patients were referred 
for CCA on the basis of CTA fi ndings. Moreover, in the present study, no nitroglycerine 
was administered before the CT scan. Furthermore, concerns have been raised about CTA 
radiation dose, especially with respect to the long term effects. However, the recent intro-
duction of single heart beat imaging (320-row CTA), dose modulation and particularly 
prospective triggering have drastically reduced patient radiation dose. Future research 
will most likely focus on further decreasing radiation exposure while maintaining good 
image quality.
Conclusion
The present study is the fi rst to perform a comprehensive evaluation of the diagnostic 
accuracy of CTA for the detection of signifi cant stenosis and for the presence of athero-
sclerosis. In this regard, the diagnostic accuracy of CTA for the detection of the presence 
of atherosclerosis was superior over the detection of signifi cant stenosis. Possibly, the 
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Background: Multidetector computed tomography angiography (CTA) provides informa-
tion on plaque extent and stenosis in the coronary wall. More accurate lesion assessment 
may be feasible with CTA as compared to invasive coronary angiography (ICA). Accord-
ingly, lesion length assessment was compared between ICA and CTA in patients referred 
for CTA who underwent subsequent percutaneous coronary intervention (PCI).
Methods: 89 patients clinically referred for CTA and were subsequently referred for ICA 
and PCI. On CTA, lesion length was measured from the proximal to the distal shoulder of 
the plaque. Quantitative coronary angiography (QCA) was performed to analyze lesion 
length. Stent length was recorded for each lesion.
Results: In total, 119 lesions were retrospectively identifi ed. Mean lesion length on CTA was 
21.4±8.4 mm and on QCA 12.6±6.1 mm. Mean stent length deployed was 17.4±5.3 mm. 
Lesion length on CTA was signifi cantly longer than on QCA (difference 8.8±6.7 mm, 
p<0.001). Moreover, lesion length visualized on CTA was also signifi cantly longer than 
mean stent length (CTA lesion length-stent length was 4.2±8.7 mm, p<0.001).
Conclusion: Lesion length assessed by CTA is longer than that assessed by ICA. Pos-
sibly, CTA provides more accurate lesion length assessment than ICA and may facilitate 









Invasive coronary angiography (ICA) has been traditionally used for evaluation of the 
presence and severity of coronary artery disease (CAD). Accordingly, the technique has 
been extensively utilized to guide further treatment strategies, such as percutaneous 
coronary intervention (PCI) with stent placement. In particular, the choice for stent length 
and diameter is frequently decided on the basis of the 2-dimensional ICA images. How-
ever, although ICA has an excellent ability to visualize the lumen and severity of luminal 
narrowing, the presence of atherosclerotic plaque in the arterial wall cannot be accurately 
visualized.1 The chosen stent length may not always match the true atherosclerotic plaque 
length and could potentially lead to insuffi cient stent coverage of the plaque and possible 
development of post-stent complications such as arterial dissection, in-stent restenosis 
and stent thrombosis.2-4
Several studies comparing ICA to intravascular ultrasound (IVUS) have shown that ICA 
indeed underestimates plaque extent.1 5 6 Multidetector computed tomography angiog-
raphy (CTA) is increasingly used to non-invasively evaluate the presence of CAD7 8, and a 
growing number of patients referred for ICA will have previously undergone non-invasive 
evaluation by CTA. A particular strength of this modality is that it is able to not only 
visualize luminal narrowing but also the extent of atherosclerotic plaque in the arterial 
wall.9 10 Accordingly, in patients with previous CTA, who subsequently underwent ICA and 
PCI, lesion length on CTA was compared to length on ICA.
METHODS
Patients 
A total of 89 patients were retrospectively analyzed, who were clinically referred for CTA 
and had subsequent ICA and PCI with stent implantation. All clinical data were retrieved 
from the departmental Cardiology Information System (EPD-Vision®, Leiden University 
Medical Center). In each patient, the presence of CAD risk factors such as diabetes, sys-
temic hypertension, hypercholesterolemia, positive family history, smoking and obesity, 
were noted.
Multidetector computed tomography coronary angiography
Data acquisition 
Contra-indications for CTA were 1) (supra) ventricular arrhythmias, 2) renal insuffi ciency 
(glomerular fi ltration rate<30 ml/min), 3) known allergy to iodine contrast material, 4) 
severe claustrophobia, 5) pregnancy. Patients received beta-blocking medication (50-100 
mg metoprolol orally, or 5-10 mg intravenously) 1 hour before CTA examination if the 
heart rate was above 65 beats per minute, unless contra-indicated. Forty-seven patients 



















Otawara, Japan). Scan parameters were: 400 ms gantry rotation time, 100 to 135 kV tube 
voltage and a tube current of 250 to 350 mA, depending on body shape. Thirty-six patients 
were scanned on a 320-detector row volumetric scanner (Aquilion ONE, Toshiba Medical 
Systems, Otawara, Japan). The heart was imaged in a single heartbeat, using prospective 
triggering with exposure interval depending on the heart rate. Scan parameters were: 
350 ms gantry rotation time, 100 to 135 kV tube voltage and a tube current of 400 to 580 
mA, depending on body mass index. In total, 60 to 90 ml contrast material (Iomeron 400, 
Bracco, Milan, Italy) was administered with a rate of 5 - 6 ml/sec followed by a saline fl ush. 
Subsequently, data sets were reconstructed in the best available phase and transferred to 
a remote workstation.
CTA lesion length assessment
Post-processing of the CTA scans was performed on a dedicated workstation (Vitrea FX 
2.0.2, Vital images Minnetonka, MN, USA). Coronary anatomy was assessed in a stan-
dardized manner by dividing the coronary artery tree into 17 segments according to the 
modifi ed American Heart Association classifi cation. CTA lesion length was evaluated in 
consensus by 2 experienced readers who were blinded to quantitative coronary angiog-
raphy (QCA) lesion length fi ndings. Firstly, the location of lesions was identifi ed on ICA. 
To match lesions identifi ed on ICA with lesions on CTA, landmarks such as coronary ostia, 
side-branches and calcium deposits were used. A plaque on CTA was defi ned as a structure 
≥1mm2 in the coronary artery lumen.11 Secondly, on CTA, lesion length was determined 
on curved multiplanar reconstructions (MPR’s) in two different angles for every lesion in 
which PCI was performed. Lesion length (mm) was measured on CTA from the proximal 
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Figure 1. Example of atherosclerotic lesion length measurement in two different views on 
multidetector computed tomography angiography images with the use of a dedicated software 
tool. In panel (A), a 3 dimensional volume rendered reconstruction of the heart with the left 
anterior descending coronary artery (LAD) is shown (arrow). (B) In panel (B) lesion length 
measurement is performed of a non-calcifi ed lesion in the mid LAD. In this view, lesion length 
measured was 16.6 mm. In panel (C), lesion length measurement is performed of the same lesion, 








to distal shoulder of the plaque with a dedicated Vitrea software display tool (Vitrea FX 
2.0.2, Minnetonka, MN, USA) (Figure 1). A tandem lesion within 4 mm of the edge of lesion 
was considered as part of the lesion. The average of these two measurements was taken 
as the fi nal CTA lesion length. Radiation dose was quantifi ed with a dose-length product 
conversion factor of 0.014 mSv/(mGy∙cm).12 For the 320-row CTA, patients with a low 
heart rate (<60 bpm) were scanned full dose at 70-80% of R-R interval and estimated 
mean radiation dose was 3.2 ± 1.1 mSv. Patients with a higher heart rate (60-65 bpm) were 
scanned full dose at 65-85% of R-R interval and estimated mean radiation dose was 7.1 ± 
1.7 mSv. For the 64-row CTA: The estimated mean radiation dose was 18.1 ± 5.9 mSv, all 
performed with retrospective gating. 
Quantitative coronary angiography
QCA analysis was performed by observer unaware of CTA fi ndings with the use of QCA-
CMS version 6.0 (Medis, Leiden, The Netherlands). Prior to measuring lesion length, images 
were calibrated with use of the contrast fi lled catheter. Subsequently, per lesion, the two 
best orthogonal projections were chosen on which measurements were performed to 
minimize foreshortening. Consequently, lesion length (mm) was measured from the proxi-
mal shoulder to the distal shoulder of the lesion. The longest length measured on QCA 
was used for further analysis. In addition, highest percent diameter stenosis as measured 
by QCA was reported for each lesion. The choice and size of stent used were left to the 
discretion of operator. Per lesion, stent diameter and length were reported. If more than 
one stent was planned, the total stent length of all combined stents deployed was used.
Statistical analysis
Continuous variables were expressed as mean and standard deviation, and categorical 
data were expressed in numbers and percentages. Paired variables were analyzed with 
Wilcoxon signed rank tests. Statistical analysis was performed using SPSS software (version 
16.0, SPSS inc., Chicago, IL, USA). A p-value<0.05 was considered statistically signifi cant.
RESULTS
Of the 89 patients, 4 were excluded in which the target lesion length was not quantifi able 
on CTA. These lesions were either a total chronic occlusion (n=2) or in-stent restenosis 
(n=2). Furthermore, 2 patients were excluded due to impaired CTA image quality. Con-
sequently, 83 patients (59 males (71%), mean age 62 ±10 years) and 119 lesions were 
included in the analysis. Baseline patient characteristics are described in Table 1. The 
average time interval between CTA and PCI was 63 ±110 days. As determined by QCA, 
the mean percent stenosis of the lesions was 71 ±11%. Overall, lesions were most often 
located in the left anterior descending coronary artery (56 lesions, 47%) followed by the 



















24%). Concerning plaque composition, 27 lesions (23%) were non-calcifi ed, 72 lesions 
(60%) were mixed and 20 lesions (17%) were calcifi ed. 
Lesion length 
The mean lesion length measured on CTA was 21.4 ±8.4 mm, as compared to a mean 
lesion length on QCA of 12.5 ±6.1 mm resulting in a mean difference (CTA lesion length 
- QCA lesion length) of 8.8 ±6.7 mm. Only 2 lesions were longer on QCA than on CTA, 
however the difference between these 2 lesions was only minor (13.2 mm on CTA versus 
14.3 mm on QCA and 5.7 mm on CTA versus 6.7 mm on QCA). Overall, mean CTA lesion 
length was signifi cantly longer than mean QCA lesion length (p<0.001), as demonstrated 
in Figure 2. At Bland-Altman analysis, mean differences (±SD) of 8.8 ±6.7 mm were 
observed between CTA and ICA, with 95% limits of agreement ranging from -4.3 to 22.0 
Table 1. Patient characteristics (n=83).
 n (%)
Age (mean ±standard deviation) 62 ±10
Gender (male/female) 59/24




Family History 37 (45%)
Smoking 33 (40%)
Previous stent (%) 18 (22%)
Complications during PCI
Edge dissection 6 (7%)
Stent thrombosis* 1 (1%)
BMI, body mass index 
* Defi ned as defi nite, probable and possible stent thrombosis within 1 month
Figure 2. Box plot showing the difference 
between lesion length assessment on 
multidetector computed tomography 
angiography (CTA) and quantitative coronary 
angiography (QCA). Lesion length assessment is 








(Figure 3). The mean diameter of stents deployed was 3.1 ±0.3 mm, ranging from 3.0 mm 
to 4.0 mm. The length of stents deployed ranged from 8.0 mm to 33.0 mm (mean 17.5 
±5.3 mm). Accordingly, lesion length on CTA was also signifi cantly longer than mean stent 
length (CTA lesion length - stent length was 4.2 ±8.7 mm, p<0.001). Furthermore, mean 
stent length exceeded lesion length on QCA; stent length - QCA lesion length was 4.8 
±6.2 mm (p<0.001). 
DISCUSSION
Comparison between ICA and non-invasive CTA demonstrated that lesion length mea-
sured by CTA was substantially longer than lesion length measured by ICA. In addition, 
lesion length on CTA was compared to the stent length selected for PCI. Interestingly, 
lesion length measured by CTA signifi cantly exceeded the mean length over which the 
stent was deployed. 
There are only very limited data regarding lesion length measurement with CTA. Soon 
et al compared atherosclerotic lesion length between ICA and CTA (16-slice) in 30 patients 
and 44 lesions and observed that lesion length was signifi cantly longer on CTA than on 
ICA with a median difference of 9.8 mm (95% confi dence interval of 7.3-13.3).13 Moreover, 
the fi nding that ICA signifi cantly underestimates atherosclerotic lesion length has also 
been demonstrated by Yamagishi et al, who compared atherosclerotic lesion length on 
ICA to grayscale IVUS, the current gold standard for the evaluation of atherosclerosis.5 
The authors demonstrated that lesion length on ICA (mean lesion length of 12.4 ±6.1 
mm) was signifi cantly shorter than lesion length measured by IVUS (mean lesion length 
of 16.3 ±8.9 mm). 
Although angiographically detected coronary atherosclerosis has been linked 
to outcome in several clinical trials 14-17, it has been suggested that ICA considerably 
underestimates the overall extent of CAD.18 Indeed, when compared to IVUS, the presence 




























Figure 3. Bland-Altman plot of lesion length 
(mm) shows the difference between each pair 
plotted against the average value of the same 
pair (solid line, mean value of difference; dotted 



















compared the detection of atherosclerosis on ICA to IVUS and found that only 7% of 
segments described as normal on ICA were truly without any atherosclerotic plaque on 
IVUS.1 Conversely, non-invasive CTA has been shown to provide accurate evaluation of 
coronary plaque burden,9 19-21 with a good correlation for detecting and characterizing 
atherosclerotic plaque in comparison to histology.22-24 Moreover, Leber et al demon-
strated a sensitivity and specifi city of 16-slice CTA for the detection of coronary lesions 
as determined on IVUS of 85% and 92%, respectively.11 However, small plaques located 
in distal segments were more diffi cult to evaluate, particularly in CTA scans with reduced 
image quality.11
The large difference between ICA and CTA lesion length assessment can be explained 
by the excellent ability of CTA to visualize plaque and vessel remodelling in the arterial 
wall, in contrast to ICA. Indeed, ICA only shows the contrast fi lled lumen and is unable to 
visualize the arterial wall (with the exception of large calcifi cations), and reference seg-
ments may not be optimally evaluated by ICA.25 Indeed, with traditional invasive coronary 
angiography, lesions with outward (positive) remodeling are frequently underestimated 
or missed. Moreover, CTA is not hampered by limitations of angiographic projection such 
as foreshortening or diffi culties in case of tortuous vessels. However, it is of importance 
to identify the presence of atherosclerosis even at sites without signifi cant luminal nar-
rowing, and some acute coronary syndromes may be triggered by sudden disruption of 
atherosclerotic plaques that caused neither signifi cant luminal narrowing nor chest pain 
complaints before the event.26 It has been suggested that the most rupture prone part of 
the plaque is not at the maximum point of luminal narrowing but actually located in the 
shoulders of the plaque.27 Accordingly, it is important to assess the entire plaque length.
It has also been demonstrated that insuffi cient coverage of the target lesion increases 
the risk for in-stent restenosis and stent thrombosis. Fujii et al. retrospectively evalu-
ated lesion characteristics using IVUS leading to stent thrombosis after PCI.2 The authors 
observed that stent thrombosis occurred in stents with signifi cantly more residual plaque 
upstream and downstream from the stent as compared to lesions without stent thrombo-
sis. Okabe et al explored which IVUS related fi ndings predicted the risk for the develop-
ment of stent thrombosis.3 The authors observed that residual disease at the edge of the 
stent was associated with subsequent stent thrombosis. Of note, a higher residual plaque 
burden proximal from the stent has also been associated with increased rates of in-stent 
restenosis.4 Accordingly, optimal assessment of the lesion length may improve success 
and outcome of interventional procedures.28
Limitations
Several limitations need to be addressed. First, there was a time-interval between CTA and 
PCI during which atherosclerosis may have progressed. Second, only lesions subsequently 
treated by PCI were included in the study. Therefore, the current observations are only 
based on lesions with a high grade stenosis. Third, in the current study QCA was not part 
of the clinical routine of the laboratory and the difference between the CTA lesion length 








assessment. Furthermore, the attending interventional cardiologist did not incorporate 
lesion topography on CTA before performing PCI. However, future studies should be per-
formed to evaluate the value and improved outcome of CTA lesion assessment prior to PCI.
Conclusion
Lesion length assessed by CTA is longer than lesion length assessed by ICA, which may 
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Background: The purpose of the study was to systematically compare calcifi cation pat-
terns in plaques on computed tomography angiography (CTA) with plaque characteristics 
on intravascular ultrasound with radiofrequency backscatter analysis (IVUS-VH). 
Methods: In total, 108 patients underwent CTA and IVUS-VH. On CTA, calcifi cation pat-
terns in plaques were classifi ed as non-calcifi ed, spotty or dense calcifi cations. Plaques 
with spotty calcifi cations were differentiated into small spotty (< 1 mm), intermediate 
spotty (1 - 3 mm) and large spotty calcifi cations (≥ 3 mm). Plaque characteristics deemed 
more high-risk on IVUS-VH were defi ned by % necrotic core (NC) and presence of thin 
cap fi broatheroma (TCFA). 
Results: Overall, 300 plaques were identifi ed both on CTA and IVUS-VH. % NC was sig-
nifi cantly higher in plaques with small spotty calcifi cations as compared to non-calcifi ed 
plaques (20% vs. 13%, p=0.006). In addition, there was a trend for a higher % NC in 
plaques with small spotty calcifi cations than in plaques with intermediate spotty calcifi ca-
tions (20% vs. 14%, p=0.053). Plaques with small spotty calcifi cations had the highest % 
TCFA as compared to large spotty and dense calcifi cations (31% vs. 9% and 31% vs. 6%, 
p<0.05).
Conclusion: Plaques with small spotty calcifi cations on CTA were related to plaque char-
acteristics deemed more high-risk on IVUS-VH. Therefore, CTA may be valuable in the 









Computed tomography angiography (CTA) is a rapidly evolving technique that has the 
ability to non-invasively and accurately detect signifi cant coronary artery stenosis and 
coronary atherosclerotic plaque.1-5 A potentially interesting application of CTA would 
be the identifi cation of patients or lesions that have an increased likelihood of plaque 
rupture leading to acute coronary events. Several previous studies have identifi ed specifi c 
plaque characteristics which are frequently observed with CTA in patients presenting with 
acute coronary syndrome (ACS).6-8 Among these characteristics, a spotty pattern of cal-
cifi cations has been related to the presence of ACS.6-8 Indeed, preliminary data with CTA 
demonstrated that culprit lesions in patients with ACS had a higher prevalence of smaller 
spotty calcifi cations than target lesions in patient with stable complaints.9 Moreover, 
the presence of spotty calcifi cations on CTA were associated with a higher likelihood of 
developing ACS.8 
More detailed information on plaque characteristics can be obtained by intravascular 
ultrasound with radiofrequency backscatter analysis (IVUS-VH).10 11 This technique was 
developed to improve grayscale intravascular ultrasound tissue characterization and 
provide detailed quantitative information on plaque composition in vivo.12 13 Addition-
ally, the presence of thin cap fi broatheroma (TCFA) on IVUS-VH was demonstrated to be 
independently predictive of major cardiovascular events during follow-up.14 
However, the relation between calcifi cation patterns on CTA and plaque characteristics 
on IVUS-VH has not been previously reported. Furthermore, in previous studies, the 
defi nition of spotty calcifi cation on CTA has been variable. Indeed, defi nitions for spotty 
calcifi cation on CTA have ranged from presence of any calcifi ed material embedded in 
non-calcifi ed plaque to a specifi c threshold regarding the size of calcifi cation. Subse-
quently, due to the inconsistency of defi nitions, comparability of spotty calcifi cations 
on CTA between investigations is hampered. Therefore, the purpose of the study was to 
perform a systematic evaluation of plaques with different calcifi cation patterns on CTA 
and relate this to plaque characteristics on IVUS-VH. 
METHODS
Patient population and study protocol
A total of 108 patients were included in this evaluation who underwent CTA prior to 
invasive coronary angiography with IVUS-VH of 1 to 3 vessels, as part of clinical protocol. 
For this retrospective evaluation, consecutive patients were selected as part of an ongoing 
registry addressing the relative merits of CTA in relation to other imaging techniques.15 
Patient with chest pain were referred for imaging for the non-invasive evaluation of coro-
nary artery disease (CAD), according to clinical protocol. Thereafter, patients were referred 
for invasive coronary angiography in combination with IVUS-VH based on the patient’s 


















of CAD. During invasive coronary angiography, an experienced interventional cardiolo-
gist decided whether IVUS studies should be performed. Clinical history was evaluated 
between the CTA examination and invasive coronary angiography to ensure that neither 
acute coronary syndromes nor worsening of angina occurred between examinations. 
Exclusion criteria for CTA examination were: (i) (supra) ventricular arrhythmias, (ii) renal 
failure (glomerular fi ltration rate < 30 mL/min), (iii) known allergy to iodine contrast mate-
rial, (iv) severe claustrophobia, (v) pregnancy. Patient data were prospectively collected 
in the departmental Cardiology Information System (EPD-Vision©, Leiden University 
Medical Center, Leiden, the Netherlands) and retrospectively analyzed. Our institutional 
review board does not require its approval and written informed consent for retrospective 
technical analysis of data, as was the case for this study. In each patient, the presence of 
risk factors for CAD and medication (use of aspirin, statins, beta-blocking medication and 
angiotensin-converting enzyme (ACE) inhibitors) were recorded. 
CTA
Image acquisition
CTA examination was performed using either a 64-row helical scanner (Aquilion 64, 
Toshiba Medical Systems, Toshiba Medical Systems, Otawara, Japan) or a 320-row volu-
metric scanner (Aquilion ONE, Toshiba Medical Systems, Otawara, Japan). If the patient’s 
heart rate was ≥ 65 beats/minute and no contra-indications existed, beta-blocking 
medication (metoprolol 50 or 100 mg, single oral dose, 1 hour prior to examination) 
was administered. Scan parameters for the 64-row contrast enhanced scan were: 400 
ms gantry rotation time, collimation of 64 x 0.5 mm, tube voltage of 100 - 135 kV and 
tube current of 250 - 350 mA, depending on body posture. Non-ionic contrast mate-
rial (Iomeron 400, Bracco, Milan, Italy or Ultravist 370, Bayer Schering Pharma AG Berlin, 
Germany) was administered with an amount of 80 - 110 ml followed by a saline fl ush 
with a fl ow rate of 5 ml/s. Datasets were reconstructed from the retrospectively gated 
raw data, the best phase was reconstructed with an interval of 0.3 mm. Using a single test 
slice reconstructed throughout the various phases of the heart cycle, other suitable R - R 
intervals were examined for additional reconstructions. Concerning the 320-row contrast 
enhanced scan; imaging was performed in a single volume using prospective triggering 
with exposure interval depending on the heart rate. If the heart rate was ≥ 60 beats/min, 
the phase window was set 65 - 85% of R - R interval, if the heart rate was stable and < 60 
beats/min the phase window was set at 70 - 80% of R - R interval. Scan parameters were: 
350 ms gantry rotation time, 320 x 0.5 mm collimation, 100 - 135 kV tube voltage and a 
tube current of 400 - 580 mA, depending on body mass index (BMI). Overall, 60 - 90 ml 
contrast material (Iomeron 400, Bracco, Milan, Italy) was administered with a rate of 5 - 6 
ml/s followed by a saline fl ush. Data acquisition was performed during an inspiratory 
breath hold of approximately 4 - 10 seconds. Subsequently, images were reconstructed 










CTA datasets were evaluated using dedicated software (Vitrea 2.0 or Vitrea FX 1.1 Vital images, 
Minnetonka, MN, USA). Analysis was performed with the use of available post-processing 
tools such as cross-sectional axial slices and multiplanar reconstructions. One experienced 
reader, blinded to the IVUS-VH results, evaluated the CTA datasets. The coronary arteries 
were divided into 17 segments according to the modifi ed American Heart Association clas-
sifi cation.16 Each segment was evaluated for the presence of any atherosclerotic plaque. 
Structures > 1 mm2 within and/or adjacent to the coronary artery lumen, which could be 
clearly distinguished from the vessel lumen, were defi ned as atherosclerotic plaque.3
Calcifi cation patterns in plaques on CTA were classifi ed morphologically as non-calci-
fi ed, spotty calcifi cations or dense calcifi cations. Non-calcifi ed plaques were defi ned as a 
plaque with low CT attenuation located in the vessel wall in at least 2 independent image 
planes and clearly distinguishable from the contrast-enhanced lumen and pericardial tis-
sue without any calcifi cation.17 Plaques with spotty calcifi cations were defi ned as follows: 
length (extent in the longitudinal direction of the vessel) of the calcifi cation < 3/2 of vessel 
diameter and width (extent of the calcifi cation perpendicular to the longitudinal direction 
of the vessel) of the calcifi cation < 2/3 of vessel diameter, as previously described (Figure 
1).17 Plaques with spotty calcifi cation were further differentiated according to their length 
(extent of the calcifi cation parallel to the longitudinal direction of the vessel on curved 
multiplanar reconstruction) into small spotty (< 1 mm), intermediate spotty (1 - 3 mm) 
and large spotty calcifi cations (≥ 3 mm) as measured with caliper function (for illustra-
tion see Figure 2).18 Dense calcifi cations were defi ned as a plaque with high CT density, 
completely calcifi ed and with calcifi cations present bilateral on cross-sectional axial slices. 
6.2 mm 2.3 mm 1.6 mm
Vessel diameter Length calcification Width calcification
A B C
Figure 1. Example of measurement of spotty calcifi cation. Plaques with spotty calcifi cations were 
defi ned as follows: length (extent in the longitudinal direction of the vessel) of the calcifi cation 
< 3/2 of vessel diameter and width (extent of the calcifi cation perpendicular to the longitudinal 
direction of the vessel) of the calcifi cation < 2/3 of vessel diameter. (A) Measurement of vessel 
diameter (blue line) perpendicular to long vessel axis (dashed white line). (B) Measurement of 
length of calcifi cation (blue line) parallel to long vessel axis (dashed white line). (C) Measurement of 




















Conventional invasive coronary angiography was performed according to standard pro-
tocols. IVUS examinations were acquired with a 20 MHz, 2.9 F phased-array IVUS catheter, 
(Eagle Eye, Volcano Corporation, Rancho Cordova, CA, USA) and a dedicated IVUS-console 
(Volcano Corporation, Rancho Cordova, CA, USA) after intracoronary administration of 
nitroglycerine. Under fl uoroscopic guidance, the IVUS catheter was introduced distally in 
the coronary artery and a motorized automated pullback with a continuous speed of 0.5 
mm/s was used until the catheter reached the guiding catheter. Images were stored on 
CD-ROM or DVD for off-line analysis. 
Image analysis 
IVUS-VH analysis was performed by two experienced observers blinded to baseline 
patient characteristics and CTA fi ndings with the use of dedicated software (QCU-CMS, 
version 4.59, Medis Medical Imaging Systems, Leiden, The Netherlands). First, contour 
detection (lumen and media interface) was performed manually with the use of cross-
sectional views to provide compositional output.19 Secondly, on a frame-by-frame basis, 
the four different tissue components were differentiated and labeled with four different 
color-codes (fi brotic tissue was labeled in dark green, fi bro-fatty tissue in light green, 
necrotic core in red and dense calcium in white), as validated previously.10 The mean per-
centage of each plaque component was obtained in the full length of the lesion observed 
on the CTA examination. A lesion on intravascular ultrasound imaging was defi ned as at 
least three consecutive frames with a plaque burden of at least 40%.20 In addition, the 
presence of the thin cap fi broatheroma (TCFA) was evaluated on a per-lesion basis. TCFA 
3.3 mm
2.0 mm0.7 mm
Small spotty Intermediate spotty Large spotty
A B C
Figure 2. Illustration of the different types of spotty calcifi cation. (A) Small spotty calcifi cation (< 1 



















Figure 3. Example of anatomical matching of computed tomography angiography (CTA) with 
intravascular ultrasound with radiofrequency backscatter analysis (IVUS-VH) datasets. (A) 
Straightened multiplanar reconstruction of left anterior descending coronary artery in which 
various landmarks have been identifi ed (left circumfl ex artery (LCx), fi rst and second diagonal 
branch (D1 and D2). (B, C) Corresponding grayscale intravascular ultrasound and IVUS-VH datasets 
in longitudinal view in which identical landmarks have been matched to CTA dataset (yellow dashed 


















was defi ned as a lesion with a plaque burden ≥ 40%, presence of >10% confl uent necrotic 
core on three consecutive frames and necrotic core in contact with the lumen for along 
the lumen circumference.14 21 22 High-risk plaque characteristics on IVUS-VH were defi ned 
by % of necrotic core and presence of TCFA. 
To ensure that identical plaques were assessed by CTA and IVUS-VH, coronary ostia 
and side branches were used as landmarks and distances from the landmarks to the target 
lesions were measured (Figure 3). On CTA, distances were measured using multiplanar 
reconstructions. On IVUS-VH, longitudinal reconstructed ECG triggered datasets were 




Figure 4. Example of small spotty calcifi cations as assessed on computed tomography angiography 
(CTA) with high-risk plaque characteristics on intravascular ultrasound with radiofrequency 
backscatter analysis (IVUS-VH). (A) Multiplanar reconstruction of the right coronary artery 
(RCA) demonstrating a plaque with non-calcifi ed elements and spotty calcifi cations (arrow). (B) 
Enlargement of the same plaque demonstrating a spotty calcifi cation with a length of 0.7 mm. 
(C) Longitudinal reconstructed ECG triggered IVUS-VH run with superimposed color coded map. 
The plaque (white arrow) corresponds to the same plaque on CTA demonstrating a large necrotic 
core and multiple small spotty calcifi cations. (D) Cross-sectional axial image of the same plaque 












Figure 5. Example of a plaque with dense calcifi cations on computed tomography angiography 
(CTA) with corresponding grayscale and intravascular ultrasound with radiofrequency backscatter 
analysis (IVUS-VH) images. (A) Curved multiplanar reconstruction of the right coronary artery (RCA) 
demonstrating a plaque with dense calcifi cations (arrow). Inlay showing cross-sectional axial image 
of the same plaque with calcifi cations present bilateral of the coronary artery. (B) Enlargement 
of the same plaque reporting the length of the calcifi cation (4.5 mm). (C) Grayscale IVUS image 
demonstrating a heavily calcifi ed plaque with corresponding IVUS-VH image (D) showing a plaque 


















alignment of plaques on CTA and IVUS-VH, we identifi ed matching slices between the 
2 modalities and could determine the proximal and distal end of a lesion. Examples of 
different calcifi cation patterns on CTA with corresponding IVUS-VH images are demon-
strated in Figure 4 and 5.
Statistical analysis
Plaques available on both CTA and IVUS-VH were included in the lesion based analysis. 
Plaque composition (% fi brotic, fi bro-fatty, necrotic core and dense calcium) and pres-
ence of TCFA was compared between lesions with different calcifi cation patterns on CTA 
(non-calcifi ed, small spotty calcifi cations, intermediate spotty calcifi cations, large spotty 
calcifi cations and dense calcifi cations). If normally distributed, continuous values were 
expressed as means (± standard deviation) and differences in plaque composition and 
type were assessed using an analysis of variance (ANOVA). If not normally distributed, 
values were expressed as medians (interquartile range (IQR)) and differences in plaque 
composition and type were assessed using the Kruskall-Wallis test. To account for pos-
sible clustering of coronary artery plaques within patients, the generalized estimating 
equation (GEE) method was applied to evaluate the differences in plaque characteristics 
between the groups of different calcifi cation patterns on CTA (non-calcifi ed, small spotty 
calcifi cations, intermediate spotty calcifi cations, large spotty calcifi cations and dense 
calcium). This was performed with proc GENMOD with a binominal distribution for the 
outcome variable, the link function specifi ed as a logistical (presence of TCFA) or a linear 
(% fi brotic, fi bro-fatty, necrotic core and dense calcium) distribution and patients as sepa-
rate subjects. Due to lack of power, we did not perform post-hoc analysis. A p-value of < 
0.05 was considered statistically signifi cant. Statistical analysis was performed using SPSS 
17.0 software (SPSS Inc., Chicago. Illinois).
RESULTS
Out of a total of 108 patients, 33 patients (31%) were scanned with a 64-row CTA scanner 
and 75 patients (69%) with a 320-row CTA scanner. Baseline patient characteristics are 
provided in Table 1. In summary, 80 patients (74%) were male and mean age was 57 
± 10 years. IVUS-VH examination was successfully performed in 264 vessels (81%) of 
the available 324 vessels without complications (right coronary artery (RCA), n=88; left 
anterior descending coronary artery (LAD), n=98; left circumfl ex coronary artery (LCx), 
n=78). In the remaining vessels, IVUS imaging could not be performed due to severe ves-
sel tortuousity, severe stenosis, vessel occlusion or due to time-constraints in the cathlab
Baseline CTA and IVUS-VH results
In total, 799 plaques were demonstrated on CTA and in 300 plaques (38%) IVUS-VH 
was also available. Of the 300 plaques identifi ed on CTA, 78 plaques (26%) were non-








had intermediate spotty calcifi cations (1 - 3 mm), 54 plaques (18%) had large spotty 
calcifi cations (≥ 3 mm) and 33 plaques (11%) had dense calcifi cations. On IVUS-VH, the 
average plaque length analyzed was 26 ± 18 mm. The most prevalent plaque component 
was fi brotic tissue (58%, IQR 50 - 63%), followed by necrotic core (15%, IQR 10 - 21%), 
fi bro-fatty tissue (13%, IQR 8 - 21%), and dense calcium (6%, IQR 3 - 10%). Visual plaque 
assessment revealed that 52 plaques (17%) were classifi ed as TCFA.
Comparison of calcifi cation patterns on CTA and plaque composition on 
IVUS-VH
The results comparing calcifi cation patterns on CTA against relative plaque composition 
on IVUS-VH are reported in Table 2. Small spotty calcifi cations contained less fi bro-fatty 
tissue (9%, IQR 6 - 15%) as compared to non-calcifi ed plaques (12%, IQR 8 - 22%), 
intermediate spotty calcifi cations (13%, IQR 7 - 21%), large spotty calcifi cations (15%, 
IQR 9 - 25%) and dense calcifi cations (20%, IQR 13 - 25%, p<0.05). In line with this 
observation, the more calcifi ed plaques contained signifi cantly more dense calcium on 
IVUS-VH than the non-calcifi ed plaques (9%, IQR 6 - 11% versus 3%, IQR 1 - 6%, p< 
Table 1. Baseline patient characteristics
Number of patients 108
Age (years) 57 ± 10
Male gender 80 (74%)





Family history of CAD 49 (45%)
Obesity (≥ 30 kg/m2) 21 (19%)
Medication at time of referral
Aspirin 61 (57%)
Statins 69 (64%)
ACE inhibitor 53 (49%)
Beta-blockers 58 (54%)
Previous myocardial infarction 22 (20%)
Previous PCI 29 (27%)
Data are absolute values, percentages or means ± standard deviation.
†Defi ned as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥ 90
mm Hg or the use of antihypertensive medication.
‡Serum total cholesterol ≥ 230 mg/dL or serum triglycerides ≥ 200 mg/dL or treatment with lipid 
lowering drugs. 



















0.001). More importantly, necrotic core was signifi cantly higher in plaques with small 
spotty calcifi cations (20%, IQR 12 - 24%) as compared to non-calcifi ed plaques (13%, 
IQR 6 - 20%, p=0.006). In addition, there was a trend for a higher percentage of necrotic 
core in plaques with small spotty calcifi cations than in plaques with intermediate spotty 
calcifi cations (p=0.053). Moreover, as demonstrated in Figure 6, plaques with small spotty 
calcifi cations were demonstrated to have a high percentage of TCFA (31%) as compared 
to large spotty calcifi cations (9%) and dense calcifi cations (6%, p<0.05). In addition, there 
was a trend for plaques with small spotty calcifi cations to have a higher percentage of 
TCFA than plaques with intermediate spotty calcifi cations (17%, p=0.073). However, no 
signifi cant difference was demonstrated between the percentage of TCFA in plaques with 
small spotty calcifi cations and non-calcifi ed plaques (p=0.37).
Table 2. Plaque composition on intravascular ultrasound with radiofrequency backscatter analysis 
(IVUS-VH) is reported in relation to the different calcifi cation patterns on computed tomography 
angiography (CTA). 
Non-calcifi ed Small spotty
 (< 1 mm)
Intermediate 
spotty







% Fibrotic 61 (55 - 68) 56 (50 - 63) 58 (50 - 64) 54 (49 - 59) 54 (49 - 59) < 0.001
% Fibro-fatty 12 (8 - 22)* 9 (6 - 15) 13 (7 - 21)* 15 (9 - 25)* 20 (13 - 25)* < 0.001
% Necrotic Core 13 (6 - 20)* 20 (12 - 24) 14 (9 - 21)** 17 (13 - 21) 14 (12 - 22) 0.003
% Dense calcium 3 (1 - 6)* 7 (4 - 13) 6 (3 - 10) 9 (6 - 13) 9 (6 - 11) < 0.001
Data in parentheses are percentages with 95% confi dence intervals.
* p-value < 0.05, individual groups compared to plaques with small spotty calcifi cations as 
reference group















































Figure 6. Bar graph represents the percentage 
of thin cap fi broatheroma (TCFA) in relation 
to the different calcifi cation patterns on 
computed tomography angiography (CTA). 
As is shown, in particular plaques with small 
spotty calcifi cations on CTA contain the highest 
percentage of TCFA as compared to large spotty 
calcifi cations and dense calcium. (*) Small 
spotty calcifi cations did not have more TCFA 









The present study systematically evaluated the relation between different calcifi cation 
patterns on CTA and plaque characteristics on invasive IVUS-VH. It was demonstrated that 
plaques with spotty calcifi cations, in particular the smaller spotty calcifi cations (< 1 mm) 
had plaque characteristics deemed high-risk on IVUS-VH, as defi ned by a higher % of 
necrotic core and presence of TCFA. 
Interestingly, the present fi ndings are in line with histopathological studies which have 
reported that lesions associated with acute coronary events are often not heavily calci-
fi ed.20 21 23 Burke et al studied the degree of calcifi cation in serial sections of coronary 
arteries in sudden coronary death cases and observed that plaque ruptures showed 
relatively little calcifi cation and that most acute plaque ruptures resulting in sudden 
death occurred in areas of only mild speckled calcifi cation.21 Furthermore, smaller calcium 
deposits on grayscale IVUS have been related to more unstable clinical presentation such 
as unstable angina and myocardial infarction. Beckman et al measured the arc of calcium 
in lesions of 78 patients and found that the average arc of calcium was greatest (32 ± 
7°) in patients with stable angina, less (15 ± 4°) in patients with unstable angina, and 
least (10 ± 5°) in patients with acute myocardial infarction (p< 0.014).24 In line with these 
fi ndings, van der Hoeven et al studied 60 patients with acute myocardial infarction on 
grayscale IVUS and demonstrated that small calcifi ed spots (arc < 45°, length < 1.5 mm) 
were more common in the culprit lesions as compared to the adjacent distal and proximal 
segments.18 Accordingly, Ehara et al confi rmed the fi ndings in a larger patient population 
of 178 patients with grayscale IVUS.25 The authors found that not only the frequency of 
calcium deposits was signifi cantly different between patients with stable, unstable angina 
and myocardial infarction but also calcium deposits were signifi cantly longer in patients 
with stable angina (mean length of 4.3 ± 3.2 mm) as compared to patients with unstable 
angina (mean length of 1.9 ± 1.8) and myocardial infarction (mean length of 2.2 ± 1.6). 
Thus, these fi ndings support the concept that there may be a signifi cant difference in 
the pattern of coronary calcifi cations, particularly with respect to size and length of the 
deposits, among patients with stable and unstable angina.
Non-invasively, calcium scoring with electron beam computed tomography (EBCT) 
showed similar fi ndings. Although a higher calcium score has been related to larger 
plaque areas and worse prognosis26, when comparing coronary calcium scores of patients 
with stable angina to patients with acute myocardial infarction, signifi cant differences 
were observed.27 Extensive calcium was more often present in the coronary arteries of 
patients with chronic stable angina, whereas patients with acute myocardial infarction 
demonstrated a more diffuse pattern of calcifi cations. More interestingly, using contrast-
enhanced CTA, the presence of spotty calcifi cations were frequently present in lesions of 
patients with ACS but rarely observed in culprit lesions of patients with stable CAD.9 Simi-
larly, Motoyama et al demonstrated both retrospectively and prospectively with CTA that 
non-calcifi ed plaques with spotty calcifi cations and positive remodelling were associated 


















the aforementioned fi ndings were not related to invasive observations. Interestingly, a 
previous study by our institution evaluated the association between plaque composition 
on CTA and the presence of high-risk features on IVUS-VH in a smaller population of 50 
patients.28 It was demonstrated that the more high-risk plaques (TCFA) were most often 
present in mixed plaques (32%) on CTA. Although similar to the current fi ndings, the % 
of TCFA in mixed plaques was higher in the previous evaluation than in the current study. 
This could probably be explained by difference in the size and baseline characteristics 
of the patient population. In addition, the amount of dense calcium in the current study 
is somewhat lower than reported in other studies. However, this could be explained by 
the inclusion of a substantial number (65%) of patients presenting with acute coronary 
syndrome, known to have substantially less calcifi ed arteries.
Interestingly, earlier investigations have used various defi nitions of spotty calcifi cations 
on CTA. For instance, some investigations described spotty calcifi cation as any calcifi ed 
material embedded within a non-calcifi ed plaque, whereas other use a threshold of calci-
fi ed material less than 3 mm in size.7 9 29 However, a comprehensive approach for the 
evaluation of the extent of the spotty calcifi cations on CTA is preferred, thereby improving 
reproducibility and use in risk stratifi cation. The strength of the current study is that a 
systematic approach for the evaluation of spotty calcifi cations was applied, demonstrat-
ing that indeed the smaller spotty calcifi cations were related to the plaque characteristics 
deemed more high-risk such as necrotic core and presence of TCFA.
Importantly, the fi ndings are clinically relevant considering that CTA is increasingly used 
for the assessment of CAD and the use of this technique is extended from assessment of 
stenosis to the evaluation of the vessel wall. Nevertheless, even with the latest generation 
CTA scanners, exact identifi cation of the lipid core and thin fi brous cap is not feasible 
at the moment. Therefore, assessment of spotty calcifi cation on CTA may be benefi cial 
for individualized risk stratifi cation in combination with other high-risk features such as 
cardiovascular risk factors and biomarkers. Perhaps, CTA has a potential application in the 
context of identifying the “vulnerable” patient at risk for ACS. However, the clinical and 
prognostic impact of these fi ndings has to be evaluated in future prospective studies. 
Limitations
First, due to the limitations of intravascular ultrasound, not all plaques on CTA were also 
evaluated by IVUS-VH. In addition, detection of the thin fi brous cap (< 65 μm) is not 
yet feasible as IVUS-VH has a limited radial resolution of only 100 μm. Furthermore, it 
has been suggested that dense calcium on IVUS-VH is related to artifacts in the form of 
a halo of necrotic core surrounding dense calcium. However, no standardized method 
for correcting for this issue is currently available. Additionally, no other high risk plaque 
characteristics were assessed on CTA. Potentially, incorporating other CTA variables such 
as degree of stenosis and overall plaque burden, may allow for better risk stratifi cation. 
In addition, this study performed a retrospective analysis of data possibly introducing a 
bias with regards to lesion selection. Future evaluations examining on the relationship 








in a more prospective manner. Moreover, reproducibility information on the measurement 
of calcifi cation on CTA was not provided. Lastly, CTA is inherently associated with radiation 
exposure. However, recently, dose-saving algorithms and prospective ECG triggering were 
introduced to substantially reduce radiation dose.30
Conclusion
The current study demonstrated that plaques with small spotty calcifi cations on CTA were 
related to plaque characteristics deemed more high-risk on invasive IVUS-VH. Therefore, 
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Background: Coronary computed tomography angiography (CTA) allows direct evalu-
ation of the vessel wall and thus positive remodeling, which is a marker of vulnerability. 
The purpose of this study was to assess the association between positive remodeling on 
CTA and vulnerable plaque characteristics on virtual histology intravascular ultrasound 
(VH IVUS). 
Methods: A total of 45 patients (78% male, age 58 ±11 years) underwent CTA followed by 
VH IVUS. On CTA, the remodeling index (RI) was determined for each lesion by a blinded 
observer using quantitative analysis. Positive remodeling was defi ned based on RI ≥1.0. 
Percentage necrotic core and presence of thin-capped fi broatheroma (TCFA) were used as 
markers for plaque vulnerability on VH IVUS.
Results: In total, 99 atherosclerotic plaques were evaluated, of which 37 lesions (37.4%) 
were identifi ed as having positive remodeling on CTA. Higher levels of plaque vulner-
ability were identifi ed in lesions with positive remodeling as compared to lesions without 
positive remodeling. Percentage necrotic core was signifi cantly higher in lesions with 
positive remodeling (15.7% ±7.8%) as compared to lesions without this characteristic 
(10.2% ±7.2%) (p<0.001). Furthermore, signifi cantly more TCFA lesions were identifi ed in 
positively remodeled lesions (n=16; 43.2%) than in lesions without positive remodeling 
(n=3; 4.8%) (p<0.001).
Conclusion: Lesions with positive remodeling on CTA are associated with increased levels 
of plaque vulnerability on VH IVUS, including a higher percentage necrotic core and a 
higher prevalence of TCFA. Accordingly, evaluation of remodeling on CTA may provide a 









Non-invasively, coronary computed tomography angiography (CTA) has emerged as a 
promising modality to detect coronary atherosclerosis. The technique allows for direct 
evaluation of the coronary artery vessel wall, thereby enabling to some extent non-
invasive evaluation of plaque morphology and composition.1 Due to technical restrictions, 
CTA cannot provide detailed visualization of fi brous cap thickness or necrotic core size. 
However, the presence of positive remodeling, which is an important surrogate marker of 
vulnerability,2 3 can be reliably assessed.4-6 Moreover, previous studies have demonstrated 
a relation between positive remodeling as assessed on CTA and presentation with acute 
coronary syndrome (ACS).5 6 However, a direct comparison of plaque remodeling on CTA 
and plaque characteristics on virtual histology intravascular ultrasound (VH IVUS) has not 
yet been performed. The purpose of this study was to assess the association between 
positive remodeling on CTA and vulnerable plaque characteristics on VH IVUS.
METHODS
Patient population
The patient population consisted of 45 patients who underwent both CTA and invasive 
coronary angiography in combination with VH IVUS. Patients were clinically referred for 
CTA because of known or suspected coronary artery disease (CAD), followed by invasive 
coronary angiography and VH IVUS. Referral for invasive coronary angiography was 
based on clinical presentation and/or imaging results. VH IVUS was performed to further 
evaluate the extent and severity of disease in order to determine further management 
more precisely and elucidate possible discrepancies between non-invasive and invasive 
angiographic fi ndings. Contra-indications for CTA were (1) (supra) ventricular arrhythmias, 
(2) renal insuffi ciency (glomerular fi ltration rate<30ml/min, (3) known allergy to iodin-
ated contrast agents, (4) severe claustrophobia, (5) pregnancy. Exclusion criteria for IVUS 
were severe vessel tortuosity, severe stenosis or vessel occlusion. Risk factors for CAD 
were derived from existing patient medical record data. For this retrospective evaluation, 
patients with good to moderate image quality on CTA and available quantitative analyses 
were selected from an ongoing registry.7
CTA and VH IVUS acquisition
CTA was performed using either a 64-detector row (n=34) helical scanner or a 320-detec-
tor row (n=11) volumetric scanner (Aquilion 64 or Aquilion ONE, Toshiba Medical Systems, 
Otawara, Japan) as previously described.8,9 Patients with an elevated heart rate (≥65 
beats/min) were administered beta-blockers (oral metoprolol 50 or 100mg, single dose, 1 
hour before examination), if not contra-indicated. Unless contra-indicated, nitroglycerin 
0.4mg sublingual was administered immediately before contrast injection. During the CTA 





























reconstructed at 75% of the R-R interval, with a slice thickness of 0.50 mm and a recon-
struction interval of 0.25 mm. In case of motion artifacts, additional reconstructions were 
explored to obtain images with most optimal image quality for evaluation. For processing 
and evaluation CTA data were transferred to an off-line workstation. 
The VH IVUS examinations were performed during invasive coronary angiography. 
Invasive coronary angiography was performed according to standard protocols. Patients 
were administered nitroglycerin intracoronary before induction of the IVUS catheter 
(Eagle Eye, Volcano Corporation, Rancho Cordova, CA, USA). The ultrasound catheter 
was positioned in the coronary artery, and motorized pull back at a speed of 0.5 mm/s 
was used until the catheter reached the guiding catheter. The VH IVUS data were stored 
digitally and assessed offl ine.
CTA and VH IVUS analysis
The CTA examinations were evaluated by an independent and experienced observer who 
was blinded to the VH IVUS results, using a dedicated and extended version of the QAngio 
CT software (QAngio CT 1.1, Medis medical imaging systems, Leiden, The Netherlands).10 
On CTA data sets, the dedicated software was used to detect both lumen and vessel wall 
contours. According to the modifi ed American Heart Association classifi cation, coronary 
arteries were divided into 17 segments.11 Only segments that were available on both VH 
IVUS and CTA were analyzed. Coronary plaques were defi ned as structures >1 mm2 within 
and/or adjacent to the coronary artery lumen, which could be clearly distinguished from 
the vessel lumen.12 Per segment, coronary plaque was selected at the site of the most 
severe luminal narrowing. The detected lumen and vessel wall contours were used for 
automated quantitative measurements of coronary plaques. At the level of the minimal 
lumen area (MLA), the remodeling index (RI) was calculated by dividing the cross-sectional 
vessel wall area by the corresponding reference area. The cross-sectional reference area 
was determined in the normal appearing reference area as close as possible to the respec-
tive coronary lesion. The presence of positive remodeling was defi ned as a RI ≥1.0.13
The VH IVUS analysis was performed by two experienced observers who were blinded 
to baseline patient characteristics and CTA results, with the use of dedicated software 
(pcVH2.1, Volcano Corporation, Rancho Cordova, CA, USA). The previously described 
17-segment model was used to ensure that similar plaques were analyzed with CTA and 
VH IVUS. Side branches and coronary ostia were used as anatomical markers.
For each lesion identifi ed on both CTA and VH IVUS, MLA and corresponding vessel 
area were determined. In addition, percentage plaque burden was calculated as plaque 
cross-sectional area divided by the vessel cross-sectional area multiplied by 100.14 Four 
different plaque components, namely fi brotic tissue, fi bro-fatty, necrotic core and dense 
calcium, were differentiated into different color codes. The different plaque components 
were calculated as percentage of the plaque burden. Plaque type was determined on VH 
IVUS using a classifi cation based on the differentiation of the four plaque components 
as described previously.7 In total, four different plaque types were identifi ed, namely 








fi broatheroma (TCFA). TCFA lesions were defi ned as lesions with a plaque burden ≥40%, 
the presence of confl uent necrotic core of >10%, and no evidence of an overlying fi brous 
cap.7 Both the percentage necrotic core and the presence of TCFA were used to determine 
plaque vulnerability on VH IVUS.15
Statistical analysis
Statistical analysis was performed using SPSS 18.0 (SPSS, Inc., Chicago, Illinois). Continuous 
data are represented as means (±SD). Categorical data are expressed as absolute numbers 
or percentages. Segments available on both CTA and VH IVUS were included in the lesion-
based analysis. Plaque vulnerability on VH IVUS (as defi ned by the percentage necrotic 
core and the presence of TCFA) was assessed in lesions with positive remodeling (RI ≥1.0) 
on CTA and compared to the remaining lesions that did not show positive remodeling (RI 
<1.0) on CTA. Comparisons were performed by chi-square analysis. A p value of <0.05 was 
considered statistically signifi cant.
Table 1. Patient characteristics (n=45)
Age (years) 58 ±11
Men/women 35/10
Heart rate during CTA (beats per minute) 57 ±8
Stable angina/Suspected acute coronary syndrome 27/18
At least one stenosis with >50% diameter narrowing on invasive coronary angiography) 32 (71%)
No. of vessels diseased: 1 17 (53%)
No. of vessels diseased: 2 6 (19%)
No. of vessels diseased: 3 9 (28%)
Cardiovascular risk factors
Diabetes Mellitus 10 (22%)
Hypertension† 29 (64%)
Hypercholesterolemia‡ 26 (58%)
Current Smoker 20 (44%)
Obesity¥ 8 (18%)
Data are absolute values or means ± standard deviation.
Data in parentheses are percentages.
†Defi ned as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90
mm Hg or the use of antihypertensive medication.
‡Serum total cholesterol ≥230 mg/dL or serum triglycerides ≥200 mg/dL or treatment with
Lipid lowering drugs. 
¥Body mass index ≥30 kg/m2






























In total, 45 patients (78% male, age 57.8 ±11 years) who underwent CTA followed by VH 
IVUS were enrolled retrospectively. Characteristics of the patient population are provided 
in Table 1. In all patients CTA and VH IVUS studies were of suffi cient imaging quality for 
analysis. In total, 99 plaques were identifi ed on both CTA and the corresponding available 
VH IVUS analyses. Of theses 99 atherosclerotic plaques, 37 lesions (37.4%) were classifi ed 
as positive remodeled (RI ≥1.0) on CTA. In the remaining 62 lesions (62.6%) no positive 
remodeling (RI <1.0) was observed. On VH IVUS, the most prevalent plaque component 
was fi brotic tissue (52% ±16%), followed by fi bro-fatty tissue (19% ±12%), necrotic core 
(13% ± 8%) and dense calcium (8% ±9%). Qualitative evaluation of coronary lesions on 
VH IVUS revealed the presence of pathological intimal thickening, fi broatheroma and 
fi brocalcifi c lesions in respectively 37 (37.4%), 30 (30.3%) and 13 (13.1%) of lesions. Finally, 
TCFA were identifi ed in 19 lesions (19.2%).
Lesions identifi ed as positive remodeled (RI ≥1.0) on CTA had a signifi cantly higher 
plaque burden on VH IVUS as compared to lesions without positive remodeling (RI <1.0) 
as shown in Table 2. Percentage necrotic core was also signifi cantly higher in the positive 
remodeled lesions (RI ≥1.0) as compared to lesions without positive remodeling (RI <1.0). 
No differences in relation to the presence or absence of positive remodeling on CTA were 
observed in the percentage of fi brotic tissue, fi bro fatty tissue and dense calcium.
Qualitative evaluation of plaque types as shown in Figure 1, revealed an equal distribu-
tion of the presence of fi broatheroma (9 (24%) versus 21 (34%), p=0.32) between lesions 
with positive remodeling (RI ≥1.0) as compared to lesions without positive remodeling 
(RI <1.0). Furthermore, no signifi cant difference of the presence of fi brocalcifi c plaques 
(3 (8%) versus 10 (16%), p=0.36) were observed between the two groups. Pathological 
Table 2. VH IVUS characteristics between lesions with and without positive remodeling on CTA
Plaque characteristics on VH IVUS Presence of positive 
remodeling on CTA
Absence of positive 
remodeling on CTA
p value
Minimal lumen area (mm2) 8 ±4 9 ±5 0.38
Vessel area* (mm2) 16 ±6 15 ±6 0.24
Plaque burden (%) 51 ±10 41 ±16 <0.001
Fibrotic (%) 55 ±9 51 ±19 0.18
Fibro-Fatty (%) 20 ±11 18 ±13 0.58
Necrotic core (%) 16 ±8 10 ±7 0.001
Dense calcium (%) 9 ±6 7 ±11 0.25
Data are represented as mean ± standard deviation
*at minimal lumen area









intimal thickening was signifi cantly more often observed in lesions without positive 
remodeling (RI ≥1.0) on CTA; 28 lesions (45%) without positive remodeling (RI <1.0) on 
CTA were classifi ed as showing pathological intimal thickening as compared to 9 lesions 
(24%) with positive remodeling (RI ≥1.0) on CTA (p=0.04). Importantly, as shown in Figure 
1, 16 lesions (43.2%) with positive remodeling (RI ≥1.0) on CTA were identifi ed as TCFA. In 
contrast, only 3 lesions (4.8%) without positive remodeling (RI <1.0) on CTA were classi-
fi ed as TCFA (p<0.001). An example of a lesion with positive remodeling (RI ≥1.0) on CTA 






















Figure 1. Relative distribution of visually 
assessed plaque types on VH IVUS between 
lesions with positive remodeling and 
lesions without positive remodeling on CTA. 
Signifi cantly more lesions classifi ed as PIT 
were present in lesions without positive 
remodeling. Percentage of FA and FC were 
not signifi cantly different between lesions 
with positive remodeling and lesions without 
positive remodeling. Signifi cantly more TCFA 
lesions were identifi ed in lesions with positive 
remodeling on CTA. (Abbreviations: PR+, 
lesions with positive remodeling (RI ≥1.0) on 
CTA; PR –, lesions without positive remodeling 
(RI <1.0) on CTA; PIT, pathological intimal 
thickening; FA, fi broatheroma; FC, fi brocalcifi c 







Figure 2. An example of a lesion with 
positive remodeling on 320-row CTA and 
corresponding fi ndings on VH IVUS. (A) 
Curved multiplanar reconstruction of the 
left anterior descending coronary artery 
showing a large plaque in the proximal 
segment of the vessel. The diameter of 
the vessel at the plaque site is larger as 
compared to the diameter at the reference 
sections (1,2), indicating the presence of 
positive remodeling. (B and C) Corresponding 
longitudinal (B) and cross-sectional (C) VH 
IVUS images demonstrate indeed an outward-
remodeled lesion, with a large plaqueburden 
(69%) and a large amount of necrotic core 































In the present study, positive remodeling on CTA was related to vulnerable plaque cha-
racteristics on VH IVUS. Lesions with positive remodeling on CTA were shown to have a 
signifi cantly higher plaque burden on VH IVUS. A larger amount of necrotic core and a 
higher prevalence of TCFA were found in lesions with positive remodeling on CTA.
The current fi ndings are consistent with previous investigations, showing that compen-
satory enlargement of the vessel wall, including eccentric plaque growth, is strongly asso-
ciated with necrotic core area and macrophage infi ltration.15 16 Indeed, histopathological 
data have confi rmed that vulnerable plaques are almost always associated with positive 
remodeling.17-19 Also during in vivo VH IVUS studies, a similar connection between posi-
tive remodeling and plaque composition has been reported.20 In 41 patients, Rodriguez-
Granillo et al. described a signifi cantly larger percentage of necrotic core in positively 
remodeled vessels as compared to vessels with negative remodeling. Furthermore, 56% of 
positively remodeled lesions were classifi ed as TCFA, indicating a higher risk phenotype. 
In the current study, non-invasive imaging with CTA was used to identify the presence of 
positive remodeling. Previous studies have shown that reliable assessment of remodeling 
on CTA is feasible.4-6 21 Achenbach et al. determined RI in 44 patients with high-quality 
CTA data sets and observed higher indices in nonstenotic (<50% diameter reduction) 
as compared to stenotic lesions.4 In a subset of patients, measurements on CTA were 
verifi ed against IVUS, revealing a close correlation (r2=0.82). Consequently, several stud-
ies have explored whether the presence of positive remodeling on CTA may indicate 
an increased likelihood of vulnerability. Interestingly, lower attenuation values on CTA 
have been observed in lesions with positive remodeling as compared to lesions without 
this phenomenon.21 In turn, a correlation between lower attenuation values on CTA and 
increased lipid-rich and necrotic core content on IVUS has been observed.12 22 Accord-
ingly, these observations indirectly suggested that positively remodeled lesions on CTA 
may have a higher proportion of necrotic core, a hypothesis that was tested in the current 
study. In addition, the presence of positive remodeling on CTA has been related to clinical 
presentation with ACS.5 23 Two retrospective studies investigated the differences in coro-
nary plaque features between ACS patients and patients presenting with stable angina 
pectoris.5 23 As compared to lesions in stable patients, culprit lesions in ACS displayed 
more non-calcifi ed plaque, spotty calcifi cations and higher remodeling indices. Moreover, 
in a prospective study in 1.059 patients with a follow-up duration of 27 ±10 months, 
patients with plaques showing both positive remodeling and a low attenuation value on 
CTA were found to have a higher likelihood of developing ACS over time6. In contrast, 
absence of lesions with these characteristics on CTA conferred an excellent outcome.
Currently, the use of CTA is gradually shifting from assessment of degree of stenosis 
to evaluation of atherosclerotic plaque burden and risk assessment. The present study 
showed that lesions identifi ed as positive remodeled on CTA were associated with plaque 








artery vessel wall, including evaluation of positive remodeling, may potentially allow more 
individualized risk stratifi cation, based on CTA.
The following limitations need to be acknowledged. This feasibility study is a retro-
spective analysis in selected optimal conditions. Only patients with a CTA data set of 
diagnostic image quality were included and assessment of remodeling may be more 
diffi cult in data sets with lower image quality. Accordingly, our current fi ndings are based 
on a relatively small study population and need to be validated in a larger, more challeng-
ing study population. Our observations indicate that with increasing remodeling index, 
the likelihood of TCFA also increases. However, this observation does not implicate that 
a lesion with a remodeling index of ≥1.0 is per defi nition a vulnerable lesion. Possibly, 
additional markers are needed to predict the presence of a vulnerable lesion with higher 
accuracy. Of note, other characteristics of vulnerable plaque on CTA were not analyzed 
in this particular study. Importantly, while the presence of positive remodeling on CTA 
may have value for risk stratifi cation in addition to clinical characteristics and other CTA 
variables, the implications of this particular observation for prognosis and therapeutic 
management remain to be determined. Finally, the radiation exposure associated with 
CTA currently still restricts its widespread use. Notably however, novel dose-saving algo-
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Patients presenting with acute chest pain constitute a common and important diagnostic 
challenge. Therefore, interest has been raised in using computed tomography (CT) for 
non-invasive visualization of coronary artery disease in patients presenting with acute 
chest pain. Due to rapid developments in coronary CT angiography technology, high 
diagnostic accuracies for detecting coronary stenosis can be obtained. Additionally, CT 
is an excellent modality in patients whose symptoms suggest other non-coronary causes 
of acute chest pain such as aortic aneurysms, aortic dissection or pulmonary embolism. 
Furthermore, acquisition of the coronary arteries, thoracic aorta and pulmonary arteries 
in a single CT examination is feasible, allowing “triple rule-out”. Finally, other applications 
such as the evaluation of plaque composition, myocardial function and perfusion are 
currently under investigation and may also become valuable in the setting of acute chest 
pain. However, although CT shows great potential in evaluating patients with acute chest 
pain, more randomized clinical trials are needed to determine the value of this technique 
in this challenging patient population.
INTRODUCTION
Since the introduction of computed tomography (CT) in the early 1970s the technique 
has evolved into an essential imaging tool in general medicine. With this technique, 
non-invasive high resolution cross-sectional imaging of internal structures such as the 
brain, thorax and abdomen was permitted, thereby gradually replacing the more invasive 
radiographic techniques.1 Moreover, CT angiography has evolved as a very accurate tool 
Figure 1. Surface rendered volumetric 3D images of the coronary arteries and side-branches 
providing a 3D overview of the coronary artery tree and their relative position to the underlying 
cardiac structures, including the left ventricle (LV) and right ventricle (RV). (A) Anterior view of the 
left circulation demonstrating the left anterior descending coronary artery (LAD) with fi rst diagonal 
branch (D1). Moreover, the left circumfl ex coronary artery (LCx) can be identifi ed. The left atrium 
(LA) and right ventricular outfl ow tract (RVOT) can be also appreciated in this view. (B) Cranial view 
demonstrating a volume rendered image of right coronary artery (RCA) and left main coronary 
artery (LM) and their main branches originating from the right and left coronary cusp, respectively. 























for the visualization of the aorta and pulmonary arteries. However, high quality imag-
ing of the coronary arteries remained challenging due to small vessel size, movement 
and tortuous anatomy requiring high temporal, spatial and contrast resolution. In the 
late 1990s, the fi rst 4-slice spiral CT scanner was developed with suffi cient resolution to 
allow visualization of the coronary arteries. Preliminary investigations using these earlier 
generation multislice CT scanners established the potential of multislice CT for detect-
ing signifi cant coronary stenosis in comparison to conventional coronary angiography 
(CCA).2-4 Since then, coronary multislice CT angiography has developed into a promising 
non-invasive alternative to invasive CCA. With each successive generation of scanners 
from 4-slice to the present 64-slice and even 320-slice scanners, temporal and spatial 
resolution improved markedly due to faster gantry rotation times, thinner detectors and 
volumetric coverage. These new developments currently allow motion free visualisation 
of the entire coronary artery tree with high diagnostic accuracy for detecting coronary 
stenosis (Figure 1).5 6
Owing to these rapid developments, interest has been raised in using CT for the 
evaluation of patients presenting with acute chest pain. In the intensive coronary care 
unit (ICCU), acute chest pain is the most common clinical presentation of coronary artery 
disease (CAD). The diagnosis of acute coronary syndrome (ACS) is straightforward in high 
risk patients with typical chest pain, typical electrocardiography (ECG) changes, and eleva-
tion of serum cardiac enzymes, whereas it is diffi cult in patients presenting with atypical 
chest pain, non-diagnostic or normal ECG and normal initial cardiac enzymes. Indeed, 
up to 8% of patients with ACS are misdiagnosed and inappropriately discharged home.7 
Conversely, only a minority of “low risk” patients (i.e., those with initially normal electro-
cardiograms and cardiac enzymes) actually suffer from myocardial ischemia.8 Therefore, 
most patients presenting with acute chest pain are evaluated with serial ECGs and cardiac 
enzymes followed by a rest and/or stress-imaging study. However, this approach leads 
to many unnecessary hospital admissions and is both time-consuming and expensive 
and thus, resource-intensive. Therefore, a non-invasive and rapid examination to establish 
or exclude CAD as the underlying cause of symptoms could substantially improve the 
clinical care of patients admitted to the ICCU, reducing hospital admissions and costs. For 
this purpose, coronary CT angiography may constitute an attractive modality as it offers 
relatively simple and fast image acquisition. 
This chapter will focus on the evolving role of coronary CT angiography (including 
coronary calcium scoring) in the diagnosis of patients with acute chest pain. Furthermore, 
the role of CT in diagnosing other important causes of acute chest pain, concerning the 
great vessels such as aortic aneurysms, acute aortic dissection, and pulmonary emboli, 
will be addressed. Lastly, an overview of a wide range of other CT applications is provided 









CORONARY CT ANGIOGRAPHY: TECHNIQUE, ACQUISITION AND POST-
PROCESSING
CT is an imaging modality which has an X-ray source (tube) and detectors on opposite 
sides of a gantry that continuously rotates around the patient. During the CT scan the 
patient is moved through the gantry. Subsequently, the X-ray source emits photons col-
limated into a fan beam which are, after partial absorption and dispersion, reabsorbed 
by the detectors. Computer systems process these data into three-dimensional (3D) 
volumetric information, which can be transferred to CT workstations and be evaluated 
using multiple post-processing techniques. Fast image acquisition is essential for the 
acquirement of motion-free images and as multiple factors infl uence CT quality, proper 
patient preparation and appropriate CT acquisition techniques are critical to guarantee 
diagnostic image quality. 
Patient preparation
Proper patient preparation is important for obtaining diagnostic image quality. Therefore, 
before referring a patient for coronary CT angiography, a short patient history should 
be taken. Overall, a history of a severe allergic reaction to contrast agents, impaired 
renal function (glomerular fi ltration rate < 30 ml/min), presence of atrial fi brillation and 
pregnancy are considered contra-indications. The patient should refrain from food and 
liquids preferably three hours before the examination, to prevent nausea as a reaction to 
the contrast agent. Moreover, a low and stable heart rate in the range of approximately 50 
to 60 beats per minute is preferred during image acquisition. To achieve a low and stable 
heart rate, beta-blocking medication is frequently administered prior to the examination, 
unless contra-indicated. Lastly, to ensure for rapid delivery of the contrast agent bolus for 
coronary CT angiography, an intravenous catheter should be present for delivery of the 
contrast agent, preferably in the right antecubital vein (18-20 gauge).
ECG triggering and image acquisition
The range of the current 64-slice scanners is not large enough to cover the entire heart 
in one rotation and therefore several heart cycles are needed to image the entire heart. 
To compensate for cardiac motion and synchronize the start of the systole, ECG gating 
is needed to obtain phase-compatible images. Currently, there are two approaches of 
scanning the beating heart; with retrospective gating and prospective triggering (Figure 
2). Firstly, retrospective ECG gating collects data during the whole R-R interval in several 
heart beats with 64-slice scanners. Afterwards, the most optimal phase in which the 
coronary arteries have the least motion artifacts can be selected, most often being in mid 
diastole. As data acquisition is throughout the cardiac cycle, ventricular function can be 
analyzed as well. A newer scanning technique is prospective triggering in which the start 
of scanning is triggered by the R-wave and the scanning is performed only during diastole 
or another pre-specifi ed part of the cardiac cycle. An advantage is that the patient is 























correct any motion artifacts that occurred due to changes in heart rate or arrhythmias. 
Prospective triggering with dose modulation can be used for coronary artery imaging 
(full dose at the mid diastole of the cardiac cycle) in combination with ventricular function 
analysis (low dose throughout the other parts of the cardiac cycle).
Depending on the scanner type, imaging can be performed in helical (“spiral”) mode 
with continuous table movement and continuous or modulated acquisition, or in step-
and-shoot mode with multiple volumetric acquisitions reconstructed into a single dataset. 
A wide-volume detector allows full cardiac acquisition in a single gantry rotation, e.g. a 
320-detector row scanner that allows a maximum of 16 cm scan-range in a single rota-
tion.10 
When positioning the patient, this should be in a supine position with both arms above 
the head. The ECG leads are best positioned above and below the level of the scan surface 
to prevent streak artifacts. Importantly, to make sure that the entire heart is imaged, the 
CT examination must start from approximately 1-2 cm below the carina to 2 cm below the 
apex. Of note, if other structures (e.g. pulmonary arteries, aorta, bypass grafts) need to be 
visualized, a larger scan length should be selected.
For coronary calcium scoring, a low-dose ECG triggered non contrast-enhanced scan 
is performed before the contrast-enhanced CT examination and reconstructed to 3 mm 
slices. Additionally, this scan can be used to determine the proper location and scan range 
for coronary CT imaging. For a regular 64-slice scanner, a rapid infusion of 60 - 100 ml 
of contrast material with a fl ow-rate of 5 ml/s is used, followed by a saline fl ush. Typical 
scan parameters are: a pitch of 0.375, rotation time of 333-500 ms, tube voltage of 120 
kV and tube current of 300 mAs. When using a bolus-triggered start of the CT scan, the 
start is automatically initiated if the preset contrast-enhancement threshold level in the 
descending aorta is reached. Alternatively, a test bolus injection can be used to determine 
the contrast transit time. Subsequently, data acquisition is performed at half-inspiratory 
breath hold of approximately 10 seconds. 
Figure 2. Figure showing the mechanism of 
retrospective ECG gating versus prospective 
ECG triggering. With retrospective gating data 
are continuously acquired while simultaneously 
recording the ECG of the patient. Therefore, 
retrospective reconstruction can be performed in 
every phase of the R-R interval. With prospective 
triggering, the X-ray beam is on only during 
a pre-selected phase of the R-R interval and 
reconstruction can only be performed in the 
scanned phase, for example in mid diastole (70 - 









After data acquisition, images are reconstructed and sent to a dedicated workstation for 
post-processing. If a non contrast-enhanced dataset is acquired, coronary calcium score 
can be quantifi ed according to the Agatston method on a vessel and patient basis.11 
Commonly, coronary CT angiography datasets are reconstructed with continuous images 
using thin increments (typically 0.5 - 0.6 mm slice thickness). Retrospectively gated axial 
images can be reconstructed in any phase of the cardiac cycle. However, when prospective 
triggering was used, images can only be reconstructed in the pre-specifi ed R-R acquisition 
interval. Most often reconstructions are performed in the relatively motion-free phase of 
mid diastole (70 - 80% of R-R interval) which is generally least affected by motion artifacts. 
For post-processing, various types of algorithms are available. The thin axial slices are 
considered the source information of CT imaging (Figure 3). Accordingly, the cardiac struc-
tures and coronary arteries can be easily evaluated by scrolling through the images in axial 
Figure 3. Typical example of axial contrast-enhanced images (0.5 mm slice thickness), which 
can be used to evaluate cardiac structures (such as the left ventricle (LV), left atrium (LA), right 
ventricle (RV) and aorta (Ao)) and coronary arteries by scrolling through the slices in the cranio-
caudal direction. Four images have been selected to demonstrate to anatomy of the heart. (A) 
Axial image showing the left main (LM) coronary artery at the level of the ostium which arises 
from the left coronary cusp and bifurcates fi rst into the left anterior descending coronary artery 
(LAD). (B) Slightly more distal axial image showing the left circumfl ex coronary artery (LCx) and the 
fi rst diagonal branch (D1) which has originated from the LAD. (C) Axial image demonstrating the 
origin of the right coronary artery (RCA) from the right coronary cusp and the mid segments of 
the LCx, LAD and D1. (D) Axial image at midventricular level which shows the mid segment of the 
























direction (Online supplemental movie 1). Additionally, curved multiplanar reconstructions 
(MPR) allow visualization of the entire coronary artery in a single image which is useful 
for depicting the entire coronary lumen and evaluating degree of stenosis. Furthermore, 
maximum intensity projections (MIP) can be reconstructed which represent a series of con-
tiguous CT slices stacked into a single image (“slab”). Moreover, MIPs are very suitable for 
assessment of longer length of vessel segments and may facilitate in evaluating the degree 
of stenosis. Lastly, 3D volume rendering provides a 3D image of the heart and vessels 
(Online supplemental movie 2). An excellent overview of the coronary anatomy is provided, 
although 3D volume rendering is generally not used for assessing the degree of stenosis.
A systematic approach is important when evaluating a coronary CT angiogram. If 
coronary calcium scoring has been performed, the Agatston score is reported on a patient 
and vessel basis. In addition, the patient based Agatston score is commonly placed in a 
percentile rank based on the known distribution of coronary calcium scores in relation to 
patient age and sex to facilitate interpretation of the coronary calcium score. With regard 
to the coronary CT angiogram, the quality of the scan should be mentioned as this infl u-
ences the diagnostic certainty of the study. Findings are commonly reported similar to the 
traditional CCA report. Typically, the coronary segments are described as normal, mild (< 
30% wall irregularities), non-signifi cant (30 - 50% stenosis), signifi cant (> 50% stenosis), 
severe stenosis (> 70%) and occlusion. Presence and patency of stents and bypasses are 
reported, if evaluable. Segments effected by severe calcifi cations, motion and breathing 
artifacts should also be mentioned in the report. 
CORONARY CALCIUM SCORE
It has been widely verifi ed that presence of coronary calcifi cations only occurs in the pres-
ence of coronary atherosclerosis.12 Both electron beam computed tomography (EBCT) 
and multislice CT have been used over the past years for the non-invasive evaluation of 
coronary calcifi cations, both demonstrating high sensitivities for the detection of CAD. 
An example of coronary calcium scoring is provided in Figure 4.13 14 For quantifi cation of 
the coronary calcifi cations, the Agatston method (a method that multiplies the calcifi ed 
area by a density factor based on the highest Hounsfi eld values within this area) has 
been traditionally used.11 Total coronary calcium scores are generally divided into normal 
(zero calcium), mild (1 - 100), moderate (100 - 400) and severe (> 400).15 Although newer 
quantifi cation methods have been introduced (calcifi ed volume (mm3) and mass (mg) 
measurements), no clinical studies have provided data using these methods. 
Coronary calcium score in general population
Several population based studies have demonstrated that the calcium score increases with 
higher age thereby refl ecting the natural progression of atherosclerosis. In addition, men 
tend to have higher coronary calcium scores than women of similar age. Therefore, when 








distribution within age and sex.13 16 Moreover, the relation between the presence of obstruc-
tive CAD and presence and extent of coronary calcium has been extensively studied.17 
The presence of coronary calcifi cations was demonstrated to have a high sensitivity and 
negative predictive value for the presence of obstructive disease, however a very limited 
specifi city was reported.17 18 Indeed, extensive calcifi cations (resulting in a high coronary 
calcium score) can be present even in the absence of signifi cant luminal narrowing. There-
fore, although high coronary calcium scores are often associated with obstructive CAD, 
the technique may be more suited to provide an estimate of total plaque burden rather 
than stenosis severity. Interestingly, numerous investigations have shown that the extent of 
coronary calcium burden translates into prognostic information. Coronary calcium scoring 
has therefore been proposed as a tool for stratifying cardiac risk. In fact, several large trials 
have reported that elevated coronary calcium scores have predictive value for cardiovascu-
lar events, both independently and incrementally to cardiovascular risk factors.19 20 
Coronary calcium score in patients with ACS
In the specifi c clinical setting of acute chest pain, a few initial investigations with EBCT 
have been conducted to assess the value of coronary calcium scoring; however, the num-
ber of patients in these studies was relatively limited.21-23 Georgiou et al performed a 
prospective observational study of 192 patients with acute chest pain and demonstrated 
that the presence of coronary calcium was a strong predictor of future cardiac events.21 
In addition, the authors elegantly demonstrated that the absence of coronary calcifi ca-
tions had a very low risk for future cardiac events (< 1%). Moreover, McLaughlin et al 
performed coronary calcium scoring in 134 patients with suspected ACS and a normal or 
non-diagnostic ECG. The authors found that the absence of calcium had a high negative 




Figure 4. Example of coronary calcium scoring with non contrast-enhanced computed tomography. 
Calcium deposits can be recognized as bright white structures located in the coronary arteries. (A) An 
example of a patient without calcium (arrow) in the proximal left anterior descending coronary artery 























Nevertheless, when comparing coronary calcium scores of patients with stable angina 
to patients with acute myocardial infarction, signifi cant differences have been observed.24 
Extensive calcium was more often present in the coronary arteries of patients with chronic 
stable angina, whereas patients with acute myocardial infarction demonstrated only 
mildly calcifi ed or non-calcifi ed culprit arteries. Similar results were shown in a study by 
Henneman et al who showed that in 40 patients suspected of ACS coronary calcium was 
absent in 13 patients (33%).25 Importantly, in 5 (39%) of the 13 patients without coronary 
calcium, signifi cant CAD was identifi ed on CCA (example shown in Figure 5). Thus, par-
ticularly in the acute setting, absence of coronary calcifi cation may not invariably imply 
the absence of atherosclerotic plaque. Moreover, the presence of coronary calcifi cation 
does not by defi nition explain the actual cause of chest pain. Evidently, there is a need for 
more research to defi ne the role of coronary calcium scoring in patients with acute chest 
pain. The current guidelines therefore do not recommend coronary calcium scoring as a 
screening method for patients suspected of ACS.26 However, in asymptomatic patients 
initially classifi ed as being at intermediate risk, knowledge of the extent of coronary cal-








Figure 5. Example of a patient presenting with suspected ACS in which calcium scoring and 
contrast-enhanced coronary CT angiography was performed to exclude coronary artery disease. 
Although no calcium was demonstrated by the calcium score (A), an obstructive non-calcifi ed 
plaque with a super-imposed thrombus in the right coronary artery (RCA) was detected on 
coronary CT angiography (B,C). The volume rendered 3D reconstruction (B) and curved multiplanar 
reconstruction (C) show an occlusion in the mid segment of the RCA (white arrows). (D) This fi nding 
was confi rmed on invasive conventional coronary angiography (white arrow). Ao; aorta, LAD; left 
anterior descending coronary artery, LCx; left circumfl ex coronary artery. Reprinted with permission 









Left anterior descending coronary artery
Left circumflex coronary artery
Figure 6. Example of coronary CT angiography performed to rule out ACS in a 43 year old 
male admitted because of acute chest pain and intermediate risk profi le. Curved multiplanar 
reconstructions (MPRs) in two different views of the right coronary artery, left anterior descending 

























Evaluation of CAD in general population with coronary CT angiography
With the current generation 64-slice scanners with improved temporal and spatial 
resolution a good diagnostic accuracy for detection of obstructive CAD both in proximal 
coronary vessels and smaller distal vessels has been observed. Indeed, a high sensitivity 
(ranging from 85 - 99%) and specifi city (ranging from 83 - 90%) of 64-slice CT angiogra-
phy for the detection of obstructive lesions as compared to CCA has been demonstrated.5 
6 27 More importantly, due to the high negative predictive value, coronary CT angiography 
has an excellent ability to exclude signifi cant CAD (Figure 6). Accordingly, if patients show 
normal coronary arteries on coronary CT angiography no further testing is required and 
patients can be reassured. However, a signifi cant limitation of CT angiography remains 
the relatively low positive predictive value (ranging from 64 to 93%). As a result, athe-
rosclerotic lesions are still frequently being overestimated on CT which occasionally 
may lead to unnecessary referral for invasive CCA. Moreover, it should be noted that 
the diagnostic performance of CT coronary angiography is infl uenced by the pre-test 
likelihood of signifi cant CAD (Table 1). Indeed, a recent study showed that the benefi t 
from this non-invasive modality is highest in patients with a low to intermediate pre-test 
likelihood for CAD due to its excellent ability to rule out obstructive CAD.28 Similar results 
were recently published by Henneman et al demonstrating that coronary CT was able 
to rule out coronary atherosclerosis in 58% of patients with low pre-test likelihood.29 
However, in patients with a high pre-test likelihood, CT was often abnormal and CAD was 
ruled out in only 17% of patients. Consequently, the remaining 83% of patients with a high 
pre-test likelihood and abnormalities on coronary CT angiography still required further 
functional and/or invasive testing. Therefore, to avoid layered testing and delayed diag-
nosis, these patients should be directly referred for either functional testing or invasive 
CCA. Accordingly, current guidelines state that if the pre-test likelihood of CAD is high, 
invasive CCA remains the test of fi rst choice and the additional value of non-invasive 
coronary angiography may be limited. 
Table 1. Diagnostic accuracy of 64-slice CT angiography for detection for signifi cant stenosis 
(≥ 50%) according to pre-test probability. As can be derived from the table, patients with a low 
to intermediate likelihood benefi t the most from non-invasive coronary CT angiography as the 
sensitivity and specifi city (and negative predictive value to rule out CAD) is higher in these patients. 
Data adapted from Meijboom et al.28 
Pre-test 
probability
N Sensitivity Specifi city PPV NPV
Low 66 100% 93% 78% 100%
Intermediate 83 100% 84% 80% 100%








Evaluation of CAD in patients with suspected ACS with coronary CT 
angiography
A major advantage of coronary CT angiography is that it is a non-invasive, fast and accu-
rate modality for ruling out the presence of CAD and severe stenosis, features that are 
particularly useful in the emergency department. Several investigations have assessed 
the value of coronary CT angiography in patients presenting with ACS (an example is 
provided in Figure 7). Preliminary studies investigating the effi cacy of CT in the diagnosis 







Figure 7. Example of non-invasive coronary angiography with computed tomography in a patient 
presenting with suspected ACS. In (A), a 3D volume rendered reconstruction is provided, showing 
a large dominant right coronary artery (RCA) with signs of luminal narrowing (white arrow). (B) 
A curved multiplanar reconstruction (MPR) of the RCA is shown demonstrating the presence of 
signifi cant luminal narrowing in the mid segment (arrow). (C) Another curved MPR in a different 
view, revealing the presence of signifi cant stenosis (arrows). Cross-sectional CT images (inlays) show 
the presence of calcifi ed plaque proximal to the stenosis (a), exclusively non-calcifi ed plaque within 
the stenosis (b), and no coronary plaque distal from the stenosis (c). (D) Conventional coronary 























hospitalized with suspected ACS and found a moderate sensitivity (80%) and specifi city 
(89%) for the detection of signifi cant CAD (defi ned as ≥ 50% luminal narrowing).30 Sub-
sequent studies have been performed using 64-slice systems (Table 2), with higher spatial 
and temporal resolution, evaluating coronary plaque and stenosis in patients presenting 
with ACS.32-36 For instance, Rubinshtein and colleagues evaluated the effi cacy of coronary 
CT angiography for initial triage in 58 patients with suspected ACS and assessed clinical 
outcomes during a follow-up of 15 months.36 During the follow-up period, no deaths or 
myocardial infarctions occurred in the 35 patients discharged from the emergency depart-
ment after initial triage and with normal CT fi ndings. The authors concluded that coronary 
CT angiography had a high positive predictive value for diagnosing ACS, whereas a nor-
mal CT study predicted a low rate of major adverse cardiovascular events and favourable 
outcome during follow-up. Most recently, the ROMICAT (Rule Out Myocardial Infarction 
using Computed Assisted Tomography) trial evaluated 368 patients suspected of ACS and 
demonstrated that 50% of patients with acute chest pain with a low to intermediate likeli-
hood of ACS were free of CAD by coronary CT angiography and had no ACS. The authors 
concluded that given the large number of such patients, initial evaluation with coronary 
CT angiography may signifi cantly improve patient management in the emergency depart-
ment. These results are in line with most studies signifying that coronary CT angiography 
is useful and safe in ruling out CAD and facilitates early and accurate release of patients 
with acute chest pain.32-36 Additionally, CT evaluation reduced diagnostic time, lowered 
costs and required fewer repeat investigations when compared to standard of care.32 Of 
note, the majority of patients included in the abovementioned studies were classifi ed as 
having a low to intermediate risk for ACS (normal or non-diagnostic ECG and normal fi rst 
cardiac enzymes). In addition, the presence of a signifi cant stenosis on coronary CT does 
not by defi nition confi rm the presence of ACS. Importantly, there is no additional role for 
coronary CT angiography in patients with evident myocardial infarction. Naturally, high 
risk patients should immediately be referred for invasive CCA and coronary CT angiogra-
phy would only cause signifi cant delay. At present, there are no formal guidelines for the 
use of CT in patients with acute chest pain, although appropriateness criteria and con-
sensus documents have recently been published.37 38 Currently, more large randomized 
clinical trials should be performed to determine the accuracy and benefi ts of coronary CT 
Table 2. Studies assessing the diagnostic accuracy of dedicated coronary 64-slice CT angiography 
in patients presenting with acute chest pain in the emergency department.
N Pre-test 
probability
% ACS Sensitivity Specifi city PPV NPV
Hoffman et al.33 103 Low 14% 100% 82% 47% 100%
Gallagher et al.39 85 Low 8% 86% 92% 50% 99%
Rubinstein et al.36 58 Intermediate 34% 100% 92% 87% 100%
Goldstein et al.32 99 Low 8% 100% 74% 25% 100%
Hoffman et al.34 368 Low 8% 100% 84% 35% 100%








angiography for triage of patients with acute chest pain prior to implementation of this 
technique. However, in the future, initial evaluation with coronary CT angiography may 
play an important role, especially in a population with low to intermediate risk for ACS in 
whom the incremental value of non-invasive imaging may have a signifi cant impact on 
patient management.
CT ANGIOGRAPHY OF AORTA AND PULMONARY ARTERIES
Non-cardiac causes of acute chest pain concerning vascular structures in the thorax such 
as aortic aneurysms, dissection, pulmonary emboli and pathology of the chest wall can 
be easily visualized by CT angiography. CT angiography of other vascular beds than the 
heart is less complex if non ECG gating techniques are used. ECG gating may be used to 
improve image quality. In addition, contrast-enhancement in the blood pool is required 
to visualize the vascular structures; therefore intravenous contrast is still needed. Several 
common principles should be applied to all imaging protocols to provide optimal diag-
nostic image quality such as bolus-timing for optimization of contrast delivery in the 
vessel, fast high resolution acquisition and administration of approximately 60 - 120 ml 
of contrast material (dependent on patient size, contrast agent used and scanner type) 
injected at rapid infusion rates (4 – 5 ml/s).
Thoracic aortic aneurysm
In general, an ascending aortic diameter equal to or greater than 4 cm (when younger 
than 60 years old) is considered an aneurysm (Figure 8). Atherosclerosis is, as expected, 
the most frequent cause of thoracic aneurysms (70%). Two different types of thoracic 
aortic aneurysms can be identifi ed according to their pathological features. First, a true 
aneurysm, in which all three layers of the vessel wall are involved (intima, media and 
adventitia) and which is characterized by a fusiform shape (Figure 8). Secondly, a false 
aneurysm (or pseudo-aneurysm), in which the intima is disrupted and the blood is con-
tained by the adventitia. CT angiography is the most robust tool for evaluating aortic 
aneurysms and some key features should be evaluated when using CT such as maximal 
aortic diameter, presence of thrombus, shape and extent of the aneurysm, involvement of 
aortic branches, relationship to adjacent structures and presence of aortic calcifi cations. 
As in 23% of cases a thoracic aneurysm co-exists with an abdominal aortic aneurysm, 
evaluation of the whole aorta should be performed. Most importantly, CT shows excellent 
accuracy for characterizing important features of aneurysms.40 
Aortic dissection 
Aortic dissection is the most common disorder of the acute aortic syndromes and also 
has the highest mortality rate. Aortic dissection occurs when a tear in the media layer 
allows blood to enter within and along the vessel wall and results in separation of the 























development of a true and false lumen, separated by a “fl ap”. There are currently two 
classifi cation systems: the De Bakey classifi cation and the Stanford classifi cation. The De 
Bakey type I dissection involves both the ascending and descending thoracic aorta. The 
De Bakey type II dissection only involves the ascending aorta while the De Bakey type 
III dissection only involves the descending aorta. The Stanford system is more clinically 
useful and uses the following classifi cation: In Stanford type A the dissection is located in 
the ascending aorta and aortic arch, either with or without involvement of the descending 
aorta, while Stanford type B dissections are limited to the descending aorta alone. Type 
A acute aortic dissection has the worst prognosis and generally should be immediately 
surgically repaired to avoid fatal complications.
When aortic dissection is suspected, urgent high resolution imaging is required to 
confi rm the diagnosis. For this purpose; CT angiography, magnetic resonance imaging 
(MRI) and transesophageal echocardiography (TEE) have been shown to be equally accu-
rate for confi rming or excluding the diagnosis of thoracic aortic dissection.41 Currently, 
CT angiography is the most commonly used technology for the assessment of patients 
suspected of aortic dissection (Figure 9). Indeed, CT angiography has an excellent sen-
sitivity and specifi city of almost 100% for the detection of aortic dissection, as has been 
reported by various studies.42 43 CT scanning protocols for patients suspected of thoracic 
aortic dissection should include unenhanced (for depicting intramural hematoma) and 
Figure 8. Electrocardiography (ECG)-gated thoracic computed tomography (CT) showing an 
aneurysm of the ascending aorta in a coronal view and 3D volume rendering representation. 
Acquisition was performed by 2 x 16 cm volume rotations with a 320-detector-row CT scanner. 
As a result of the time delay between the two rotations in combination with short contrast bolus 
injection, a difference in pulmonary artery contrast-enhancement can be observed (arrowhead). 
The pulmonary artery contrast difference does not hamper evaluation of the aorta. Note the sharp 
reconstruction of the ascending aorta using ECG-gating at end-systole at a cardiac frequency of 75 








contrast-enhanced image acquisition with visualization of the entire aorta. The key 
features of dissection on contrast-enhanced images are: a fl ap separating two lumens 
(usually the convexity of the intimal fl ap is towards the false lumen), contrast arriving 
in the true lumen fi rst followed by the false lumen, slower fl ow in the false lumen and 
presence of pleural and/ or pericardial effusion. CT should also be used to accurately 
locate the position of the intimal tear site, as this is important for the surgical approach. 
Pulmonary embolism
The renowned Wells’ clinical decision rule is used to risk stratify patients suspected of 
pulmonary embolism.44 This is a scoring method based on various clinical risk factors and 
stratifi es patients as low, intermediate or high risk. If a patient has a score of greater than 
four, further testing is required. CT pulmonary angiography has been demonstrated to 
provide high diagnostic accuracy for the detection of pulmonary embolism and patients 
with a high-quality negative CT examination do not require further examination.45 46 On 
CT, pulmonary emboli are shown as fi lling defects in the contrast-enhanced central or 
(sub)segmental pulmonary arteries (Figure 10). Currently, contrast-enhanced CT pulmo-
nary angiography is the imaging method of choice for the detection of pulmonary emboli 
and thus replacing ventilation-perfusion imaging.
TRIPLE RULE-OUT CT 
The concept of the ‘‘triple rule-out’’ protocol is to simultaneously exclude all three poten-
tially life threatening causes of acute chest pain, such as ACS or myocardial infarction, 











Figure 9. Thoracic computed tomography (CT) angiography showing a type A aortic dissection 
(A). The right coronary artery is contrast-enhanced and has its origin from the true lumen 
(arrow, B). The right coronary artery has double appearance due to motion artefacts in this 
non-electrocardiography (ECG) gated scan. The left main coronary artery stem (arrow, C) is also 
contrast-enhanced and had its origin from the true lumen. Carotid and subclavian arteries as 
well as the visceral arteries all had their origin from the true lumen. Note the almost complete 
disruption between the true and false lumen of the descending aorta (arrowheads B, C). F, false 























rule-out scan protocol includes coverage of the entire thorax cavity including the aortic 
arch. Although 16-slice scanners have allowed for the adequate evaluation of coronary 
arteries, these systems were not fast enough to provide a high resolution scan of the entire 
thorax in addition to an ECG gated scan of the coronary arteries. Newer, state-of-the-art 
64-slice scanners with wider anatomic coverage are able to scan the entire thorax includ-
ing the pulmonary arteries, thoracic aorta and coronary arteries in a single breath hold 
of approximately 15 - 20 seconds. However, an important technical challenge of a ‘‘triple 
rule-out’’ scan protocol is to ensure that high contrast-enhancement is present simultane-
ously in both the right and left circulation to evaluate the pulmonary and aorta including 
the coronary arteries. Recent data reporting the implementation of a tri-phasic contrast 
injection protocol (fi rst bolus of 100 ml of at 5 ml/s, followed by a second bolus of 30 ml 
contrast at 3 ml/s, followed by a saline fl ush) showed promising results with satisfactory 
contrast-enhancement of coronary, aortic, and pulmonary vasculature in a single breath 
hold.47 Potentially, this new approach may improve the triage of patients presenting to 
the emergency department with acute chest pain, and provide a faster algorithm to make 
a diagnosis. However, it is crucial that patients should be carefully selected to ensure the 
appropriate use of a triple rule-out CT protocol. Indeed, as the triple rule-out protocol 
may involve retrospective gating of the entire thorax, radiation dose is high, even more 
than the radiation dose observed in dedicated coronary CT angiography.48 49 Prospec-
tive gating techniques may reduce radiation dose, but cannot be applied effectively in 
patients with high heart rates. Therefore, patients with symptoms highly suggestive for 
either ACS, acute pulmonary embolism or acute aortic dissection, should be referred for 
a work-up specifi cally designed for this purpose (such as invasive CCA if a patient has a 




Figure 10. Patient with acute pulmonary embolism and high embolus-load. Massive emboli in the 
left and right pulmonary arteries can be observed (arrows, A). Note severe dilatation of the right 
ventricle (RV, B) with interventricular septum shift to the left and compression of the left ventricle 








automatically confi rm the presence of ACS. In the remaining patients with uncertain cause 
of the acute chest pain complaints, a triple rule-out protocol can be considered. Initial 
studies suggest that a triple rule-out CT angiography protocol for evaluation of patients 
with acute chest pain is feasible and that quantitative parameters of image quality may 
be comparable to the conventional, dedicated coronary and pulmonary CT angiography 
protocols.50 51 A study evaluating the diagnostic value of triple rule-out with 64-slice CT in 
the emergency department demonstrated that this technique facilitated the differential 
diagnosis of chest pain.50 In total, 55 patients underwent 64-slice CT angiography and in 
22 patients (40%) a defi nite diagnosis was made (pulmonary embolism (n = 10), coronary 
stenosis (n = 9), and aortic dissection (n = 1)). Furthermore, a recent study demonstrated 
that the triple rule-out protocol could potentially identify a subset of patients with acute 
chest pain who can safely be discharged from the emergency department without adverse 
events during a 30-day follow-up.52 Indeed, more randomized control trials are needed 
to determine whether this protocol is safe, cost-effective, and improves clinical decision 
making before routine use of such a technique can be justifi ed. 
OTHER APPLICATIONS OF CT 
Evaluation of plaque composition
An important advantage of coronary CT angiography is that not only luminal narrowing 
can be visualized but also atherosclerotic plaque composition. Three different plaques 
types can be distinguished by coronary CT; non-calcifi ed plaque, mixed plaque and calci-
fi ed plaque. More interestingly, plaque composition on coronary CT angiography has been 
linked to clinical presentation. Indeed, non-calcifi ed and mixed plaques have been shown 
to be more prevalent in patients with ACS whereas extensively calcifi ed plaques have 
been associated with stable CAD.53 In addition, it has been suggested that certain plaque 
features have prognostic value. In prospective studies, non-calcifi ed plaques with low 
attenuation values, positive remodeling and spotty calcifi cations have been associated 
with subsequent development of ACS (Figure 11).54 55 Although further characterization 
of non-calcifi ed plaque remains challenging, more improvements are expected, possibly 
allowing for improved identifi cation of patients at risk.56
Evaluation of myocardial function
Another particular advantage of CT angiography is that it allows assessment of cardiac 
function. If data have been collected during the whole cardiac cycle, images can be ret-
rospectively reconstructed in several phases. The end-systolic and end-diastolic phases 
can then be used to determine end-systolic and end-diastolic volumes to derive left 
ventricular ejection fraction. Indeed, numerous studies have shown that global left ven-
tricular function by CT correlates well with echocardiography and MRI although a slight 
tendency of CT to overestimate end-systolic volumes and thus slightly underestimate 























abnormalities can be reliably evaluated as compared to MRI.59 However, as images should 
be acquired throughout the cardiac cycle, left ventricular function protocols are associated 
with increased radiation exposure. Accordingly, the necessity of function measurements 
with CT should be carefully determined in each patient.
Evaluation of myocardial infarction
Over recent years, MRI has been successfully employed to image the presence of infarcted 
myocardium with delayed enhancement imaging. However, several studies have dem-
onstrated that the presence of myocardial infarction can be also identifi ed on CT.60 Due 
to the pharmokinetics of the contrast material a difference between the accumulation 
of contrast in infarcted and normal myocardium can be visualized. Accordingly, early 
hypoenhancement can be observed on the CT images during the fi rst pass of contrast 
medium at the area of infarcted myocardium. In addition, delayed hyperenhancement of 
infarcted tissue can be detected similar to MRI. Interestingly, a good correlation between 
infarct imaging with CT and other imaging modalities such as MRI and nuclear imaging 
has been demonstrated.60-62 Moreover, a good correlation between enhancement patterns 
(both early hypoenhancement and late hyperenhancement) and recovery of myocardial 
function at a follow-up of 3 months was found, suggesting that CT may be useful to 
predict myocardial functional recovery after infarction.63 However, it is important to real-
ize that in general, delayed enhancement imaging with CT requires additional imaging 
and thus involves additional radiation exposure. Also, a larger amount of contrast agent is 
Figure 11. Kaplan-Meier curve demonstrating the cumulative event free rate for development of 
ACS on the basis of plaque features which include positive vessel remodelling and low-attenuation 
plaques. Patient stratifi cation was performed according to the presence of 2- and 1-feature 
positive, and 2-feature negative plaques/no plaques. Interestingly, 2-feature positive plaques show 
signifi cant worse survival than 1-feature positive or 2-feature negative plaques. Reprinted with 








required for delayed enhancement imaging as compared to imaging the coronary arteries 
alone. 
Evaluation of myocardial perfusion
A major limitation of coronary CT angiography is that the hemodynamical signifi cance of 
atherosclerotic lesions cannot be assessed. Indeed, functional information is of particular 
importance in regard to lesions with borderline luminal narrowing. Interestingly, due to 
recent developments in scanner technology, it has become possible to image myocardial 
perfusion and to determine the presence of ischemia through perfusion imaging during 
stress.64 The technique is based on myocardial tissue attenuation changes during the 
infusion of contrast medium. Consequently, CT perfusion imaging can detect the pres-
ence of myocardial perfusion defects during stress that resolve during rest, indicating the 
presence of ischemia. Recent studies have been published demonstrating the feasibil-
ity of stress-rest myocardial perfusion imaging with CT in humans.65-67 Blankstein et al 
demonstrated using 64-slice CT that an adenosine stress CT protocol can identify stress-
induced myocardial perfusion defects with a diagnostic accuracy comparable to SPECT.65 
Additionally, the average radiation with this protocol was similar to the SPECT radiation 
dose. In addition, George et al showed that using both 64-slice and 256-slice CT that the 
combination of coronary CT angiography and adenosine perfusion CT allowed detection 
of hemodynamically relevant lesions with high diagnostic accuracy.66 Importantly, the 
combination of both anatomical and functional data may improve the diagnostic accu-
racy of CT and optimize patient management. However, before CT perfusion imaging can 
be implemented in daily clinical practice, its accuracy should be confi rmed in additional, 
larger prospective studies.
EXTRACARDIAC FINDINGS
Beyond evaluating the coronary arteries, other cardiac fi ndings and/or extracardiac 
fi ndings may be identifi ed during coronary CT angiography. Interestingly, extracardiac 
Figure 12. Large diaphragmatic hernia causing 
intra-thoracic located stomach (between arrows). 
Large diaphragmatic hernia may cause chest 
























fi ndings provide an explanation for chest pain complaints in 4% to 8% of patients (Figure 
12)68 69 or may be incidental fi ndings not related to chest complaints. Several studies 
have shown that extracardiac fi ndings are present in a large proportion of patients 
(approximately 50%).68-71 However, many of these fi ndings are not signifi cant and do not 
require follow-up or treatment, such as an incidental small calcifi ed pulmonary nodule 
or calcifi ed lymph nodes. However, 2% to 5% of patients do have signifi cant fi ndings 
requiring immediate further diagnostic action, such as a suspected malignancy which may 
necessitate immediate therapeutic actions, or the presence of acute pulmonary embolism 
or pneumonia.68 70 72 73 Other fi ndings, e.g., pulmonary nodules with low suspicion for 
malignancy, may require non-urgent further investigation or follow up.74 It is estimated 
that the patient population requiring further follow-up comprises approximately 15% of 
patients undergoing coronary CT angiography.68-71 75 76 
For coronary artery assessment, a zoomed-in small fi eld-of-view focused on the heart 
is reconstructed as to obtaining maximal spatial resolution for evaluation. However, this 
focused view only reveals 36% of the total chest volume, whereas 70% of the total chest 
volume has been exposed to radiation.73 Substantially more signifi cant extracardiac 
pathology is found on maximum full-fi eld reconstructions than on small-fi eld reconstruc-
tions.70 Therefore the maximum full-fi eld reconstructions should be reviewed for optimal 
identifi cation of extracardiac pathology.68 70 71 73 
LIMITATIONS AND FUTURE DEVELOPMENTS
Limitations
Coronary CT angiography has several major limiting factors that effects its usefulness in 
patients admitted to the emergency department and the ICCU. The technique is particu-
larly limited in patients with an irregular heart rhythm, elevated heart rate and a high body 
mass index. Indeed, the heart rate and regularity of the rhythm is closely related to image 
quality and accuracy of coronary stenosis assessment. Therefore, it is essential to provide 
adequate pre-medication with beta-blockers (orally or intravenously) to reduce the heart 
rate below 65 beats/min for optimal image quality. Moreover, coronary CT angiography 
has particularly been criticized to be an important source of ionizing radiation in the 
population. The effective radiation dose with retrospective 64-slice CT coronary angi-
ography is estimated to range approximately from 7 to 23 mSv.77 However, with the use 
of ECG dose modulation, a method that reduces tube current during systole, a radiation 
dose reduction of 30 to 50% can be achieved.49 Moreover, prospective ECG triggered CT 
angiography has been shown to reduce radiation dose by 80% often resulting in effec-
tive radiation doses of < 3 mSv.78 Notably, the triple rule-out CT angiography protocol is 
associated with an even higher radiation dose than with dedicated coronary CT and mean 
radiation doses of 18 mSv have been reported. However, when implementing ECG dose 
modulation, the mean radiation dose can be reduced to < 10 mSv.79 In addition, con-








it is essential to verify that renal function is not impaired prior to referring patients for 
contrast-enhanced CT angiography studies. 
Future developments 
CT technology is evolving quickly. Most recently 256- and 320-detecter row scanners have 
been introduced, which have higher volume coverage and improved temporal and spatial 
resolution.10 80 Complete volume coverage of the heart in a single heart beat is possible 
thereby reducing the motion artifacts in patients with irregular heart rates. Furthermore, 
additional radiation dose reduction has been achieved with the implementation of 
prospective ECG triggering by scanning only during a small pre-defi ned phase of the 
R-R interval. Moreover, dual-source CT systems with 2 × 128 detector rows have been 
introduced demonstrating a high temporal resolution of 75 ms (approximately half of the 
temporal resolution of the fastest 64-slice CT) making it possible to freeze cardiac motion 
and obtain diagnostic quality images of the coronary arteries regardless of heart rate. 
Initial studies with dual-source coronary CT in patients presenting with chest pain have 
reported high negative predictive values of almost 100% for detecting coronary artery 
stenoses, even in patients with higher heart rates.81 Most recently, high-pitch ECG trig-
gered (“Flash Spiral”) dual-source CT scanners have shown promising results. The novelty 
of this technique lies in the very high pitch which results in fast image acquisition without 
cardiac motion artifacts and a very low radiation exposure (mean estimated effective 
radiation dose of 1.0 ±0.3 mSv).82 Nevertheless, as these techniques are relatively new, 
only limited data are currently available. Prospective studies are needed to validate these 
novel applications of CT for use in standard clinical practice.
PERSONAL PERSPECTIVE 
Preliminary data suggest that coronary CT angiography has the potential to evaluate 
patients with acute chest pain and possibly improve diagnosis and management stra-
tegies. Improvements in technology (faster gantry rotation times, thinner detectors, 
volumetric coverage) and consequential improvement in image quality have resulted in 
a high diagnostic accuracy for detecting obstructive CAD in stable patients with low to 
intermediate likelihood. However, despite the excellent negative predictive value for rul-
ing out of CAD, there are still a considerable number of false positive studies. Moreover, 
another drawback is that at present the hemodynamical signifi cance of a lesion cannot be 
evaluated. Nevertheless, there are some features distinctive for coronary CT angiography 
which renders this technique very suitable for use in the diagnostic work-up of patients 
presenting with acute chest pain. The technique is non-invasive, relatively fast and simple 
to use and generally widely available. Furthermore, contrast-enhanced CT angiography is 
the imaging modality of choice regarding the detection of non-coronary causes of acute 
chest pain such as aortic aneurysms, aortic dissection, or pulmonary embolism. Notably, 























referring patients for coronary CT angiography. However, newer CT systems are avail-
able with dose saving innovations such a prospective triggering and dose modulation, 
allowing substantial radiation dose reduction. Overall, large randomized controlled trials 
are needed to assess the safety, effi cacy and cost-effectiveness of the use of coronary CT 
angiography in patients with acute chest pain, before an evidence based recommenda-
tion can be made. 
CONCLUSION
A major advantage of coronary CT angiography is that it is a non-invasive, fast and 
accurate modality for ruling out the presence of CAD and severe stenosis, features that 
are particularly useful in the emergency department. Recent investigations have demon-
strated that use of coronary CT angiography is very promising in the diagnostic work-up 
of patients presenting with acute chest pain. Accordingly, if patients show normal coro-
nary arteries on coronary CT angiography no further additional testing is required and 
patients can be reassured. Moreover, a normal CT angiography without any sign of CAD 
appears to be associated with a good short-term prognosis. However, the presence of 
some degree of coronary atherosclerosis might not fully exclude the presence of ACS and 
therefore further investigations are still needed. Nevertheless, coronary CT angiography 
is an excellent modality in patients whose symptoms suggest other non-coronary causes 
of acute chest pain such as aortic aneurysms, aortic dissection or pulmonary embolism. 
Accordingly, coronary CT angiography has much promise for evaluation of patients with 
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Computed tomography (CT) coronary angiography has become a highly accurate nonin-
vasive approach for delineation of the presence and severity of coronary atherosclerosis.1-9 
Cardiac CT is optimally suited for the evaluation of patients with a low or intermediate risk 
of coronary disease, allowing the non-invasive rule-out of coronary disease at relatively 
low cost and risk.10-18 However, the appropriate radiation dose remains an important issue 
in cardiac CT. On one hand, a too low radiation dose may result in a high level of image 
noise and therefore in non-diagnostic images. On the other hand, using higher radiation 
exposure levels may put patients at unnecessary risk of radiation damage.19-26 Effective 
strategies to reduce radiation dose, such as prospective gating, heart rate control, ECG-
correlated modulation of the tube current, and tube voltage below 100 kV, are becoming 
more and more applied in the clinical situation.27-31
Recently, Buechel et al.32 evaluated a large group of 612 patients referred for CT coro-
nary angiography by 64-slice computed tomography. Intravenous metoprolol (2 to 30 
mg) was administered if necessary to achieve a target heart rate below 65 beats/min. 
Using prospective ECG-triggering a mean effective radiation dose of 1.8 ± 0.6 mSv was 
obtained with a diagnostic image quality in 96.2% of segments. The authors concluded 
that low-dose CT coronary angiography by prospective ECG-triggering is feasible in the 
vast majority of an every-day population, whereby a heart rate below 62 beats/min favors 
diagnostic image quality. Blankstein et al.33 investigated the effective radiation dose and 
image quality of 100 kV versus 120 kV tube voltage among patients referred for cardiac 
dual source CT imaging in 294 consecutive patients. They convincingly demonstrated that 
use of low kV resulted in a substantial reduction of radiation dose without compromising 
image quality. The effective radiation dose for the 100 kV and 120 kV scans was 8.5 and 
15.4 mSv, respectively. In the recently published PROTECTION II trial, Hausleiter et al.34 
studied 400 non-obese patients undergoing CT angiography with either 100 kV or 120 
kV CT coronary angiography. The study specifi cally examined the impact of a reduction 
in tube voltage to 100 kV using 64-slice CT angiography systems from three different 
manufacturers. It was demonstrated that a further 31% reduction in radiation exposure 
could be obtained with 100 kV tube voltage settings while image quality was preserved. 
Zhang et al.35 prospectively evaluated image quality parameters, contrast volume and 
radiation dose at the 100 kV tube voltage setting during CT coronary angiography using 
a 320-row computed tomography scanner. The effective radiation dose was 2.12 ± 0.19 
mSv for 100 kV, being a reduction of 54% compared to 4.61 ± 0.82 mSv for 120 kV. 
Diagnostic image quality was achieved in 98.2% of coronary segments with 100 kV and 
98.6% of coronary segments with 120 kV. Therefore, the 100 kV setting allowed signifi cant 
reductions in contrast material volume and effective radiation dose while maintaining 
adequate diagnostic image quality. 
In the International Journal of Cardiovascular Imaging, Wang et al.36 investigated the 
feasibility of a body mass index-adapted low-dose 80 kV scan protocol using prospec-
tively ECG-triggered high-pitch spiral coronary CT angiography in 106 patients referred 
for coronary CT angiography to rule out coronary artery disease. The image quality and 

























demonstrated that an adequate diagnostic image quality was obtained in more than 98% 
of coronary segments using the 80, 100, and 120 kV tube voltage settings (p = 0.482). 
Image noise was signifi cantly higher with 80 kV compared to 100 kV and 120 kV tube volt-
age settings. The effective dose using 80 kV (0.36 ± 0.03 mSv) was signifi cantly lower than 
that using 100 kV (0.86 ± 0.08 mSv), or the 120 kV tube voltage setting (1.77 ± 0.18 mSv). 
Use of a tube voltage of 80 kV for patients with a body mass index ≤ 22.5 kg/m² resulted 
in a further dose reduction of 58% and 80% compared with 100 kV and 120 kV protocols, 
while maintaining diagnostic image quality. Particularly in patients with slim body shape, 
a further reduction of tube voltage to 80 kV may be advisable. The authors concluded 
that 80 kV high-pitch spiral coronary CT angiography is feasible for patients with body 
mass index ≤ 22.5 kg/m². The authors also suggested that the amount of contrast material 
could be decreased, reducing contrast media-associated nephropathy and avoiding the 
obscuration of calcifi cation caused by excessively high Hounsfi eld value. To further reduce 
the high image noise, they introduced iterative reconstruction in clinical routine practice. 
Consequently, the authors propose a combination of a low kV scan protocol, reduced 
contrast material injection protocol, and iterative reconstruction for an acceptable low 
radiation dose together with preserved image quality. 
The above-mentioned fi ndings by Wang et al.36 have been underscored by Abada et 
al.37, who used a 64-slice CT 80 kV tube voltage setting in 11 patients with body weight < 
60 kg. The authors reported a dose reduction by up to 88% without a negative infl uence 
on image quality. Achenbach et al.38 reported a case of 74-year-old patient with 63 kg 
body weight using 80 kV tube voltage and showed adequate diagnostic image quality 
and a dose reduction of 80% compared with a standard 120 kV tube voltage setting. 
In summary, the study by Wang et al.36 validly demonstrates that further reduction in 
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Background: Multidetector computed tomography coronary angiography (CTA) has 
emerged as a feasible imaging modality for non-invasive assessment of coronary artery 
disease (CAD). Recently, 320-row CTA systems were introduced, with 16-cm anatomical 
coverage, allowing image acquisition of the entire heart within a single heart beat. The 
aim of the present study was to assess the diagnostic accuracy of 320-row CTA in patients 
with known or suspected CAD.
Methods: A total of 64 patients (34 male, mean age 61 ± 16 years) underwent CTA and 
invasive coronary angiography. All CTA scans were evaluated for the presence of obstruc-
tive coronary stenosis by a blinded expert, and results were compared to quantitative 
coronary angiography (QCA). 
Results: Four patients were excluded from initial analysis due to non-diagnostic image 
quality. Sensitivity, specifi city, positive and negative predictive values to detect ≥ 50% 
luminal narrowing on a patient basis were 100%, 88%, 92% and 100%, respectively. 
Moreover, sensitivity, specifi city, positive and negative predictive values to detect ≥ 70% 
luminal narrowing on a patient basis were 94%, 95%, 88% and 98%, respectively. With 
inclusion of non-diagnostic imaging studies, sensitivity, specifi city, positive and negative 
predictive values to detect ≥ 50% luminal narrowing on a patient basis were 100%, 81%, 
88% and 100%, respectively.
Conclusion: The current study shows that 320-row CTA allows accurate non-invasive 









Cardiovascular disease is the leading cause of morbidity and mortality in the Western 
world. Early detection of coronary artery disease (CAD) is of vital importance as timely 
treatment may signifi cantly reduce morbidity and mortality. Although invasive coronary 
angiography remains the standard of reference for the evaluation of CAD, multidetector 
computed tomography coronary angiography (CTA) has recently emerged as a robust 
imaging modality for the non-invasive evaluation of CAD.1 With sub-millimeter spatial 
resolution this technique allows detailed visualization of luminal narrowing as well as 
atherosclerotic changes within the coronary vessel wall. Advances in CTA technology have 
led to continuous improvements in image quality as well as reduction in radiation dose 
and contrast material. Recently, 320-row CTA systems were introduced, with enhanced 
cranio-caudal volume coverage as compared to 64-row systems. With 16-cm anatomical 
coverage (0.5 mm x 320 detectors), this new generation of CTA scanners allows image 
acquisition of the entire heart within a single gantry rotation and heart beat. Accordingly, 
wide volume CTA, in combination with prospective image acquisition, allows for a marked 
decrease in scan time and time of breath-hold, resulting in decreased radiation dose 
and contrast material as compared to retrospective helical imaging requiring multiple 
heart beats. In addition, improved temporal resolution and scan time result in an overall 
reduction of cardiac motion artifacts’ and eliminate the problem of stair-step artifacts’, 
observed during step-and-shoot acquisition techniques and helical imaging.2-5
The diagnostic accuracy of 320-row CTA in the evaluation of signifi cant coronary artery 
stenosis has not been previously reported. Therefore, the purpose of the current study 
was to evaluate the diagnostic accuracy of 320-row CTA in the identifi cation of signifi cant 
CAD, compared to invasive coronary angiography as the standard of reference.
METHODS
Patient population
The study population consisted of 64 patients (34 male, mean age 61 ± 16 years) who were 
scheduled for invasive coronary angiography and in whom also CTA was performed. Referral 
for CTA of patients scheduled for conventional coronary angiography was based on patient 
eligibility and availability of the CT scanner. Exclusion criteria for CTA examination were: 1) 
(supra)ventricular arrhythmias, 2) renal failure (glomerular fi ltration rate < 30 ml/min), 3) 
known allergy to iodine contrast material, 4) severe claustrophobia, 5) pregnancy. Diagnostic 
invasive coronary angiography served as the standard of reference. Patients with total cal-
cium score > 1000 or previous coronary artery bypass grafting (CABG) were excluded from 
the study. Based on these exclusion criteria, 2 patients with atrial fi brillation were excluded 
from CTA. Furthermore, 8 patients with previous CABG and 16 patients with a total calcium 
score exceeding 1000 were excluded from the study. The mean interval between invasive 






















condition of the patients occurred between the examinations. Table 1 presents an overview 
of the main clinical characteristics of the study population. The study was conducted in 
accordance with the principles of the Declaration of Helsinki. All patients gave written 
informed consent to the study protocol, which was approved by the local Ethics Committee.
CTA data acquisition
CTA studies were performed using a 320-row CTA scanner (Aquilion ONE, Toshiba Medical 
Systems, Otawara, Japan) with 320 detector rows (each 0.5 mm wide) and a gantry rota-
tion time of 350 ms. Metoprolol was administered orally (50-100 mg depending on heart 
rate) 1 hour before data acquisition to patients with a heart rate exceeding 65 beats per 
minute (bpm), unless contraindicated. The entire heart was imaged in a single heart beat, 
with a maximum of 16 cm cranio-caudal coverage. During the scan, the ECG was regis-
tered simultaneously for prospective triggering of the data. The phase window was set at 
65-85% of R-R interval in patients with a heart rate ≥ 60 bpm, and 75% of R-R interval in 
patients with stable heart rate < 60 bpm. In patients requiring LV function measurements, 
prospective ECG triggered dose modulation was used, scanning an entire cardiac cycle 
and attaining maximal tube current at 75% (when stable heart rate < 60 bpm) or 65-85% 
(when heart rate ≥ 60 bpm) of R-R interval. When prospective dose modulation was used, 
Table 1. Clinical characteristics of the study population
Number of patients 64
Age (yrs) 61 ± 16 
Men / women 34 / 30
Average calcium score (Agatston) 184 ± 223
BMI * (kg/m²) 26 ± 3




Current smoker 12 (19%)
Previous myocardial infarction 15 (23%)
Anterior wall 2 (3%)
Inferior wall 10 (15%)
Posterior wall 3 (5%)
Previous percutaneous coronary intervention 18 (28%)













the tube current outside of the pre-defi ned interval was 25% of the maximal tube current.
Tube voltage and current were adapted to body mass index (BMI) and thoracic anatomy. 
Tube voltage was 100 kV (BMI < 23 kg/m²), 120 kV (BMI 23 - 35 kg/m²) or 135 kV (BMI ≥ 
35 kg/m²) and maximal tube current was 400-580 mA (depending on body weight and 
thoracic anatomy). A tri-phasic injection of intra-venous contrast was used and the total 
amount of non-ionic contrast media (Iomeron 400; Bracco, Milan, Italy) injected into the 
antecubital vein was 60-80 ml (depending on body weight). First, 50-70 ml of contrast 
media was administered at a fl ow rate of 5.0 or 6.0 ml/s, followed by 20 ml of 50% con-
trast/saline. Subsequently, a saline fl ush of 25 ml was administered at a fl ow rate of 3.0 
ml/s. In order to synchronize the arrival of the contrast media and the scan, bolus arrival 
was detected using automated peak enhancement detection in the left ventricle using 
a threshold of +180 Hounsfi eld Units. All images were acquired during an inspiratory 
breath-hold of approximately 5 seconds. An initial data set was reconstructed at 75% of 
R-R interval, with a slice thickness of 0.50 mm and a reconstruction interval of 0.25 mm. 
If multiple phases were obtained, additional reconstructions were explored in case of 
motion artifacts in order to obtain images with the least motion artifacts. For processing 
and evaluation, images were transferred to a remote workstation with dedicated CTA 
analysis software (Vitrea FX 1.0, Vital Images, Minnetonka, MN, USA). CTA was performed 
successfully in all patients without complications. During the CTA examination mean heart 
rate (± SD) was 60 ± 11 bpm. Radiation dose was quantifi ed with a dose-length product 
conversion factor of 0.014 mSv/(mGy×cm) as described.6
When scanning prospectively, full dose at 75% of R-R interval, estimated mean radia-
tion dose was 3.9 ± 1.3 mSv (range 2.7 - 6.2 mSv). When scanning prospectively, full dose 
at 65-85% of R-R interval, estimated mean radiation dose was 6.0 ± 3.0 mSv (range 3.1 – 
11.8 mSv). The estimated mean radiation dose for prospectively ECG triggered modulated 
scans was 10.8 ± 2.8 mSv (range 4.5 – 14.2 mSv). The average investigation time for the 
CTA acquisitions was approximately 20 minutes.
CTA image analysis
CTA image analysis was performed by 2 observers in consensus, experienced in the 
evaluation of CTA and blinded to the invasive coronary angiography data. First, general 
information regarding the status and anatomy of the coronary arteries was obtained using 
three-dimensional volume rendered reconstructions. Subsequently, axial slices were visu-
ally examined for the presence of signifi cant narrowing by determining the presence of ≥ 
50% and ≥ 70% reduction of luminal diameter as recommended by the SCCT guidelines 
for the interpretation and reporting of CTA.7 CTA analysis was assisted by curved multipla-
nar reconstructions of all vessels. Data was analyzed on a segmental, vessel and patient 
basis. Coronary anatomy was assessed in a standardized manner by dividing the coronary 
artery tree into 17 segments according to a modifi ed American Heart Association clas-
sifi cation.8 Each segment was determined interpretable or uninterpretable and evaluated 
for the presence of ≥ 50% and ≥ 70% stenosis. Subsequently vessel based analysis was 






















applied. However, if more than 1 segment in a single vessel was deemed uninterpretable, 
the vessel was considered to be of non-diagnostic image quality. Finally, a patient based 
analysis was performed using a similar approach. In case 1 vessel was uninterpretable, an 
intention to diagnose strategy was applied. However, if more than 1 vessel was uninterpre-
table, the entire scan was considered to be of non-diagnostic image quality. Accordingly, 
diagnostic image quality, the presence of ≥ 50% and the presence of ≥ 70% stenosis were 
assessed on a segmental, vessel and patient level. Of note, the presence of restenosis in 
a stented segment was identifi ed by reduced or complete absence of contrast within the 
stent as well as reduced or absent runoff of contrast distally to the stented segment.
Invasive coronary angiography analysis
Invasive coronary angiography was performed according to standard techniques. 
Angiograms were assessed by an experienced observer blinded to the results of CTA. The 
available coronary segments were identifi ed on the basis of the American Heart Associa-
tion guidelines. The same segmental model with identical defi nitions was used for both 
the invasive coronary angiography and CTA analysis. Subsequently, all segments were 
visually classifi ed as normal (no atherosclerosis or minor wall irregularities with ≤ 20% 
luminal narrowing) or abnormal (presence of stenosis with > 20% luminal narrowing). All 
segments visually scored as abnormal were quantifi ed using a dedicated and validated 
quantitative coronary angiography (QCA) software package (QAngioXA 6.0, CA-CMS, 
Medis Medical Imaging Systems, Leiden, The Netherlands). Each segment was evaluated 
for the presence of signifi cant stenosis by determining the presence of ≥ 50% and ≥ 70% 
luminal diameter reduction in the angiographic view with most severe luminal narrowing. 
Obstructive CAD was defi ned as luminal narrowing of ≥ 50% on QCA analysis.
Statistical analysis
Data were analyzed on segment, vessel and patient basis. Sensitivity, specifi city and positive 
and negative predictive values, including 95% confi dence intervals (CI), for the detection of 
≥ 50% and ≥ 70% luminal narrowing on invasive coronary angiography were calculated. 
In an initial analysis, the diagnostic accuracy was determined excluding segments, vessels 
or patients of non-diagnostic image quality. In a subsequent analysis, non-diagnostic seg-
ments, vessels or patients were included in the analysis, and were considered positive (≥ 
50% luminal narrowing). In the analysis on a vessel basis, the left main was considered part 
of the left anterior descending artery (LAD) and the intermediate branch was considered 
part of the left circumfl ex artery (LCx). Continuous data were expressed as mean ± standard 
deviation (SD). Statistical analyses were performed using SPSS software version 16 (SPSS, 
Inc., Chicago, Illinois). A value of p < 0.05 was considered statistically signifi cant and all 
reported p-values were two-sided. Generalized estimating equation (GEE) method was 
applied for stenosis evaluation (for both the presence of ≥ 50% and ≥ 70% stenosis) to 
account for clustering of coronary artery segments within patients. The GEE analyses were 
performed with proc GENMOD with a binominal distribution for the outcome variable, the 










In a total of 839 segments available for analysis, invasive coronary angiography identifi ed 
72 segments containing signifi cant stenosis. However, 12 segments (1%) were uninterpre-
table as a result of: motion artifacts (n=7), extensive calcifi cations (n=2), vessel of small 
diameter (n=2) and blooming artifact due to stent (n=1). Eight uninterpretable segments 
were located in the right coronary artery (RCA) (segment 1, n=2; segment 2, n=3; segment 
3, n=2; segment 4, n=1), two uninterpretable segments were located in the LCx (segment 
11, n=1; segment 13, n=1) and two uninterpretable segments were located in the LAD (seg-
ment 7, n=1; and segment 8, n=1). In the remaining 827 segments, CTA analysis correctly 
ruled out signifi cant stenosis in 735 segments. In a total of 62 segments, signifi cant lesions 
were correctly identifi ed on CTA, while 21 segments deemed non-obstructive on coronary 
angiography, were incorrectly classifi ed as obstructive by CTA. Consequently, the sensitivity 
and specifi city for the detection of ≥ 50% stenosis on a segment basis were 87% and 97%, 
respectively, and positive and negative predictive values were 75% and 99% respectively. 
The diagnostic accuracy for the detection of ≥ 50% luminal narrowing excluding and 
including non-diagnostic segments, as well as the diagnostic performance for the detec-
tion of ≥ 70% luminal narrowing are shown in Tables 2 and 3, respectively. As determined 
with GEE analyses, the presence of a signifi cant stenosis on CTA was highly predictive for 
the presence of a signifi cant stenosis on CAG, both for ≥ 50% luminal narrowing (odds ratio 
(OR) 5.5, 95% CI 4.6 - 6.5) and ≥ 70% luminal narrowing (OR 7.7, 95% CI 5.6 - 9.8).
Table 2. Diagnostic accuracy of 320-row CTA for the detection of ≥ 50% coronary stenosis.
Segment Analysis Vessel Analysis Patient Analysis
Excluding non-diagnostic segments, vessels and patients
Non-diagnostic 12/839, 1% 2/177, 1% 4/64, 6%
Sensitivity 62/71 (87%, 80%-95%) 48/51 (94%, 88%-100%) 35/35 (100%)
Specifi city 735/756 (97%, 96%-98%) 114/124 (92%, 87%-97%) 22/25 (88%, 75%-100%)
PPV 62/83 (75%, 65%-84%) 48/58 (83%, 73%-92%) 35/38 (92%, 84%-100%)
NPV 735/744 (99%, 98%-99.6%) 114/117 (97%, 95%-100%) 22/22 (100%)
Diagnostic Accuracy 797/827 (96%, 95%-98%) 162/175 (93%, 89%-96%) 57/60 (95%, 89%-100%)
Including non-diagnostic segments, vessels and patients
Sensitivity 63/72 (88%, 80%-95%) 48/51 (94%, 88%-100%) 37/37 (100%)
Specifi city 735/767 (96%, 94%-97%) 114/126 (90%, 85%-96%) 22/27 (81%, 67%-96%)
PPV 63/95 (66%, 57%-76%) 48/60 (80%, 70%-90%) 37/42 (88%, 78%-98%)
NPV 735/744 (99%, 98%-99.6%) 114/117 (97%, 95%-100%) 22/22 (100%)
Diagnostic Accuracy 798/839 (95%, 94%-97%) 162/177 (92%, 87%-96%) 59/64 (92%, 86%-99%)
Data are absolute values used to calculate percentages. Data in parenthesis are percentages with 
95% confi dence intervals. Patients with scans of non-diagnostic image quality were excluded from 
vessel and segment analysis.
CI, confi dence interval; CTA, computed tomography angiography; NPV, negative predictive value; 























In 177 vessels evaluated, a total of 51 signifi cantly obstructed vessels were identifi ed 
on invasive coronary angiography. In total, 2 vessels (1%) were rendered non-diagnostic 
on CTA analysis due to motion artefacts in a patient with increased HR during acquisi-
tion (RCA, n=1) and small vessel lumen (LCx, n=1). In the remaining 175 vessels, CTA 
correctly ruled out signifi cant stenosis in 114 vessels. One or more signifi cant lesions 
were correctly identifi ed by CTA in 48 vessels, whereas CTA overestimated lesion size in 
10 vessels. The absence of signifi cant stenosis was incorrectly identifi ed by CTA in only 
3 vessels (LAD, n=2; LCx n=1), resulting in a sensitivity and specifi city of 94% and 92%, 
respectively. Positive and negative predictive values were 83% and 97%, respectively. The 
diagnostic accuracy for the detection of ≥ 50% luminal narrowing excluding and includ-
ing non-diagnostic vessels, as well as the diagnostic performance for the detection of ≥ 
70% luminal narrowing are depicted in Tables 2 and 3.
Patient analysis
Out of 64 CTA examinations, four scans (6%) were of non-diagnostic image quality caused 
by: severe motion artifacts due to extra-systole during image acquisition (n=1) and an 
unexpected rise in HR during contrast administration (n=1), poor contrast attenuation 
(n=1) and heavy calcifi cations (n=1). In the remaining 60 CTA examinations, invasive coro-
nary angiography identifi ed 35 patients with obstructive CAD. All patients (100%) were 
correctly identifi ed by CTA. However, in one patient, CTA incorrectly identifi ed a signifi cant 
lesion in the RCA, while an actual obstructive lesion in the LAD was underestimated. In 
another patient, CTA underestimated a stenosis in the LAD while obstructive CAD in the 
RCA was correctly identifi ed. In a third patient, CTA underestimated a stenosis in the 
LCx while obstructive CAD in the LAD was correctly identifi ed. In all other patients, the 
correct stenosis was identifi ed by CTA. In addition, in a total of 22 patients, CTA correctly 
ruled out the presence of signifi cant CAD. Only 3 patients were incorrectly diagnosed 
Table 3. Diagnostic accuracy of 320-row CTA for the detection of ≥ 70% coronary stenosis.
Segment Analysis Vessel Analysis Patient Analysis
Non-diagnostic 12/839, 1% 2/177, 1% 4/64, 6%
Sensitivity 23/24 (96%, 88%-100%) 17/18 (94%, 84%-100%) 15/16 (94%, 82%-100%)
Specifi city 795/803 (99%, 98%-99.7%) 153/157 (97%, 95%-99.9%) 42/44 (95%, 89%-100%)




153/154 (99%, 98%-100%) 42/43 (98%, 93%-100%)
Diagnostic Accuracy 818/827 (99%, 98%-99.6%) 170/175 (97%, 95%-99.6%) 57/60 (95%, 89%-100%)
Data are absolute values used to calculate percentages. Data in parenthesis are percentages with 
95% confi dence intervals. Patients with scans of non-diagnostic image quality were excluded from 
vessel and segment analysis.
CI, confi dence interval; CTA, computed tomography angiography; NPV, negative predictive value; 








with obstructive CAD on CTA. In two patients, a heavily calcifi ed lesion was incorrectly 
classifi ed as obstructive (LAD, n=1; RCA, n=1). In a third patient, a 40% stenosis of the 
second diagonal branch was incorrectly deemed obstructive on CTA. Importantly, how-
ever, on a patient basis, no patients with signifi cant CAD were missed by CTA. Therefore, 
the sensitivity and specifi city for the detection of ≥ 50% stenosis on a patient basis was 
100% and 88% respectively. In addition, positive and negative predictive values were 92% 
and 100%, respectively. Table 2 presents an overview of diagnostic accuracy and negative 
and positive predictive values excluding and including non-diagnostic CTA examinations. 
In addition, Table 3 presents an overview of the diagnostic accuracy for the detection of 
≥ 70% coronary stenosis.
DISCUSSION
The present study demonstrated excellent diagnostic accuracy for the assessment of 
obstructive CAD using 320-row CTA. On a patient level, a negative predictive value of 
100% and a diagnostic accuracy of 95% were shown for the detection of ≥ 50% stenosis. 
When including scans of non-diagnostic image quality, the patient based diagnostic 
accuracy was 92% while the negative predictive value remained 100%. Importantly, no 
patients with signifi cant CAD were missed using 320-row CTA. Furthermore, the excellent 
negative predictive value on segment, vessel and patient basis suggests that CTA might 
be particularly valuable in the exclusion of signifi cant CAD. These results are in line with 
previous published data on the performance of 64-row CTA.9-12
In addition, excellent diagnostic performance for the evaluation of stenosis ≥ 70% was 
observed using 320-row CTA, with a negative predictive value of 98% and a diagnostic 
accuracy of 95% on a patient basis. These fi ndings are in line with previously published 
data using a 70% stenosis cut-off in the evaluation of CAD using 64-row CTA.12
At present, limited data are available on the diagnostic accuracy of 320-row CTA. Previ-
ously, a case report has been published directly comparing 320-row CTA and invasive 
coronary angiography, reporting excellent agreement between the two investigations in 
a single patient.13 Furthermore, in a study by Rybicki et al, consistently excellent image 
quality was observed in over 89% of segments in 40 consecutive patients referred for 320-
row CTA.3 In four of these patients, the observations on CTA were confi rmed on invasive 
coronary angiography.
Technological advancements
Although diagnostic accuracy of 320-row CTA may be comparable to the performance of 
64-row scanners, advantages of this new technology lie in improved image acquisition as 
well as reduced radiation dose compared to retrospectively gated 64-row CTA. For the fi rst 
time since the introduction of CTA technology, 16-cm volumetric data acquisition within a 
single gantry rotation has become possible, allowing full cardiac imaging within a single 






















image acquisition allows for a signifi cant reduction of contrast material and breath-hold 
time (with a total breath-hold time of 5 s) as compared to CTA systems requiring multiple 
heart beats to image the entire heart. Figures 1 and 2 represent examples of single heart 
beat CTA of patients with normal coronary arteries and 3-vessel disease, respectively.
Furthermore, 320-row systems have increased temporal resolution (350 ms per gantry 
rotation) which reduces cardiac motion artifacts. Although certain types of 64-row systems 
have a slightly higher temporal resolution (330 ms per gantry rotation), these systems can 
only cover a small volume (3.2 cm) in a single heart beat.14 Similarly, dual-source systems, 
with even superior temporal resolution (83 ms), allow limited cranio-caudal coverage per 
rotation.15 In contrast, 320-row CTA allows volumetric data acquisition with full cardiac 
coverage in a single rotation, eliminating the problem of stair-step artifacts associated 
with helical and step-and-shoot scanning techniques.
Figure 1 Non-invasive coronary angiography using 320-row CTA revealing the absence of 
signifi cant CAD.
Panel A shows a 3-dimensional volume rendered reconstruction of the heart, providing an overview 
of the left anterior descending artery (LAD), proximal left circumfl ex artery (LCx) and proximal 
right coronary artery (RCA). Panel B, C and D represent the curved multiplanar reconstructions 
of a normal RCA, LAD and LCx, respectively, without signifi cant CAD. Panel E and F show the 








Recently, several new approaches have been developed to reduce CTA radiation dose. 
First, dose modulation was introduced, allowing tube current modulation throughout 
the cardiac cycle16, decreasing radiation exposure at the cost of increased image noise 
during low tube current. Subsequently, prospective ECG triggering became available, 
allowing data acquisition during a narrow pre-defi ned portion of the R-R interval (usually 
end-diastolic phase when the heart is relatively motion-free), resulting in a substantial 
reduction in radiation dose.17 Importantly, volumetric data acquisition used by 320-row 
CTA may further reduce radiation exposure by eliminating helical oversampling.18 Indeed, 
in the current study, using 320-row CTA in combination with prospective ECG triggering, 
radiation doses as low as 2.7 mSv were achieved in patients with a low and stable heart 
rate, while diagnostic image quality was maintained in 94% of patients scanned. Moreover, 
a recent investigation by Steigner and colleagues, using 320-row CTA in combination with 
Figure 2 Non-invasive coronary angiography with 320-row CTA revealing 3-vessel disease.
Panel A represents a 3-dimensional volume rendered reconstruction of the heart, with an overview 
of the left anterior descending artery (LAD) and left circumfl ex artery (LCx), revealing multi-vessel 
disease (arrows). Panel B shows the curved multiplanar reconstruction of the right coronary artery 
(RCA) with two signifi cant atherosclerotic lesions (arrows). Panel C reveals multiple severe lesions 
(arrows) in the proximal segment of the LAD. In panel D, a severe lesion (arrow) in the LCx is shown. 






















prospective ECG triggering in the evaluation of 41 patients, concluded that a phase win-
dow width of 10% may reduce radiation dose (to an estimated 5.3 mSv) while maintaining 
diagnostic image quality in over 90% of patients.19 Therefore, compared to retrospectively 
gated 64-row CTA, prospectively gated 320-row CTA may considerably reduce radiation 
exposure to the patient, while maintaining good image quality. Of note, even lower mean 
radiation doses have been reported recently in studies using new-generation 64-row CTA 
with prospectively ECG triggered step-and-shoot technology. These studies, however, 
were performed using maximal dose reduction by using tube voltages with a maximum 
of 100 or 120 kV as well as performing image acquisition during a minimal phase window 
of only 75% of the cardiac cycle.20 21 Other technical advances, such as adaptive collima-
tion and high-pitch spiral acquisition may also allow signifi cant radiation reduction using 
scanning techniques requiring multiple heart beats.22 23
Limitations
Despite promising initial results, the following limitations to the present study should 
be considered. First, CTA is inherently associated with radiation exposure. Concerns have 
been raised about radiation dose, especially with respect to the long term sequelae in 
younger people and women of childbearing age.24 Accordingly, careful patient selection is 
warranted and conservative imaging protocols, with respect to radiation dose, should be 
aimed for. Second, the present study was conduced in a relatively small group of patients. 
In addition, CTA was performed in patients referred for invasive coronary angiography, 
creating a selection bias of patients with a relatively high prevalence of signifi cant CAD. 
Thus, the present diagnostic performance was achieved in an intermediate-to-high 
prevalence patient population. As a result, the current data may not be directly applicable 
to patients with a low-to-intermediate prevalence of CAD. Third, at present, quantitative 
methods to analyze CTA are limited. Nevertheless, development of dedicated quantifi ca-
tion techniques is ongoing, and may substantially improve objectivity and reproducibility 
of the degree of stenosis observed on CTA. Fourth, as a single-centre study, the generaliz-
ability of the present results is limited. Last, as CTA and invasive coronary angiography 
analysis were performed blinded, differences in segment allocation may have occurred. 
Although differences in segment classifi cation may have affected the results on a seg-
ment basis, the effect on vessel and particularly patient basis may have been negligible.
Future directions
Prospective studies in larger patient populations are required to further establish the diag-
nostic accuracy 320-row CTA in the detection of CAD in a low-to-intermediate likelihood 
population. Moreover, 320-row CTA acquisition protocols for optimal image acquisition 
and decreased radiation dose need to be further defi ned. As CTA technology continues to 
develop, future research will most likely continue to focus on further decreasing radiation 









The current study demonstrates that 320-row CTA is highly sensitive for the detection of 
signifi cant CAD. Importantly, on a patient basis, no patients with signifi cant CAD ≥ 50% 
were missed. The high negative predictive value suggests this technique is particularly 
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Background: The purpose of the study was to evaluate the performance of 320-row com-
puted tomography angiography (CTA) in the identifi cation of signifi cant coronary artery 
disease (CAD) in patients presenting with acute chest pain and to examine the relation to 
outcome during follow-up.
Methods: A total of 106 patients with acute chest pain underwent CTA to evaluate pres-
ence of CAD. Each CTA was classifi ed as: normal, non-signifi cant CAD (<50% luminal 
narrowing) and signifi cant CAD (≥50% luminal narrowing). CTA results were compared 
with quantitative coronary angiography. After discharge, the following cardiovascular 
events were recorded: cardiac death, non-fatal infarction, and unstable angina requiring 
revascularization. 
Results: Among the 106 patients, 23 patients (22%) had a normal CTA, 19 patients (18%) 
had non-signifi cant CAD on CTA, 59 patients (55%) had signifi cant CAD on CTA and 5 
patients (5%) had non-diagnostic image quality. In total, 16 patients (15%) were imme-
diately discharged after normal CTA and 90 patients (85%) underwent invasive coronary 
angiography. Sensitivity, specifi city, and positive and negative predictive values to detect 
signifi cant CAD on CTA were 100, 87, 93, and 100%, respectively. During mean follow-up 
of 13.7 months, no cardiovascular events occurred in patients with a normal CTA examina-
tion. In patients with non-signifi cant CAD on CTA, no cardiac death or myocardial infarc-
tions occurred and only 1 patient underwent revascularization due to unstable angina.
Conclusion: In patients presenting with acute chest pain, an excellent clinical perfor-
mance for the non-invasive assessment of signifi cant CAD was demonstrated using 
CTA. Importantly, normal or non-signifi cant CAD on CTA predicted a low rate of adverse 









Every year, a substantial number of patients present at the emergency department with 
acute chest pain complaints.1 While diagnosis is relatively straightforward in case of typi-
cal ECG changes and elevated biomarkers, a substantial number of patients present with 
both biomarkers and ECG that are either within normal limits or inconclusive. Accordingly, 
most patients will undergo extensive work-up including invasive coronary angiography to 
exclude coronary artery disease (CAD) as the cause of their symptoms to avoid inappro-
priate discharge. However, this approach leads to many unnecessary hospital admissions 
and is both time-consuming and expensive. Therefore, a non-invasive and rapid examina-
tion to establish or exclude CAD as the underlying cause of symptoms could substantially 
improve the clinical care of patients presenting with acute chest pain.
Several studies have suggested that computed tomography coronary angiography 
(CTA) may be of value in the diagnostic work-up in patients with acute chest pain in the 
emergency department.2-4 Recently, a new generation of scanners has been introduced 
equipped with 320 detector rows of 0.5 mm wide, yielding a maximum of 16 cm cranio-
caudal coverage.5 This design allows three-dimensional volumetric whole-heart imaging 
in a single gantry rotation. Accordingly, a marked reduction in radiation dose is achieved 
by the elimination of oversampling or overranging, observed with helical scanning tech-
niques.6 In addition, the 320-row CTA system eliminates the problem of stair-step artifacts 
caused by inter-heartbeat variations as well as a reduction in cardiac motion artifacts. 
Furthermore, the temporal resolution has improved (175 ms using half reconstruction) 
resulting in superior image quality and accuracy for the detection of CAD.7 8 
The performance of 320-row CTA in the evaluation of signifi cant CAD in clinical prac-
tice in patients presenting with acute chest pain and the relation to outcome has not 
been previously reported. Therefore, the purpose of the current study was to evaluate the 
performance of 320-row CTA in the identifi cation of signifi cant CAD in patients presenting 
with acute chest pain and to examine the relation to outcome during follow-up. 
METHODS
The population consisted of patients included as part of an ongoing clinical registry who 
presented with acute chest pain to the Emergency Department. In all patients, physicians 
had suffi cient clinical suspicion for an ischemic origin of chest pain and admitted these 
patients to the hospital to rule out presence of signifi cant CAD.9 10 However, patients 
presenting with an ST-segment elevation myocardial infarction (STEMI) were excluded 
and were immediately referred for direct percutaneous coronary intervention (PCI). 
According to clinical protocol, patients were referred for CTA imaging for non-invasive 
evaluation of acute chest pain. Consequently, patients were referred for invasive coronary 
angiography (ICA) based on clinical presentation and/or imaging results to further evalu-




















with acute chest pain, a conservative approach was applied before discharging patients 
after CTA examination. If CTA examination showed no signifi cant CAD and was of good 
to reasonable image quality and was in line with clinical presentation and/or biomarkers, 
patients were subsequently discharged from the hospital. The remaining patients (abnor-
mal CTA, uninterpretable CTA or high clinical suspicion of CAD) were referred for ICA, 
which served as the standard of reference. In addition, TIMI risk scores were calculated 
and patients were classifi ed as low, intermediate or high risk.11 
Exclusion criteria for CTA examination were: (i) (supra) ventricular arrhythmias and/or 
increased heart rate, (ii) renal failure (glomerular fi ltration rate <30 mL/min), (iii) known 
allergy to iodine contrast material, (iv) severe claustrophobia, (v) pregnancy, (vi) previous 
coronary artery bypass grafting (CABG), (vii) contra-indications for beta-blockers, (viii) 
clinically unstable presentation and (ix) STEMI.
CTA data acquisition
Prior to CTA examination, beta-blocking medication (metoprolol 50 or 100 mg, single 
oral dose, 1 hour prior to CTA examination) was administered if the heart rate was ≥65 
beats per minute, unless contra-indicated. If heart rate was still ≥65 beats per minute on 
arrival to the scanner and if no medical contra-indications existed, intravenous metoprolol 
(2.5-10 mg) was added. In addition, sublingual nitroglycerin (0.4 or 0.8 mg sublingual) 
was administered 5 minutes prior to start scan. In all patients CTA was performed using a 
320-row CTA scanner (Aquilion ONE, Toshiba Medical Systems, Otawara, Japan) with 320 
detector rows (each 0.5 mm wide) before ICA. The entire heart was imaged in a single 
volume, with a maximum of 16 cm cranio-caudal coverage, using prospective ECG trigger-
ing. If the heart rate was stable and <60 beats/min the phase window was set at 70-80% of 
R-R interval, if the heart rate was 60-65 beats/min the phase window was set at 65-85% of 
R-R interval and if the heart rate was ≥65 beats/min the phase window was set at 30-80% 
of the R-R interval (using multiple beats). Tube voltage and current were adapted to body 
mass index (BMI). Tube voltage was 100 kV (BMI <23 kg/m2), 120 kV (BMI, 23-35 kg/m2), or 
135 kV (BMI ≥35 kg/m2) and maximal tube current was 400–580 mA (depending on body 
weight). Contrast material was administered in a triple-phase protocol: fi rst a bolus of 60 
to 80 ml, followed by 40 ml of a 50:50 mixture of contrast and saline, followed by saline 
fl ush with a fl ow rate of 5-6 ml/sec (Iomeron 400®). Automatic bolus arrival detection 
was used to synchronize arrival of the contrast in the left ventricle with a threshold of 
+180 Hounsfi eld Units. All images were acquired during an inspiratory breath-hold of 
approximately 5 seconds. First, a data set was reconstructed in the end-diastolic phase 
(75% of R-R interval) with a slice thickness of 0.5 mm and a reconstruction interval of 
0.25 mm. If motion artifacts were present, multiple phases were reconstructed to obtain 
maximal diagnostic image quality. Total time for the CTA examination was typically 10 to 
15 minutes. Data sets were transferred to a remote workstation (Vitrea FX 1.0, Vital Images, 
Minnetonka, MN, USA). Radiation dose was quantifi ed with a dose-length product con-
version factor of 0.014 mSv/(mGy x cm). When scanning prospectively at 70-80% of R-R 








65 - 85% of R-R interval, estimated mean radiation dose was 6.0 ± 1.7 mSv. The estimated 
mean radiation dose was 12.0 ± 4.5 mSv when scanning prospectively with multiple beats.
CTA image analysis
Assessment of the contrast-enhanced CTA datasets for the presence of signifi cant CAD 
was performed by 2 experienced investigators. CTA examinations were assessed as rec-
ommended by the SCCT guidelines for the interpretation and reporting of CTA.12 Image 
quality was scored as good, reasonable, moderate or non-diagnostic.13 Coronary anatomy 
was assessed in a standardized manner by dividing the coronary artery tree into 17 seg-
ments according to a modifi ed American Heart Association (AHA) classifi cation.14 Each 
segment was deemed interpretable or uninterpretable, and evaluated for the presence of 
≥50% luminal narrowing on the axial slices with the assistance of multiplanar and curved 
multiplanar reconstructed images. Subsequently, vessel-based analysis was performed. 
In the analysis on a vessel basis, the left main was considered part of the left anterior 
descending coronary artery (LAD) and the intermediate branch was considered part of 
the left circumfl ex coronary artery (LCx). Of note, if one segment was uninterpretable, an 
intention to diagnose strategy was applied. However, if more than one segment in a single 
vessel was uninterpretable, the vessel was considered to be of non-diagnostic image qual-
ity. Finally, a patient-based analysis was performed using a similar approach. Each CTA 
was classifi ed according to three groups: normal, non-signifi cant CAD (<50% luminal nar-
rowing) and signifi cant CAD (≥50% luminal narrowing). If one vessel was uninterpretable, 
an intention to diagnose strategy was applied. However, if more than one vessel was 
uninterpretable, the entire scan was considered to be of non-diagnostic image quality. 
Invasive coronary angiography
ICA was performed according to standard protocols. Quantitative coronary angiography 
(QCA) analysis was performed on a segment basis by an observer unaware of CTA fi ndings 
with the use of validated QCA software (QAngioXA 6.0, CA-CMS, Medis Medical Imaging Sys-
tems, Leiden, The Netherlands). Coronary artery segments by QCA were also evaluated using 
a 17-segment AHA coronary tree model. The tip of the catheter was used for calibration and 
for each segment examined, the reference diameter and minimum luminal diameter were 
measured and percent diameter stenosis was reported. Measurements were performed on 
at least two orthogonal projections and the highest percent diameter stenosis was used for 
further analysis. Signifi cant CAD was defi ned as ≥50% luminal narrowing on QCA analysis.
Follow-up
Revascularization procedures (percutaneous coronary intervention (PCI) and/or CABG) 
during hospitalization were recorded. After discharge, patient follow-up data were gath-
ered from the departmental Cardiology Information system by a single observer blinded 
to the baseline CTA and ICA results using clinical visits or contacted by standardized 
telephone interviews. The following cardiovascular events were regarded as clinical 




















revascularization. Cardiac death was defi ned as death by acute myocardial infarction, 
ventricular arrhythmias, or refractory heart failure. Non-fatal infarction was defi ned based 
on criteria of typical chest pain, elevated cardiac enzyme levels, and typical changes on 
the ECG.15 Unstable angina was defi ned according to the European Society of Cardiology 
guidelines as acute chest pain with or without the presence of ECG abnormalities, and 
negative cardiac enzyme levels.9
Statistical analysis 
First, the performance (sensitivity, specifi city, positive and negative predictive values 
including 95% confi dence intervals) of CTA for the detection of signifi cant CAD (defi ned 
as luminal narrowing ≥50% on QCA) was calculated on patient, vessel and segment basis. 
ICA was the standard of reference for detection of signifi cant CAD and a patient, vessel 
or segment was classifi ed as true positive if signifi cant CAD was identifi ed correctly by 
CTA. Initially, the performance of 320-row CTA was determined excluding patients, ves-
sels and segments of non-diagnostic image quality. Subsequently, a second analysis was 
performed in which non-diagnostic patients, vessels and segments were included in the 
analysis and were considered positive for signifi cant CAD. Clinical events were reported 
as numbers and percentages according to three groups: normal CTA, non-signifi cant CAD 
on CTA (<50% luminal narrowing) and signifi cant CAD on CTA (≥50% luminal narrowing). 















































Figure 1. Flow chart of patient inclusion. CTA indicates computed tomography coronary 










In total, 204 patients with a primary complaint of acute chest pain were found eligible 
during the inclusion period. Exclusion criteria were present in 98 patients (48%) (clinical 
instability (n=25), impaired renal function (n=16), previous CABG (n=15), (supra) ven-
tricular arrhythmias and/or increased heart rate (n=9), scanner availability (n=6), contra-
indications to beta-blockers (n=3) and other (n=24) (Figure 1). The remaining study 
population consisted of 106 patients who underwent non-invasive coronary angiography 
with a 320-row CTA scanner. Baseline patient characteristics are described in Table 1. In 
summary, mean age was 57 ± 10 years and 71 patients were male (67%). The majority of 
patients (83%) had a low to intermediate TIMI risk score.
Table 1. Baseline patient characteristics
Number of patients 106
Age 57 ± 10




Family history of CAD 54 (51%)
Current smoker 41 (39%)
Diabetes 17 (16%)
Obesity (≥30 kg/m2) 29 (27%)





Previous myocardial infarction 28 (26%)
Previous PCI 32 (30%)





Average heart rate during CTA 58 ±8
Data are absolute values, percentages or means ± standard deviation.
†Defi ned as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or the use 
of antihypertensive medication.
‡Serum total cholesterol ≥230 mg/dL or serum triglycerides ≥200 mg/dL or treatment with lipid 
lowering drugs. 
Abbreviations: CAD, coronary artery disease; ACE, angiotensin converting enzyme; PCI, percutane-
ous coronary intervention; TIMI, thrombolysis in myocardial infarction, QCA; quantitative coronary 





















Overall, image quality was good in 50 patients (47%), reasonable in 40 patients (38%) and 
moderate in 11 patients (10%). Five patients (5%) had a non-diagnostic CTA examination. 
Furthermore, 23 patients (22%) had a normal CTA 19 patients (18%) had non-signifi cant 
CAD on CTA, 59 patients (55%) had signifi cant CAD on CTA, and the remaining 5 patients 
(5%) with non-diagnostic scan quality were considered as signifi cant CAD on CTA. In 16 
patients (15%) with a normal CTA examination, clinical presentation and biomarkers were 
in line with the CTA fi ndings and therefore patients were discharged home (case example 
illustrated in Figure 2). Nevertheless, the remaining 7 patients with a normal CTA examina-
tion had a high clinical suspicion of CAD and they were still referred for ICA. In total, 90 
patients (85%) were clinically referred for ICA (case example illustrated in Figure 3). 
Patient based analysis
When excluding patients with non-diagnostic scan quality, CTA correctly identifi ed the 
presence of signifi cant CAD in all 55 patients (100%). Furthermore, CTA correctly excluded 
signifi cant CAD in 26 of 30 patients (87%). Thus, only 4 patients were overestimated on 
CTA. Importantly, no patients with signifi cant CAD on ICA were missed by CTA. Accordingly, 
when excluding non-diagnostic CTA examinations, sensitivity and specifi city on a patient’s 
basis were 100% and 87%, respectively. Moreover, when including non-diagnostic CTA 
examinations (considered as positive for the presence of signifi cant CAD), sensitivity and 
specifi city on a patient basis were 100% and 81%, respectively (Table 2). 
Vessel analysis
Out of the 255 vessels (85 patients) evaluated on CTA, 6 vessels (2%) (the right coronary 
artery (RCA), n=5 and LAD, n=1) were deemed non-diagnostic. Regarding the vessels with 
diagnostic image quality, 93 of 94 vessels were correctly identifi ed by CTA as signifi cant 
CAD on ICA. Additionally, 147 of 155 vessels were correctly identifi ed as normal or non-
signifi cant CAD by CTA. However, 1 vessel which was deemed as signifi cant CAD on ICA 
was incorrectly classifi ed as non-signifi cant CAD on CTA. Moreover, CTA overestimated 
8 vessels as signifi cant CAD which were classifi ed as non-signifi cant CAD on ICA. Thus, 
when excluding non-diagnostic vessels from analysis, sensitivity and specifi city on a vessel 
basis were 99% and 95%, respectively. However, when including non-diagnostic vessels, 
sensitivity and specifi city on a vessel basis were 99% and 92%, respectively (Table 2).
Segment analysis
In total, 44 of 1216 segments (4%) were deemed non-diagnostic on CTA examination. 
Of the 44 segments, 21 segments were located in the RCA, 15 segments were located 
in the LAD and 8 segments were located in the LCx. Out of the 1172 segments with 
diagnostic image quality, signifi cant CAD was correctly identifi ed by CTA in 136 of the 
149 segments. Moreover, CTA correctly ruled out presence of signifi cant CAD in 989 of 
1023 segments. Nevertheless, CTA overestimated 34 lesions that were considered as 








were deemed as signifi cant CAD on ICA. Accordingly, when excluding non-diagnostic 
segments, the sensitivity and specifi city for the detection of signifi cant CAD on a segment 
basis were 91% and 97%, respectively. Notably, when including non-diagnostic segments, 
the sensitivity and specifi city for the detection of signifi cant CAD on a segment basis were 









Figure 2. Non-invasive coronary angiography using 320-row computed tomography angiography 
(CTA) of a 42 year-old male presenting with acute chest pain revealing a normal CTA examination. 
The patient was subsequently discharged home and no events occurred during follow-up. (A) A 
three-dimensional volume-rendered reconstruction of the heart, providing an overview of the left 
anterior descending coronary artery (LAD) and proximal right coronary artery (RCA). (B-D) The 
curved multiplanar reconstructions of a normal RCA, LAD, and left circumfl ex coronary artery (LCx), 































Figure 3. Non-invasive coronary angiography using 320-row computed tomography angiography 
of a 68 year-old female presenting with acute chest pain revealing a signifi cant lesion in the 
mid left anterior descending coronary artery (LAD). (A) A three-dimensional volume-rendered 
reconstruction of the heart, providing an overview of the LAD and left circumfl ex coronary artery 
(LCx) revealing signs of luminal narrowing in the mid LAD (arrow). (B, C) Curved multiplanar 
reconstruction of the LAD demonstrating a signifi cant stenosis in the mid LAD (arrow and b, 
respectively). (D) Corresponding invasive coronary angiography image confi rming the presence of a 








Revascularization during admission period
In relationship to CTA fi ndings, in the 7 patients with normal CTA, no revascularization was 
performed. Of the 19 patients with non-signifi cant CAD on CTA examination, PCI was per-
formed in 2 patients (11%), both with angiographically non-signifi cant CAD. One patient 
underwent PCI with stent placement due to coronary spasm and 1 patient underwent 
PCI because of angiographically non-signifi cant lesion which was deemed signifi cant on 
intravascular ultrasound. In the 59 patients with signifi cant CAD on CTA examination, 
PCI was performed in 42 patients (71%), CABG was performed in 6 patients (10%) and 7 
patients (12%) were treated conservatively. Lastly, in 5 patients with non-diagnostic image 
quality, 3 patients had signifi cant CAD on ICA, PCI was performed in 1 patient (20%), 
CABG was performed in 1 patient (20%) and 1 patient (20%) was treated conservatively.
Clinical end points during follow-up
The mean follow-up period was 13.7 months (25-75th percentile: 6.5-18.7 months). The 
overall cardiovascular event rate was low (3.8%), only 4 cardiovascular events occurred 
in all patients. Of note, 1 patient with non-signifi cant CAD on CTA and normal coronary 
arteries on ICA died of a non-cardiac cause 12 days after the angiographic procedure as 
a result of the consequences of severe chronic pulmonary hypertension which developed 
after previous liver transplantation. Importantly, no cardiovascular events occurred in the 
23 patients with a normal CTA examination. In the 19 patients with non-signifi cant CAD 
Table 2. Diagnostic performance of 320-row computed tomography angiography for detection 
of signifi cant coronary artery disease in patients presenting with acute chest pain, excluding and 
including non-diagnostic segments, vessels and patients.
Segment Analysis Vessel Analysis Patient Analysis
Excluding non-diagnostic segments, vessels and patients
Sensitivity 136/149 (91%, 87 - 96%) 93/94 (99%, 97 - 100%) 55/55 (100%)
Specifi city 989/1023 (97%, 96 - 98%) 147/155 (95%, 91 - 98%) 26/30 (87%, 75% - 99%)
PPV 136/170 (80%, 74 - 86%) 93/101 (92%, 87 - 97%) 55/59 (93%, 87 - 99.6%)
NPV 989/1002 (99%, 98 - 99%) 147/148 (99%, 98 - 100%) 26/26 (100%)
Diagnostic Accuracy 1125/1172 (95%, 95 - 97%) 240/249 (96%, 94 - 99%) 81/85 (95%, 91 - 99.7%)
Including non-diagnostic segments, vessels and patients
Non-diagnostic 44/1216 (4%) 6/255 (2%) 5/90 (6%)
Sensitivity 138/151 (91%, 87 - 96%) 95/96 (99%, 97 - 100%) 58/58 (100%)
Specifi city 989/1065 (93%, 91 - 94%) 147/159 (92%, 88 - 97%) 26/32 (81%, 68 - 95%)
PPV 138/214 (64%, 58 - 71%) 95/107 (89%, 83 - 95%) 58/64 (91%, 83 - 98%)
NPV 989/1002 (99%, 98 - 99%) 147/148 (99%, 98 - 100%) 26/26 (100%)
Diagnostic Accuracy 1127/1216 (93%, 91 - 94%) 242/255 (95%, 92 - 98%) 84/90 (93%, 88 - 98%)
Data are absolute values used to calculate percentages. Data in parentheses are percentages with 
95% confi dence intervals. Patients with scans of non-diagnostic image quality were excluded from 
vessel and segment analyses. 




















on CTA, no cardiac death or myocardial infarctions occurred and only 1 patient (5.3%) was 
hospitalized because of unstable angina and underwent revascularization for a borderline 
lesion in the LAD. Moreover, in the 59 patients with signifi cant CAD on CTA, 1 patient 
(1.7%) underwent non-fatal myocardial infarction and 2 patients (3.4%) were revascular-
ized because of unstable angina. Lastly, in the 5 patients with a non-diagnostic CTA no 
cardiovascular events occurred.
DISCUSSION
Several studies have recently shown a high sensitivity and specifi city of 320-row CTA for 
the detection of signifi cant CAD in patients electively referred for ICA.7 8 16 However, to 
the best of our knowledge, the clinical performance of the 320-row scanner in patients 
presenting with acute chest pain has not been previously reported. Therefore, the purpose 
was to evaluate the performance of 320-row CTA in the identifi cation of signifi cant CAD in 
patients presenting with acute chest pain and to assess clinical outcome. 
In summary, 16 patients were discharged after normal CTA without further invasive 
examination. In the remaining subset of patients with acute chest pain referred for ICA, an 
excellent sensitivity and specifi city of 100% and 87% for the detection of signifi cant CAD 
using CTA was demonstrated when excluding scans with non-diagnostic image quality. In 
addition, a negative predictive value of 100% was observed, indicating that 320-row CTA 
did not miss any patients with signifi cant CAD. When including CTA scans of non-diag-
nostic image quality, sensitivity and negative predictive value remained high (100%), but 
specifi city decreased to 81%. In all patients with a normal CTA, no cardiovascular events 
occurred in the follow-up period. The excellent negative predictive value of 320-row CTA 
suggests that this technique could be useful in ruling out CAD in patients presenting with 
acute chest pain. Nevertheless, as demonstrated by the relatively low specifi city values, 
lesion severity is still being overestimated by CTA as compared to ICA. 
The present fi ndings seem to be in line with previous studies evaluating the diagnostic 
accuracy with 64-row CTA for the detection of the presence of coronary stenosis in patients 
presenting with acute chest pain.2-4 17 18 Recently, Chow et al assessed the diagnostic 
accuracy of 64-row CTA in 107 patients with acute chest pain as compared to ICA.19 The 
investigators demonstrated a good diagnostic accuracy of 64-row CTA for detection of 
signifi cant CAD (defi ned as ≥50% luminal narrowing), reporting sensitivity, specifi city, and 
positive and negative predictive values on a patient basis of 94%, 90%, 89%, and 94%, 
respectively. Similarly, Meijboom et al also reported a high diagnostic accuracy of 64-row 
CTA for detecting signifi cant CAD in 104 patients with non-ST elevation myocardial 
infarction.20 In line with our fi ndings, the investigators reported an excellent sensitivity 
and negative predictive value of 100%. However, specifi city was also relatively low (75%). 
These studies suggest that CTA could be an attractive non-invasive modality to exclude 








Regarding the performance of 320-row CTA, Dewey et al recently assessed the diag-
nostic accuracy of 320-row CTA in 30 patients with stable chest pain as compared to ICA.8 
Besides signifi cantly reducing radiation dose, the investigators demonstrated a good 
diagnostic accuracy of 320-row for detection of signifi cant CAD (defi ned as ≥50% luminal 
narrowing), reporting sensitivity, specifi city, and positive and negative predictive values 
on a patient basis of 100%, 94%, 100%, and 92%, respectively. Similarly, de Graaf et al 
demonstrated a high diagnostic accuracy of 320-row CTA for detection of signifi cant CAD 
in 64 patients referred for ICA.7 As compared to the older generation 64-row CTA scanners, 
one of the main advantages of the 320-row CTA system is the improved z-axis coverage 
of 16 cm that can cover the entire heart in a single gantry rotation. Therefore, 320-row 
CTA can accurately acquire images of the heart in a single heartbeat, which is substantially 
faster than the 6-10 seconds needed for 64-row CTA. Accordingly, a decreased amount 
of contrast is needed and breath hold is reduced to a minimum. Furthermore, due to 
the volumetric scanning approach, the presence of stair-step artifacts and typical pitch 
artifacts are eliminated. Lastly, as the entire heart can be imaged in one rotation, there is 
potential to assess myocardial perfusion as part of the acute chest pain work-up. These 
advantages of volumetric scanning may substantially optimize image quality and could 
possibly expand the use of CTA.
The excellent negative predictive value of CTA has made it a particular interesting 
modality for rapid diagnosis of patients with acute chest pain. Importantly, patients with 
a normal CTA had an excellent clinical outcome without cardiovascular events during the 
follow-up period. Therefore, the present fi ndings demonstrate that the strength of CTA 
is that it can completely and safely rule out presence of CAD. Nevertheless, events still 
occurred in patients with signifi cant as well as non-signifi cant CAD on CTA, indicating 
that presence of plaque on CTA may still be considered relevant in this patient popula-
tion. Notably, in the present study, the overall cardiovascular event rate was low (3.8%). 
However, in the majority of patients (both low and high risk) underwent subsequent 
intervention after CTA, including revascularization and initiation of anti-atherosclerotic 
medical treatment, which may have had a positive effect on outcome.
In line with the present study, several studies have demonstrated that coronary CTA is 
useful and safe in ruling out CAD and facilitates early and accurate release of patients with 
acute chest pain.3 4 18 Rubinshtein and colleagues prospectively studied 58 patients with 
acute chest pain in the emergency department and evaluated the performance of 64-row 
coronary CTA for diagnosing or excluding acute coronary syndrome.4 The investigators 
evaluated clinical outcomes during a follow-up of 15 months and found that no deaths or 
myocardial infarctions occurred in the 35 patients discharged from the emergency depart-
ment with a normal CTA. In a larger cohort, Hollander et al prospectively evaluated 586 
low to intermediate risk patients who received 64-row CTA in the emergency department 
for evaluation of acute chest pain.18 Interestingly, patients discharged from the emergency 
department with a negative CTA (n=476, 84%) had a very low event rate of 0.2% (n=1). 
These studies demonstrate that CTA has a high positive predictive value for diagnosing an 




















of major adverse cardiovascular events during follow-up. Furthermore, CTA evaluation in 
patients with acute chest pain has been shown to signifi cantly reduce time to diagnosis, 
lower costs and require fewer repeat investigations when compared to standard of care.2 
As a result, the noninvasive assessment of coronary anatomy and presence of signifi cant 
stenosis with 320-row CTA may impact clinical management in patients presenting with 
acute chest pain.
Clinical implications
In the current study, patients with acute chest pain and a normal CTA examination had 
an excellent clinical outcome without cardiovascular events during the follow-up period. 
Therefore, it seems that patients presenting with acute chest pain and a normal CTA can 
be safely discharged. Furthermore, although CTA still overestimates lesion severity, most 
patients with signifi cant CAD on CTA (81%) were subsequently revascularized by means 
of PCI or CABG. Thus, 320-row CTA was demonstrated to be a relatively safe and use-
ful technique for both excluding and including CAD in patients with acute chest pain. 
Nevertheless, it is important to realize that the presence of signifi cant CAD on CTA does 
not necessarily equal myocardial ischemia, unless microcirculatory fl ow is impeded. 
Indeed, anatomical assessment of the coronaries is most reassuring when the vessels 
are normal or have minimal disease. In addition, even though 320-row CTA signifi cantly 
reduces radiation dose and contrast dose, careful patient selection regarding age, renal 
function and body mass index are of fundamental importance to optimize use of CTA. 
Furthermore, heart rate reduction is essential for acquiring diagnostic image quality and 
is usually more challenging in patients admitted to the emergency department. Currently, 
use of CTA in symptomatic patients has a class IIa recommendation for patients with an 
intermediate pre-test likelihood of obstructive disease, suggesting that this technique 
can be an appropriate alternative for the evaluation of patients with acute chest pain.21 22
Limitations
The following limitations of the present study should be considered. First, in the present 
study a referral bias is present as patients are referred for ICA on the basis of CTA exami-
nation fi ndings in combination with clinical presentation and/or other imaging results. 
Nevertheless, this approach refl ects current clinical practice and thus could possibly be 
valuable in evaluating the use of this new imaging technique. Secondly, no quantita-
tive measurements were performed on segments assessed with 320-row CTA, such as 
percentage luminal narrowing. Although visual estimation will be suffi cient in most seg-
ments, more precise grading of luminal narrowing is preferred. However, new develop-
ments are ongoing, and dedicated software techniques are being expected. Furthermore, 
a substantial number of patients with acute chest pain were excluded such as patients 
with hemodynamic or electrical instability, or ongoing chest pain to prevent further delays 
of revascularization treatment. Therefore, coronary CTA is not generally applicable to all 
patients with acute chest pain. In addition, the presence of a signifi cant stenosis on coro-








Potentially, a combination of anatomical CTA images with functional information would 
be preferable. Finally, radiation dose still remains of concern. Nevertheless, with the new 
320-row systems as well as prospective triggering, radiation dose may be even lower than 
estimated radiation dose with conventional ICA.8 23
Conclusion
The present study shows that 320-row CTA enables accurate and safe evaluation of sig-
nifi cant CAD in patients presenting with acute chest pain. Importantly, a negative CTA 
predicted a low rate of adverse cardiovascular events and favorable outcome during 
follow-up. Consequently, the noninvasive assessment of coronary anatomy and presence 
of signifi cant CAD with 320-row CTA may impact clinical management in patients present-
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Background: A considerable number of patients with an acute coronary syndrome (ACS) 
who present with a zero or low calcium score (CS) still demonstrate coronary artery 
disease (CAD) and signifi cant stenosis. The aim of the present study was to evaluate the 
relationship between the CS and the degree and character of atherosclerosis in patients 
suspected of ACS versus patients with stable CAD, obtained by computed tomography 
angiography (CTA) and virtual histology intravascular ultrasound (VH IVUS).
Methods: Overall, 112 patients were studied; 53 with ACS and 59 with stable CAD. CS and 
CTA was performed and followed by VH IVUS. On CTA, each segment was evaluated for 
plaque and classifi ed as non-calcifi ed, mixed or calcifi ed. Vulnerable plaque characteris-
tics on VH IVUS were defi ned by % necrotic core and presence of thin cap fi broatheroma 
(TCFA). 
Results: If CS was zero, patients with ACS had a higher mean number of plaques (5.0±2.0 
vs 2.0±1.9, p<0.05) and non-calcifi ed plaques (4.6±3.5 vs 1.3±1.9, p<0.05) on CTA than 
stable CAD. In zero CS, VH IVUS demonstrated that patients with ACS had a larger amount 
of necrotic core area (0.58±0.73 vs 0.22±0.43 mm2, p<0.05) and higher mean number of 
TCFA (0.6±0.7 vs 0.1±0.3, p<0.05) than stable CAD. 
Conclusion: Even in the presence of a zero CS, patients with ACS have increased plaque 
burden as well as increased vulnerability as compared to stable CAD. Accordingly, absence 
of coronary calcifi cation does not exclude the presence of clinically relevant and poten-









The prognostic value of the coronary calcium score (CS) has been extensively investigated, 
and very low rates of cardiac events have been demonstrated in individuals with a zero 
CS.1-4 However, preliminary data in patients presenting with acute coronary syndrome 
(ACS) suggest a larger contribution of non-calcifi ed plaque to the overall plaque burden 
as compared with patients with stable coronary artery disease (CAD).5 6 As a consequence, 
a zero or low CS may signifi cantly underestimate the overall plaque burden in the set-
ting of ACS.7 However, at present, data on how clinical presentation impacts the relation 
between CS and coronary plaque characteristics are still scarce. An important advantage 
of computed tomography angiography (CTA) over the CS is that additional information 
on stenosis severity and plaque composition can be obtained.8 9 Invasively, virtual histol-
ogy intravascular ultrasound (VH IVUS) offers detailed information on coronary plaque 
characteristics.10-12 The aim of the present study was to compare the relationship between 
the CS and plaque characteristics in patients with ACS versus patients with stable CAD, 
assessed non-invasively by CTA and invasively by VH IVUS. 
METHODS
Patients and Study Protocol
The study population consisted of 112 patients without known CAD (defi ned as previ-
ous myocardial infarction, coronary arterial bypass grafting and percutaneous coronary 
intervention) who were referred for CTA imaging for non-invasive evaluation of chest pain. 
Subsequently, patients were referred for invasive coronary angiography (ICA) in combina-
tion with VH IVUS based on patient’s clinical presentation and/or imaging results. Patient 
data were prospectively collected in the departmental Cardiology Information System 
(EPD-Vision®, Leiden University Medical Center, Leiden, the Netherlands) and retrospec-
tively analyzed. Patients with diagnostic CTA image quality were selected from an ongo-
ing registry addressing the relative merits of CTA in relation to other imaging modalities. 
A total of 53 patients were included with suspected ACS, which was defi ned according 
to the guidelines of the European Society of Cardiology and the American College of 
Cardiology/American Heart Association.13 14 The remaining 59 patients presented to the 
outpatient clinic with stable chest pain complaints.15 Contra-indications for CTA were 1) 
(supra) ventricular arrhythmias, 2) renal insuffi ciency (glomerular fi ltration rate <30 ml/
min), 3) known allergy to iodine contrast material, 4) severe claustrophobia, 5) pregnancy. 
CTA acquisition
The CS and CTA scans were performed using either a 64-row or a 320-row scanner 
(Aquilion 64 or Aquilion ONE, Toshiba Medical Systems, Otawara, Japan). Beta-blocking 
medication (metoprolol 50 or 100 mg) was administered if the patient’s heart rate was 


































scan (tube voltage of 120 kV and tube current of 200 mA) was performed to assess the 
total CS.16 A total CS of 0 was defi ned as no calcium, a CS of 1-399 was defi ned as mild 
calcium and a CS of ≥400 was defi ned as severe calcium. A standard scanning protocol 
was followed for the 64-row as well as for the 320-row contrast enhanced CTA scan, as 
previously described.17 18 
CTA analyzation
CTA datasets were evaluated using dedicated software (Vitrea 2.0 or Vitrea FX 1.1 Vital 
images, Minnetonka, MN, USA) by two experienced readers, blinded to baseline patient 
characteristics, CS and VH IVUS results. The coronary arteries were divided into 17 seg-
ments according to a modifi ed American Heart Association classifi cation.19 Per segment 
one coronary plaque (if present) was selected at the site of the most severe luminal narrow-
ing. To describe plaque composition, plaques were further classifi ed as: 1) non-calcifi ed 
plaque (plaques with lower density compared to contrast-enhanced lumen without any 
calcifi cation), 2) mixed plaque (non-calcifi ed and calcifi ed elements in single plaque) 3) 
calcifi ed plaque (plaques with high density compared to contrast-enhanced lumen). 
VH IVUS acquisition
The VH IVUS examinations were performed during ICA according to standard protocols. 
A dedicated IVUS-console (Volcano Corporation, Rancho Cordova, CA, USA) was used for 
the examination. VH IVUS was performed with a 20 MHz, 2.9 F phased-array IVUS catheter 
(Eagle Eye, Volcano Corporation, Rancho Cordova, CA, USA). Subsequently, with a speed 
of 0.5 mm/s, motorized automated IVUS pullback was performed until the IVUS catheter 
reached the guiding catheter. Images were stored for off-line analysis. 
VH IVUS analyzation
VH IVUS analysis was performed by two experienced observers blinded to baseline 
patient characteristics, CS and CTA results. Offl ine analysis of the VH IVUS images was 
performed using dedicated software (pcVH 2.1 and VIAS 3.0, Volcano Corporation, Ran-
cho Cordova, CA, USA). The lumen and the media-adventitia interface were defi ned by 
automatic contour detection and on all individual frames manual editing was performed. 
Analysis was performed on a per plaque basis. Plaque area (mm2) was defi ned as plaque 
area plus media area and was calculated as vessel area minus lumen area. Four plaque 
components were differentiated into different color-codes (fi brotic tissue displayed in 
dark green, fi bro-fatty in light green, necrotic core in red and dense calcium in white), as 
validated previously.20 Vulnerable plaque characteristics on VH IVUS were defi ned by % 
of necrotic core and presence of thin cap fi broatheroma (TCFA). A TCFA was defi ned as a 
lesion with a plaque burden ≥40%, the presence of confl uent necrotic core of >10%, and 









Statistical analysis was performed using SPSS 16.0 (SPSS, Inc., Chicago, Illinois). The 
impact on clinical presentation (ACS versus stable CAD) of coronary plaque characteristics 
(plaque burden and composition) on CTA was explored in all patients and related to the CS 
score (no, mild or severe). Finally, the impact of clinical presentation on coronary plaque 
characteristics in relation to the CS score was also evaluated using VH IVUS. Continuous 
values are expressed as means (±SD). Continuous values were assessed with the Student’s 
t test if normally distributed or with the Mann-Whitney test if not normally distributed. 
Categorical values are expressed as number (%) and compared between groups with the 
2-tailed Chi-square test. A p-value of <0.05 was considered statistically signifi cant. 
RESULTS
Patients
Overall, 112 patients were studied of which 53 patients presented with ACS and 59 pre-
sented with stable CAD. No differences were observed in the prevalence of risk factors for 
CAD between the 2 groups (Table 1). In patients with ACS, cardiac troponin levels were 
Table 1. Patient characteristics
Patient characteristics of the study population compared between patients with suspected acute 
coronary syndrome (ACS) and stable coronary artery disease (CAD). Only the calcium score was 
signifi cantly higher in patients presenting with stable CAD as compared to patients with suspected ACS.





Age (years) 57±11 58±11 0.69
Male 37 (70%) 35 (59%) 0.25
Obesity (body mass index ≥ 30 kg/m2) 12 (23%) 8 (14%) 0.24
Hypertension† 28 (53%) 36 (61%) 0.38
Hypercholesterolemia‡ 32 (60%) 29 (49%) 0.23
Positive family history 25 (47%) 29 (49%) 0.83
Smoker 25 (47%) 22 (37%) 0.29
Type 2 diabetes mellitus 9 (17%) 17 (29%) 0.14
Mean calcium score 149±141 530±1258 <0.001
Presence of signifi cant stenosis§
(≥50% luminal narrowing)
31 (58%) 35 (59%) 0.93
Data are absolute values, percentages or means ± standard deviation.
†Defi ned as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or the use 
of antihypertensive medication.
‡Serum total cholesterol ≥230 mg/dL or serum triglycerides ≥200 mg/dL or treatment with lipid 
lowering drugs.
§Visually assessed on invasive coronary angiography


































elevated in 11 patients (21%) and in 31 patients (58%) signifi cant CAD was demonstrated 
on ICA. VH IVUS could be performed in all patients and was obtained in 241 vessels (124 
vessels (51%) in ACS and 117 vessels (48%) in stable CAD). Regarding the CS, calcium was 
absent (CS of 0) in 11 patients (21%) with ACS and 10 patients (17%) with stable CAD. 
Moreover, mild calcium (CS of 1-399) was observed in 37 patients (70%) with ACS and in 
32 patients (54%) with stable CAD. Severe calcium (CS of ≥400) was demonstrated in 5 
patients (9%) with ACS and 17 patients (29%) with stable CAD (p=0.04).
CTA fi ndings
In total, 662 coronary plaques were indentifi ed on CTA. Overall, 327 coronary plaques 
(49% of the total amount of plaques) were observed in patients with ACS whereas 335 
coronary plaques (51% of the total amount of plaques) were observed in patients with 
stable CAD (p=0.14). No difference in total plaque burden on CTA, refl ected by the mean 
number of total plaques per patient, was observed between patients with ACS (6.3±3.1) 
and stable CAD (5.7±3.7, p=0.30). Subsequently, the mean number of plaques per patient 
was compared between patients with ACS and stable CAD within the various CS catego-
ries (Figure 1). If coronary calcium was absent, signifi cantly more plaques were present 
in patients with ACS (5.0±3.2) than patients with stable CAD (2.0±1.9, p=0.04). Similarly, 
if coronary calcium was mild, signifi cantly more plaques were still detected in patients 
with ACS (6.6±3.0) than patients with stable CAD (5.0±2.9, p=0.02). However, if coronary 
calcium was severe, no differences were observed. 
The differences in plaque composition were evaluated within the various CS categories 
between patients with ACS and stable CAD. Regarding non-calcifi ed plaques, if coronary 




























Figure 1. Relation between CS and plaque burden on CTA
Bar graph demonstrating the difference in the mean number of plaques per patient on CTA within 
different calcium score categories (no, mild and severe calcium) between patients presenting 
with ACS and stable CAD. As demonstrated, if coronary calcium was absent or mild on CTA, 
patients with ACS had a signifi cantly higher mean number of plaques than patients with stable 
CAD. However, in severe calcium, the mean number of plaques on CTA was not different between 
patients with ACS and stable CAD. ACS, acute coronary syndrome; CAD, coronary artery disease; 








with ACS (4.6±3.5) than patients with stable CAD (1.3±1.9, p=0.03). Similarly, if coronary 
calcium was mild, signifi cantly more non-calcifi ed plaques were observed in patients with 
ACS (2.9±2.5) than patients with stable CAD (1.9±2.4, p=0.03). However, with regard to 
severe coronary calcium, no signifi cant differences were identifi ed in the mean number 
of non-calcifi ed plaques between patients with ACS (0.8±1.1) and stable CAD (1.5±1.5, 
p=0.36). Regarding mixed plaques, if coronary calcium was mild, more mixed plaques 
were observed in patients with ACS than patients with stable CAD (3.0±2.1 vs 1.6±1.9, 
p=0.002). In contrast, regarding calcifi ed plaques, in patients with mild or severe calcium, 
calcifi ed lesions were more prominent in patients with stable CAD as compared to patients 
with ACS for each CS category.
VH IVUS fi ndings
VH IVUS was available in 429 coronary plaques of which 219 plaques were present in 
patients with ACS (49% of total amount of plaques) and 210 plaques were present in 
patients with stable CAD (51% of total amount of plaques). No difference in total plaque 
burden on VH IVUS, refl ected by the mean plaque area per patient, was observed between 
patients with ACS (7.55±3.09 mm2) and stable CAD (7.68±3.14 mm2, p=0.66). In addition, 
the difference in plaque area between patients with ACS and stable CAD within the vari-
ous CS categories was assessed as presented in Figure 2. Accordingly, if coronary calcium 
was absent, plaque area (mm2) was signifi cantly higher in coronary plaques of patients 
with ACS as compared to patients with stable CAD. However, in case of mild or severe 
coronary calcium, plaque area (mm2) was not signifi cantly different between patients with 
ACS and stable CAD. 
Plaque composition on VH IVUS was compared between patients with ACS and stable 






























Figure 2. Relation between CS and plaque burden on VH IVUS
Bar graph demonstrating the difference in mean plaque area (mm2) on VH IVUS within different 
calcium score categories (no, mild and severe calcium) between patients with ACS and stable CAD. 
As demonstrated, if coronary calcium was absent, patients with ACS had signifi cantly larger mean 
plaque area on VH IVUS than patients with stable CAD. However, in mild or severe calcium, plaque 
area was not different between patients with ACS and stable CAD. ACS, acute coronary syndrome; 


































calcium was absent, necrotic core area (mm2) was signifi cantly higher in coronary plaques 
of patients with ACS than stable CAD. This difference was still preserved when coronary 
calcium was mild. However, regarding severe coronary calcium, no differences in necrotic 
core area between coronary plaques of patients with ACS and patients with stable CAD 
were identifi ed. Regarding the mean number of TCFA within different CS categories, the 
number of TCFA was signifi cantly higher in patients with ACS in all CS categories as com-
pared to stable CAD, which is demonstrated in Figure 4. An example of a patient with ACS 


































Figure 3. Relation between CS and plaque composition on VH IVUS
Bar graph demonstrating the difference in mean necrotic core area (mm2) on VH IVUS within 
different calcium score categories (no, mild and severe calcium) between patients with ACS and 
stable CAD. As demonstrated, if coronary calcium was absent or mild, patients with ACS had 
signifi cantly larger mean necrotic core area on VH IVUS than patients with stable CAD. However, in 
the presence of severe calcium, mean necrotic core area was not different between patients with 





























Figure 4. Relation between CS and TCFA on VH IVUS
Bar graph demonstrating the difference in mean number of TCFA on VH IVUS within different 
calcium score categories (no, mild and severe calcium) between patients with ACS and stable CAD. As 
demonstrated, patients with ACS had signifi cantly larger number of TCFA on VH IVUS than patients 
with stable CAD in all calcium score categories. ACS, acute coronary syndrome; CAD, coronary artery 


















Figure 5. Example of patient with zero CS and extensive atherosclerosis
Example of a patient suspected of an acute coronary syndrome without coronary calcifi cation but 
with relevant coronary atherosclerosis. The coronary calcium score showed no presence of coronary 
calcium in the entire coronary artery tree (Panel A, B, C). Additionally, 320-row CTA was performed. 
The 3D volume reconstruction showed signs of luminal narrowing in the LCx (Panel D, white arrow). 
On the multiplanar reconstruction of the LCx a substantial non-calcifi ed plaque (white arrow) was 
demonstrated suggestive of signifi cant luminal narrowing on cross-sectional view (enlargement) 
(Panel E). Grayscale IVUS confi rmed substantial non-calcifi ed plaque burden with signifi cant luminal 
narrowing and signs of thrombus (Panel F). Virtual histology IVUS showed a large plaque without 
calcifi cations and large necrotic core area (red). Ao, aorta; IVUS, intravascular ultrasound; LAD, left 
anterior descending coronary artery; LCx, left circumfl ex coronary artery; LM, left main; OM, obtuse 



































The main fi nding of the present study was that clinical presentation (ACS versus stable 
CAD) has a strong impact on the relation between the CS and coronary plaque character-
istics. Although the mean number of plaques was similar between patients with ACS and 
stable CAD, when coronary calcium was absent the plaque burden on CTA was signifi cantly 
larger in patients with ACS than in patients with stable CAD. Invasive VH IVUS fi ndings 
paralleled non-invasive CTA fi ndings. When coronary calcium was absent, a signifi cantly 
larger plaque area (mm2) was observed in patients with ACS as compared to patients 
with stable CAD. Regarding plaque composition, when coronary calcium was absent or 
mild, a signifi cantly higher number of both non-calcifi ed and mixed plaques on CTA was 
observed in patients with ACS as compared to patients with stable CAD. Importantly, 
as demonstrated invasively with VH IVUS, when coronary calcium was absent, a higher 
degree of high-risk plaque features (more TCFA and necrotic core) was noted in ACS. 
Consequently, the present fi ndings indicate that if the CS is zero in patients with ACS, 
the presence of substantial atherosclerotic plaque burden cannot be reliably excluded, as 
demonstrated both non-invasively by CTA and invasively by VH IVUS.
Initially, the observation that a zero CS does not exclude substantial plaque burden 
appears to be in confl ict with data from the general population. Indeed, an extensive body 
of previous published reports exists supporting the value of CS as a marker of plaque 
burden, and thus indirectly of prognosis.1-4 23 Large, multicenter trials have shown that 
absence of calcium is consistently associated with a low risk of either obstructive stenosis 
or cardiovascular events. Nonetheless, it should be noted that these data have been based 
predominantly on asymptomatic, low-risk populations and may not be fully representa-
tive of symptomatic patients at higher risk. Several studies have investigated the pres-
ence of atherosclerosis or signifi cant stenosis in patients without detectable calcium.24 
25 Akram et al reported in asymptomatic patients without calcium that the prevalence of 
signifi cant stenosis was zero.24 In symptomatic patients, however, the prevalence of sig-
nifi cant stenosis increased to 8%. Moreover, these observations may be more pronounced 
in patients presenting with unstable symptoms, as suggested by Henneman et al.7 In 
patients with ACS, the authors showed that signifi cant luminal narrowing was present in 
39% of patients with a zero CS. 
It is conceivable that underlying differences in plaque composition in relation to clini-
cal presentation may infl uence the reliability of CS as a marker of plaque burden. Indeed, 
previous histopathological data have demonstrated that lesions associated with ACS are 
not often heavily calcifi ed.26-28 Moreover, several post-mortem series have reported that 
calcifi cations develop relatively late in the process of atherosclerosis.22 29 In fact, intimal 
thickening with lipid accumulation is typically the fi rst stage of atherosclerosis. This 
process is followed by the growth of the lipid core, fi brous cap formation and possibly 
deposition of small calcifi cations in the plaque.22 Interestingly, Burke et al demonstrated 
in a series of sudden cardiac death patients that plaque ruptures show relatively little 








areas of only mild calcifi cation.29 Indeed, calcium is not often demonstrated in the culprit 
lesions of ruptured plaques but is more often related to stable CAD. It seems that, in 
contrast to the destabilizing effects of the lipid core, calcium is a more stabilizing force.30 
Similarly, previous studies comparing plaque composition between patients presenting 
with ACS and stable CAD have also revealed a relatively lower proportion of extensive 
calcifi cations. Notably this observation has been reported using both non-invasive and 
invasive imaging modalities.26 31-34 Also, in the present study relative plaque composi-
tion on CTA was signifi cantly different in patients with ACS than in patients with stable 
CAD. More non-calcifi ed and mixed lesions were observed in patients with ACS, whereas 
patients with stable CAD showed more calcifi ed plaques. The observed difference in 
plaque composition was shown to strongly infl uence the relationship between CS and 
plaque burden and composition. Importantly, as demonstrated invasively for the fi rst 
time, absence of calcium in patients presenting with ACS does not exclude the potential 
presence of vulnerable atherosclerotic plaque. Accordingly, the current study provides a 
valuable link between previous studies in patients with ACS, reporting a lower extent of 
calcium on the one hand and an increased rate of obstructive CAD in the absence of cal-
cium on the other hand. Moreover, our observations may also indicate that as compared 
to stable or asymptomatic patients, the negative predictive value of absent or low CS for 
cardiovascular events may be reduced in patients at higher risk, such as patients with ACS. 
In this population, more detailed imaging tools may be preferred to establish or exclude 
the presence of substantial and potentially vulnerable plaque burden. 
The following limitations of the present study should be considered. First, the present 
study only evaluated 112 patients in a single center. Ideally, a larger patient population 
should be studied, preferably in a multicenter setting. Second, based on the current small 
size of the study population it was not be possible to draw any fi rm conclusions if smaller 
subgroups of the CS were used. Future studies with larger cohorts are necessary to perform 
analysis with smaller subgroups of the CS. Third, one of the general disadvantages of CTA 
is the use of ionizing radiation and contrast. Therefore, careful patient selection regarding 
age, renal function and body mass index are of fundamental importance to optimize use 
of CTA. Furthermore, image protocols should be carefully selected to prevent unnecessary 
exposure to radiation. In addition, a referral bias could be present, as in a limited number 
of cases patients were referred for invasive imaging on the basis of CTA fi ndings. Lastly, 
correlation with events would be of interest. However, due to the relative novelty of the 
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Background: The purpose was to determine the rate of subsequent invasive coronary 
angiography (ICA) and revascularization in relation to computed tomography coronary 
angiography (CTA) results. In addition, independent determinants of subsequent ICA and 
revascularization were evaluated. 
Methods: CTA studies were performed using a 64-row (n=413) or 320-row (n=224) mul-
tidetector scanner. The presence and severity of CAD were determined on CTA. Following 
CTA, patients were followed up for one year for the occurrence of ICA and revasculariza-
tion. 
Results: A total of 637 patients (296 male, 56±12 years) were enrolled and 578 CTA inves-
tigations were available for analysis. In patients with signifi cant CAD on CTA, subsequent 
ICA rate was 76%. Among patients with non-signifi cant CAD on CTA, subsequent ICA rate 
was 20% and among patients with normal CTA results, subsequent ICA rate was 5.7% 
(p<0.001). Of patients with signifi cant CAD on CTA, revascularization rate was 47%, as 
compared to a revascularization rate of 0.6% in patients with non-signifi cant CAD on CTA 
and no revascularizations in patients with a normal CTA results (p<0.001). Signifi cant CAD 
on CTA and signifi cant three-vessel or left main disease on CTA were identifi ed as the 
strongest independent predictors of ICA and revascularization. 
Conclusion: CTA results are strong and independent determinants of subsequent ICA 
and revascularization. Consequently, CTA has the potential to serve as a gatekeeper for 
ICA to identify patients who are most likely to benefi t from revascularization and exclude 









Invasive coronary angiography (ICA) is routinely used for the identifi cation of patients with 
suspected coronary artery disease (CAD). Advantages of ICA are high resolution imaging 
and the possibility of revascularization by percutaneous coronary intervention (PCI). Due 
to its invasive nature, ICA is associated with a small risk of complications, radiation expo-
sure and relatively high cost of hospital stay. Additionally, the rate of normal ICA examina-
tions is still quite high and health-care costs associated with the increase in ICA and 
revascularization rates are substantial. Moreover, a recent multicenter study showed that 
PCI has no superiority over pharmacological therapy in patients with stable CAD.1 Accord-
ingly a non-invasive test to select the most suitable patients for ICA and revascularization 
would be preferable. Most traditional non-invasive cardiac imaging techniques rely on 
the detection of stress-inducible ischemia.2 However, with the introduction of computed 
tomography coronary angiography (CTA), the non-invasive anatomic assessment of CAD 
with high diagnostic accuracy has become possible. Prior studies have shown that CTA 
allows reliable patient risk stratifi cation, and normal CTA examinations indicate good 
prognosis.3 4 Although CTA cannot replace ICA, this technique could serve as a gatekeeper 
for ICA in selected patients, and thus avoid unnecessary additional examinations. At the 
same time concerns have been raised that CTA may trigger unnecessary referral for ICA. 
Rates of ICA and interventional therapy following CTA have been largely unreported. The 
purpose of the present study therefore was to determine the rate of subsequent ICA and 
revascularization in relation to CTA results. Furthermore, independent determinants of 
subsequent ICA and revascularization were investigated.
METHODS
Patient population
The study group consisted of patients who were referred for CTA as part of a large ongo-
ing registry exploring the prognostic value of CTA.5 Reasons for referral were typical chest 
pain, atypical chest pain and non-anginal chest pain, according to the appropriate use 
criteria for cardiac computed tomography.6 Exclusion criteria for CTA investigation were: 
renal insuffi ciency (glomerular fi ltration rate < 30 ml/min), (supra)ventricular arrhythmias, 
known allergy to iodine contrast material, severe claustrophobia, pregnancy and high 
heart rate in the presence of contra-indications to β-blocker medication.7 Patients were 
entered prospectively into the departmental patient information system (EPD-Vision®, 
Leiden University Medical Center) and retrospectively analysed. Patients with known CAD 
or congenital cardiac abnormalities were excluded from the study.
CTA data acquisition
CTA studies were performed using a 64-row (n=413) or 320-row (n=224) multidetector 
































64 and 320 simultaneous detector rows, respectively (each 0.5 mm wide), as previously 
described.8 9 One hour before the investigation, oral β-blocker medication (metoprolol 
50 or 100 mg) was administered to patients with a heart rate ≥ 65 beats/min, unless 
contra-indicated. The total amount of non-ionic contrast media (Iomeron 400; Bracco, 
Milan, Italy) injected into the antecubital vein was 60-100 ml (depending on scanner type 
and body weight) at a fl ow rate of 5.0 - 6.0 ml/s. In order to synchronize the arrival of the 
contrast media, bolus arrival was detected using a real-time bolus tracking technique. All 
images were acquired during a single inspiratory breath-hold of maximally 12 seconds for 
64 row-CTA and 5 seconds for 320-row CTA. For 64-row CTA, a helical-scanning technique 
was used as previously described.10 In brief, during the examination the ECG was regis-
tered simultaneously for retrospective gating of the data. A collimation of 64 x 0.5 mm 
was used. During 320-row CTA, the ECG was registered simultaneously for prospective 
triggering of the data. A collimation of 320 x 0.5 mm was used and the entire heart was 
imaged in a single heart beat, as previously reported.11
CTA data analysis
Data were transferred to a remote workstation with dedicated analysis software (for 
64-row CTA reconstructions: Vitrea 2; for 320-row CTA reconstructions: Vitrea FX 2.0, Vital 
Images, Minnetonka, MN, USA). First, calcium score was assessed and an overall Agatston 
score was registered for each patient. Next, coronary arteries were evaluated as previ-
ously described.8 Presence of CAD was assessed as recommended by the SCCT guidelines 
for the interpretation and reporting of CTA.12 Each scan classifi ed as having (1) normal, 
(2) non-signifi cant CAD (luminal narrowing < 50% in diameter), (3) obstructive CAD (≥ 
50% luminal narrowing), as described.13 In addition, the presence of signifi cant left main 
disease and signifi cant three-vessel disease was noted. After data evaluation, CTA results 
were entered in into the departmental Cardiology Information System (EPD-Vision®) 
without recommendations for further clinical management. Further clinical management 
was determined at the discretion of the referring cardiologist.
ICA and revascularization
Following CTA, patients were followed up for one year for the occurrence of ICA and 
revascularization. Patient follow-up information was obtained by one observer, blinded 
to the baseline CTA results, using data from clinical visits and/or standardized telephone 
interviews. 
Statistical analysis
Statistical analysis was performed using SPSS software (version 16.0, Inc., Chicago, Illi-
nois). Quantitative data were expressed as mean ± standard deviation (SD). Categorical 
variables were described as numbers and percentages and comparison was performed 
by chi-square test. Univariate analysis of clinical baseline variables and signifi cant CAD 
on CTA was performed. For each variable, odds ratio (OR) and 95%-confi dence interval 








revascularization were performed (using backward elimination method with p-value > 0.2 
as the criterion for elimination) to determine the independent association with signifi cant 
CAD on CTA and signifi cant three-vessel or left main disease on CTA, each corrected 
for clinical baseline variables (age, gender, diabetes, hypercholesterolemia, hypertension, 




A total of 637 patients were enrolled in the study population. An overview of the patient 
characteristics is shown in Table 1. In brief, 47% of patients were male with a mean age of 
56 ± 12 years. Reasons for referral were typical chest pain in 21%, atypical chest pain in 
46% and non-anginal chest pain in 33%. A total of 27 scans (4.2%) were of non-diagnostic 
image quality, and excluded from the analysis. The presence of blooming artifacts in 
patients with a high calcium score ≥400 accounted for 7 uninterpretable scans. Further-
more, 30 patients (3.8%) were lost to follow-up and 2 patients died before follow up was 
completed. As a result, a total of 578 patients were included in the analysis.
Table 1.
Clinical characteristics (n= 637)
Age (years) 56 ± 12




Family history of CAD)‡ 46%
Smoking 20%
Obesity§ 21%
Reason of referral for CTA
Typical chest pain 21%
Atypical chest pain 46%
Non-anginal chest pain 33%
* Serum total cholesterol ≥ 230 mg/dl and/or serum triglycerides ≥ 200 mg/dl or treatment with 
lipid lowering drugs, † Defi ned as systolic blood pressure ≥ 140 mm Hg and/or diastolic blood 
pressure ≥ 90 mm Hg and/or the use of antihypertensive medication, ‡ Defi ned as presence of 
coronary artery disease in fi rst degree family members at < 55 years in men and < 65 years in 
women, § Defi ned as a BMI ≥ 30 kg/m2

































In a total of 578 patients, CTA results were normal in 212 patients (37%), non-signifi cant 
CAD was observed in 177 patients (30%) and signifi cant (≥ 50%) CAD was identifi ed in 
189 patients (33%). Additionally, signifi cant three-vessel or left main disease on CTA was 
observed in 34 patients (5.9%), while the presence of signifi cant three-vessel or left main 
disease could not be determined in 2 patients due to insuffi cient image quality.
ICA
Subsequent to CTA, ICA was performed in 190 patients (33%). The mean duration between 
CTA and ICA was 2.6 ± 2.7 months. Of the 189 CTA investigations with signifi cant CAD, 
subsequent ICA rate was 76% (n=143). Among 177 patients with non-signifi cant CAD on 
CTA, subsequent ICA rate was 20% (n=35) and among 212 patients with normal CTA results, 
subsequent ICA rate was 5.7% (n=12; p<0.001). Figure 1 illustrates the relationship between 
CTA results and subsequent ICA. Moreover, of the 34 patients with signifi cant three-vessel or 
left main disease on CTA, subsequent ICA rate was 88% (n=30), while ICA rate in 542 patients 
without signifi cant three-vessel or left main disease on CTA was 29% (n=158, p<0.001).
Univariate regression analysis was performed to identify determinants of subsequent ICA. 
Table 2 shows that signifi cant CAD on CTA (OR 22.62) as well as signifi cant three-vessel or 
left main disease on CTA (OR 18.23) were identifi ed as a signifi cant univariate determinant 
of subsequent ICA. Furthermore, the clinical baseline variables age, gender, hypercho-
lesterolemia, hypertension and smoking were signifi cant univariate determinants of ICA. 
Subsequently, multivariate logistic regression analysis for ICA was performed to determine 
the independent association with signifi cant CAD on CTA and signifi cant three-vessel or left 
main disease on CTA, each corrected for clinical baseline variables in a separate model. Sig-
nifi cant CAD on CTA (OR 18.60) and signifi cant three-vessel or left main disease on CTA (OR 
15.67) were identifi ed as the strongest independent predictors of ICA. Other determinants 
of ICA of lesser statistical signifi cance were gender and smoking. Table 2 shows the results 































Figure 1. Bar graph illustrating the 
relationship between degree of CAD on CTA 



































Figure 2. Bar graph illustrating the relationship 
between degree of CAD on CTA and 
revascularization.
Table 2. Independent determinants of subsequent ICA and revascularization
Variable Univariate Multivariate
OR (95%-CI) p-value OR (95%-CI) p-value
ICA
Age 1.05 (1.03-1.06) <0.001 1.02 (0.99-1.04) 0.112
Gender 1.92 (1.35-2.73) <0.001 1.81 (1.13-2.91) 0.014
Diabetes 1.35 (0.87-2.08) 0.182 - -
Hypercholesterolemia 2.19 (1.53-3.14) <0.001 1.42 (0.87-2.30) 0.162
Hypertension 2.09 (1.47-2.98) <0.001 1.51 (0.93-2.46) 0.098
Family history of CAD 0.83 (0.58-1.17) 0.282 - -
Smoking 2.70 (1.78-4.09) <0.001 2.35 (1.33-4.14) 0.003
Obesity 1.08 (0.69-1.67) 0.749 - -
Signifi cant CAD on CTA* 22.62 (14.41-35.51) <0.001 18.60 (11.46-30.19) <0.001
Signifi cant three-vessel or left 
main disease on CTA*
18.23 (6.32-52.59) <0.001 15.67 (4.59-53.43) <0.001
Revascularization
Age 1.05 (1.03-1.07) <0.001 1.02 (0.99-1.06) 0.134
Gender 2.80 (1.73-4.53) <0.001 2.90 (1.54-5.46) 0.001
Diabetes 2.08 (1.24-3.49) 0.005 2.10 (1.00-4.43) 0.050
Hypercholesterolemia 2.31 (1.46-3.66) <0.001 1.45 (0.78-2.69) 0.243
Hypertension 1.92 (1.22-3.04) 0.005 - -
Family history of CAD 0.67 (0.42-1.07) 0.095 - -
Smoking 3.43 (2.11-5.58) <0.001 3.24 (1.60-6.57) 0.001
Obesity 1.09 (0.62-1.92) 0.773 - -
Signifi cant CAD on CTA* 338.06 (46.53-2456.30) <0.001 282.61 (38.21-2090.31) <0.001
Signifi cant three-vessel or left 
main disease on CTA*
15.62 (7.27-33.54) <0.001 12.31 (5.52-28.91) <0.001
* Each variable was included in a separate model corrected for clinical baseline variables (age, 
gender, diabetes, hypercholesterolemia, hypertension, family, smoking and obesity). Results from 
multivariate analysis for clinical baseline variables shown in the table were derived from the model 

































A total of 89 patients (15%) underwent revascularization, of whom 74 patients underwent 
PCI and 15 patients coronary artery bypass grafting (CABG). Of the 189 patients with 
signifi cant CAD on CTA, revascularization rate was 47% (n=88), as compared to a revascu-
larization rate of 0.6% (n=1) in 348 patients with non-signifi cant CAD on CTA. Of note, this 
patient had a signifi cant lesion in the distal RCA, which was underestimated on CTA. No 
revascularizations were performed in patients with a normal CTA examination (p<0.001). 
The frequency of revascularization in relation to CAD on CTA is illustrated in Figure 2.
In 34 patients with signifi cant three-vessel or left main disease on CTA, revascularization 
rate was 68% (n=23), as compared to 12% (n=64) in 542 patients without signifi cant three-
vessel or left main disease on CTA (p<0.001). Table 2 shows that signifi cant CAD on CTA (OR 
338.06) as well as signifi cant three-vessel or left main disease on CTA (OR 15.62) were iden-
tifi ed as signifi cant determinants of revascularization in univariate analysis. Furthermore, 
the clinical baseline variables age, gender, hypercholesterolemia, hypertension and smok-
ing were signifi cant univariate determinants of revascularization. Next, multivariate logistic 
regression analysis for revascularization was performed to determine the independent 
association of signifi cant CAD on CTA and signifi cant three-vessel or left main disease on 
CTA, each corrected for clinical baseline variables in a separate model. Multivariate regres-
sion analysis identifi ed signifi cant CAD on CTA (OR 282.61) and signifi cant three-vessel 
or left main disease on CTA (OR 12.31) as the strongest predictors of revascularization. 
Additional signifi cant determinants were gender and smoking. In Table 2, the results of uni- 
and multivariate regression analysis to identify determinants of revascularization are shown.
DISCUSSION
The present clinical investigation evaluated the association between CTA results and 
subsequent rates of ICA and revascularization. The majority of patients with signifi cant 
CAD on CTA were referred for subsequent ICA (76%), while in patients with normal CTA 
results a very low rate of referral was demonstrated (5.7%). Additionally, no patients with 
normal CTA results underwent revascularization. Moreover, signifi cant CAD and signifi cant 
three-vessel or left main disease on CTA were identifi ed as the strongest independent 
determinants of subsequent ICA and revascularization.
Previous literature
The use of CTA to reliably exclude signifi cant CAD is supported by extensive literature 
validating this technique against ICA.14 Nevertheless, limited information is available 
regarding the infl uence of CTA results on clinical decision making and referral for 
downstream testing such as ICA. Henneman and colleagues previously showed that a 
substantial proportion of patients with suspected CAD have normal coronaries on CTA 








signifi cant stenosis may be excluded using CTA. Furthermore, Chow et al. recently studied 
the clinical impact of CTA on the rate of normal ICA. In a large cohort of 7017 consecutive 
patients who were referred for ICA before and after implementation of a dedicated CTA 
program, the implementation of CTA had a positive effect on ICA referral by reducing the 
frequency of normal ICA from 32% to 27%.16 The present results expand on these fi ndings, 
in identifying a strong association between CTA results and referral for ICA. Moreover, 
the current fi ndings showed a high percentage of normal and non-signifi cant CT results. 
Considering that normal CTA examinations are associated with a good prognosis,17 these 
data imply that, using CTA, a large proportion of patients with chest pain or a high risk 
profi le may be safely excluded from ICA.
Even though signifi cant CAD on CTA was the strongest predictor for revascularization, 
still a considerable proportion of patients (24%) with signifi cant CTA results were not 
referred for ICA. Similarly, a small percentage of patients with non-signifi cant and normal 
CTA results (20% and 5.7%, respectively) were referred for ICA. These fi ndings could be 
explained by the fact that other clinical information and test results, such as exercise ECG 
or myocardial perfusion imaging (MPI), may have also infl uenced referral for ICA. Indeed, 
clinical presentation and functional information also infl uence subsequent referral to ICA 
and revascularization. While no previous studies have investigated ICA rates in relation 
to CTA results, a prior investigation by Bateman and colleagues showed comparable ICA 
referral rates in patients who were referred for MPI using single photon emission com-
puted tomography (SPECT).18 In a group of 4162 patients with a mean follow up of 8.9 
months, 60% of patients with high-risk ischemia were referred for ICA, as compared with 
9% with mild ischemia and 3.5% of patients without ischemia on SPECT. In this popula-
tion, 40% of high-risk patients were not referred for invasive imaging, most likely due to 
the fact that other clinical information and previous study results also infl uenced patient 
management. A more recent study by Shaw et al. showed comparable results.19 In analyz-
ing post-SPECT referral rates, 52% of patients with 3 ischemic perfusion areas underwent 
ICA. Unfortunately, studies directly comparing CTA and MPI are not available, and future 
investigations are warranted.
Anatomical and functional imaging prior to ICA
Most traditional non-invasive cardiac imaging techniques rely on the detection of stress-
inducible ischemia.18 20 21 In this setting, perfusion abnormalities or systolic dysfunction 
serve as surrogate markers for fl ow-limiting CAD.22 Although CTA and MPI (the most 
frequently applied functional imaging technique) provide complementary information,22 
concerns about radiation exposure preclude the use of both CTA and MPI in all patients. 
With the introduction of CTA, the use of MPI as a gatekeeper for ICA has been challenged.23 
First, CTA has a negative predictive value approaching 100%, making it an excellent 
modality for the exclusion of CAD in patients with a low-to-intermediate pre-test likeli-
hood. Conversely, MPI enables the identifi cation of perfusion abnormalities, due to which 
































patients with unknown CAD.24 Thus, individual patient characteristics are important in the 
choice of non-invasive imaging modality to further guide patient management. Second, 
while both MPI and CTA are associated with radiation exposure, radiation exposure of CTA 
has been substantially reduced using novel low-dose algorithms. In daily clinical practice, 
however, the choice of non-invasive imaging modality prior to ICA may also depend on 
availability20 and local expertise. Finally, with the large increase in health-care costs, focus 
is increasingly shifting to cost-effective use of resources. Preliminary results suggest that 
costs of CTA as a gatekeeper for ICA may be signifi cantly lower than MPI25 and therefore 
more cost-effective. Nevertheless, precise cost-benefi t analyses are currently not available 
and further studies evaluating the relationship between CTA and MPI in selecting patients 
for ICA are warranted.
Clinical implications
The use of CTA to exclude signifi cant CAD may allow cardiologists to restrict referral for ICA 
to patients in whom the need for interventional therapy is highly likely.26 In patients with 
a normal CTA examination CAD can be safely ruled out and the patient may be reassured. 
Conversely, patients with signifi cant stenosis on CTA should be referred for further evalua-
tion. Furthermore, patients with recurrent or worsening symptoms as well as patients with 
left main or three-vessel disease on CTA could be directly referred for ICA. In patients with 
non-signifi cant stenosis on CTA, however, medical therapy and lifestyle interventions may 
be appropriate and these patients may be excluded from ICA. Nevertheless, in patients 
with uncertain results, functional analysis could be performed to further guide referral for 
ICA. Notably, while CTA may aid risk stratifi cation for the presence of CAD in patients with 
a low-to-intermediate risk profi le, CTA may be less useful in patients with known CAD, in 
whom the need for ICA and interventional therapy is likely.6 27 28
Limitations
Several limitations of the present study merit further consideration. Firstly, CTA is inher-
ently associated with ionizing radiation.29 Secondly, CTA and ICA do not provide informa-
tion regarding the functional signifi cance of a lesion. Combined anatomic and perfusion 
imaging using either a hybrid imaging approach or volumetric CTA in a single examination 
would be advantageous and research is ongoing.30 Third, the effect of other clinical infor-
mation, such as perfusion imaging, may have also infl uenced referral for ICA. However, 
studying the effects other tests as well as cost-benefi t analysis were beyond the scope of 
this study. Last, the present investigation did not evaluate clinical outcome. Future studies 
are needed to evaluate the effect of CTA on clinical outcome and health-care costs.
Conclusion
The present investigation showed that the results of CTA are strong and independent 
determinants of subsequent ICA as well as revascularization. Consequently, CTA has the 
potential to serve as a gatekeeper for ICA to identify patients who are most likely to 
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Background: Previous studies have shown that the presence of stenosis alone on mul-
tislice computed tomography (MSCT) has a limited positive predictive value for the pres-
ence of ischemia on myocardial perfusion imaging (MPI). The purpose of this study was 
to assess which variables of atherosclerosis on MSCT angiography are related to ischemia 
on MPI.
Methods: Both MSCT and MPI were performed in 514 patients. On MSCT, the calcium 
score, degree of stenosis (≥50% and ≥70% stenosis), plaque extent and location were 
determined. Plaque composition was classifi ed as non-calcifi ed, mixed or calcifi ed. Isch-
emia was defi ned as a summed difference score ≥2 on a per patient basis.
Results: Ischemia on MPI was observed in 137 patients (27%). On MSCT, on a patient 
basis, multivariate analysis showed that the degree of stenosis (presence of ≥70% ste-
nosis, OR 3.5), plaque extent and composition (mixed plaques ≥3, OR 1.7 and calcifi ed 
plaques ≥3, OR 2.0) and location (atherosclerotic disease in left main coronary artery and/
or proximal left anterior descending coronary artery, OR 1.6) were independent predictors 
for ischemia on MPI. In addition, MSCT variables of atherosclerosis such as plaque extent, 
composition and location had signifi cant incremental value for the prediction of ischemia 
over the presence of ≥70% stenosis.
Conclusion: In addition to the degree of stenosis, MSCT variables of atherosclerosis 
describing plaque extent, composition and location are predictive of the presence of 









Over the past decade, multislice computed tomography (MSCT) angiography has 
emerged as a non-invasive modality for visualization of the coronary arteries. Recently, 
several studies have addressed the diagnostic accuracy of MSCT as compared to invasive 
coronary angiography reporting high accuracies for the detection of 50% stenosis.1 
Importantly, the high negative predictive value of 99% indicates that the technique may 
be particularly useful for ruling out the presence of coronary artery disease (CAD) in 
patients with lower likelihood of CAD. On the other hand, while MSCT angiography pro-
vides insight into the severity and extent of anatomical disease, it is currently unable to 
evaluate the hemodynamical relevance of CAD. In fact, previous studies have revealed a 
large discrepancy between the presence of atherosclerosis on MSCT angiography and the 
presence of ischemia during functional testing.2-5 These investigations demonstrated that 
approximately only half of obstructive stenoses (≥50% luminal narrowing) on MSCT were 
associated with abnormal perfusion, whereas a large proportion of obstructive lesions on 
MSCT did not result in perfusion abnormalities.
Therefore, identifi cation of anatomical MSCT variables of atherosclerosis that are asso-
ciated with ischemia on MPI, in addition to the presence of obstructive CAD, may improve 
selection of further diagnostic and/or therapeutic management. Thus, the purpose of this 
study was to identify variables of atherosclerosis on MSCT angiography that are related to 
ischemia on MPI, in addition to the presence of obstructive CAD.
METHODS
Patients and study protocol
The study population consisted of 524 patients who were clinically referred for functional 
and anatomical imaging because of chest pain or an elevated risk profi le as part of an 
ongoing registry addressing the relative merits of MSCT in relation to other imaging 
techniques. Patients underwent both myocardial perfusion imaging (MPI) with stress-rest 
gated single photon emission computed tomography (SPECT) and MSCT within 3 months 
in two different institutions. Patients were included at the University Hospital in Zurich, 
Switzerland (n=263) and at the Leiden University Medical Center, Leiden, the Netherlands 
(n=261). Exclusion criteria were: known CAD (previous myocardial infarction, percutane-
ous coronary intervention and coronary artery bypass surgery), atrial fi brillation, renal 
insuffi ciency (glomerular fi ltration rate <30 ml/min), known allergy to iodine contrast and 
pregnancy. The clinical symptoms of included patients were recorded and patients were 
further classifi ed as having a low, intermediate or high pre-test likelihood of obstructive 



























Patients were instructed to withhold beta-blocking medication and calcium antagonists 
48 hours before examination and caffeine 12 hours before examination. For each center 
a different gated MPI protocol was used. In Leiden (n=261) a two-day gated stress-rest 
SPECT protocol was performed using either technetium-99 tetrofosmin (500 MBq) or 
technetium-99m sestamibi (500 MBq). In patients that were able to exercise, symptom-
limited bicycle test was performed and in patients unable to exercise pharmacological 
stress was performed using adenosine or dobutamine. In Zurich (n=263) a one day gated 
stress-rest SPECT was performed using adenosine stress and technetium-99m tetrofosmin 
(300 MBq at peak stress and 900 MBq at rest). The images were acquired on a triple-
head SPECT camera (GCA 9300/HG, Toshiba Corp., Tokyo, Japan) or a dual-head detector 
camera (Millennium VG & Hawkeye, General Electric Medical Systems, Milwaukee, WI, 
USA; or Vertex Epic ADAC Pegasus, Philips Medical Systems, Eindhoven, the Netherlands). 
All cameras were equipped with low energy high resolution collimators. A 20% window 
was used with a 140-keV energy peak of technetium-99m and data were stored in a 64x64 
matrix.
Subsequently, stress-rest gated MPI datasets were quantitatively evaluated using 
previously validated automated software.7 The data were reconstructed into long- and 
short-axis perpendicular to the heart axis. A 20-segment model was used in which the 
myocardial segments were assigned to the different perfusion territories. Each segment 
was scored by an experienced observer according to the standard scoring scale of 0-4 
(normal, mild, moderate, severe reduction or absence of uptake). The total segmental 
perfusion scores during stress and rest were added to calculate the summed stress score 
(SSS) and the summed rest score (SRS), respectively. The summed difference score (SDS) 
was calculated as the sum of difference between the SRS and SSS. Ischemia was defi ned as 
a SDS ≥2 and severe ischemia was defi ned as a SDS ≥8.8 On a per vessel basis, the presence 
of ischemia was assessed visually in the corresponding vascular territory. Consequently, 
ischemia in the anterior and septal wall was allocated to the left anterior descending 
coronary artery, ischemia in the lateral wall was allocated to the left circumfl ex coronary 
artery and ischemia in the inferior wall was allocated to the right coronary artery.9
MSCT coronary angiography
Heart rate and blood pressure were evaluated before each scan. If a patient’s heart rate 
was above 65 beats per minute and no contra-indications existed, beta-blocking medica-
tion was administered one hour before the examination (50-100 mg metoprolol orally or 
5-10 mg metoprolol intravenously). 
In the fi rst 41 patients data acquisition was performed using a 16-slice MSCT scanner 
(Aquilion 16, Toshiba Medical Systems, Otawara, Japan) with a collimation of 16 x 0.5 mm, a 
gantry rotation time of 400 ms, tube voltage of 120 kV and tube current of 250 to 350 mA. 
A 64-slice MSCT scanner (Aquilion 64, Toshiba Medical Systems, Otawara, Japan or General 
Electrics Lightspeed VCT, Milwaukee, WI, USA) was used for the remaining 483 patients 








135 kV and tube current of 250 to 350 mA, depending on body shape. First, a non-contrast 
enhanced low dose scan prospectively triggered at 75% of the R-R interval was performed 
before helical scanning. This examination was used for calcium scoring and followed by 
a triggered helical scan. For the 16-slice MSCT non-ionic contrast (Iomeron 400, Bracco, 
Milan, Italy) was administered in the ante-cubital vein, with a dose of 130 to 140 ml and a 




Figure 1. Assessment of variables of atherosclerosis on multislice computed tomography (MSCT) 
Examples of the classifi cation of different variables of atherosclerosis on MSCT. Panel A: Assessment 
of the presence of atherosclerosis: curved multiplanar reconstruction (MPR) of right coronary artery 
(RCA) revealing the absence of atherosclerosis. Panel B: Assessment of the degree of stenosis: 
MPR showing a lesion resulting in ≥50% stenosis in the mid RCA (arrow). Panel C: Assessment 
of the extent and composition of atherosclerotic disease: MPR of the left anterior descending 
coronary artery (LAD) revealing a single mixed plaque (arrow). Panel D: Assessment of location of 
atherosclerosis: MPR of the LAD demonstrating the presence of an atherosclerotic lesion in the left 


























administered with a fl ow rate of 5 ml/s followed by a saline fl ush. Automatic detection of 
peak enhancement in the descending aorta was used for timing. Subsequently data sets 
were reconstructed at the best phase of the R-R interval and transferred to dedicated work 
stations (Vitrea2, Vital Images, USA, or Advantage, GE Healthcare, USA). 
The non-contrast enhanced CT images were used to calculate the calcium score using 
the Agatston method.10 MSCT angiographic examinations were evaluated in consensus 
by 2 experienced readers including an interventional cardiologist blinded to stress-rest 
SPECT fi ndings. A 17-segment model modifi ed according to the American Heart Associa-
tion was used and for each segment was determined if atherosclerosis was present using 
axial and/or orthogonal images and curved multiplanar reconstructions. If atherosclerosis 
was present, the degree of stenosis was graded as non-obstructive (<50% stenosis), 
obstructive (≥50% stenosis) and severely obstructive (≥70% stenosis). Additionally, the 
extent of atherosclerosis was determined by assessing the number of diseased segments. 
Consequently, plaques were scored according to plaque composition (non-calcifi ed, 
mixed or calcifi ed). Non-calcifi ed plaques were regarded as plaques having a lower 
CT attenuation compared to the contrast lumen and no visible calcifi cations, calcifi ed 
plaques were plaques with predominantly high CT attenuation and without non-calcifi ed 
plaque elements and mixed plaques were plaques consisting of both non-calcifi ed and 
calcifi ed elements. Lastly, the location of disease was classifi ed as being present in left 
main coronary artery (LM) and/or proximal left anterior descending coronary artery (LAD) 
or not (example provided in Figure 1).
Statistical analysis
Continuous data were expressed as mean and standard deviation, and categorical data 
were expressed in numbers and percentages. Binary logistic regression analysis was 
performed to determine the predictive value of MSCT variables of atherosclerosis for 
presence of ischemia on MPI on both a patient and vessel basis. First univariate analysis 
of baseline clinical risk variables (age and gender),6 calcium score and MSCT variables 
was performed. To analyze the predictive value of variables of atherosclerosis on MSCT 
(degree of stenosis, plaque extent, composition and location), optimal binary cutoffs were 
created for analysis. For each variable, an odds ratio with 95% confi dence interval (OR (CI 
95%) was calculated. 
The current study used 2 generations of MSCT scanners (16-slice and 64-slice), thus to 
correct for scanner type, scanner type was included in the univariate analysis. In addition, 
interaction was assessed between scanner type and MSCT variables of atherosclerosis 
(describing degree of stenosis, plaque extent, composition and location). In this analysis, 
no interaction was demonstrated between MSCT scanner type and MSCT variables of 
atherosclerosis (data not shown).
The intention was to build a multivariate model that combines clinical variables and 
MSCT variables of atherosclerosis for the prediction of ischemia on MPI, in a stepwise 
fashion. The fi rst model consisted of clinical risk variables only. Consequently, the presence 








mixed plaques and ≥3 calcifi ed plaques). Finally, plaque location (atherosclerotic disease 
in the LM and/or proximal LAD) was added to the model. For each next iterative step, 
variables may not remain statistically signifi cant. Thus, all variables with a p-value <0.15 
were kept in the model in order not to miss clinically relevant predictors of ischemia. 
The performance of the fi nal multivariate model for prediction of ischemia on both a 
patient and vessel basis was studied with respect to discrimination and calibration. Discrimi-
nation was quantifi ed by a measure of concordance, the c-index. For binary outcomes the 
c-index is identical to the area under the receiver operating characteristic (ROC) curve. The 
c-index lies between 0.5 and 1, and is better if closer to one.11 Calibration refers to whether 
the predicted risks agree with the observed risk frequencies. Calibration was measured with 
the Hosmer-Lemeshow goodness-of-fi t test (p>0.10 considered to indicate lack of deviation 
between the model and observed event rates). Statistical analysis was performed using SPSS 
software (version 16.0, SPSS inc., Chicago, IL, USA) and SAS software (The SAS system 6.12, 
Cary, NC, USA: SAS Institute Inc). A p-value <0.05 was considered statistically signifi cant.
Table 1. Baseline patient characteristics
n (%)
Male 302 (59%)
Age (years) 60 ±11




Positive family history for CAD 191 (37%)
Smoking currently 153 (30%)
Pre-test likelihood
Low pre-test likelihood 113 (22%)
Intermediate pre-test likelihood 334 (65%)
High pre-test likelihood 67 (13%)
Symptoms patient population
Typical chest pain 78 (15%)
Atypical chest pain 146 (28%)
Non-anginal chest pain 41 (8%)
Asymptomatic 181 (35%)
Other (dyspnea, tiredness, dizziness ect.) 68 (13%)




























In total, 524 patients were enrolled in the present study. In 10 patients (2%) the MSCT data 
set was not interpretable because of an irregular or elevated heart rate and these patients 
were excluded from the analysis. Therefore, 514 patients were included in the analysis. 
Baseline patient characteristics are described in Table 1.
Stress-rest gated MPI results
In 87 patients symptom-limited bicycle test was performed and in the remaining 427 
patients pharmacological stress was applied using either adenosine (n=395) or dobuta-
mine (n=32). MPI imaging results are presented in Table 2. The mean SSS was 2.8 ±4.5, the 
mean SRS was 1.5 ±3.0 and the mean SDS was 1.3 ±3.6. Ischemia (SDS ≥2) was observed 
in 137 patients (27%). Within this group, 16 patients (3%) were shown to have severe 
ischemia (SDS ≥8). 
Table 2. Imaging results of MPI, calcium score and MSCT angiography
n (%)
MPI
Normal perfusion (SDS <2) 377 (73%)
Ischemia (SDS ≥2) 137 (27%)








Presence of non-obstructive CAD 354 (69%)
Presence of obstructive CAD (≥50%) 157 (31%)
Presence of severely obstructive CAD (≥70%) 83 (16%)
Extent and Composition
Non-calcifi ed plaques ≥3 39 (8%)
Mixed plaques ≥3 93 (18%)
Calcifi ed plaques ≥3 126 (25%)
Location
LM and/or proximal LAD diseased 74 (14%)
MPI, myocardial perfusion imaging; SDS, summed difference score; MSCT, multislice computed 
tomography; CAD, coronary artery disease; LM, left main coronary artery; LAD, left anterior 









Average heart rate during MSCT acquisition was 63 ±10 beats per minute. The baseline 
calcium score and MSCT imaging results are shown in Table 2. The mean calcium score 
was 324 ±751. 
MSCT predictors for ischemia on MPI: patient based analysis
Results of the univariate analysis regarding the predictive value of MSCT variables for 
ischemia on MPI (patient basis) are listed in Table 3. As demonstrated, scanner type (16-
slice or 64-slice) was not related to the presence of ischemia on MPI. To determine the 
independent predictive value of MSCT variables of atherosclerosis for ischemia on MPI, 
multivariate models were created including MSCT variables of atherosclerosis corrected 
for baseline clinical variables and the presence of severely obstructive CAD (Table 4). 
Interestingly, several MSCT variables of atherosclerosis remained predictive of ischemia 
on MPI in the multivariate model. Regarding contrast enhanced MSCT coronary angiog-
raphy, degree of stenosis (presence of ≥50% and ≥70% stenosis), extent and composition 
Table 3. Univariate analysis for prediction of ischemia on MPI on patient basis
OR (CI 95%) P-value Reference
Clinical 2.0 (1.4-3.8) <0.001
Calcium score
1-100 0.6 (0.4-0.9) 0.02 Calcium score 0
101-400 1.2 (0.7-2.0) 0.48 Calcium score 0
>400 4.8 (3.1-7.5) <0.001 Calcium score 0
MSCT angiography
MSCT scanner type (64-slice) 1.3 (0.7-2.6) 0.46 16-slice MSCT
Degree
Number of obstructive segments 1.4 (1.3-1.6) <0.001
Presence obstructive CAD* 5.4 (3.5-8.3) <0.001 Absence obstructive CAD
Presence severely obstructive CAD† 6.8 (4.1-11.2) <0.001 Absence severely obstructive CAD
Extent and Composition
Number of non-calcifi ed plaques 1.1 (1.0-1.2) 0.15
Number of mixed plaques 1.3 (1.2-1.4) <0.001
Number of calcifi ed plaques 1.3 (1.2-1.4) <0.001
Non-calcifi ed plaques ≥3 0.9 (0.4-2.0) 0.86 Non-calcifi ed plaques <3
Mixed plaques ≥3 3.9 (2.5-6.3) <0.001 Mixed plaques <3
Calcifi ed plaques ≥3 3.3 (2.2-5.1) <0.001 Calcifi ed plaques <3
Location
LM and/or proximal LAD diseased 3.4 (2.2-5.3) <0.001 Absence disease LM and/or proximal LAD
MPI, myocardial perfusion imaging; OR (CI 95%), odds ratio with 95% confi dence interval; MSCT, 
multislice computed tomography; CAD, coronary artery disease; LM, left main coronary artery; LAD, 


























(presence of ≥3 mixed plaques and/or ≥3 calcifi ed plaques) and location (atherosclerotic 
disease in LM and/or proximal LAD) remained independent predictors of ischemia. An 
example of a patient with all predictors on MSCT is provided in Figure 2. 
MSCT predictors for ischemia on MPI: vessel based analysis
Results of the univariate analysis regarding the predictive value of MSCT variables for 
ischemia on MPI (vessel basis) are listed in Table 5. To determine the independent predic-
tive value of MSCT variables of atherosclerosis for ischemia on MPI on a vessel basis, 
multivariate models were created including MSCT variables of atherosclerosis which were 
corrected for baseline clinical risk variables (Table 6). Interestingly, several MSCT variables 
of atherosclerosis remained predictive of ischemia on MPI in the multivariate model on a 
vessel basis. Indeed, degree of stenosis (presence of ≥50% and ≥70% stenosis) and extent 
and composition (presence of ≥2 mixed plaques and/or ≥2 calcifi ed plaques) remained 
signifi cant independent predictors of ischemia. 
Table 4. Multivariate models for prediction of ischemia on MPI on patient basis
OR (CI 95%) P-value Reference
Model I
Clinical 2.0 (1.4-3.8) <0.001
Model II
Clinical 1.6 (1.1-2.3) 0.01
Presence obstructive CAD* 5.0 (3.3-7.7) <0.0001 Absence obstructive CAD
Model III
Clinical 1.7 (1.2-2.5) 0.006
Presence severely obstructive CAD† 6.2 (3.7-10.4) <0.0001 Absence severely obstructive CAD
Model IV
Clinical 1.6 (1.1-2.3) 0.02
Presence severely obstructive CAD† 3.8 (2.2-6.7) <0.0001 Absence severely obstructive CAD
Mixed plaques ≥3 2.0 (1.2-3.5) 0.012 Mixed plaques <3
Calcifi ed plaques ≥3 2.3 (1.5-3.7) <0.0001 Calcifi ed plaques <3
Model V
Clinical 0.7 (1.1-2.4) 0.008
Presence severely obstructive CAD† 4.2 (2.5-7.3) <0.0001 Absence severely obstructive CAD
Calcifi ed plaques ≥3 1.9 (1.2-3.1) 0.01 Calcifi ed plaques <3
LM and/or proximal LAD diseased 1.8 (1.1-3.0) 0.03 Absence disease LM and/or proximal LAD
Model VI
Clinical 1.6 (1.1-2.4) 0.01
Presence severely obstructive CAD† 3.5 (2.0-6.3) <0.0001 Absence severely obstructive CAD
Mixed plaques ≥3 1.7 (0.9-3.1) 0.053 Mixed plaques <3
Calcifi ed plaques ≥3 2.0 (2.2-3.3) 0.007 Calcifi ed plaques <3
LM and/or proximal LAD diseased 1.6 (0.9-2.7) 0.107 Absence diseaset LM and/or proximal LAD
MPI, myocardial perfusion imaging; OR (CI 95%), odds ratio with 95% confi dence interval; CAD, 
coronary artery disease; LM, left main coronary artery; LAD, left anterior descending coronary 

















Figure 2. Example of a 72 year-old male patient exhibiting all the signifi cant predictors on 
multislice computed tomography (MSCT) for prediction of ischemia on myocardial perfusion 
imaging (MPI)
In panel A, a 3D volume rendered reconstruction is provided, showing the left anterior descending 
coronary artery (LAD). Panel B: A curved multiplanar reconstruction (MPR) of the LAD is shown 
demonstrating the presence of obstructive CAD (≥50%) in the proximal segment (arrow). Panel C: 
Another curved MPR of the LAD is shown in a different view, revealing the presence of multiple 
diseased segments (cross sectional images a, b and c), the presence of obstructive lesion in the 
LAD (arrow c) and the presence of mixed plaque (cross sectional images a, b and c). Panel D: Stress 
single photon emission computed tomography (SPECT) short axis image showing the presence of a 
perfusion defect, particularly evident in the antero-septal region (arrow). Panel E: Rest SPECT short 


























Incremental value of angiographic MSCT variables of atherosclerosis to 
predict ischemia on MPI
In total, 157 patients (31%) had obstructive CAD and 83 patients (16%) had severely 
obstructive CAD on MSCT. Regarding these patients, 80 patients (51%) and 52 patients 
(63%) revealed ischemia on MPI, respectively. Moreover, of the 259 patients with at least 
Table 5. Univariate analysis for prediction of ischemia on MPI on vessel basis
OR (CI 95%) P-value Reference value
Clinical 1.9 (2.5-1.4) <0.001
MSCT angiography
Degree
Number of obstructive segments 2.0 (1.7-2.4) <0.001
Presence obstructive CAD* 4.0 (3.0-5.3) <0.001 Absence obstructive CAD
Presence severely obstructive CAD† 5.3 (3.6-7.8) <0.001 Absence severely obstructive CAD
Extent and Composition
Number of non-calcifi ed plaques 1.2 (1.0-1.4) 0.08
Number of mixed plaques 1.6 (1.4-1.8) <0.001
Number of calcifi ed plaques 1.4 (1.2-1.6) <0.001
Non-calcifi ed plaques ≥2 1.0 (0.6-1.9) 0.91 Non-calcifi ed plaques<2
Mixed plaques ≥2 3.0 (2.1-4.2) <0.001 Mixed plaques <2
Calcifi ed plaques ≥2 2.1 (1.5-2.9) <0.001 Calcifi ed plaques <2
MPI, myocardial perfusion imaging; OR (CI 95%), odds ratio with 95% confi dence interval; MSCT, 
multislice computed tomography; CAD, coronary artery disease; *stenosis ≥50%, †stenosis ≥70%
Table 6. Multivariate models for prediction of ischemia on MPI on vessel basis
OR (CI 95%) P-value Reference
Model I
Clinical 1.9 (2.5-1.4) <0.001
Model II
Clinical 1.8 (1.4-2.2) <0.001
Presence obstructive CAD* 3.8 (2.8-5.0) <0.001 Absence obstructive CAD
Model III
Clinical 1.8 (1.5-2.2) <0.001
Presence severely obstructive CAD† 5.0 (3.3-7.3) <0.001 Absence severely obstructive CAD
Model IV
Clinical 1.8 (1.4-2.2) <0.001
Presence severely obstructive CAD† 3.5 (2.3-5.3) <0.001 Absence severely obstructive CAD
Mixed plaques ≥2 1.9 (1.3-2.8) <0.001 Mixed plaques <2
Calcifi ed plaques ≥2 1.8 (1.3-2.5) <0.001 Calcifi ed plaques <2
MPI, myocardial perfusion imaging; OR (CI 95%), odds ratio with 95% confi dence interval; CAD, 








one of the signifi cant predictors on MSCT, only 119 patients (33%) showed ischemia on 
MPI. Example of a patient demonstrating only one signifi cant predictor and a normal MPI 
is provided in Figure 3. In addition, of the 22 patients with all of the signifi cant predictors 
on MSCT (describing degree of stenosis, plaque extent, composition, and location), 18 
patients (82%) showed ischemia on MPI. 
Finally, the performance of the multivariate models for prediction of ischemia on both 








Figure 3. Example of a 69 year-old female patient exhibiting an obstructive lesion on multislice 
computed tomography (MSCT) while myocardial perfusion imaging (MPI) showed normal perfusion
A 3D volume rendered reconstruction is provided in panel A, showing the left anterior descending 
coronary artery (LAD) and left circumfl ex coronary artery (LCx). Panel B: A curved multiplanar 
reconstruction (MPR) of the right coronary artery (RCA) is shown demonstrating the presence of 
non-obstructive non-calcifi ed plaque (arrow). Panel C: A curved MPR of the LAD is shown revealing 
the presence of a single non-obstructive mixed plaque (arrow). Panel D: A curved MPR of LCx is 
shown demonstrating the presence of obstructive lesion (however <70%) in the mid LAD (arrow). 
Panel E: Single photon emission computed tomography (SPECT) short axis image showing normal 


























respect to discrimination and calibration. Discrimination was quantifi ed by a measure of 
concordance, the c-index. In this model, plaque extent, composition and location had 
signifi cant incremental value over clinical risk stratifi cation and the presence of severely 
obstructive CAD (p<0.05) for the prediction of ischemia on both a patient and vessel 
basis (Figure 4 and Figure 5, respectively). The performance of the model (calibration) was 
assessed by the Hosmer-Lemeshow goodness-of-fi t test (p>0.10 considered to indicate 
lack of deviation between the model and observed event rates). As demonstrated in Fig-
ure 6, on both a patient and vessel basis, the estimated risk of the models showed good 
agreement with the observed risk frequencies.
DISCUSSION
The main fi ndings of the present study can be summarized as follows. In a population 
with predominantly low-to-intermediate pre-test likelihood for CAD, MSCT variables of 
atherosclerosis such as plaque extent, composition and location were signifi cant predic-
tors of ischemia on MPI, over the presence of obstructive CAD. Moreover, the incremental 
value of angiographic MSCT variables of atherosclerosis over clinical risk stratifi cation and 
the presence of severely obstructive CAD was investigated. In this model, plaque extent, 




























Figure 4. Bars representing the c-index (area under the curve) on the y-axis illustrating the 
incremental predictive value of angiographic multislice computed tomography (MSCT) variables of 
atherosclerosis for the prediction of ischemia on myocardial perfusion imaging (MPI) on a patient 
basis. The addition of the degree of stenosis (presence of ≥70% stenosis) provided incremental 
predictive information to baseline clinical variables for the prediction of ischemia on MPI on a 
patient basis. Furthermore the addition of extent and composition of atherosclerosis (≥3 calcifi ed 
plaques) and location (atherosclerotic disease in the left main coronary artery and/or proximal left 
anterior descending coronary artery) on MSCT resulted in further incremental predictive value over 





























Figure 5. Bars representing the c-index (area under the curve) on the y-axis illustrating the 
incremental predictive value of angiographic multislice computed tomography (MSCT) variables of 
atherosclerosis for the prediction of ischemia on myocardial perfusion imaging (MPI) on a vessel 
basis. The addition of the degree of stenosis (presence of ≥70% stenosis) provided incremental 
predictive information to baseline clinical variables for prediction of ischemia on MPI on a vessel 
basis. Furthermore the addition of extent and composition of atherosclerosis (≥2 mixed plaques 
and ≥2 calcifi ed plaques) on MSCT resulted in further incremental predictive value over baseline 
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Figure 6. Hosmer-Lemeshow plot of estimated risk for ischemia on multislice computed 
tomography (MSCT) (x-axis) versus observed risk for ischemia on myocardial perfusion imaging 
(MPI) (y-axis) by decile of risk, on a patient (A) and vessel (B) basis.
A calibration plot is shown for the prediction of ischemia on MPI (myocardial perfusion imaging) 
by the multivariate model of atherosclerosis variables on MSCT. Patient basis analysis is shown in 
panel A, describing model VI in Table 4. Vessel basis analysis is demonstrated in panel B, describing 
model IV in Table 5. The diagonal line in both plots demonstrates a good fi t on both a patient and 
vessel basis. The Hosmer-Lemeshow goodness-of-fi t test statistic was p=0.93 on a patient basis and 


























(atherosclerotic disease in LM and/or proximal LAD) further signifi cantly enhanced pre-
diction of ischemia over clinical risk stratifi cation and the presence of severely obstructive 
CAD.
Previous investigations assessing the relation between MSCT and MPI demonstrated 
that normal coronary arteries on MSCT were highly associated with normal perfusion on 
MPI.12 Accordingly, patients with normal coronary arteries on MSCT may be reassured and 
in general do not require further testing. Nevertheless, in a substantial number of patients 
MSCT will reveal the presence of atherosclerotic disease. However, previous comparisons 
demonstrated that only half of patients with stenosis of 50% or greater showed abnormal 
perfusion, resulting in a low positive predictive value of merely 50%.4 5 Accordingly, with 
the expanding use of MSCT, clinicians will be increasingly confronted with patients having 
an obstructive lesion detected on MSCT but without information on the hemodynamic 
relevance. To determine further management, additional evaluation with functional imag-
ing techniques remains necessary in these patients. However, if the likelihood of ischemia 
on MPI can be estimated more accurately based on MSCT results, a more appropriate 
selection of further testing and management can be achieved. Possibly, knowledge of 
the extent, composition and location of atherosclerotic disease, as can be derived from 
MSCT, may enhance prediction of the presence of ischemia over the mere assessment of 
the degree of stenosis. 
Extent and composition of atherosclerosis 
In addition to the presence of a single stenotic lesion in the coronary arteries, previous 
studies have reported that diffuse atherosclerosis also contributes to ischemia.13 14 By 
measuring coronary fl ow reserve, de Bruyne et al. demonstrated that diffuse atheroscle-
rotic disease can cause a decline in coronary fl ow despite the absence of obstructive CAD.13 
These fi ndings suggest that the severity of perfusion abnormalities not only depends on 
the presence of obstructive disease but is also infl uenced by the atherosclerotic burden 
in the coronary artery. The current study is in line with these observations, suggesting 
that more extensive atherosclerotic plaque burden indicates a higher likelihood for 
ischemia. Moreover, the present results parallel previous studies comparing MPI with 
coronary calcium scoring.15 16 He et al. studied the relationship between the presence of 
stress-induced ischemia on MPI and coronary artery calcium (CAC) and demonstrated in 
approximately 4000 asymptomatic patients that CAC was predictive of ischemia on MPI.16 
However, only a minority of patients (22%) with an abnormal CAC had abnormal perfusion 
on MPI. Similarly, Berman et al. established that the frequency of abnormal perfusion was 
related to the magnitude of CAC abnormality.17 However, patients with normal MPI results 
frequently had extensive atherosclerosis on the basis of CAC criteria, indicating that a 
normal MPI did not exclude the presence of CAD. Conversely, the presence of CAC did not 
necessarily result in perfusion abnormalities on MPI. Therefore, although a relation exists 
between the extent of atherosclerosis and ischemia, the extent alone may not be a strong 








of the extent of CAD with other variables of atherosclerosis identifi ed on MSCT can refi ne 
identifi cation of patients with ischemic MPI. 
In the present study, extent of mixed and calcifi ed plaque independently predicted the 
presence of ischemia on MPI. Indeed, mixed and calcifi ed lesions are thought to typically 
represent the more advanced stages of atherosclerosis and thus linked with larger plaque 
volume and a higher extent of ischemia. Additionally, plaque composition on MSCT has 
previously been linked to abnormal perfusion on SPECT by Lin et al. in 163 patients.18 The 
authors demonstrated that the presence of mixed plaques was found to be the strongest 
independent predictor of abnormal perfusion (OR 1.6, p=0.01). The current and previous 
studies indicate that an association between extent and composition of atherosclerosis 
and a higher likelihood of ischemia may exist. Accordingly, plaque extent and composi-
tion should be taken into consideration when evaluating and reporting coronary MSCT 
angiograms. However, the exact underlying mechanisms remain largely unknown and 
should be further investigated. 
Location of atherosclerosis 
Location of atherosclerotic disease has been shown to infl uence myocardial perfusion. In 
general, the more proximal the location of stenosis, the more severe and extensive the 
corresponding perfusion abnormality will be. Conversely, the effect of distal lesions on 
myocardial perfusion will be limited as a smaller amount of myocardium is involved. In 
the current study, location of atherosclerotic disease in the LM and/or proximal LAD was 
demonstrated to be a predictor for the presence of ischemia on MPI. Similarly, previous 
studies have shown that patients with angiographically observed atherosclerotic disease 
in the LM and/or proximal LAD are at higher risk for events. Califf et al. developed the 
jeopardy score (an angiographic risk stratifi cation score) which, in addition to severity of 
disease, incorporated location of atherosclerotic disease to estimate the amount of myo-
cardium at risk.19 As more proximally located lesions were associated with a higher occur-
rence of events, the jeopardy score demonstrated to allow improved risk stratifi cation as 
compared to other angiographic scoring techniques. Interestingly, Lin et al. adapted this 
scoring technique for MSCT angiography; the MSCT segment-at-risk score.18 Using this 
method, individuals with reversible defects could be more accurately identifi ed. 
Clinical implications
Recently, MSCT cardiac imaging has been increasingly applied for the evaluation of 
patients presenting with suspected CAD. The reported high negative predictive values of 
almost 100% precipitate MSCT as a particularly effective technique for ruling out the pres-
ence of obstructive CAD. Accordingly, if patients show normal coronary arteries on MSCT 
angiography further testing is not required, whereas if atherosclerotic disease has been 
verifi ed on MSCT, unfortunately no information is provided on the hemodynamical rel-
evance. As a result, the decision which patient requires further functional testing or direct 
invasive evaluation with potential revascularization currently remains largely dependent 


























with pre-test likelihood and clinical judgment. Preferably, more information than merely 
presence of luminal narrowing is required from this technique. In our study several MSCT 
variables of atherosclerosis were identifi ed which were associated with a higher likelihood 
of ischemia. Moreover, integration of all MSCT variables of atherosclerosis signifi cantly 
improved prediction of the presence of ischemia on MPI. Possibly, these results may allow 
a more refi ned and individualized assessment of patients undergoing MSCT angiography 
and provide the basis for the development of an algorithm to improve identifi cation of 
patients requiring more aggressive therapy or intervention. 
However, it is important to realize that in the current study, MSCT and MPI data were 
acquired in two different institutions with slightly different image acquisition protocols, 
which may have infl uenced our fi ndings. 
Conclusion
The results of the current study demonstrate that in addition to the presence of obstruc-
tive CAD, anatomical MSCT variables describing plaque extent, composition and location 
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Coronary atherosclerosis remains one of the leading causes of morbidity and mortality 
in the modern western world. It has been established that the majority of acute coro-
nary events (>70%) are caused by plaque rupture followed by thrombus formation. The 
most common substrate for thrombus formation has been proposed to be the thin cap 
fi broatheroma; a plaque with a large necrotic core and thin fi brous cap (<65 μm thick) 
infi ltrated by macrophages and lymphocytes. Notably, a considerable number of patients 
who present with an acute coronary event due to rupture or erosion of an atherosclerotic 
plaque do not experience any prior symptoms. This observation emphasizes the need 
to improve the early detection of atherosclerosis. Traditionally, imaging of the coronary 
arteries has focused on the assessment of the coronary lumen and the presence of 
severe stenosis by means of invasive coronary angiography. However, invasive coronary 
angiography only allows the assessment of the lumen and is less suited to evaluate the 
presence of non-obstructive atherosclerosis, including the presence of (potentially high-
risk) plaques. As a result, there is an emerging need for imaging modalities that can 
identify atherosclerotic lesions with high-risk features indicating increased vulnerability. 
In this regard, non-invasive techniques may be valuable, as they may identify high-risk 
patients at a relatively early stage before an adverse events occurs and may provide the 
opportunity for novel treatment strategies. Accordingly, this thesis focuses on the perfor-
mance and clinical impact of imaging modalities for the evaluation of atherosclerosis and 
detection of vulnerable plaques in the coronary arteries. 
The general introduction in Chapter 1 of this thesis provides a description of the 
rationale to improve early detection of atherosclerosis and vulnerable plaque before the 
occurrence of an adverse cardiac event. An overview of the currently available invasive 
and non-invasive modalities for the imaging of coronary atherosclerosis and vulnerable 
plaque is provided, describing the individual strengths and accuracies of each imaging 
modality. Lastly, the outline of the current thesis is presented.
Part 1
Part 1 describes the current advances of computed tomography angiography (CTA) in the 
characterization of coronary atherosclerosis and vulnerable plaque. CTA is a rapidly evolv-
ing imaging tool that allows for the non-invasive visualization of coronary atherosclerosis. 
The temporal and spatial resolution have improved with each new scanner generation, 
resulting in superior image quality and diagnostic accuracy for the detection of coronary 
stenosis. CTA is not only able to identify stenosis, but also has the potential to provide 
information on lesion morphology and plaque composition. Further improvement in 
plaque characterization, however, is needed before accurate evaluation of plaque compo-
sition and subsequent identifi cation of patients at higher risk of events can be achieved.
In Chapter 2, the performance of the novel volumetric CTA system regarding plaque 
characterization was evaluated. This scanner is equipped with 320-detector rows and can 
















in the coronary arteries. In this chapter, plaque observations on 320-row CTA were com-
pared to plaque composition on virtual histology intravascular ultrasound (VH IVUS) in 65 
patients. On CTA, three plaque types were identifi ed: non-calcifi ed, mixed and calcifi ed. 
On VH IVUS, plaque composition (% fi brotic, fi bro-fatty, necrotic core, dense calcium) and 
presence of thin cap fi broatheroma (more high risk) were evaluated. Plaque observations 
on 320-row CTA show good agreement to relative plaque composition on VH IVUS. More-
over, mixed plaques on 320-row CTA parallel the more vulnerable plaque on VH IVUS.
In Chapter 3, the relation between plaque composition and degree of stenosis was 
evaluated by CTA and VH IVUS. In 78 patients CTA was performed (identifying 3 plaque 
types; non-calcifi ed, calcifi ed, mixed) followed by invasive coronary angiography and VH 
IVUS. VH IVUS evaluated plaque composition (% fi brotic, fi bro-fatty, necrotic core, dense 
calcium) and plaques were visually classifi ed. For each plaque, degree of stenosis was 
evaluated by quantitative coronary angiography. Interestingly, plaque types on CTA were 
equally distributed among signifi cant (≥ 50%) and non-signifi cant stenoses. In addition, 
VH IVUS observed no differences in % fi brotic, fi bro-fatty, dense calcium and necrotic 
core. Importantly, thin cap fi broatheroma (the more vulnerable plaque) was distributed 
equally between signifi cant and non-signifi cant stenosis (p=0.18). This study indicates 
that there is no evident relation between the degree of stenosis and plaque composition 
or vulnerability.
Chapter 4 assessed the difference in location between site of greatest vulnerability and 
site of most severe narrowing with invasive VH IVUS. In 92 patients, the site of greatest 
vulnerability on VH IVUS was defi ned as the cross-section with the largest necrotic core 
area per vessel, the maximum necrotic core site and the site of most severe narrowing was 
defi ned the minimum lumen area site. The distance from both the maximum necrotic core 
site and minimum lumen area site to the origin of the coronary artery was evaluated with 
a dedicated software tool in the longitudinal IVUS view. In addition, the presence of a thin 
cap fi broatheroma was assessed. Interestingly, there was a substantial difference between 
the minimum lumen area site and maximum necrotic core site (10.8 ±20.6 mm). Moreover, 
the maximum necrotic core site was located at the minimum lumen area site in only 7 
vessels (5%). In 92 vessels (66%) the maximum necrotic core site was located proximally to 
the minimum lumen area site and in 40 vessels (29%) distally to the minimum lumen area 
site. The present fi ndings demonstrate that the site of greatest vulnerability is rarely at 
the site of most severe narrowing. Moreover, the site of greatest vulnerability is frequently 
located proximal from the site of most severe narrowing.
In Chapter 5, the aim of the study was to systematically investigate the accuracy of 
CTA for detecting signifi cant stenosis (using conventional coronary angiography as the 
reference standard) versus detecting the presence of atherosclerosis (using IVUS as refer-
ence of standard). CTA correctly ruled out signifi cant stenosis in 53 of 53 (100%) patients. 
However, 9 patients (19%) were incorrectly diagnosed as having signifi cant lesions on CTA 
resulting in sensitivity, specifi city, positive and negative predictive values of 100%, 85%, 
81% and 100%. Interestingly, CTA correctly ruled out the presence of atherosclerosis in 
















(100%). No patients were incorrectly classifi ed, resulting in sensitivity, specifi city, positive 
and negative predictive values of 100%. These fi ndings confi rm that the diagnostic per-
formance of CTA is superior in the evaluation of presence or absence of clinically relevant 
atherosclerosis as compared to the evaluation of signifi cant stenosis.
More accurate lesion assessment may be feasible with CTA as compared to invasive 
coronary angiography. Accordingly, lesion length assessment was compared between 
invasive coronary angiography and CTA in patients referred for CTA who underwent sub-
sequent percutaneous coronary intervention in Chapter 6. In 89 patients, lesion length 
was measured from the proximal to the distal shoulder of the plaque on CTA. Quantitative 
coronary angiography was performed to analyze lesion length. Interestingly, lesion length 
on CTA was signifi cantly longer than on quantitative coronary angiography (difference 8.8 
±6.7mm, p<0.001). Moreover, lesion length visualized on CTA was also signifi cantly longer 
than mean stent length (CTA lesion length-stent length was 4.2 ±8.7 mm, p<0.001). The 
study concludes that CTA provides more accurate lesion length assessment than invasive 
coronary angiography and may facilitate improved guidance of percutaneous treatment 
of coronary lesions.
Several previous studies have identifi ed specifi c plaque characteristics which are fre-
quently observed with CTA in patients presenting with acute coronary syndrome. Among 
these characteristics, a spotty pattern of calcifi cations and positive remodeling have been 
related to the presence of acute coronary syndrome. Chapter 7 systematically compared 
calcifi cation patterns in plaques visualized on CTA with vulnerable plaque characteris-
tics on VH IVUS in 108 patients. Interestingly, plaques with small spotty calcifi cations 
on CTA were related to more vulnerable plaque characteristics on VH IVUS. Chapter 8 
further addressed this issue by assessing the association between positive remodeling on 
quantitative CTA and vulnerable plaque characteristics on VH IVUS. On CTA, the remodel-
ing index was determined for each lesion using a novel dedicated quantitative analysis 
strategy. Notably, the study confi rms that lesions with positive remodeling on CTA were 
associated with a higher percentage necrotic core and a higher prevalence of thin cap 
fi broatheroma. Accordingly, evaluation of spotty calcifi cations and remodeling on CTA 
may be valuable markers for plaque vulnerability.
Part 2
In part 2 of this thesis, the relation between characterization of atherosclerosis on CTA 
and the effect on clinical management was evaluated in more detail. Chapter 9 provides 
an overview regarding the evolving role of coronary CTA (including coronary calcium 
scoring) in the diagnosis of patients with acute chest pain which constitute a common 
and important diagnostic challenge. As a result of rapid developments in coronary CTA 
technology, high diagnostic accuracies for detecting coronary stenosis are obtained. 
Additionally, CTA is an excellent modality in patients whose symptoms suggest other 
non-coronary causes of acute chest pain such as aortic aneurysms, aortic dissection, or 
















with acute chest pain, more randomized clinical trials are needed to determine the value 
of this technique in this challenging patient population. 
Chapter 10 addresses effective strategies to reduce radiation dose with CTA. On the 
one hand, a conservative approach regarding radiation dose may result in a high level of 
image noise and therefore in non-diagnostic images. On the other hand, higher radia-
tion exposure may put patients at unnecessary risk of radiation damage. Thus, effective 
strategies to reduce radiation dose, such as prospective triggering, heart rate control, 
ECG-modulation of the tube current, and use of tube voltage below 100 kV, will need to 
be applied in the clinical setting.
Chapter 11 evaluated the diagnostic accuracy of the novel 320-row CTA in the evalu-
ation of signifi cant coronary artery stenosis in 64 patients, compared with invasive coro-
nary angiography as the standard of reference. High sensitivity, specifi city, and positive 
and negative predictive values to detect ≥ 50% luminal narrowing on a patient basis of 
100%, 88%, 92%, and 100%, respectively, were demonstrated. The study concludes that 
320-row CTA allows for accurate non-invasive assessment of signifi cant coronary artery 
disease (CAD). Chapter 12 further addressed the diagnostic accuracy of 320-row CTA, 
specifi cally in patients presenting with acute chest pain and examined the relation to 
outcome during follow-up. Among the 106 patients presenting with chest pain, 22% had 
a normal CTA, 18% had non-signifi cant CAD on CTA and 55% had signifi cant CAD on CTA 
(5% had uninterpretable CTA). Sensitivity, specifi city, and positive and negative predictive 
values to detect signifi cant CAD on CTA were 100%, 87%, 93%, and 100%, respectively. 
The study concludes that in patients presenting with acute chest pain, an excellent clinical 
performance for the non-invasive assessment of signifi cant CAD is demonstrated using 
320-row CTA. Importantly, normal or non-signifi cant CAD on CTA predicted a low rate of 
adverse cardiovascular events and favorable outcome during follow-up.
The aim of Chapter 13 was to evaluate the relationship between the calcium score 
and the degree and character of atherosclerosis in patients suspected of acute coronary 
syndrome versus patients with stable CAD. Overall, 112 patients were studied; 53 with 
acute coronary syndrome and 59 with stable CAD. CTA and VH IVUS were performed 
to evaluate plaque characteristics. Interestingly, if the calcium score was zero, patients 
with acute coronary syndrome had a higher mean number of plaques and non-calcifi ed 
plaques on CTA than patients with stable CAD. In zero calcium score, VH IVUS demon-
strated that patients with acute coronary syndrome had a larger amount of necrotic core 
area and higher mean number of thin cap fi broatheroma than stable CAD. Thus, even 
in the presence of a zero calcium score, patients with acute coronary syndrome have 
increased plaque burden as well as increased vulnerability as compared to stable CAD. 
The aim of Chapter 14 was to determine the relation between CTA fi ndings and the 
rate of subsequent invasive coronary angiography and revascularization. A total of 1042 
CTA investigations were available for analysis. In patients with signifi cant CAD on CTA, 
subsequent invasive coronary angiography rate was 64%. In patients with non-signifi cant 
CAD on CTA, subsequent invasive coronary angiography rate was 12% and in patients with 
















Of patients with signifi cant CAD on CTA, revascularization rate was 36%, as compared to a 
revascularization rate of 0.3% in patients with non-signifi cant CAD on CTA and no revas-
cularizations in patients with a normal CTA results (p<0.001). This chapter concludes that 
CTA results are strong and independent determinants of subsequent invasive coronary 
angiography and revascularization. 
Previous studies have shown that the presence of stenosis alone on CTA only has a 
limited value for predicting the presence of ischemia on myocardial perfusion imaging. In 
the last chapter (Chapter 15), different variables of atherosclerosis on CTA were related 
to ischemia on myocardial perfusion imaging to determine the different predictors of 
ischemia in 514 patients. On a patient basis, multivariate analysis showed that the degree 
of stenosis (presence of ≥70% stenosis, OR 3.5), plaque extent and composition (mixed 
plaques ≥3, OR 1.7 and calcifi ed plaques ≥3, OR 2.0) and location (atherosclerotic disease 
in left main coronary artery and/or proximal left anterior descending coronary artery, 
OR 1.6) were independent predictors for ischemia on myocardial perfusion imaging. In 
addition, CTA variables of atherosclerosis such as plaque extent, composition and loca-
tion had signifi cant incremental value for the prediction of ischemia over the presence of 
≥70% stenosis. Thus, in addition to the degree of stenosis, CTA variables of atherosclerosis 
describing plaque extent, composition and location are predictive of the presence of 
ischemia on myocardial perfusion imaging. 
Conclusions
During the past few years CTA has rapidly developed into a versatile non-invasive imaging 
modality. While imaging of the coronary arteries to determine or rule out the presence 
of stenosis will remain one of the main indications, additional information on plaque 
severity and composition can be obtained. The improvements in technology (faster 
gantry rotation times, an increasing number of detectors, volumetric image acquisition) 
and consequential improvement in image quality have resulted in advances in the charac-
terization of coronary atherosclerosis and vulnerable plaque. Interestingly, the diagnostic 
performance of CTA was superior in the evaluation of presence or absence of clinically 
relevant atherosclerosis as compared to the evaluation of signifi cant stenosis. Regard-
ing plaque observations with the novel 320-row CTA scanner, the results showed good 
agreement to relative plaque composition on invasive VH IVUS. Moreover, mixed plaques 
on 320-row CTA paralleled the more vulnerable plaque on VH IVUS. In addition, lesions 
with spotty calcifi cations and positive remodeling on CTA were associated with a higher 
percentage necrotic core and a higher prevalence of vulnerable plaques. Accordingly, 
evaluation of spotty calcifi cations and remodeling on CTA may be valuable markers for 
plaque vulnerability. 
The relation between characterization of atherosclerosis on CTA and its effect on clini-
cal management was also evaluated. As a result of rapid developments in coronary CTA 
technology, high diagnostic accuracies of 320-row CTA for detecting coronary stenosis 
were obtained in patients with stable chest pain complaints as well as in patients pre-
















prognostic value, patients with acute coronary syndrome and zero calcium had increased 
plaque burden as well as increased vulnerability as compared to patients with stable 
chest pain. Accordingly, absence of coronary calcifi cation did not exclude the presence 
of clinically relevant and potentially vulnerable atherosclerotic plaque burden in patients 
with acute coronary syndrome. Lastly, in addition to the degree of stenosis, CTA variables 
of atherosclerosis describing plaque extent, composition and location were predictive of 
the presence of ischemia on myocardial perfusion imaging. Possibly, these results may 
allow a more refi ned and individualized assessment of patients undergoing CTA imaging 
and provide the basis for the development of an algorithm to improve identifi cation of 
patients requiring more aggressive therapy or intervention.


















Ondanks verbeteringen in behandeltechnieken blijven plotse hartdood en een hartinfarct 
(door afsluiting van een kransslagader) tot de voornaamste redenen behoren van ziekte 
en sterfte in de geïndustrialiseerde wereld. Veel patiënten met een hartinfarct hebben 
nooit eerder klachten gehad zoals pijn op de borst of kortademigheid. Onderzoek heeft 
laten zien dat niet zo zeer de ernst van de atherosclerotische vernauwing in de krans-
slagader, maar juist de bestanddelen waaruit de aderverkalking (plaque) bestaat (ofwel 
het “type plaque”) een belangrijke rol speelt in het ontwikkelen van cardiale complicaties, 
zoals een hartinfarct of zelfs plotse dood. Juist de aanwezigheid van “kwetsbare” plaques 
geven meer risico op een hartinfarct. Een “kwetsbare” plaque bestaat uit een vetopho-
ping in de binnenbekleding van de vaatwand en onder een dunne kap bevindt zich een 
kern van vettige stoffen zoals cholesterol met dode cellen. Zonder dat een patiënt ooit 
eerder klachten heeft gehad kan deze plaque scheuren, wat de vorming van bloedstol-
sels bevordert, de kransslagader afsluit en een hartinfarct veroorzaakt. Met standaard 
invasieve coronairangiografi e (een onderzoeksmethode waarbij de bloedcirculatie van 
het hart door middel van röntgenopnamen en contrast in beeld wordt gebracht) kan wel 
de ernst van de vernauwing zichtbaar worden gemaakt, maar niet de aanwezigheid van 
de kwetsbare plaques. Hierdoor zijn op dit moment meerdere niet-invasieve en invasieve 
technieken in ontwikkeling om met hoge nauwkeurigheid de verschillende bestanddelen 
van atherosclerotische plaques te herkennen. Het bestuderen van het type plaque kan 
mogelijk een aanknopingspunt zijn voor verbeterde inschatting van een individueel 
verhoogd risico evenals verbeterde preventie. In dit proefschrift wordt de rol en klinische 
betekenis van beeldvormende technieken in 1) het eerder herkennen en 2) karakteriseren 
van atherosclerose en kwetsbare plaques in de kransslagaderen beschreven. 
De algemene inleiding in Hoofdstuk 1 van dit proefschrift geeft een beschrijving van 
de huidige invasieve en niet-invasieve technieken die beschikbaar zijn voor het beoor-
delen van plaques in de kransslagaders. Van elke techniek worden de voor- en nadelen 
beschreven, evenals de huidige nauwkeurigheid, die op basis van de huidige literatuur 
bekend is. Als laatste wordt de indeling van het huidige proefschrift beschreven.
Deel 1
In het eerste gedeelte van dit proefschrift wordt de onlangs geïntroduceerde niet-inva-
sieve techniek “Computed Tomography Angiography (CTA)” besproken. Op niet-invasieve 
wijze kan de aanwezigheid van atherosclerotische plaques in de kransslagaders met CTA 
beoordeeld worden. Met deze techniek is er een onderscheid tussen de verschillende 
plaque types mogelijk. Een groot voordeel van deze techniek is dat terwijl invasieve 
beeldvorming beperkt is tot symptomatische patiënten met een hoog risico op ernstige 
vernauwingen, CTA ook toegepast kan worden in patiënten met een lagere voorafkans op 
ernstige vernauwingen vanwege het lage risico op complicaties. Op deze manier kan de 
aanwezigheid van atherosclerose in een vroeger stadium gedetecteerd worden. Echter, op 
















de verschillende plaque types die gezien worden met CTA en is er geen systematische ver-
gelijking met de invasieve techniek “Virtual Histology Intravascular Ultrasound (VH IVUS)”. 
VH IVUS is een invasieve techniek die in tegenstelling tot angiografi e, een cross-sectionele 
beeldvorming van de kransslagaders en een uitgebreide beoordeling van de atheroscle-
rotische plaque vanuit binnen uit biedt. Deze techniek gebruikt spectrale analyse van de 
echografi sche gegevens (backscatter radiofrequentie signalen) om de samenstelling en 
de karakteristieken van de plaque te analyseren met een hoge nauwkeurigheid.
In Hoofdstuk 2 wordt de prestatie van de nieuwe 320-rij CTA scanner geëvalueerd. 
Deze nieuwe scanner heeft 320 detectoren op een rij en kan mogelijk het vermogen 
van CTA om plaques te karakteriseren verbeteren. In dit hoofdstuk wordt plaque com-
positie op 320-rij CTA vergeleken met invasieve VH IVUS. Op CTA beelden werden de 
volgende plaques geïdentifi ceerd: niet-gecalcifi ceerd, gemixed en gecalcifi ceerd. Met VH 
IVUS beoordeelden we de verschillende typen atherosclerose en beoordeelden we of er 
“kwetsbare” plaques aanwezig waren in de kransslagaders. De conclusie van dit hoofdstuk 
was dat plaque waarnemingen met 320-rij CTA goed overeenkomen met relatieve plaque 
compositie op VH IVUS. Vooral de plaques die gemixed waren op CTA hadden de gevaar-
lijke “kwetsbare” plaque kenmerken op VH IVUS. 
In Hoofdstuk 3 wordt de relatie tussen de ernst van de vernauwing en het type plaque 
beoordeeld door middel van niet-invasieve CTA en invasieve VH IVUS. De ernst van de 
vernauwing van de kransslagaders werd beoordeeld met behulp van een kwantitatieve 
software die speciaal hiervoor ontwikkeld is. Een ernstige vernauwing werd geduid als 
meer dan 50% vernauwing van de kransslagader. In totaal werden 227 plaques (bij 78 
patiënten) gevonden waarvan 43 plaques (19%) een ernstige vernauwing hadden. Er 
werden geen verschillen waargenomen in plaque karakteristieken (zoals “necrotic core” 
en “dense calcium”) op CTA and VH IVUS tussen plaques met een ernstige vernauwing en 
plaques zonder een ernstige vernauwing. Zelfs de meer gevaarlijke plaques werden even 
vaak gevonden in plaques met ernstige vernauwing als zonder ernstige vernauwing. Uit 
deze resultaten kunnen we concluderen dat er geen verschillen in plaque karakteristieken 
bestaan tussen plaques met ernstige en zonder ernstige vernauwing.
De verschillen in locatie tussen de kwetsbare plaques en plaques met de ernstigste 
vernauwing worden beoordeeld in Hoofdstuk 4. Het idee was dat de meeste plaques 
niet altijd vanzelfsprekend ter plaatse van de meest kwetsbare plaques gelokaliseerd 
zijn. Per kransslagader werd de meest kwetsbare plaque gedifi nieerd als de locatie met 
de meeste “necrotic core” en de ernstigste vernauwing werd gedefi nieerd als de locatie 
met het kleinste lumen oppervlakte. In totaal werden 92 patiënten en 139 kransslagaders 
beoordeeld. Er werd een aanzienlijk verschil gemeten tussen de locatie van de meest 
kwetsbare plaque en de locatie van de ernstigste vernauwing (10,8 ± 20,6 mm). Daarnaast 
werd waargenomen dat de kwetsbare plaques vaak proximaal (vooraan) gelokaliseerd 
zijn in de kransslagaders ten opzichte van de locatie van de ernstigste vernauwing. De 
resultaten van dit onderzoek wijzen uit dat de locatie van de kwetsbare plaques niet altijd 
















Het doel van Hoofdstuk 5 was om de diagnostische nauwkeurigheid (sensitiviteit en 
specifi citeit) van CTA om signifi cante vernauwingen in de kransslagaders te herkennen 
, te onderzoeken. Vervolgens werd dit vergeleken met de nauwkeurigheid van CTA om 
de aanwezigheid van atherosclerose in de kransslagaders aan te tonen. De sensitiviteit is 
een maat voor de “gevoeligheid” van de test, de specifi citeit bepaalt hoe “specifi ek” de 
test is. Voor het aantonen van signifi cante vernauwingen (vergeleken met de standaard 
coronairangiografi e) werd een sensitiviteit gevonden van 100% en een specifi citeit van 
85%. Voor het aantonen van atherosclerose (vergeleken met intravasculaire echo) werd 
een sensitiviteit van 100% en specifi citeit van 100% gevonden. Deze resultaten bevestigen 
dat CTA nauwkeuriger is in het beoordelen van klinisch relevante atherosclerose dan het 
beoordelen van signifi cante vernauwingen.
CTA kan de omvang van de plaque in de kransslagaderwand beter beoordelen dan 
de standaard coronairangiografi e. Hoofdstuk 6 beschrijft de vergelijking tussen het 
beoordelen van de lengte van de plaque op CTA met standaard coronair angiografi e. De 
lengte van de plaque werd gemeten bij 89 patiënten met CTA en met standaard invasieve 
coronairangiografi e (met behulp van speciaal ontwikkelde software, genaamd “quantita-
tive coronary angiography”). De lengte van de plaques was aanzienlijk langer op CTA dan 
op coronairangiografi e. Dit duidt erop dat CTA waarschijnlijk een meer accurate meting 
van de lengte van de plaque geeft en dit mogelijk een betere techniek is om de lengte van 
de stent te bepalen dan de standaard coronairangiografi e. Het is van belang de lengte van 
de stent goed in te schatten om zo de vernauwing op de beste manier te behandelen en 
zo complicaties te voorkomen.
Eerdere onderzoeken met CTA hebben bepaalde plaque karakteristieken aangetoond 
die vaker werden waargenomen in patiënten met acute pijn op de borst, ook wel bekend 
als een acuut coronair syndroom (ACS), dan bij patiënten met stabiel coronarialijden 
(stabiele pijn op de borst). Eén van deze plaque karakteristieken was het aanwezig zijn van 
kleine ronde (“spotty”) kalkspatjes en een ander karakteristiek was naar buiten uitzetten 
van de vaatwand ter hoogte van de plaque (“positive remodeling”). In Hoofstuk 7 worden 
de verschillende soorten kalk in plaques op CTA vergeleken met invasieve VH IVUS bij 
108 patiënten. Hier werd aangetoond dat inderdaad de kleine ronde “spotty” kalkspatjes 
op CTA meer gevaarlijke kenmerken hadden, zoals de aanwezigheid van een “thin cap 
fi broatheroma” en “necrotic core” op VH IVUS, dan de meer ernstig verkalkte plaques. In 
Hoofdstuk 8 wordt aangetoond met speciaal ontwikkelde kwantitatieve sofware dat de 
plaques met “positive remodeling” op CTA ook meer gevaarlijke kenmerken hadden op 
VH IVUS. Dus het aantonen van kleine ronde “spotty” kalkspatjes en “positive remodeling” 
in plaques op CTA kunnen mogelijk aanwijzingen zijn voor aanwezigheid van de meer 
gevaarlijke “kwetsbare” plaques. 
Deel 2
In het tweede deel van dit proefschrift wordt de klinische betekenis van het beoordelen 
van atherosclerose op CTA verder uitgediept. Hoofstuk 9 geeft een overzicht over de toe-
















de recente technische ontwikkeling, zoals het vermeerderen van het aantal detectorrijen, 
heeft CTA een hoge nauwkeurigheid wat betreft het herkennen van ernstige vernau-
wingen in de kransslagaders. Daarnaast is CTA ook een belangrijk middel om andere 
levensbedreigende oorzaken van pijn op de borst uit te sluiten zoals een longembolie, 
dissectie of aneurysma van de aorta. Ondanks dat CTA een steeds grotere rol heeft in 
het diagnostisch proces van patiënten met acute pijn op de borst, zijn er meer grotere 
gerandomiseerde studies nodig die de waarde van deze techniek in deze setting kunnen 
bepalen. Hoofdstuk 10 bespreekt effectieve strategieën om de stralingbelasting van het 
CTA onderzoek zo beperkt mogelijk te houden. Het is belangrijk de voordelen van dosis 
vermindering (schade door straling) af te wegen tegen de nadelen van stralingsverminde-
ring (ruizige beelden en slechtere scan kwaliteit). Effectieve manieren om de stralingsdosis 
te verminderen kunnen bereikt worden door het aanpassen van de scantechnieken zoals 
o.a. prospectief scannen, ECG modulatie toepassen, een lage hartslag, lage dosis kV en/
of mA.
Hoofdstuk 11 beschrijft de diagnostische nauwkeurigheid van de nieuwe 320-rij CTA 
scanner voor het herkennen van signifi cante vernauwingen in de kransslagaders bij 64 
patiënten vergeleken met standaard coronairangiografi e. De resultaten laten zien dat 
de sensitiviteit, specifi citeit, positief voorspellende waarde en negatief voorspellende 
waarde respectievelijk 100%, 88%, 92% en 100% waren. Deze studie bevestigt dat 320-rij 
CTA een zeer goede en nauwkeurige niet-invasieve techniek is voor het herkennen van 
signifi cante vernauwingen in de kransslagaderen. Hoofdstuk 12 gaat hier nog iets verder 
op in en beschrijft de nauwkeurigheid van de nieuwe 320-rij CTA scanner specifi ek in 106 
patiënten die zich presenteren met acute pijn op de borst. Daarnaast werden diezelfde 
patiënten gemiddeld 13 maanden gevolgd om te kijken of er cardiale gebeurtenissen 
(cardiale dood, het optreden van een hartinfarct of onstabiele angina pectoris) plaatsvon-
den na de CTA. Van de 106 patiënten met pijn op de borst, had 22% geen kransslagader 
afwijkingen, 18% had wel atherosclerose maar geen signifi cante vernauwing en 55% had 
een signifi cante vernauwing. De sensitiviteit, specifi citeit, positief voorspellende waarde 
en negatief voorspellende waarde voor het hebben van een signifi cante vernauwing 
waren hoog, namelijk respectievelijk 100%, 87%, 93% en 100%. In alle patiënten met 
een normale CTA vonden geen cardiale gebeurtenissen plaats gedurende de genoemde 
periode. Met andere woorden, 320-rij CTA lijkt een nauwkeurig en veilig alternatief voor 
het beoordelen van vernauwingen in de kransslagaders bij patiënten met acute pijn op 
de borst. 
Eerdere onderzoeken hebben laten zien dat de prognostische waarde van de kalkscore 
erg goed is en dat er zeer weinig cardiale gebeurtenissen plaatsvinden bij patiënten bij 
de afwezigheid van kalk (kalkscore van 0), vooral bij patiënten met een laag risico op 
ernstige vernauwingen of zonder klachten als pijn op de borst. Recentelijk werd echter 
aangetoond dat in patiënten met acute pijn op de borst, een kalkscore van 0 de aanwezig-
heid van signifi cante vernauwingen niet uitsluit. Hoofdstuk 13 beschrijft de relatie tussen 
de kalkscore en de compositie van atherosclerose in patiënten met acute pijn op de borst 
















patiënten bestudeerd waarvan 53 met ACS en 59 met stabiele klachten. Bij een kalkscore 
van 0 hadden patiënten met ACS meer plaques en met name meer niet-gecalcifi ceerde 
plaques op CTA vergeleken met patiënten met stabiele klachten. Op VH IVUS werd bij een 
kalkscore van 0, meer “necrotic core” en meer kwetsbare plaques gevonden. De conclusie 
van dit hoofdstuk is dat zelfs bij afwezigheid van kalk op de kalkscan, patiënten met ACS 
meer plaques en meer kwetsbare plaque kenmerken hebben dan patiënten met stabiele 
klachten. Oftewel, een kalkscore van 0 bij patiënten met ACS sluit aanzienlijke atheroscle-
rose en aanwezigheid van kwetsbare plaques niet uit. 
In Hoofdstuk 14 wordt de frequentie van verwijzing voor invasieve coronairangiogra-
fi e en revascularisatie (dotteren, stent plaatsing of omleidingen) na een CTA onderzoek 
van de kransslagaders in kaart gebracht. In totaal werden 1042 patiënten via CTA scans 
beoordeeld. Deze patiënten werden gedurende 1 jaar gevolgd. In patiënten met een sig-
nifi cante vernauwing op CTA onderging vervolgens 64% invasieve coronairangiografi e. In 
patiënten met niet-signifi cante vernauwing onderging 12% invasieve coronairangiografi e. 
En in patiënten met normale bevindingen onderging 3,6% invasieve coronairangiografi e. 
Vervolgens onderging 36% van de patiënten met een signifi cante vernauwing op de CTA 
een revascularisatie. In patiënten met een niet-signifi cante vernauwing onderging 0,3% 
een revascularisatie en bij patiënten met een normale CTA onderging 0% revascularisatie 
binnen een jaar. Uit de resultaten blijkt dat CTA een sterke en onafhankelijke voorspeller 
is voor latere verwijzing voor invasieve coronairangiografi e en revascularisatie. Bovendien 
kan CTA als poortwachter fungeren voordat verwijzing naar invasieve coronairangiografi e 
plaatsvindt. 
Eerdere onderzoeken hebben laten zien dat het hebben van een signifi cante vernau-
wing in de kransslagaders op CTA maar in 50% van de gevallen leidt tot zuurstoftekort in 
de hartspier (ischemie). In het laatste hoofdstuk, Hoofdstuk 15, wordt de voorspellende 
waarde van verschillende variabelen van atherosclerose op CTA voor het hebben van zuur-
stof tekort op “single photon emission computed tomography (SPECT)” bestudeerd. Deze 
studie laat inderdaad zien dat de uitgebreidheid, compositie en locatie van de plaques 
toegevoegde waarde hebben voor het voorspellen van zuurstoftekort in de hartspier op 
SPECT. 
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doorgebracht samen, het waren zeker de leukere uurtjes van mijn promotietijd. Bedankt 
voor de kopjes thee en alle hulp. Computer boys (Hilke, Tom, Wybo), ontzettend bedankt 
voor jullie ondersteuning. Enno, zonder jouw steun met software, computers en hard 
drives was dit boekje niet tot stand gekomen. Natuurlijk wil ik graag alle collega’s in de 
tuin (Hadrian, Carine, Jan, Roxana, Rutger, Roderick, Jan Willem, Louisa, Mihaly, Hans, Sum-
Che, Joep, Jeffrey, Sander, Helene, Georgette, Marieke, Victoria en Dominique) bedanken. 
Verder wil ik Eric Boersma niet vergeten, bedankt voor uw hulp met mijn statistische 
problemen.
Ellen en Jael, wat hebben we het altijd fi jn gehad samen, even koffi e drinken, lunchen 
en soms ook even klagen over alles waar we mee zaten. Jullie hebben mijn promotietijd 
kleur gegeven, hopelijk kunnen we deze afspraken nog lang voortzetten. Dennis, wat heb 
jij het soms moeilijk gehad tussen al die vrouwen, maar ik vind je echt een mooi mens, 
bedankt voor al je advies (en alle koffi e!). 
Daarnaast wil ik in het bijzonder het CT team bedanken (Gabija, Jaap, Mark, Fleur, Noor, 
Caroline, Cees, Michiel, Robert en Agnieska), we hebben veel tijd samen doorgebracht 
achter de scanner, met Prof. Jukema koffi e gedronken, scans uitgewerkt, fantastische 
congressen meegemaakt, elkaar gesteund met praatjes houden, bedankt voor alles (I 
will never forget Vegas!). Michiel, een speciaal bedankje voor jou, je was een topper als 
student en volgens mij nu ook een topper als onderzoeker, bedankt voor je inzet.
Joanne, zonder jou was dit boekje nooit zo mooi geworden. Ik weet niet hoe ik het 
moeten doen zonder jou. Als ik denk aan alle tijd en moeite had die jij in mijn promotie 
hebt gestoken, ben ik je zó ontzettend dankbaar. Bedankt voor je stimulatie en feedback, 
je tips en trucs, je positiviteit en geduld. Ik zal het nooit vergeten.
Fleur, mijn maatje, mijn beste collegaatje, mijn vriendin. Hoe had ik het zonder jou 
kunnen overleven? Wij samen in de imaging kamer, wat een stel! Ik heb jou de afgelopen 
3 jaar vaker gezien dan iedereen. Samen op congres, Mrs and Mrs van Velzen, we hebben 
echt veel van de wereld gezien. Ik zal deze tijd nooit vergeten, ook al zien we elkaar nu 










Mijn lieve vriendinnen, (Doreen, Nina, Mirjam, Barbara, Laurence, Mandy, Brigitte, 
Anese, Gwen, Meike, Carlijn en Julie) eindelijk zijn jullie van het gezucht en gesteun over 
mijn promotie af en is er meer tijd voor leuke dingen. Bedankt voor jullie eindeloze sup-
port. Brigitte, ik vind het geweldig hoe jij mijn proefschrift hebt doorgespit op zoek naar 
foutjes, bedankt dat je mijn paranimf wilt zijn. 
Nog een speciaal bedankje voor Merel. Ik vind het super dat je me hebt geholpen met 
het ontwerpen van de voorkant van dit boekje. Je bent zo creatief. Ik vind het resultaat 
echt prachtig. Bedankt!
Pap en mam, er zijn geen woorden voor mijn dankbaarheid. Jullie hebben mij altijd 
gestimuleerd om gelukkig te zijn, het beste uit mezelf te halen en alles gedaan om dit 
mogelijk te maken. Zonder jullie steun had deze dag nooit bestaan. Ik heb heel veel geluk 
gehad met ouders als jullie. Hannah en Michelle, mijn lieve zusjes, bedankt voor alle steun 
de afgelopen jaren en ik weet dat jullie er altijd voor me zijn. Ook opa en oma van Velzen, 
Nana, tante Jannie, Mathijs, Marianne, Frans, Derek en Isabelle, bedankt voor jullie liefde 
en steun.
Rolf, mijn lief, mijn dank aan jou is de allergrootste. Zonder jouw geduld, liefde, steun, 
positivisme, energie en stomme grapjes (of zoals jij het noemt: hele goede humor) had ik 
hier niet gestaan. Jij bent de belangrijkste (en aller-grappigste) persoon in mijn leven en 















De auteur van dit proefschrift is geboren op 20 januari 1982 te Fullford, Groot-Brittannië. 
Op jonge leeftijd verhuisde zij naar Nederland en behaalde in 1999 het eindexamen VWO 
aan het PENTA college CSG de Angelus Merula te Spijkenisse. Vervolgens startte zij de 
studie Geneeskunde in het Erasmus Medisch Centrum te Rotterdam. Tijdens de doctoraal 
fase van haar studie verrichtte zij van 2002 tot 2003 wetenschappelijk onderzoek aan 
de kinderchirurgische intensive care van het Erasmus MC-Sophia kinderziekenhuis onder 
leiding van Prof. Dr. D. Tibboel. Tevens reisde zij in 2006 af naar Melbourne, Australië, 
voor een co-schap op de afdeling Anaesthesie. In augustus 2006 behaalde zij cum laude 
haar artsenbul. Na haar afstuderen werkte zij eerst als arts op de spoedeisende hulp in 
het Vlietland ziekenhuis te Vlaardingen alwaar haar interesse voor de cardiologie werd 
gewekt. Vervolgens heeft zij van 2007 tot 2008 als arts-assistent cardiologie gewerkt in 
het Amphia ziekenhuis te Breda. In 2008 startte zij haar promotie traject op de afdeling 
cardiologie in het Leids Universitair Medisch Centrum onder leiding van Prof. Dr. E.E. van 
der Wall en Prof. Dr. J.J. Bax. De resultaten hiervan staan beschreven in dit proefschrift. 
Per 1 juni 2011 is zij begonnen aan de opleiding cardiologie verbonden aan het Leids 
Universitair Medisch Centrum. Momenteel volgt zij de vooropleiding Interne Geneeskunde 
in het Sint Franciscus Gasthuis te Rotterdam.
